data_2f77_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f77 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.269 0.557 . . . . 1.0 109.499 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.15 139.31 52.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 1.0 109.568 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 67.9 mt -90.86 104.08 16.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.855 . . . . 1.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.8 p -82.27 168.63 17.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 1.0 109.565 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -53.84 -41.39 67.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 1.0 109.489 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -66.39 -45.64 79.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 1.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -62.96 -35.99 81.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 1.0 109.428 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.43 -36.97 85.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 1.0 109.578 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -61.63 -41.74 97.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.404 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 t -59.63 -43.32 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.297 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -56.33 -46.92 79.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.228 -0.92 . . . . 1.0 109.347 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.98 -38.0 89.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 1.0 108.884 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.88 -41.51 99.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 1.0 108.772 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.77 -37.73 79.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 1.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -59.15 -44.98 92.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 1.0 109.099 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.51 -37.35 86.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 1.0 109.344 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.78 -39.1 93.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 1.0 109.338 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.26 -42.53 86.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 1.0 109.325 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.9 p -63.68 -31.73 72.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 1.0 109.342 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.58 -18.6 61.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 1.0 109.24 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.87 47.85 0.65 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.62 132.92 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 1.0 109.466 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.8 93.96 3.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.144 -0.973 . . . . 1.0 109.226 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.36 160.65 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 1.0 109.363 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -72.73 151.45 42.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 1.0 109.453 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.67 -40.17 92.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.872 . . . . 1.0 109.257 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.58 57.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.0 109.487 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -61.44 -37.5 83.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 1.0 109.409 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -62.23 -45.28 94.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 1.0 109.369 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.91 -41.41 97.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 1.0 109.405 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 1.0 109.415 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -56.63 -49.14 75.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 1.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -59.95 -42.23 93.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 1.0 109.419 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.22 -44.13 95.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.0 109.292 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -61.2 -45.48 94.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 1.0 109.548 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.93 -44.69 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 1.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 69.9 tttt -64.2 -31.51 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 1.0 109.436 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' X' ' 44' ' ' TRP . 99.0 m-20 -70.7 -19.32 62.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 1.0 109.587 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 30.9 m -53.89 -52.25 61.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 1.0 109.378 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.698 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -116.13 -60.73 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 1.0 109.504 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 74.0 Cg_exo -41.5 -54.58 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.868 2.379 . . . . 1.0 112.203 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.52 ' O ' ' O ' ' X' ' 40' ' ' ASP . 8.4 m0 -127.65 113.01 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 1.0 109.58 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -61.49 -44.52 92.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 1.0 109.81 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.4 Cg_exo -59.6 141.71 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.699 2.266 . . . . 1.0 112.378 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -97.99 159.21 15.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 1.0 109.665 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.43 133.7 12.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.846 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.94 155.23 22.74 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.794 -1.323 . . . . 1.0 109.794 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -91.91 135.08 34.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 1.0 109.303 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.447 HD12 HG21 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -102.21 134.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 1.0 109.518 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -75.55 137.94 41.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 1.0 109.756 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.95 -34.19 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 1.0 109.392 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.85 -38.05 89.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 1.0 109.452 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.18 -20.36 52.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 1.0 109.245 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.597 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 13.5 t90 -56.18 -33.95 65.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 1.0 109.719 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -59.89 -41.98 92.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 1.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.431 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 72.8 mtp180 -66.38 -39.68 89.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 1.0 109.515 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.76 -43.11 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.342 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.33 -46.61 93.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -70.02 -42.2 73.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 1.0 109.494 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.1 m -63.86 -48.41 76.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 1.0 109.544 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.84 -39.35 91.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 1.0 109.493 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -61.93 -39.67 92.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 1.0 109.456 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' X' ' 69' ' ' THR . 52.6 m-20 -63.07 -44.1 96.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 1.0 109.236 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -65.47 -35.15 80.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 1.0 109.475 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' X' ' 71' ' ' GLY . 5.1 t80 -59.05 -54.39 47.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.87 . . . . 1.0 109.45 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 95.0 m-20 -65.74 -36.57 83.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 1.0 109.311 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 17.0 m -62.93 -47.99 80.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 1.0 109.299 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.76 -52.36 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 1.0 109.209 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.26 -165.93 25.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.459 -1.457 . . . . 1.0 109.459 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -67.19 -16.56 48.99 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.953 2.435 . . . . 1.0 111.952 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.55 -54.6 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 1.0 109.198 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -63.74 -43.6 95.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 1.0 109.404 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 27.3 m -148.63 92.42 4.47 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 1.0 109.431 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.55 -166.55 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.873 2.382 . . . . 1.0 112.166 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.66 -12.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 1.0 109.416 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -66.17 -33.2 75.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 1.0 109.421 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.15 -47.18 81.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.446 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -64.92 -45.67 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 1.0 109.4 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -59.77 -47.12 86.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 1.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -63.15 -40.89 98.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 1.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.597 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.5 t-105 -61.69 -37.98 86.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.05 -42.57 76.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.882 . . . . 1.0 109.223 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.31 -41.59 98.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 1.0 109.586 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -63.75 -43.53 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -0.941 . . . . 1.0 109.412 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.54 -37.63 58.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.0 109.501 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.21 -42.3 72.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.0 109.309 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.32 -48.02 83.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 1.0 109.396 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -72.69 -36.74 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.914 . . . . 1.0 109.434 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -63.11 -39.74 95.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 1.0 109.536 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -63.62 -40.96 98.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 1.0 109.57 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -88.75 117.48 27.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 1.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.75 138.17 56.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 1.0 109.564 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 1.0 109.572 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.256 0.55 . . . . 1.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.3 130.81 46.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 1.0 109.423 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 64.4 mt -91.93 104.66 17.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 1.0 109.717 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -82.46 168.37 17.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.434 -0.791 . . . . 1.0 109.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.96 -41.46 67.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 1.0 109.413 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.76 -45.13 79.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 1.0 109.606 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.85 -31.67 73.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.2 -0.938 . . . . 1.0 109.344 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -70.74 -40.65 72.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 1.0 109.925 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -60.66 -49.75 76.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 1.0 109.644 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -65.19 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 1.0 109.361 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.61 -40.96 93.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 1.0 109.019 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.22 -36.41 84.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 1.0 108.875 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.7 -41.42 99.12 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 109.126 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.6 -40.71 88.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 1.0 109.329 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -59.38 -44.57 92.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 1.0 109.046 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.08 -38.61 91.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.301 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.1 -40.98 87.02 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.021 -1.05 . . . . 1.0 109.207 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.41 -30.61 71.34 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.991 -1.068 . . . . 1.0 109.162 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 31.4 p -77.06 -31.46 56.12 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.346 -0.846 . . . . 1.0 109.535 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.429 ' HE ' ' CG2' ' X' ' 24' ' ' VAL . 15.9 ptt85 -75.57 -19.3 59.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.112 -0.993 . . . . 1.0 109.29 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.73 48.47 0.3 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . 0.429 ' CG2' ' HE ' ' X' ' 22' ' ' ARG . 69.7 t -123.11 139.47 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 1.0 109.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -125.39 98.2 5.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.743 . . . . 1.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -132.04 138.63 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 1.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.94 150.15 39.17 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.361 -0.837 . . . . 1.0 109.631 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.15 -35.36 80.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 1.0 109.128 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 1.0 109.305 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -62.88 -37.47 87.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.185 -0.947 . . . . 1.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.11 -44.77 94.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 1.0 109.631 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.67 -43.11 94.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 1.0 109.429 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 1.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.86 -48.45 78.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 1.0 109.571 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.82 -41.05 97.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 109.209 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.41 -44.93 95.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 1.0 109.271 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.48 -48.07 79.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.58 -45.03 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.908 . . . . 1.0 109.327 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 51.4 tttm -64.38 -34.22 77.66 Favored 'General case' 0 C--O 1.2 -1.516 0 CA-C-O 122.103 0.954 . . . . 1.0 108.938 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 2.9 m-20 -69.42 -20.73 63.79 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 120.242 -1.536 . . . . 1.0 109.646 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -54.28 -61.04 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.0 110.926 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.455 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -102.68 -59.09 0.09 OUTLIER Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.334 -0.854 . . . . 1.0 110.728 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.8 Cg_exo -41.7 -48.6 5.72 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.599 2.199 . . . . 1.0 112.697 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -125.53 -118.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.0 109.03 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.631 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.9 OUTLIER -177.58 -41.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.0 110.227 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.8 Cg_exo -60.84 141.41 94.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.728 2.286 . . . . 1.0 112.231 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.11 164.29 15.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 1.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.0 161.12 30.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 1.0 109.753 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.03 -2.86 58.1 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.086 -1.206 . . . . 1.0 110.086 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -119.63 116.12 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.978 . . . . 1.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' X' ' 51' ' ' ILE . 0.3 OUTLIER -135.84 132.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.156 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -72.46 131.34 42.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.83 -1.169 . . . . 1.0 109.884 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.26 -42.44 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 1.0 109.581 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -57.37 -42.07 81.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.159 . . . . 1.0 109.43 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . 0.519 ' CE2' ' CG2' ' X' ' 59' ' ' VAL . 86.2 t80 -77.08 -23.76 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 1.0 109.757 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.643 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -59.56 -38.8 82.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.975 . . . . 1.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -57.09 -44.42 83.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.218 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.5 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 77.8 mtp85 -66.69 -39.02 87.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 1.0 109.487 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . 0.519 ' CG2' ' CE2' ' X' ' 55' ' ' PHE . 59.2 t -62.4 -44.1 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 1.0 109.46 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.01 73.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -65.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -1.133 . . . . 1.0 109.498 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 74.0 m -66.33 -55.16 17.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 1.0 109.715 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.52 -37.83 85.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 1.0 109.548 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -38.35 90.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 1.0 109.303 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 1.0 109.438 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -64.8 -35.44 81.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.895 . . . . 1.0 109.579 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' X' ' 71' ' ' GLY . 0.9 OUTLIER -62.15 -54.06 46.54 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.261 -0.9 . . . . 1.0 109.834 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 35.0 t-20 -64.42 -35.52 81.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.909 -1.12 . . . . 1.0 109.674 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -67.24 -46.14 74.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.288 -0.883 . . . . 1.0 109.69 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -115.15 -52.05 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.691 -0.631 . . . . 1.0 109.901 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.76 -169.19 24.23 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' X' ' 76' ' ' PRO . 13.1 Cg_exo -63.33 -22.87 72.04 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.946 2.431 . . . . 1.0 111.99 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.79 -53.06 57.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 1.0 109.346 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -65.37 -43.91 89.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.299 -0.875 . . . . 1.0 109.751 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 m -138.79 84.52 17.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.612 -0.68 . . . . 1.0 109.285 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.592 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.5 Cg_exo -60.12 152.8 62.97 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.841 2.36 . . . . 1.0 112.153 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -52.03 -4.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.968 . . . . 1.0 109.707 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.592 ' H ' ' C ' ' X' ' 76' ' ' PRO . 51.5 p -65.49 -38.62 90.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.132 -0.98 . . . . 1.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.15 77.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 1.0 109.434 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -62.6 -45.83 91.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 1.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 65.9 m -61.05 -46.76 89.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.72 -37.48 87.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 1.0 109.431 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.643 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.2 t-105 -66.75 -35.17 79.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 1.0 109.214 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -58.07 -45.36 87.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 1.0 108.865 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.72 -42.02 99.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 1.0 109.413 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.6 -45.06 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 1.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -54.19 -44.27 71.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 1.0 109.508 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.98 -35.26 76.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.067 -1.02 . . . . 1.0 109.466 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.22 -49.09 71.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.089 -1.007 . . . . 1.0 110.014 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' X' ' 93' ' ' LYS . 6.0 pt -71.77 -43.07 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 1.0 109.517 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -62.01 -48.34 80.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.68 -44.7 92.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 1.0 109.712 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.5 tttt -81.34 143.25 32.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 1.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.08 138.4 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 1.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.775 . . . . 1.0 109.369 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' X' ' 4' ' ' GLU . 56.7 mp0 -58.61 144.22 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.231 -0.918 . . . . 1.0 109.436 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 60.4 mt -97.32 101.92 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 82.4 p -80.02 170.97 15.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 1.0 109.497 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.09 -42.02 79.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 1.0 109.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.31 -45.33 80.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 1.0 109.554 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 96.7 mt-10 -62.82 -36.68 83.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 1.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.32 -40.39 97.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 1.0 109.636 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.11 -37.82 81.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 1.0 109.069 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.32 -44.74 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 1.0 109.043 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -56.09 -47.79 77.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0 109.314 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 1.0 109.002 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.283 -0.885 . . . . 1.0 109.181 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.529 ' HZ1' ' C ' ' X' ' 27' ' ' LYS . 86.0 tttt -60.35 -42.01 94.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 1.0 109.063 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -55.05 -44.69 74.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 1.0 109.111 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.08 86.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 1.0 109.168 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.94 -39.26 94.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 1.0 109.086 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.82 -41.02 90.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.382 -0.824 . . . . 1.0 109.278 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 13.8 m -59.38 -39.06 82.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 1.0 109.225 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.81 -17.81 64.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 1.0 109.26 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.67 46.57 0.96 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.358 -1.497 . . . . 1.0 109.358 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.96 134.73 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.643 -0.916 . . . . 1.0 109.374 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.46 106.75 10.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.637 -0.664 . . . . 1.0 109.231 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.518 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 53.7 t -135.9 159.14 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.657 -0.652 . . . . 1.0 109.531 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . 0.529 ' C ' ' HZ1' ' X' ' 16' ' ' LYS . 99.7 mttt -81.27 143.64 32.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.381 -0.825 . . . . 1.0 109.717 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.47 ' N ' ' NZ ' ' X' ' 16' ' ' LYS . 88.3 t80 -59.59 -39.2 83.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 1.0 109.354 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.17 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 1.0 109.543 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -64.42 -38.57 91.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 1.0 109.167 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.79 -46.06 89.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 1.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.4 -42.39 98.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 1.0 109.572 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 -36.02 82.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 1.0 109.357 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -60.48 -49.56 77.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 1.0 109.806 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.37 -44.61 90.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 1.0 109.787 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.92 -44.2 96.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 1.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . 0.468 ' O ' ' OG1' ' X' ' 41' ' ' THR . 84.2 t80 -64.11 -45.46 88.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 1.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.36 -43.41 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.275 -0.891 . . . . 1.0 109.95 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.55 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -76.24 -29.19 57.41 Favored 'General case' 0 C--O 1.187 -2.19 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' X' ' 44' ' ' TRP . 79.1 m-20 -78.17 -21.79 49.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.052 0.929 . . . . 1.0 109.83 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 41' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 37' ' ' PHE . 11.3 m -62.72 -51.27 67.83 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.363 -1.461 . . . . 1.0 111.669 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -65.11 -64.28 2.79 Favored Pre-proline 0 C--N 1.296 -1.74 0 O-C-N 121.448 -0.782 . . . . 1.0 110.998 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.55 ' CG ' ' O ' ' X' ' 39' ' ' LYS . 27.7 Cg_endo -61.23 -54.19 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.723 2.282 . . . . 1.0 112.792 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.65 ' CD2' ' O ' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -173.67 139.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.092 -1.005 . . . . 1.0 109.287 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.518 ' N ' ' HD3' ' X' ' 46' ' ' PRO . 11.8 p90 -154.42 54.93 1.15 Allowed Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 120.671 -1.268 . . . . 1.0 110.002 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 38.9 Cg_endo -78.97 -23.0 8.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.673 2.248 . . . . 1.0 112.53 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -75.97 156.16 34.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.905 . . . . 1.0 109.629 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -132.39 151.83 51.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.573 -0.704 . . . . 1.0 109.49 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' X' ' 86' ' ' ILE . . . -150.74 -176.67 23.9 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.2 m -77.37 144.05 38.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -1.18 . . . . 1.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.423 HG22 HD12 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -135.29 134.45 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.494 -0.753 . . . . 1.0 109.227 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' X' ' 53' ' ' ILE . 66.2 t0 -65.33 135.62 55.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.932 -1.105 . . . . 1.0 109.801 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 97.2 mt -69.54 -42.29 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.917 -1.115 . . . . 1.0 109.436 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.65 -39.84 77.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 1.0 109.171 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -70.5 -36.63 73.91 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.298 -0.876 . . . . 1.0 109.506 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.645 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 17.3 t90 -52.78 -37.79 60.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.163 -0.961 . . . . 1.0 109.458 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -57.32 -44.8 84.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 1.0 109.234 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 80.1 mtp85 -67.96 -43.15 79.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 1.0 109.514 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.5 -43.73 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 1.0 109.467 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.32 -48.81 77.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.49 -38.12 86.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -1.18 . . . . 1.0 109.645 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.4 m -66.73 -48.7 68.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 1.0 109.693 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.92 -46.19 88.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.333 -0.854 . . . . 1.0 109.545 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -57.13 -40.63 77.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 1.0 109.354 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -63.13 -45.97 89.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.0 109.353 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -64.84 -30.95 71.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 1.0 109.449 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.506 ' O ' ' N ' ' X' ' 71' ' ' GLY . 2.1 t80 -63.26 -54.78 31.92 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.357 -0.839 . . . . 1.0 109.847 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.418 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 76.4 m-20 -65.82 -38.97 90.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.876 -1.14 . . . . 1.0 109.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -62.5 -49.56 74.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.295 -0.878 . . . . 1.0 109.958 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.69 -51.76 2.85 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.996 -0.682 . . . . 1.0 109.97 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.41 -169.46 24.79 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.1 -20.06 50.57 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.985 2.456 . . . . 1.0 112.014 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -57.24 -51.91 67.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.97 . . . . 1.0 109.366 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.94 -46.21 82.52 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 1.0 110.004 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 29.8 m -146.01 86.84 6.94 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.537 -0.727 . . . . 1.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.42 -166.51 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.865 2.376 . . . . 1.0 112.41 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.71 -15.97 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.0 109.662 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 36.9 p -61.73 -34.14 75.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 1.0 109.277 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.55 -45.45 75.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.62 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -63.91 -46.15 86.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -61.53 -46.47 89.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 1.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.05 -42.13 98.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 1.0 109.538 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.645 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.8 t-105 -64.53 -36.73 85.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 1.0 109.163 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -55.85 -44.98 78.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 1.0 108.933 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.99 -42.94 99.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0 109.498 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' X' ' 49' ' ' GLY . 1.5 mm -61.46 -41.83 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 1.0 109.49 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.66 -36.87 67.54 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.372 -0.83 . . . . 1.0 109.181 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.86 -41.29 71.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 1.0 109.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.89 -46.98 87.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 1.0 110.403 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 6.4 pt -71.54 -41.91 72.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -0.821 . . . . 1.0 109.704 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.78 -46.71 89.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.888 . . . . 1.0 109.326 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -45.81 90.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 1.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.17 133.0 39.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 1.0 109.453 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.78 126.46 31.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 1.0 109.437 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.521 -0.737 . . . . 1.0 109.329 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.451 -0.574 . . . . 1.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . 0.467 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.7 mt-10 -56.46 141.77 41.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 1.0 109.555 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 86.3 mt -96.89 105.37 17.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 1.0 109.506 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -83.44 172.46 12.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 1.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -56.56 -46.58 80.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 1.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . 0.58 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 3.2 m-70 -66.59 -44.01 83.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 1.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 81.5 mt-10 -60.17 -38.75 84.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 1.0 109.425 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -63.64 -38.48 91.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 1.0 109.555 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.14 -40.22 89.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 1.0 109.468 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.68 -44.37 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 1.0 109.307 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.15 -41.67 75.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 1.0 109.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -66.22 -36.27 82.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 1.0 108.896 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.47 -41.11 98.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.228 -0.92 . . . . 1.0 108.815 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -40.9 98.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.0 109.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.49 -45.27 85.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 1.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.77 85.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 1.0 109.377 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.77 -38.66 91.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 1.0 109.364 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.42 -35.54 76.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 1.0 109.316 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -66.16 -39.53 89.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 1.0 109.351 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -68.55 -19.12 64.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.845 . . . . 1.0 109.255 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.22 50.01 0.48 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.97 129.84 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -1.151 . . . . 1.0 109.436 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -126.74 101.73 6.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 1.0 109.145 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.78 162.46 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 1.0 109.36 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.34 145.07 39.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.886 . . . . 1.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -59.94 -39.28 85.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.237 -0.914 . . . . 1.0 109.34 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.55 68.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 1.0 109.414 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.0 -39.62 86.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 1.0 109.392 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -63.01 -43.76 97.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 1.0 109.393 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.47 -41.52 98.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 1.0 109.435 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.31 -38.53 91.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 1.0 109.42 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.97 -49.06 78.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 1.0 109.412 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -64.01 -45.81 87.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.0 109.365 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -58.52 -43.06 89.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 1.0 109.317 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -66.4 -43.49 85.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 1.0 109.523 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.42 -45.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 1.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' CH2' ' X' ' 44' ' ' TRP . 44.5 tttm -66.62 -32.85 74.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.43 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.9 m-20 -68.85 -19.53 64.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 1.0 109.688 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 41' ' ' THR . . . . . 0.407 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 6.4 m -54.01 -61.37 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.0 109.418 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.63 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.71 -60.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 -177.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 71.4 Cg_exo -41.67 -51.81 4.16 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.891 2.394 . . . . 1.0 112.232 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.585 ' CH2' ' NZ ' ' X' ' 39' ' ' LYS . 6.5 m0 -132.95 -149.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 1.0 109.551 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.621 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.45 -44.91 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 1.0 109.877 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 36.1 Cg_exo -56.47 -31.74 86.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.725 2.283 . . . . 1.0 112.367 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.09 125.01 24.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 1.0 109.65 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -132.18 159.51 38.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.43 156.42 27.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -64.09 142.8 58.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.178 . . . . 1.0 109.382 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' X' ' 51' ' ' ILE . 0.3 OUTLIER -126.73 133.28 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 1.0 109.548 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.414 ' N ' ' CD1' ' X' ' 51' ' ' ILE . 83.8 m-20 -72.12 135.61 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 1.0 109.756 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 1.0 109.423 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.28 -41.15 97.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 1.0 109.373 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -81.51 -17.48 48.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.0 109.299 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.544 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -58.44 -37.45 75.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.997 . . . . 1.0 109.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.16 -43.47 92.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 1.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -67.09 -37.03 83.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 1.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.65 -43.22 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 1.0 109.33 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.56 -47.46 90.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.504 -1.439 . . . . 1.0 109.504 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.01 -40.34 82.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 1.0 109.44 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.0 m -65.78 -50.28 65.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 1.0 109.439 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.79 -43.2 94.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 1.0 109.519 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -61.99 -33.41 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.0 109.517 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -65.12 -43.01 93.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 1.0 109.335 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.87 -34.96 74.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 1.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' X' ' 71' ' ' GLY . 19.9 t80 -60.26 -54.85 40.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.61 -36.53 82.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.0 109.351 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -64.59 -47.14 79.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 1.0 109.313 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.68 -52.68 2.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 1.0 109.264 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.81 -164.53 26.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -73.45 -14.27 25.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.928 2.418 . . . . 1.0 111.983 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -61.49 -49.76 75.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.0 109.284 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.55 -46.3 73.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 1.0 109.324 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.453 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 35.5 m -147.24 89.28 5.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 1.0 109.484 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.23 -170.23 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.83 2.353 . . . . 1.0 112.186 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.82 -18.23 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 1.0 109.406 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.6 p -58.55 -30.86 67.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.413 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 1.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.85 -39.66 93.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 1.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 64.7 m -61.79 -46.02 91.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 1.0 109.403 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' CZ ' ' X' ' 45' ' ' PHE . 36.7 m-85 -66.64 -42.38 86.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.877 . . . . 1.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.544 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t-105 -63.86 -34.63 78.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.0 109.289 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.3 -41.05 83.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 1.0 109.202 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.61 -42.44 98.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 1.0 109.577 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.3 -41.38 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 1.0 109.394 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.515 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 47.5 mttt -53.62 -41.36 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 1.0 109.424 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.56 -37.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 1.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.72 -48.69 76.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 1.0 109.378 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -73.31 -41.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 1.0 109.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.09 -42.29 98.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 1.0 109.454 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -64.76 -42.5 95.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 1.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.18 130.28 35.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 1.0 109.459 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.71 114.88 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 1.0 109.524 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 1.0 109.62 179.496 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.73 132.34 36.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.97 102.78 15.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.87 . . . . 1.0 109.506 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -82.95 175.66 9.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.0 109.616 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -54.11 -45.55 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 1.0 109.483 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.98 -43.59 87.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.565 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -60.07 -39.46 86.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 1.0 109.387 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.8 -38.18 89.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 1.0 109.606 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -61.79 -35.85 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.911 . . . . 1.0 109.437 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.01 -43.71 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 1.0 109.318 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.55 -44.69 93.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 1.0 109.312 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.6 -37.95 83.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.179 -0.95 . . . . 1.0 108.91 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.74 -40.3 94.6 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.279 -0.888 . . . . 1.0 108.747 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.577 ' HZ3' ' N ' ' X' ' 28' ' ' TYR . 88.6 tttt -62.58 -41.1 98.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 1.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.62 -44.65 85.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.922 . . . . 1.0 109.139 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.4 -41.06 98.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.445 -0.785 . . . . 1.0 109.412 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.81 -38.03 89.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 1.0 109.251 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -58.62 -43.08 89.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.0 109.228 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.4 p -63.16 -31.26 72.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 1.0 109.384 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.83 -15.79 61.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 1.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.31 47.16 0.82 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.3 134.28 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -1.123 . . . . 1.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.7 92.98 3.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.937 . . . . 1.0 109.209 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.84 160.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 1.0 109.298 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.0 143.43 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 1.0 109.486 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.577 ' N ' ' HZ3' ' X' ' 16' ' ' LYS . 89.6 t80 -61.68 -38.48 87.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 1.0 109.296 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.81 65.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 1.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.0 m-20 -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 1.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.62 -44.58 96.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 1.0 109.391 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.37 -43.74 96.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 1.0 109.329 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.07 -37.45 85.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 1.0 109.378 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.66 -48.13 75.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 1.0 109.376 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -60.95 -41.59 96.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 1.0 109.391 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -65.14 -40.34 94.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 1.0 109.214 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.83 -42.71 99.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 1.0 109.51 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.37 -46.13 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 1.0 109.575 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 1.0 109.404 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' X' ' 44' ' ' TRP . 85.5 m-20 -70.64 -19.3 62.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 1.0 109.694 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 41' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 22.2 m -54.9 -52.92 61.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.0 109.445 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.617 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -112.89 -63.65 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 1.0 109.466 -177.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.617 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.09 -40.61 4.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.904 2.403 . . . . 1.0 112.15 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.4 m-90 -146.08 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 1.0 109.537 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 172.29 -45.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 1.0 109.889 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.5 Cg_exo -56.1 -35.37 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.693 2.262 . . . . 1.0 112.368 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -64.4 127.98 33.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 1.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -142.15 168.85 18.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 109.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.88 165.63 37.69 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 15.6 m -64.31 141.3 58.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -1.217 . . . . 1.0 109.371 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.443 HG22 HD12 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -130.0 135.12 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 30' ' ' ASP . 38.8 m-20 -68.85 138.25 54.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 1.0 109.779 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.91 -25.02 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 1.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.97 -40.49 95.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 1.0 109.358 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -76.21 -18.74 58.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 1.0 109.258 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.3 t90 -54.64 -39.09 67.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -62.66 -41.31 99.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.0 109.496 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.416 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 79.0 mtp85 -66.61 -38.46 87.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 1.0 109.477 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.31 -43.98 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 1.0 109.441 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.7 84.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 1.0 109.511 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -66.18 -37.27 85.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -1.197 . . . . 1.0 109.512 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 82.5 m -69.95 -50.43 42.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 1.0 109.522 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.11 -43.09 99.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 1.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.6 -40.14 86.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 1.0 109.439 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.68 -45.91 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 1.0 109.373 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -64.53 -35.06 79.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.485 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' X' ' 71' ' ' GLY . 1.9 t80 -59.29 -54.71 43.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 1.0 109.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.442 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 38.7 t30 -64.41 -36.71 85.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 1.0 109.281 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -67.72 -45.19 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 1.0 109.277 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.27 -52.23 2.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 1.0 109.312 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.74 -168.32 24.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.439 -1.464 . . . . 1.0 109.439 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -65.71 -20.07 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.914 2.409 . . . . 1.0 111.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.66 -54.84 39.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 1.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -64.21 -42.98 96.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 1.0 109.352 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 34.8 m -150.44 91.38 4.15 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 1.0 109.432 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -82.83 179.97 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.862 2.375 . . . . 1.0 112.213 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.62 -23.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 1.0 109.486 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 6.5 p -60.85 -34.95 75.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 1.0 109.423 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.38 72.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -69.86 -37.78 76.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -59.88 -46.98 87.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 1.0 109.403 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -61.9 -40.14 94.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.513 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.668 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.6 t-105 -66.0 -36.18 82.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -58.05 -41.67 83.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 1.0 109.255 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.49 -38.26 90.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.41 -0.806 . . . . 1.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.57 -42.7 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 1.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -57.71 -43.35 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0 109.395 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.25 -36.65 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 1.0 109.383 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.8 -51.95 59.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 1.0 109.352 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 pt -71.41 -41.09 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.0 109.411 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.33 -51.65 67.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.501 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.78 -40.68 92.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 1.0 109.541 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.16 138.77 39.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 1.0 109.533 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.69 93.85 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 1.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.0 109.564 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.26 131.28 41.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 1.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -96.91 104.54 16.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 1.0 109.486 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -77.64 170.19 17.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.868 . . . . 1.0 109.575 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -50.79 -43.17 58.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 1.0 109.379 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -68.14 -49.0 63.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 1.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.89 -35.87 77.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 1.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -60.86 -41.28 95.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 1.0 109.562 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.7 -36.04 79.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 1.0 109.464 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.41 -45.31 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 1.0 109.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.74 -45.97 81.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 1.0 109.398 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.95 -38.92 90.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 1.0 108.911 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.77 -43.14 99.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 1.0 108.765 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.545 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.26 -38.6 87.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 1.0 109.486 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.46 -46.95 87.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 1.0 109.145 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.15 93.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.313 -0.867 . . . . 1.0 109.44 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.08 -40.69 87.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 1.0 109.23 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.19 -42.07 80.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.903 . . . . 1.0 109.242 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 70.3 p -64.96 -33.93 77.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.845 . . . . 1.0 109.299 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.95 -17.64 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 1.0 109.169 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.17 48.24 0.53 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.28 -1.528 . . . . 1.0 109.28 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.92 133.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 1.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -132.0 99.0 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 1.0 109.224 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.23 163.22 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 1.0 109.357 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.92 148.81 32.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 1.0 109.499 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.545 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 59.0 m-85 -63.75 -42.93 97.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.224 -0.923 . . . . 1.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.95 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 1.0 109.455 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.25 -40.34 93.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 1.0 109.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.1 -45.93 91.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 1.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.13 -41.68 99.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 1.0 109.394 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . 0.655 ' HZ1' ' H ' ' X' ' 50' ' ' THR . 98.4 mttt -67.24 -35.83 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.34 -50.26 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 1.0 109.493 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -61.03 -41.49 96.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.0 109.417 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.56 -39.74 95.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 1.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.37 -45.58 91.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -0.802 . . . . 1.0 109.508 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 76.7 t -58.27 -49.21 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 1.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.5 mttt -64.0 -31.5 72.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.8 m-20 -67.67 -19.14 65.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.85 . . . . 1.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 9.8 m -53.78 -48.43 69.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 1.0 109.403 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.747 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -122.73 -59.6 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.747 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.5 Cg_exo -41.47 -45.69 6.03 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.88 2.386 . . . . 1.0 112.219 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.7 m-90 -139.02 113.67 9.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.152 -0.967 . . . . 1.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -64.91 -43.72 69.4 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 1.0 109.875 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -55.93 130.77 42.13 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.79 2.327 . . . . 1.0 112.373 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -119.05 133.45 55.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 1.0 109.707 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -142.51 127.72 18.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.887 . . . . 1.0 109.789 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.74 147.73 5.38 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 50' ' ' THR . . . . . 0.655 ' H ' ' HZ1' ' X' ' 33' ' ' LYS . 31.4 m -88.68 143.26 27.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.099 -1.236 . . . . 1.0 109.414 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' X' ' 51' ' ' ILE . 0.3 OUTLIER -117.14 130.27 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 1.0 109.538 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -71.88 136.79 47.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 1.0 109.784 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.74 -25.4 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 1.0 109.464 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.96 -38.66 91.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 1.0 109.396 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -82.74 -18.88 39.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 1.0 109.296 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 11.9 t90 -60.13 -38.38 82.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.0 109.64 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.563 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 31.8 mmt180 -56.88 -43.64 81.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 109.478 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.498 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.8 mtp180 -68.75 -39.4 80.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 1.0 109.479 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -61.62 -46.55 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 1.0 109.372 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.49 -48.66 68.92 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.14 -33.99 77.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 1.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.5 m -69.23 -54.04 16.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 1.0 109.454 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -64.14 -43.37 95.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 1.0 109.482 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.4 -32.2 72.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 1.0 109.467 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.43 -45.87 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 1.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -72.67 -28.86 62.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 1.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' X' ' 71' ' ' GLY . 45.1 t80 -60.03 -53.4 58.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 1.0 109.402 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -69.48 -35.67 75.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 1.0 109.336 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.1 m -62.08 -45.86 91.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 1.0 109.258 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.19 -51.25 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 1.0 109.2 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.85 -158.5 24.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.8 -13.89 17.59 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.89 2.393 . . . . 1.0 111.953 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.93 -51.6 66.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 1.0 109.213 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -64.36 -40.82 96.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 1.0 109.309 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.78 83.92 9.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 1.0 109.418 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' X' ' 78' ' ' THR . 43.5 Cg_exo -55.46 154.41 24.63 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.827 2.352 . . . . 1.0 112.265 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -53.39 -6.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 1.0 109.438 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.549 ' H ' ' C ' ' X' ' 76' ' ' PRO . 63.1 p -61.19 -41.21 96.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.87 . . . . 1.0 109.391 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.62 75.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 1.0 109.385 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -61.13 -42.8 99.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 1.0 109.425 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -63.22 -46.63 86.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -63.19 -41.74 99.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.576 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.599 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.6 t-105 -61.42 -37.53 83.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 1.0 109.367 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.95 -44.14 78.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 1.0 109.191 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.66 -40.09 92.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 1.0 109.552 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -61.6 -41.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.243 -0.91 . . . . 1.0 109.395 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.93 -39.95 79.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 1.0 109.481 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -71.09 -36.73 72.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.389 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.501 ' N ' HD12 ' X' ' 89' ' ' LEU . 7.9 mp -65.72 -43.27 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 1.0 109.386 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.5 pt -78.92 -20.74 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 1.0 109.335 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.34 -50.07 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.485 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -41.23 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 1.0 109.54 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.54 139.54 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 1.0 109.573 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -75.86 92.27 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.0 109.538 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 1.0 109.593 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.46 145.04 47.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 1.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.89 94.79 10.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 1.0 109.511 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -78.41 176.22 9.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.593 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -54.28 -45.84 72.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 1.0 109.436 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.35 -42.49 92.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.46 -39.69 88.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 1.0 109.469 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.61 -42.23 92.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 1.0 109.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -59.33 -35.37 73.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 1.0 109.415 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.4 -44.72 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.0 109.305 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' X' ' 28' ' ' TYR . 46.1 tp10 -55.92 -47.7 77.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 1.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -66.53 -37.13 84.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 1.0 108.868 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.24 -42.65 98.98 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 1.0 108.803 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.56 ' HZ1' ' C ' ' X' ' 27' ' ' LYS . 88.5 tttt -61.85 -42.06 98.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 1.0 109.555 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -52.52 -49.91 63.87 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.177 -0.952 . . . . 1.0 109.158 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.57 80.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.0 109.422 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.19 -40.38 93.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 1.0 109.251 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.68 -40.71 80.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.303 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -58.61 -33.88 70.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.449 -0.782 . . . . 1.0 109.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.87 -9.97 56.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 1.0 109.19 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.31 44.33 2.2 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.32 135.24 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 1.0 109.387 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -131.36 94.81 3.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.0 109.22 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.471 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 35.3 m -132.8 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 1.0 109.366 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . 0.56 ' C ' ' HZ1' ' X' ' 16' ' ' LYS . 68.2 mttm -73.33 147.89 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 109.47 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.554 ' N ' ' HZ1' ' X' ' 16' ' ' LYS . 51.8 t80 -59.07 -39.28 81.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.203 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.55 59.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 1.0 109.493 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.516 ' CG ' ' CG ' ' X' ' 55' ' ' PHE . 30.2 t0 -61.15 -43.56 98.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 1.0 109.404 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.0 mm? -61.62 -45.35 94.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 1.0 109.409 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.7 -42.11 98.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 1.0 109.351 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -36.0 82.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 1.0 109.415 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.53 -46.65 83.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 1.0 109.413 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.1 -41.77 90.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 1.0 109.308 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -63.34 -44.07 95.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 109.266 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 38.8 t80 -61.34 -43.59 98.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.46 -47.46 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.0 109.535 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.82 -36.76 80.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 1.0 109.425 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' X' ' 44' ' ' TRP . 84.6 m-20 -69.11 -19.65 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 1.0 109.639 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 96.4 m -54.44 -47.78 72.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 1.0 109.41 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.646 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -119.16 -64.34 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 1.0 109.461 -178.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.0 Cg_exo -40.69 -33.82 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.89 2.393 . . . . 1.0 112.174 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 6.2 m-90 -155.94 100.95 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 1.0 109.468 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.684 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -71.22 -39.92 8.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 1.0 109.901 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 26.0 Cg_exo -60.87 -34.32 91.39 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.703 2.269 . . . . 1.0 112.369 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . 0.427 ' OE1' ' OD1' ' X' ' 40' ' ' ASP . 84.4 mt-30 -65.65 124.77 23.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 1.0 109.656 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -144.4 175.16 10.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 1.0 109.847 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.82 165.58 34.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.1 m -69.92 137.52 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -1.187 . . . . 1.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.58 139.68 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 1.0 109.504 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -94.26 133.84 37.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 1.0 109.751 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mm -48.71 -23.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 1.0 109.481 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.47 -43.25 90.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 109.353 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' X' ' 55' ' ' PHE . 1.0 OUTLIER -79.79 -16.35 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 1.0 109.296 -178.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 18.1 t90 -59.32 -43.05 92.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 1.0 109.646 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.599 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 32.9 mmt180 -59.72 -42.08 92.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 1.0 109.493 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 63.4 mtp85 -71.55 -46.34 59.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 1.0 109.437 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.29 -47.92 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 1.0 109.282 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.15 -47.02 84.1 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -66.15 -37.71 86.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.172 . . . . 1.0 109.462 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 98.7 m -64.11 -56.24 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 1.0 109.48 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.6 m-85 -61.15 -44.77 96.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 1.0 109.459 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.71 -36.94 84.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 1.0 109.49 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.451 ' O ' ' OG1' ' X' ' 69' ' ' THR . 74.7 m-20 -61.73 -47.15 86.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.0 109.344 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.22 -29.54 68.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.458 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' X' ' 71' ' ' GLY . 39.9 t80 -62.42 -55.05 31.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 1.0 109.429 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -67.52 -34.91 78.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 1.0 109.33 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 15.9 m -66.34 -51.38 57.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 1.0 109.331 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -108.93 -52.44 2.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.85 -162.17 26.29 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' ' N ' ' X' ' 76' ' ' PRO . 18.9 Cg_endo -74.77 -17.88 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.946 2.431 . . . . 1.0 111.956 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.89 -52.12 66.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 1.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -64.78 -39.32 93.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 1.0 109.371 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.91 79.69 13.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 1.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.539 ' C ' ' H ' ' X' ' 78' ' ' THR . 45.8 Cg_exo -55.33 155.0 21.55 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.772 2.315 . . . . 1.0 112.222 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.79 -5.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.539 ' H ' ' C ' ' X' ' 76' ' ' PRO . 62.2 p -61.11 -33.88 74.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 1.0 109.44 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.42 ' N ' ' HG1' ' X' ' 78' ' ' THR . . . -68.3 -36.87 79.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 1.0 109.372 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.89 . . . . 1.0 109.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -61.85 -49.12 77.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 1.0 109.4 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.85 -41.97 95.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 1.0 109.524 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.539 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.4 t-105 -67.07 -34.66 78.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.89 -43.28 85.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.0 109.243 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.47 -38.14 83.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.592 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.24 -44.07 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 1.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.41 -43.78 84.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 1.0 109.441 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.89 -36.54 72.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 1.0 109.355 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.56 -50.69 66.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 1.0 109.35 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . 0.42 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.1 pt -70.45 -42.29 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.42 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 86.2 m-20 -61.53 -47.45 85.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.0 109.475 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.03 -38.85 92.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 1.0 109.614 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.93 135.65 49.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.0 109.508 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -88.74 113.21 24.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 1.0 109.638 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.0 109.626 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 80.1 mm-40 -59.87 134.41 57.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 1.0 109.545 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.87 99.76 12.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 1.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -79.61 171.68 14.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 1.0 109.563 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -55.59 -42.96 75.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 1.0 109.436 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -66.36 -44.41 83.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 1.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 90.7 mt-10 -63.3 -33.34 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 1.0 109.427 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -70.52 -39.41 74.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 1.0 109.607 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.95 -49.12 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 1.0 109.364 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.16 -34.18 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 1.0 109.324 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.2 -43.1 92.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.261 -0.9 . . . . 1.0 109.289 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.67 -34.2 77.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 1.0 108.916 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.8 -41.12 99.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.356 -0.84 . . . . 1.0 108.847 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.415 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 87.6 tttt -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.756 . . . . 1.0 109.566 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.44 -45.19 84.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 1.0 109.195 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.69 -39.75 91.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 1.0 109.403 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.77 -38.88 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 1.0 109.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 1.0 109.238 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 45.8 p -62.92 -31.37 72.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.09 -17.57 61.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 1.0 109.145 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.29 47.18 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -119.06 130.46 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.429 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.19 98.43 4.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.94 . . . . 1.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.96 160.12 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 109.288 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -74.4 143.99 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 1.0 109.489 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.415 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 63.9 m-85 -61.74 -41.42 97.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.204 -0.935 . . . . 1.0 109.26 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.77 53.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 1.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' CG ' ' X' ' 55' ' ' PHE . 15.4 t70 -63.18 -39.5 94.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 1.0 109.448 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.39 -45.56 92.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 1.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.03 -42.95 99.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 1.0 109.364 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . 0.571 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.6 mttt -65.02 -38.86 92.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 1.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -58.31 -49.62 76.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 1.0 109.391 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -63.08 -44.14 96.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 1.0 109.404 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.23 -37.54 80.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 1.0 109.265 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.76 -46.78 88.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.918 . . . . 1.0 109.533 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.44 -44.34 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 1.0 109.548 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.29 -25.58 64.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.5 m-20 -73.56 -19.58 60.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.867 . . . . 1.0 109.658 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -54.11 -41.29 68.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 1.0 109.418 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.642 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -128.06 -64.4 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.473 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.642 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 53.9 Cg_exo -40.84 -40.1 3.45 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.879 2.386 . . . . 1.0 112.183 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.517 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -142.66 116.34 9.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 1.0 109.527 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.656 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -66.5 -41.72 42.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 1.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 27.1 Cg_exo -60.82 137.72 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.768 2.312 . . . . 1.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.92 147.74 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 1.0 109.654 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -141.33 157.19 45.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 1.0 109.807 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 164.3 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 50' ' ' THR . . . . . 0.571 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 41.6 m -114.5 129.82 56.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 1.0 109.311 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.0 136.08 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 1.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.67 137.54 36.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 1.0 109.757 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.13 -23.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 1.0 109.437 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -64.68 -39.29 93.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 1.0 109.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . 0.544 ' CG ' ' OD1' ' X' ' 30' ' ' ASP . 3.1 t80 -85.2 -9.98 57.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.955 . . . . 1.0 109.283 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t90 -57.64 -38.24 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 1.0 109.646 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -61.41 -38.95 88.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 1.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 76.9 mtp180 -70.19 -36.88 74.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 1.0 109.418 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.32 -42.16 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 1.0 109.315 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.53 -48.77 84.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -66.08 -40.14 90.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -1.141 . . . . 1.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 89.3 m -64.56 -54.28 34.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 1.0 109.509 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.96 -44.46 94.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 1.0 109.446 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -60.1 -37.87 81.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 1.0 109.478 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' X' ' 69' ' ' THR . 44.9 m-20 -63.38 -41.44 98.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 1.0 109.284 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -66.24 -38.6 88.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.3 -52.45 65.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 1.0 109.402 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.61 -30.14 69.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 1.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 98.1 m -61.65 -48.14 82.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 1.0 109.257 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 -52.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 1.0 109.269 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.68 29.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' X' ' 76' ' ' PRO . 23.2 Cg_exo -60.17 -23.71 74.64 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.969 2.446 . . . . 1.0 111.899 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -52.44 -51.95 56.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.164 -0.96 . . . . 1.0 109.231 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.0 -42.43 99.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.354 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.4 81.09 14.1 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 1.0 109.485 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.7 Cg_exo -59.62 161.75 17.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.818 2.345 . . . . 1.0 112.277 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -50.19 -9.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 1.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.537 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.1 p -60.21 -35.85 76.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 1.0 109.413 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.94 94.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 1.0 109.414 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.22 -42.8 93.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 1.0 109.411 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -62.77 -45.91 90.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.426 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.513 ' OH ' ' CD2' ' X' ' 45' ' ' PHE . 18.7 m-85 -63.72 -43.25 97.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 1.0 109.475 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -63.45 -36.87 85.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 1.0 109.389 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.78 -43.54 80.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.4 -0.813 . . . . 1.0 109.223 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.27 -40.59 86.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 1.0 109.613 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -61.5 -42.48 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 1.0 109.241 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -43.2 88.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 1.0 109.508 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 97.0 mt-10 -70.91 -24.61 62.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 1.0 109.347 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.13 -49.3 12.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 6.5 pt -70.47 -42.4 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 1.0 109.426 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 16.6 p-10 -67.69 -9.51 44.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 1.0 109.491 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.428 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 88.5 tttt -62.48 -48.1 81.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 1.0 109.556 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -115.23 125.46 53.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 1.0 109.452 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -71.03 125.69 27.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 1.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 109.566 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 131.24 49.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 1.0 109.551 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.97 89.61 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 1.0 109.626 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.1 p -82.88 174.99 10.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 1.0 109.554 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -53.14 -41.02 64.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.237 -0.914 . . . . 1.0 109.282 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 5.1 m-70 -69.25 -43.69 73.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 1.0 109.415 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.96 -39.25 93.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 1.0 109.602 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.93 -36.83 84.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 109.567 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -61.06 -49.73 76.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 1.0 109.925 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.24 -34.25 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 1.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.57 -35.43 80.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.459 -0.776 . . . . 1.0 109.226 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -68.24 -39.16 82.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 1.0 108.959 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -61.43 -41.24 96.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 1.0 108.961 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.47 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.28 -40.5 94.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 1.0 109.395 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -56.2 -44.74 79.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 1.0 109.067 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -36.73 82.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 1.0 109.227 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.27 -38.74 92.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 1.0 109.068 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.53 -41.38 85.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 1.0 109.092 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -60.14 -39.14 85.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 1.0 109.103 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.41 -16.92 63.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 1.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.58 53.15 0.73 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . 0.531 ' CG2' HH21 ' X' ' 58' ' ' ARG . 38.2 t -122.06 133.4 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.583 -0.951 . . . . 1.0 109.325 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.18 96.52 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.31 163.99 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 1.0 109.503 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.45 147.78 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.47 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 96.9 m-85 -63.9 -39.95 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 1.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.26 -31.69 63.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.0 109.358 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -59.96 -42.2 93.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 1.0 109.227 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 1.0 109.359 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.26 -41.27 97.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.797 . . . . 1.0 109.28 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.27 -34.74 79.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 1.0 109.394 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.97 -48.86 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 1.0 109.693 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.18 -45.33 93.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.249 -0.907 . . . . 1.0 109.621 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -64.13 -37.85 88.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.0 109.13 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.14 -45.67 92.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 1.0 109.428 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.03 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 1.0 109.595 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.46 -32.69 74.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.011 0.91 . . . . 1.0 109.629 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.4 m-20 -68.26 -20.38 64.79 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.766 -1.209 . . . . 1.0 109.757 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 m -55.15 -57.46 11.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.878 -1.138 . . . . 1.0 110.708 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.525 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.1 OUTLIER -109.85 -59.6 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.042 0 O-C-N 121.514 -0.741 . . . . 1.0 110.634 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.1 Cg_exo -42.2 -42.25 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.494 2.129 . . . . 1.0 112.701 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.8 m-90 -142.62 -158.91 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 1.0 109.361 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.535 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 2.2 t80 -171.84 49.37 0.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 1.0 109.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 29.3 Cg_endo -67.32 -166.42 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.709 2.273 . . . . 1.0 112.132 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.08 140.6 35.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 1.0 109.581 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.4 134.99 42.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 1.0 109.758 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.03 -178.43 43.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.791 -1.324 . . . . 1.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 14.4 m -71.2 141.7 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -1.193 . . . . 1.0 109.275 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.421 HG21 HD13 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -127.77 133.58 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.761 0.791 . . . . 1.0 109.212 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' X' ' 53' ' ' ILE . 56.5 t0 -71.82 136.97 47.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.64 -1.287 . . . . 1.0 110.012 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 63.7 mt -66.56 -21.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.79 -1.194 . . . . 1.0 109.259 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -64.95 -40.05 94.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 1.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -84.39 -9.64 58.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 1.0 109.616 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.595 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 11.0 t90 -53.67 -39.88 65.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 1.0 109.795 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.24 -37.23 84.62 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.172 -0.955 . . . . 1.0 109.486 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.531 HH21 ' CG2' ' X' ' 24' ' ' VAL . 85.6 mmt-85 -68.31 -42.89 78.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.351 -0.843 . . . . 1.0 109.781 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.38 -45.13 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.29 -0.882 . . . . 1.0 109.26 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.55 97.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.68 -42.2 91.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.255 -1.144 . . . . 1.0 109.671 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.92 -50.67 61.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 1.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.48 -44.75 96.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.0 109.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.96 -35.58 75.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.181 -0.949 . . . . 1.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -64.7 -46.16 83.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 1.0 109.412 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 1.0 109.428 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' X' ' 71' ' ' GLY . 9.1 t80 -59.37 -53.29 59.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 1.0 109.716 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' X' ' 68' ' ' ASN . 51.6 t-20 -64.5 -35.92 82.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.856 -1.153 . . . . 1.0 109.473 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -65.02 -45.35 85.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.213 -0.929 . . . . 1.0 109.99 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.34 -51.87 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.141 -0.623 . . . . 1.0 109.893 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 138.74 -164.05 25.78 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 1.0 109.388 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' X' ' 76' ' ' PRO . 8.6 Cg_exo -66.41 -20.65 54.53 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.97 2.446 . . . . 1.0 111.948 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.37 -53.81 52.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 1.0 109.474 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.44 -37.27 86.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.361 -0.837 . . . . 1.0 109.667 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 34.5 m -143.59 81.21 12.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.566 -0.709 . . . . 1.0 109.198 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.502 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.0 Cg_exo -59.03 155.11 40.83 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 123.057 2.504 . . . . 1.0 112.287 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.91 -10.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 1.0 109.303 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.494 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.4 t -62.28 -33.44 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.94 -45.08 91.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.324 -0.86 . . . . 1.0 109.129 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.33 -43.43 97.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 1.0 109.479 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -61.94 -45.69 92.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 1.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -64.41 -37.22 86.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 1.0 109.433 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.448 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.1 t-105 -64.59 -35.54 81.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.87 . . . . 1.0 109.092 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.14 -43.52 95.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 1.0 109.092 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.07 -39.1 93.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.422 -0.799 . . . . 1.0 109.133 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.24 -42.47 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.0 109.552 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.595 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 63.4 mttt -55.96 -43.26 77.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.71 -35.65 79.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.923 -1.11 . . . . 1.0 109.485 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.72 -49.18 71.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.935 . . . . 1.0 109.835 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.8 pt -71.96 -40.95 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 1.0 109.308 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.32 -44.61 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.406 -0.809 . . . . 1.0 109.481 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.51 -43.19 94.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 1.0 109.401 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.0 126.17 30.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.139 -0.976 . . . . 1.0 109.498 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.81 127.91 34.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 1.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 1.0 109.465 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.319 0.58 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -58.42 138.3 56.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 1.0 109.584 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.82 103.57 15.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 1.0 109.495 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.2 p -79.29 171.3 15.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 1.0 109.571 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.5 -40.9 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 1.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.64 -46.2 76.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 1.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -62.51 -38.35 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 1.0 109.405 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -61.49 -40.91 96.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 1.0 109.551 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.95 -36.45 77.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.195 -0.941 . . . . 1.0 109.475 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.03 -44.15 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 1.0 109.34 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.95 -48.06 73.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.286 -0.884 . . . . 1.0 109.317 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -65.62 -36.31 83.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 1.0 108.805 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.05 -41.76 99.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.291 -0.881 . . . . 1.0 108.834 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 1.0 109.499 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -55.99 -46.88 78.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.19 -0.944 . . . . 1.0 109.122 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.38 -41.01 96.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.378 -0.827 . . . . 1.0 109.343 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.87 -36.44 84.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 1.0 109.287 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.89 -38.27 87.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 1.0 109.229 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 76.0 p -65.79 -33.47 75.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 1.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -70.78 -19.36 62.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 1.0 109.243 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.29 47.14 0.39 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.325 -1.51 . . . . 1.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -121.55 133.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -1.105 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.99 91.38 2.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.268 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.73 162.15 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 1.0 109.311 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.12 147.05 32.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 1.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -62.68 -34.5 77.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 1.0 109.225 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.35 69.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 1.0 109.403 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 1.0 109.386 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -60.35 -44.39 95.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 1.0 109.361 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -42.14 99.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.409 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.03 -33.57 76.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.359 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -59.39 -46.01 89.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 1.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.26 -44.51 96.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 1.0 109.402 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.63 -44.32 94.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 1.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -63.17 -46.19 88.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 1.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 69.7 t -60.39 -44.58 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 1.0 109.569 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 1.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 7.1 m-20 -68.32 -19.84 64.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 1.0 109.667 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 99.6 m -54.48 -51.48 64.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 1.0 109.393 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.683 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -118.82 -63.16 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 1.0 109.508 -177.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.3 Cg_exo -40.79 -54.22 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.897 2.398 . . . . 1.0 112.168 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -118.36 -128.25 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 1.0 109.503 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.683 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.8 OUTLIER -175.28 -41.62 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 1.0 109.908 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 34.5 Cg_exo -58.17 132.72 50.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 1.0 112.307 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -119.01 159.27 24.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 109.71 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -74.16 158.59 33.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 1.0 109.758 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.74 -4.18 63.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.855 -1.298 . . . . 1.0 109.855 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -119.7 118.28 30.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 1.0 109.308 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.465 HD12 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -136.31 135.1 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 109.497 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.465 ' H ' HD12 ' X' ' 51' ' ' ILE . 67.4 t0 -67.27 130.68 43.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.14 -38.61 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 1.0 109.417 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -61.57 -37.72 84.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 1.0 109.4 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -76.36 -24.21 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 1.0 109.305 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.659 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -57.48 -36.46 71.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.612 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.424 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 14.0 mmm180 -60.69 -41.45 95.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 1.0 109.501 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.63 -37.47 79.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 1.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.15 -44.37 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 1.0 109.306 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.35 -48.57 84.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -65.35 -41.12 94.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.163 . . . . 1.0 109.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.24 -42.87 92.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 1.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -65.76 -40.02 91.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.21 -37.95 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 1.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' X' ' 69' ' ' THR . 93.1 m-20 -63.25 -43.93 96.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 1.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.96 -31.73 71.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.477 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' X' ' 71' ' ' GLY . 17.4 t80 -59.65 -55.02 39.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 1.0 109.357 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -68.38 -34.94 76.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 1.0 109.303 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.0 m -65.01 -48.03 75.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 1.0 109.283 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -111.75 -52.37 2.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 1.0 109.329 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.97 -165.68 26.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.58 -14.46 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.911 2.407 . . . . 1.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.1 -49.79 74.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.274 -0.891 . . . . 1.0 109.302 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -66.91 -43.98 81.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 1.0 109.347 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 35.3 m -148.46 88.69 5.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 1.0 109.455 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -81.02 -176.0 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.832 2.354 . . . . 1.0 112.267 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -19.67 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 1.0 109.397 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.1 p -59.67 -33.73 71.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 1.0 109.42 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.39 73.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 1.0 109.463 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -61.63 -41.09 96.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.0 t -59.23 -46.01 89.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 1.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.28 -43.88 93.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.659 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.5 t-105 -64.32 -36.16 83.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -55.38 -43.08 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.0 109.207 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.52 -40.83 93.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 1.0 109.565 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.27 -42.28 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 1.0 109.346 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.76 -41.3 70.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 1.0 109.41 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.73 -38.75 73.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.948 . . . . 1.0 109.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.31 -49.59 73.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 1.0 109.372 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.2 pt -70.29 -41.18 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 1.0 109.436 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 69.5 m-20 -59.84 -47.08 87.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.95 . . . . 1.0 109.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.83 -41.82 97.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.61 137.48 38.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.918 . . . . 1.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 1.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.0 109.537 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mt-10 -62.41 146.51 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.517 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.12 101.84 14.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 109.484 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 6' ' ' SER . . . . . 0.424 ' H ' ' HG ' ' X' ' 6' ' ' SER . 13.3 p -83.48 170.28 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 1.0 109.431 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -54.09 -43.19 70.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 1.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -64.65 -43.49 93.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.878 . . . . 1.0 109.543 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 99.2 mt-10 -67.78 -34.91 77.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 1.0 109.371 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.3 -38.28 84.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.882 . . . . 1.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.08 -51.16 69.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.41 -33.29 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 1.0 109.261 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.21 -42.3 85.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.893 . . . . 1.0 109.177 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -63.75 -39.74 95.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.94 . . . . 1.0 108.766 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.45 -40.25 86.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.482 ' NZ ' ' CD2' ' X' ' 28' ' ' TYR . 88.0 tttt -61.39 -43.7 98.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 1.0 109.579 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -44.11 77.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 1.0 109.024 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.8 96.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 1.0 109.276 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.11 -38.04 89.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -0.899 . . . . 1.0 109.22 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -60.11 -41.39 92.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 1.0 109.297 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.5 p -63.06 -31.95 73.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.865 . . . . 1.0 109.233 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.29 -17.96 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.0 109.19 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.65 46.61 0.52 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.22 133.33 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.353 -1.086 . . . . 1.0 109.358 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.92 93.57 2.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 1.0 109.215 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.12 161.21 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 1.0 109.342 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -70.36 146.97 50.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.917 . . . . 1.0 109.491 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.482 ' CD2' ' NZ ' ' X' ' 16' ' ' LYS . 97.0 m-85 -63.67 -35.46 80.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 1.0 109.235 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.9 -34.48 69.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 1.0 109.409 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.16 -44.19 92.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 1.0 109.341 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -62.04 -45.96 91.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 1.0 109.436 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.49 -42.65 98.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 1.0 109.395 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.75 -34.36 75.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 1.0 109.384 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.76 -48.46 81.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 1.0 109.471 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -62.03 -43.72 98.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.99 -42.14 99.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 1.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.4 -43.66 96.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.43 -44.5 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.0 109.299 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -36.34 83.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 1.0 109.351 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.5 m-20 -68.3 -20.56 64.76 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.089 -1.007 . . . . 1.0 109.588 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -54.44 -52.83 60.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.19 -0.944 . . . . 1.0 109.763 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.624 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -112.35 -62.76 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.283 -0.886 . . . . 1.0 109.914 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.624 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 77.1 Cg_exo -42.33 -39.05 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.57 2.18 . . . . 1.0 112.062 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 -145.61 -146.16 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 1.0 109.435 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.603 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 174.74 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 1.0 109.902 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -54.9 -34.81 87.35 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.793 2.329 . . . . 1.0 112.396 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.89 124.07 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 1.0 109.675 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.66 158.78 43.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 1.0 109.736 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.76 163.59 31.81 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.328 . . . . 1.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.6 m -63.3 140.05 58.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.0 109.345 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -129.98 134.79 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 1.0 109.334 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' X' ' 53' ' ' ILE . 55.9 t0 -72.79 134.36 44.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 1.0 109.811 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.606 ' CG2' HH12 ' X' ' 57' ' ' ARG . 80.2 mt -64.13 -28.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 1.0 109.55 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.3 -40.05 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 1.0 109.503 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.18 -22.69 52.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.8 t90 -55.96 -37.61 69.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.142 -0.974 . . . . 1.0 109.728 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.606 HH12 ' CG2' ' X' ' 53' ' ' ILE . 28.6 mmt-85 -58.05 -38.86 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 1.0 109.46 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.48 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.4 mmt-85 -68.79 -39.62 80.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.61 -44.34 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 1.0 109.469 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.92 -48.15 74.82 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.93 -37.07 83.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 1.0 109.434 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.8 m -67.71 -51.16 52.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 1.0 109.675 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.07 -41.19 99.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 1.0 109.421 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.11 -38.72 83.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 1.0 109.445 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.425 ' O ' ' OG1' ' X' ' 69' ' ' THR . 96.0 m-20 -60.91 -44.44 97.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 1.0 109.36 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -64.74 -37.85 89.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 1.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' X' ' 71' ' ' GLY . 6.5 t80 -60.13 -53.81 53.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 1.0 109.535 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.4 -33.81 76.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 1.0 109.286 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 18.1 m -68.37 -44.23 75.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 1.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -122.36 -51.76 1.96 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 1.0 109.673 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.74 -164.29 25.2 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.8 Cg_exo -65.35 -21.51 61.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.941 2.428 . . . . 1.0 112.182 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.44 -53.03 61.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.216 -0.928 . . . . 1.0 109.314 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -66.2 -38.52 88.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 1.0 109.401 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.4 78.63 14.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' X' ' 78' ' ' THR . 35.9 Cg_exo -56.41 156.12 22.83 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.855 2.37 . . . . 1.0 112.362 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.03 -11.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 1.0 109.397 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.508 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.0 p -59.9 -38.1 81.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.0 109.44 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.425 ' N ' ' HG1' ' X' ' 78' ' ' THR . . . -55.5 -46.61 76.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 1.0 109.397 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -63.67 -44.14 94.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 1.0 109.564 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 50.7 m -61.63 -51.68 67.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 1.0 109.553 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -60.56 -41.84 95.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 1.0 109.484 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.676 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 14.2 t-105 -63.13 -40.36 97.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 1.0 109.289 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -56.27 -38.86 71.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 1.0 108.843 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.14 -42.69 99.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.532 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -61.46 -42.33 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 1.0 109.499 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.604 ' HZ2' ' CB ' ' X' ' 56' ' ' TRP . 60.8 mmtt -55.69 -40.08 71.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 1.0 109.538 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.2 -37.96 84.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.893 . . . . 1.0 109.544 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.89 -41.91 95.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.217 -0.927 . . . . 1.0 109.843 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.89 -43.14 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.0 109.658 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.91 -48.28 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.0 109.537 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.9 -43.96 94.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 1.0 109.646 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.75 130.53 35.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 1.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.97 130.04 40.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.875 . . . . 1.0 109.55 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 1.0 109.604 -179.746 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' X' ' 6' ' ' SER . 95.4 mt-10 -53.03 121.69 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 1.0 109.5 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 92.7 mt -55.37 85.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 1.0 109.484 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 6' ' ' SER . . . . . 0.531 ' N ' ' O ' ' X' ' 4' ' ' GLU . 10.0 p -81.76 171.68 14.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 1.0 109.599 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . 0.443 ' CG ' HH21 ' X' ' 10' ' ' ARG . 96.4 mt-30 -54.86 -45.86 74.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 1.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -66.55 -41.8 88.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 1.0 109.485 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -37.42 84.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 1.0 109.408 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . 0.443 HH21 ' CG ' ' X' ' 7' ' ' GLN . 86.6 mtm180 -70.54 -38.05 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 1.0 109.62 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.58 -49.72 76.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 1.0 109.441 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.94 -27.63 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.0 109.366 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.1 -40.7 90.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 1.0 109.395 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.41 -39.18 88.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.993 . . . . 1.0 108.92 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.52 -40.56 97.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.275 -0.891 . . . . 1.0 108.855 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.519 ' HZ2' ' C ' ' X' ' 27' ' ' LYS . 88.8 tttt -61.48 -38.66 88.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 1.0 109.498 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -57.87 -46.61 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 1.0 109.144 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.819 . . . . 1.0 109.43 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.35 -38.99 93.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 1.0 109.275 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.19 -44.7 92.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 1.0 109.246 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -56.27 -39.81 73.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 1.0 109.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -68.77 -17.14 63.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 1.0 109.222 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.06 0.66 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 50.1 t -122.72 136.78 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -1.109 . . . . 1.0 109.381 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.71 88.5 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 1.0 109.205 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.7 165.0 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 1.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . 0.519 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 99.7 mttt -77.01 153.74 34.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 1.0 109.45 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -61.44 -35.22 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 1.0 109.261 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.812 . . . . 1.0 109.432 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 56.5 t0 -58.52 -45.24 89.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 1.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.2 mm? -63.11 -45.26 92.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 1.0 109.4 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.39 -43.73 93.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.338 -0.851 . . . . 1.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.3 -33.41 73.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.39 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -58.89 -48.75 80.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 1.0 109.448 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -64.85 -42.22 95.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.2 -43.2 98.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.283 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.04 -45.11 94.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.366 -0.834 . . . . 1.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.2 -47.49 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 1.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -66.64 -35.71 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 109.395 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' X' ' 44' ' ' TRP . 91.6 m-20 -65.05 -19.38 65.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.673 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -54.29 -61.68 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.972 . . . . 1.0 109.362 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.631 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.77 -60.2 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 1.0 109.509 -178.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.631 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.6 Cg_exo -41.36 -44.57 5.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.883 2.389 . . . . 1.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.4 m-90 -143.17 -144.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 1.0 109.504 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.585 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.39 -46.04 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.95 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.3 Cg_exo -54.94 -33.77 83.77 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.713 2.276 . . . . 1.0 112.411 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.21 129.08 38.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 1.0 109.672 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.55 163.36 34.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 1.0 109.87 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.87 166.89 31.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.79 -1.324 . . . . 1.0 109.79 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 28.4 m -64.16 129.78 41.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 1.0 109.3 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.45 131.64 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 1.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' X' ' 54' ' ' LYS . 20.3 t0 -94.23 126.09 39.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.885 . . . . 1.0 109.697 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -44.83 -16.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -0.986 . . . . 1.0 109.482 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' X' ' 52' ' ' ASP . 98.9 mttt -67.31 -35.77 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.398 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . 0.569 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 2.3 m-85 -84.33 -10.99 57.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 1.0 109.285 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -58.24 -46.0 86.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 1.0 109.646 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 1.0 109.544 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.507 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 34.0 mmt180 -63.2 -47.9 80.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 1.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.06 -44.4 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 1.0 109.367 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.38 -48.65 82.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -66.16 -40.4 90.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -1.125 . . . . 1.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 90.0 m -62.6 -49.42 75.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.915 . . . . 1.0 109.461 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.17 -42.0 99.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 1.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -58.68 -36.46 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 1.0 109.536 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' X' ' 69' ' ' THR . 89.2 m-20 -62.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 1.0 109.326 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -67.98 -34.23 76.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.31 -0.869 . . . . 1.0 109.483 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' X' ' 71' ' ' GLY . 10.0 t80 -61.55 -54.81 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.355 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -63.34 -34.11 77.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 1.0 109.342 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.1 m -68.59 -48.26 64.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.0 109.285 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.23 -52.57 2.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 1.0 109.301 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.52 -163.65 25.18 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.5 Cg_exo -66.06 -23.38 53.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.86 2.373 . . . . 1.0 111.967 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.07 -54.76 34.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 1.0 109.24 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -65.45 -36.0 82.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.403 -0.811 . . . . 1.0 109.331 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.26 81.4 10.42 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 1.0 109.445 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.521 ' N ' ' O ' ' X' ' 72' ' ' PRO . 38.2 Cg_exo -60.27 154.36 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.868 2.379 . . . . 1.0 112.228 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 52.0 t -49.93 -11.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 1.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.519 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.3 t -63.94 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 1.0 109.356 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.03 96.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 1.0 109.418 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -64.92 -44.37 89.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 1.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.9 t -59.09 -45.47 90.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 1.0 109.408 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -65.27 -38.07 89.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 1.0 109.535 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -66.25 -37.9 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 1.0 109.411 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -55.99 -43.97 78.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 1.0 109.212 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.75 -40.39 96.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.535 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.35 -42.85 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 1.0 109.397 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -59.02 -41.32 87.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 1.0 109.492 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.92 -36.92 72.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 1.0 109.338 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.41 -45.15 88.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 1.0 109.33 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.01 -38.27 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.0 109.448 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.58 -45.14 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 1.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.95 -42.72 99.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.549 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -72.4 146.77 46.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.88 . . . . 1.0 109.498 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -101.9 93.62 5.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 1.0 109.535 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 1.0 109.557 179.8 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.1 mt-10 -60.72 136.7 58.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 1.0 109.58 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.47 100.88 13.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 109.477 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.2 p -77.56 169.63 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.0 109.565 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -52.49 -43.78 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.63 -47.89 71.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 1.0 109.527 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 94.5 mt-10 -60.27 -36.68 78.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 1.0 109.461 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -61.1 -42.62 98.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 1.0 109.63 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -59.7 -35.54 74.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 1.0 109.442 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.54 -44.51 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 109.316 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.38 -48.61 78.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.311 -0.868 . . . . 1.0 109.401 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -62.25 -38.3 88.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.23 -0.919 . . . . 1.0 108.92 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.28 -43.34 99.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 1.0 108.762 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.85 -37.38 81.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.498 -0.751 . . . . 1.0 109.523 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -57.87 -48.49 79.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 1.0 109.121 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.41 79.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 1.0 109.412 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.35 -40.28 95.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -0.843 . . . . 1.0 109.299 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.59 -38.16 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 1.0 109.217 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 68.4 p -64.13 -13.66 49.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 1.0 109.279 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.12 7.06 42.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 1.0 109.227 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 38.17 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.0 133.19 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.04 96.84 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 1.0 109.166 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.74 161.71 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 1.0 109.41 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.08 144.99 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 1.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -61.98 -37.49 85.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 1.0 109.296 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -33.78 64.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.0 109.492 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.07 -38.43 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.427 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -61.09 -43.89 98.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 1.0 109.456 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.17 -42.11 96.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 1.0 109.39 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 99.2 mttt -62.63 -38.27 89.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 1.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.56 -50.06 75.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0 109.477 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.65 -42.17 99.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 1.0 109.382 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' X' ' 40' ' ' ASP . 66.2 t0 -63.44 -39.61 94.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 1.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.43 -45.31 88.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 1.0 109.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.43 -47.58 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.96 -33.47 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 1.0 109.367 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.7 m-20 -69.78 -19.95 63.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 1.0 109.7 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 7.5 m -54.96 -61.05 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.0 109.481 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.569 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -103.04 -62.86 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.56 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.569 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.5 Cg_exo -41.32 -50.09 4.62 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.867 2.378 . . . . 1.0 112.175 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.497 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.6 m-90 -135.06 -147.19 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 1.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.14 -44.52 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 1.0 109.851 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.0 Cg_exo -58.1 -32.7 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.711 2.274 . . . . 1.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.01 124.14 18.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 1.0 109.735 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' X' ' 82' ' ' TYR . 97.0 mt-10 -141.28 161.64 37.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 1.0 109.789 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.04 169.15 41.23 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 50' ' ' THR . . . . . 0.475 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 34.7 m -64.17 138.51 58.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.116 -1.226 . . . . 1.0 109.334 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.448 HD13 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.22 135.84 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 1.0 109.479 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.448 ' H ' HD13 ' X' ' 51' ' ' ILE . 85.4 m-20 -71.83 136.29 46.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.854 . . . . 1.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -24.41 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 1.0 109.468 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -65.28 -38.96 91.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.0 109.361 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -80.57 -17.79 50.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 1.0 109.25 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.611 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.6 t90 -54.06 -37.42 64.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 1.0 109.665 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -61.53 -39.85 92.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 1.0 109.479 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -66.39 -40.36 89.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 1.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.36 -45.91 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 1.0 109.35 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -44.11 98.46 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -65.75 -40.13 91.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -1.162 . . . . 1.0 109.462 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.26 -53.66 23.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 109.534 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -61.41 -42.61 99.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 1.0 109.485 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -59.46 -36.92 76.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -62.96 -45.2 93.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 1.0 109.28 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -65.48 -38.06 88.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 1.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' X' ' 71' ' ' GLY . 8.9 t80 -60.14 -53.47 57.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 1.0 109.364 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.28 -38.86 92.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 1.0 109.282 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.8 m -64.13 -49.82 70.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.0 109.281 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.64 -52.24 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 1.0 109.329 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.09 -165.13 24.97 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' X' ' 76' ' ' PRO . 12.6 Cg_exo -65.36 -19.89 61.63 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.911 2.408 . . . . 1.0 111.968 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.86 -54.71 41.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.239 -0.913 . . . . 1.0 109.204 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.86 -37.24 85.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.88 80.15 15.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 1.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.1 Cg_exo -58.01 157.68 24.04 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.895 2.397 . . . . 1.0 112.214 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -51.66 -6.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 1.0 109.462 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.571 ' H ' ' C ' ' X' ' 76' ' ' PRO . 77.0 p -61.78 -32.97 73.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 1.0 109.371 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.07 -49.96 73.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 1.0 109.405 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 67.6 m -59.87 -43.77 94.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 1.0 109.442 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' X' ' 48' ' ' GLU . 1.2 t80 -61.43 -43.25 99.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0 109.491 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.611 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.0 t-105 -65.9 -36.0 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 1.0 109.373 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -56.78 -42.59 79.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 1.0 109.272 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.92 -42.6 97.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 1.0 109.587 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.12 -41.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 1.0 109.403 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.33 -39.21 72.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -71.08 -37.42 72.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 1.0 109.394 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.73 -46.12 83.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.895 . . . . 1.0 109.412 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -74.65 -39.55 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -61.16 -48.99 79.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 1.0 109.512 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.88 -45.0 79.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 1.0 109.596 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.52 127.11 32.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 1.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.42 132.19 51.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 1.0 109.602 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.47 -0.566 . . . . 1.0 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.45 138.83 12.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 1.0 109.44 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.08 102.46 15.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.739 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.9 p -83.98 168.85 15.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 1.0 109.528 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -52.07 -40.94 61.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 1.0 109.325 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.0 -44.94 83.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 1.0 109.396 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.36 -34.26 76.93 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 1.0 109.427 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.078 -1.014 . . . . 1.0 109.49 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -60.87 -50.26 74.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.97 . . . . 1.0 109.779 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.01 -32.81 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 1.0 109.244 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.05 -44.49 87.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 1.0 109.191 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . 0.472 ' NE2' ' OE1' ' X' ' 17' ' ' GLN . 72.6 tp60 -63.25 -37.46 87.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.918 . . . . 1.0 108.807 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.07 -39.46 89.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -0.904 . . . . 1.0 108.751 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.59 -43.12 97.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 1.0 109.095 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . 0.472 ' OE1' ' NE2' ' X' ' 14' ' ' GLN . 87.0 mt-30 -54.97 -42.26 72.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 1.0 108.77 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.457 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.26 -44.26 92.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 1.0 109.192 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.536 ' CD2' HH21 ' X' ' 22' ' ' ARG . 8.8 mt -63.15 -41.37 99.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.083 -1.01 . . . . 1.0 109.366 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.32 -38.94 91.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.278 -0.889 . . . . 1.0 109.507 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 52.4 p -64.46 -29.83 70.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.433 -0.792 . . . . 1.0 109.345 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.536 HH21 ' CD2' ' X' ' 19' ' ' LEU . 77.7 mtm180 -78.48 -13.46 59.82 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 1.0 109.554 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.03 48.21 0.73 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.52 135.58 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.715 -0.874 . . . . 1.0 109.041 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -130.09 97.3 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.406 -0.808 . . . . 1.0 109.252 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.41 160.36 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.596 -0.69 . . . . 1.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.17 152.32 32.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 1.0 109.675 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -63.99 -34.66 78.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 1.0 108.939 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -29.28 70.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 1.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.555 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 41.9 t0 -59.37 -48.48 81.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.0 109.179 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.544 ' CD2' HH22 ' X' ' 58' ' ' ARG . 10.6 mt -62.36 -42.96 99.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.937 . . . . 1.0 108.912 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.76 -42.66 99.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.265 -0.897 . . . . 1.0 108.972 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . 0.53 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.0 mttt -67.55 -35.04 78.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 1.0 109.178 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.05 -48.92 79.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 1.0 109.879 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -63.51 -43.47 97.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 1.0 109.647 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -63.38 -40.79 98.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 1.0 109.274 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . 0.632 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 53.5 t80 -61.6 -46.22 90.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.665 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.64 -39.36 69.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.048 -1.032 . . . . 1.0 109.039 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.21 -20.01 45.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 1.0 109.543 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' NE2' ' X' ' 47' ' ' GLN . 95.9 m-20 -68.13 -19.95 64.86 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.959 -1.088 . . . . 1.0 109.409 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 18.9 m -55.31 -43.51 74.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 1.0 110.332 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.528 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.7 OUTLIER -126.04 -63.12 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.538 -0.726 . . . . 1.0 109.929 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.528 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 50.3 Cg_exo -42.02 -44.07 7.22 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.662 2.242 . . . . 1.0 112.394 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.9 m0 -139.72 -146.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 109.216 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -174.42 -45.24 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 1.0 109.769 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.2 Cg_exo -58.66 140.27 94.21 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.612 2.208 . . . . 1.0 112.252 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . 0.459 ' NE2' ' OD2' ' X' ' 40' ' ' ASP . 88.7 mm-40 -105.7 158.0 17.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.592 -0.693 . . . . 1.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.69 146.04 47.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 1.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.55 -155.92 29.9 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.331 -1.507 . . . . 1.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 50' ' ' THR . . . . . 0.53 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 91.4 m -128.42 131.81 48.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.565 -0.962 . . . . 1.0 109.567 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.98 131.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.944 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' X' ' 54' ' ' LYS . 24.7 t0 -93.97 127.36 39.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 1.0 109.141 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -46.87 -16.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 1.0 109.495 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' X' ' 52' ' ' ASP . 65.1 mmtt -66.19 -35.51 80.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 1.0 109.635 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . 0.555 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 1.0 OUTLIER -83.25 -11.6 57.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 1.0 109.636 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.441 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.7 t90 -59.42 -42.94 93.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.88 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -63.85 -40.97 97.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 1.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.544 HH22 ' CD2' ' X' ' 31' ' ' LEU . 82.3 mtp180 -69.67 -47.19 64.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.0 109.568 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.62 -46.25 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 1.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.03 -45.31 96.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -67.12 -36.66 82.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -1.175 . . . . 1.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 91.7 m -67.37 -47.01 71.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.659 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . 0.632 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.0 m-85 -64.35 -40.07 95.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 1.0 109.535 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -60.23 -37.68 81.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.311 -0.868 . . . . 1.0 109.331 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.09 -48.21 77.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 1.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -62.07 -36.42 81.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.84 . . . . 1.0 109.435 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' X' ' 71' ' ' GLY . 3.0 t80 -61.86 -55.31 31.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.226 -0.921 . . . . 1.0 109.886 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.61 -36.21 83.52 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.973 -1.079 . . . . 1.0 109.711 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -64.44 -45.72 86.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 110.195 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.35 -51.96 2.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.685 -0.635 . . . . 1.0 109.967 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 141.59 -169.7 25.06 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.3 Cg_exo -65.36 -22.31 60.07 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.894 2.396 . . . . 1.0 112.102 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.13 -54.63 42.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 1.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -61.58 -39.21 90.37 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.261 -0.899 . . . . 1.0 109.614 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.29 82.01 8.48 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.449 -0.782 . . . . 1.0 109.346 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.2 Cg_exo -57.55 151.7 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.851 2.367 . . . . 1.0 112.333 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 m -49.53 -11.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.388 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.516 ' H ' ' C ' ' X' ' 76' ' ' PRO . 2.0 t -62.64 -33.12 74.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 1.0 109.371 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.28 -41.84 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.9 . . . . 1.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 1.0 109.404 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -61.43 -44.16 97.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -0.855 . . . . 1.0 109.263 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.95 -42.47 94.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.997 . . . . 1.0 109.681 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.441 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 10.2 t-105 -62.76 -36.19 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 1.0 109.315 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -58.5 -43.25 89.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 1.0 108.861 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.54 -40.53 97.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 1.0 109.271 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.0 109.619 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.48 -37.61 70.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.365 -0.835 . . . . 1.0 109.509 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -70.99 -39.79 72.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 1.0 109.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.49 -48.41 77.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 1.0 110.458 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.5 pt -72.43 -42.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.565 -0.709 . . . . 1.0 109.619 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 62.9 t0 -62.56 -37.17 85.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 1.0 109.312 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 1.0 109.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -82.2 135.15 35.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 1.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.99 123.08 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 1.0 109.426 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.705 . . . . 1.0 109.365 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.71 136.33 57.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 1.0 109.578 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.94 99.49 12.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 1.0 109.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.4 p -79.54 167.31 20.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -51.06 -42.34 60.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 1.0 109.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.6 -48.7 71.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 1.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.96 -38.92 87.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 1.0 109.4 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.49 -36.68 84.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.532 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -59.94 -42.04 93.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 1.0 109.417 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.97 -43.33 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.95 . . . . 1.0 109.304 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.36 -43.23 78.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 1.0 109.35 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.31 -35.18 80.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 1.0 108.867 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.82 -42.16 99.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0 108.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.86 -42.43 99.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 1.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -56.07 -46.49 78.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 1.0 109.144 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.0 97.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 1.0 109.407 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 1.0 109.319 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.04 -39.36 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 1.0 109.243 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 46.8 p -65.65 -29.92 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.0 109.29 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.92 -18.44 59.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 1.0 109.142 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.58 48.52 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.08 135.29 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -1.138 . . . . 1.0 109.397 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.65 101.41 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 1.0 109.125 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 161.5 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.835 . . . . 1.0 109.352 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.89 145.83 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 109.435 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.24 -41.24 99.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 1.0 109.281 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.04 64.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.426 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' CG ' ' X' ' 55' ' ' PHE . 20.6 t70 -59.12 -39.33 81.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.0 109.417 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.52 -43.08 99.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 1.0 109.417 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.29 -41.55 85.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 1.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.5 -38.37 89.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 1.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.02 -48.65 79.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 1.0 109.419 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -61.88 -42.61 99.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 1.0 109.4 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.51 -34.46 77.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.0 109.332 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.55 -46.25 86.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.539 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.91 -50.92 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.589 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' X' ' 43' ' ' PRO . 68.3 mttm -66.35 -29.88 70.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 1.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.0 m-20 -78.25 -18.59 55.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0 109.675 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 41' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 3.0 m -53.92 -61.28 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 1.0 109.396 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.558 ' N ' ' CD ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -108.98 -50.91 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 1.0 109.568 -176.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' X' ' 42' ' ' CYS . 52.7 Cg_exo -52.7 -39.34 76.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.885 2.39 . . . . 1.0 112.2 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.485 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -147.49 -150.4 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 1.0 109.544 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' X' ' 41' ' ' THR . 0.2 OUTLIER 172.9 69.31 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.877 . . . . 1.0 109.877 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 3.3 Cg_exo -75.72 159.8 38.37 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.693 2.262 . . . . 1.0 112.369 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.25 130.24 45.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 1.0 109.733 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.96 179.8 7.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 1.0 109.763 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.98 -93.43 0.17 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 29.5 m -125.92 144.79 50.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.174 . . . . 1.0 109.35 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.462 HD12 ' H ' ' X' ' 52' ' ' ASP . 0.2 OUTLIER -131.64 132.49 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 1.0 109.544 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.462 ' H ' HD12 ' X' ' 51' ' ' ILE . 65.5 m-20 -66.53 134.04 51.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 109.757 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.31 -29.07 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 1.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -44.61 93.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 1.0 109.44 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . 0.559 ' CG ' ' OD2' ' X' ' 30' ' ' ASP . 4.7 t80 -77.99 -23.22 48.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 1.0 109.285 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.609 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -55.64 -38.08 69.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 1.0 109.639 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.39 -42.1 98.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.933 . . . . 1.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 78.5 mtp85 -67.41 -37.2 82.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 1.0 109.429 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.59 -42.79 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.907 . . . . 1.0 109.356 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.29 91.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -66.82 -37.07 83.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -1.159 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 97.7 m -71.91 -44.62 63.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 1.0 109.553 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 1.0 109.472 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.87 -37.43 79.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 1.0 109.472 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -63.06 -46.25 88.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 1.0 109.32 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -65.77 -31.75 72.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 1.0 109.458 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' X' ' 71' ' ' GLY . 11.2 t80 -59.15 -54.89 41.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 1.0 109.391 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -67.6 -35.65 79.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.853 . . . . 1.0 109.335 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -65.87 -44.02 86.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 1.0 109.345 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.48 -52.55 2.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 1.0 109.275 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -164.47 26.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -73.5 -15.1 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.874 2.383 . . . . 1.0 111.913 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -61.92 -50.22 73.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 1.0 109.198 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -65.62 -43.68 88.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.878 . . . . 1.0 109.396 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 32.7 m -150.08 89.03 4.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 1.0 109.406 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.35 -175.03 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.871 2.381 . . . . 1.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 m -62.32 -18.19 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 109.383 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.1 p -62.05 -31.8 72.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 1.0 109.382 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.79 97.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -67.98 -38.64 82.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.431 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -61.29 -51.3 69.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 1.0 109.356 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -60.8 -44.34 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 1.0 109.417 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.609 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.9 t-105 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 109.351 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -56.35 -44.68 80.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 1.0 109.295 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.27 -40.41 97.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 1.0 109.559 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.25 -42.54 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 1.0 109.327 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.27 -39.94 67.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.495 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.8 -39.09 73.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 1.0 109.413 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.401 ' N ' HD22 ' X' ' 89' ' ' LEU . 3.5 mm? -64.48 -43.96 92.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 1.0 109.356 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' X' ' 93' ' ' LYS . 10.2 pt -76.17 -38.74 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 1.0 109.508 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.2 -45.0 96.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 1.0 109.509 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.88 -41.74 77.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 1.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.3 tttt -85.46 137.82 32.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.0 109.441 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.97 140.86 47.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 1.0 109.531 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 1.0 109.579 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -64.23 133.48 52.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 1.0 109.519 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.73 105.22 16.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 1.0 109.473 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.3 p -87.38 175.13 8.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 1.0 109.58 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.71 -43.63 65.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 1.0 109.435 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . 0.551 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.2 m-70 -67.88 -44.92 75.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 1.0 109.522 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.57 -39.45 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 1.0 109.369 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -62.04 -38.32 88.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.0 109.61 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.1 -41.59 88.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 1.0 109.502 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.65 -44.41 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 1.0 109.33 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -51.02 -46.0 61.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.258 -0.901 . . . . 1.0 109.392 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -66.21 -37.5 85.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 1.0 108.881 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.73 -40.22 96.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.266 -0.896 . . . . 1.0 108.826 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -62.83 -42.4 99.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 1.0 109.544 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -53.61 -45.2 69.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.146 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.23 -38.22 88.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 1.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.39 -38.46 89.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.172 -0.955 . . . . 1.0 109.275 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -57.31 -43.25 83.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.0 109.301 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.6 p -65.17 -24.44 67.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 1.0 109.284 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -82.15 -6.03 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 1.0 109.197 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.7 47.86 1.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.24 -1.544 . . . . 1.0 109.24 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.4 131.82 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -1.101 . . . . 1.0 109.356 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -132.35 88.44 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.98 . . . . 1.0 109.175 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.78 161.99 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 1.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -78.31 148.43 33.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 1.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.83 -35.05 77.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 1.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.39 65.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 1.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' X' ' 52' ' ' ASP . 89.2 m-20 -62.24 -39.62 93.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -62.01 -44.54 96.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 1.0 109.382 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.93 -41.5 99.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 1.0 109.449 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 98.9 mttt -66.27 -31.44 72.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.483 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.28 -46.77 87.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 1.0 109.449 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.15 -44.28 96.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 1.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.77 -47.3 84.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 1.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.71 -47.04 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 1.0 109.565 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.22 -32.23 73.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 1.0 109.379 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.0 m-20 -67.08 -19.59 65.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 1.0 109.663 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.4 m -54.52 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 1.0 109.371 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.65 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -106.95 -61.06 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 109.467 -177.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.65 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.2 Cg_exo -41.25 -45.12 5.63 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.887 2.391 . . . . 1.0 112.218 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.548 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.9 m-90 -135.66 -167.63 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 1.0 109.487 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.72 ' H ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -135.11 -46.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 109.885 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.72 ' CD ' ' H ' ' X' ' 45' ' ' PHE . 28.0 Cg_exo -60.74 142.67 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.73 2.287 . . . . 1.0 112.301 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -117.99 150.67 38.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 1.0 109.643 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -137.77 155.24 49.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.903 . . . . 1.0 109.743 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.55 176.66 47.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 50' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 88.3 m -119.39 135.29 54.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 1.0 109.313 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.94 141.15 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 1.0 109.515 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.43 ' OD2' ' OD1' ' X' ' 30' ' ' ASP . 91.4 m-20 -87.44 138.22 31.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 1.0 109.77 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.95 -40.82 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.081 -1.012 . . . . 1.0 109.445 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.99 -39.31 81.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.0 109.388 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -81.75 -18.06 45.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 1.0 109.277 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.632 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 8.1 t90 -63.73 -37.26 86.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.0 109.638 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -56.81 -43.07 80.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 1.0 109.508 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.493 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 17.2 mtt85 -67.83 -36.44 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 1.0 109.468 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.67 -44.01 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.382 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.47 95.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -67.77 -37.52 82.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 1.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.0 m -64.62 -52.57 56.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 109.448 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.77 -42.51 99.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 1.0 109.479 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.54 -38.95 78.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 1.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OG1' ' X' ' 69' ' ' THR . 98.0 m-20 -62.33 -44.46 96.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 1.0 109.311 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -69.29 -32.99 72.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 1.0 109.379 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' X' ' 71' ' ' GLY . 25.6 t80 -64.07 -55.21 23.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 1.0 109.411 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -70.47 -35.92 73.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 1.0 109.323 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 86.2 m -64.58 -47.16 79.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 1.0 109.301 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.48 -52.51 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 1.0 109.195 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -168.57 25.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' X' ' 76' ' ' PRO . 21.3 Cg_endo -70.08 -18.75 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.985 2.456 . . . . 1.0 111.97 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.92 -51.55 69.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 1.0 109.224 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -65.35 -38.94 91.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 1.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.6 82.49 8.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.8 Cg_exo -56.32 161.11 9.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.885 2.39 . . . . 1.0 112.302 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.44 -5.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 1.0 109.455 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.502 ' H ' ' C ' ' X' ' 76' ' ' PRO . 73.0 p -63.9 -33.48 75.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.873 . . . . 1.0 109.396 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 1.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.94 -46.79 80.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 1.0 109.377 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 75.7 m -59.42 -47.96 83.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 1.0 109.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -62.45 -40.23 95.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.0 109.501 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.632 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.6 t-105 -66.53 -36.03 81.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 1.0 109.441 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -56.24 -44.76 79.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 1.0 109.194 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.94 -39.82 95.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.635 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.0 -43.29 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.344 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.32 -43.3 83.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 1.0 109.438 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -69.45 -35.37 75.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 1.0 109.365 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.42 -47.78 75.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.357 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -74.25 -39.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 1.0 109.402 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -59.37 -46.43 88.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 1.0 109.521 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.91 -41.67 95.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 1.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -69.77 122.6 19.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 1.0 109.483 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.12 102.33 12.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 1.0 109.565 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 96.0 mt-10 -64.39 146.44 54.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 1.0 109.541 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.58 102.58 15.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 1.0 109.508 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.1 p -84.84 171.58 12.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 1.0 109.579 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -57.13 -41.49 79.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 1.0 109.435 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -66.14 -42.26 89.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 1.0 109.511 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 92.5 mt-10 -66.92 -38.23 85.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 1.0 109.428 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.56 -35.04 75.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 1.0 109.583 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.28 -49.0 78.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 1.0 109.41 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -68.21 -32.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -0.972 . . . . 1.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.46 -45.8 90.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.868 . . . . 1.0 109.334 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -62.43 -37.42 85.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 1.0 108.878 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.67 -42.28 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 1.0 108.738 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.31 -44.18 79.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 1.0 109.523 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . 0.544 HE22 ' HZ2' ' X' ' 20' ' ' LYS . 98.5 mm-40 -55.13 -42.93 73.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 1.0 109.116 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.57 -37.77 88.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.78 . . . . 1.0 109.392 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.6 -36.93 85.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.898 . . . . 1.0 109.273 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.544 ' HZ2' HE22 ' X' ' 17' ' ' GLN . 97.6 mttt -58.33 -40.68 82.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 1.0 109.218 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 77.0 p -66.42 -31.22 71.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 1.0 109.263 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.434 HH12 ' CB ' ' X' ' 18' ' ' ALA . 84.1 mtt85 -72.89 -18.26 61.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 1.0 109.212 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.78 46.37 0.78 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.309 -1.517 . . . . 1.0 109.309 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.82 132.98 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 1.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.67 95.82 3.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 1.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.02 158.11 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -0.86 . . . . 1.0 109.359 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.15 145.26 46.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.923 . . . . 1.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -57.17 -33.56 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 1.0 109.271 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.5 70.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 1.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.5 m-20 -59.72 -40.75 89.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 1.0 109.409 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.79 -44.53 96.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 1.0 109.345 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.97 -42.51 97.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 1.0 109.369 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.94 -37.13 85.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 1.0 109.356 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.04 -50.93 72.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 1.0 109.4 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.43 -42.2 98.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 1.0 109.41 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.62 -38.71 91.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.0 109.277 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -62.51 -46.47 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 1.0 109.52 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.2 -50.11 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 1.0 109.373 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' X' ' 44' ' ' TRP . 21.1 m-20 -69.98 -19.86 63.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 1.0 109.686 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -54.72 -59.34 4.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.967 . . . . 1.0 109.426 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.632 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -107.69 -62.02 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 1.0 109.487 -176.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.632 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.24 -41.75 4.87 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.919 2.413 . . . . 1.0 112.201 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.2 m-90 -141.83 -159.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 1.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.511 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -173.75 50.18 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 1.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_endo -70.58 166.69 27.79 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.753 2.302 . . . . 1.0 112.327 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.54 138.73 57.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 1.0 109.712 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.62 136.14 37.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 1.0 109.798 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.8 -173.72 37.96 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 141.37 57.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -1.206 . . . . 1.0 109.293 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.441 HG22 HD12 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -127.46 134.04 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 1.0 109.567 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 30' ' ' ASP . 98.5 m-20 -64.39 137.28 57.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 1.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.15 -23.02 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 1.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.31 -39.48 92.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 1.0 109.41 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -83.26 -10.13 58.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 1.0 109.247 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.626 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.8 t90 -58.76 -38.16 77.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 1.0 109.651 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -62.15 -40.54 96.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.0 109.466 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 74.8 mtp85 -66.08 -39.13 89.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 1.0 109.396 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.95 -43.82 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 1.0 109.39 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.31 -50.7 62.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.74 -41.67 97.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -1.164 . . . . 1.0 109.511 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 81.8 m -65.43 -52.29 54.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 1.0 109.518 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -60.98 -41.46 96.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 1.0 109.498 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -63.85 -38.72 92.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 1.0 109.465 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.95 -45.28 89.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.306 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -68.05 -30.56 69.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 1.0 109.461 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' X' ' 71' ' ' GLY . 14.9 t80 -60.44 -55.09 37.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 1.0 109.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -66.95 -36.51 82.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 1.0 109.345 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -63.85 -47.03 82.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 1.0 109.318 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.35 -52.45 2.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 1.0 109.302 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.47 -164.12 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.4 -15.45 31.17 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.928 2.419 . . . . 1.0 112.001 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.11 -54.44 44.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 1.0 109.16 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -63.27 -44.47 95.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 1.0 109.366 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 34.2 m -148.81 90.57 4.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 1.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.42 -173.84 1.96 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.85 2.367 . . . . 1.0 112.204 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.94 -16.56 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 1.0 109.431 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.422 HG21 ' N ' ' X' ' 79' ' ' ALA . 0.9 OUTLIER -57.71 -32.52 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 1.0 109.345 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.422 ' N ' HG21 ' X' ' 78' ' ' THR . . . -60.13 -42.78 95.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 1.0 109.376 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -65.04 -41.24 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 1.0 109.38 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -59.66 -48.02 83.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -65.51 -43.75 89.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 1.0 109.488 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.626 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.7 t-105 -61.67 -36.46 80.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 1.0 109.389 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -56.77 -43.19 80.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 1.0 109.277 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.48 -41.14 96.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 1.0 109.642 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.5 -41.29 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.927 . . . . 1.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -56.87 -40.04 75.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 1.0 109.497 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.01 -40.62 78.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 1.0 109.434 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.7 -46.11 86.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 1.0 109.33 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.64 -38.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.399 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.46 -45.07 92.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 1.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.95 -45.55 93.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 1.0 109.586 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.8 127.96 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 1.0 109.495 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -91.73 96.09 10.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 1.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 1.0 109.541 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.359 0.599 . . . . 1.0 109.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.07 138.43 58.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 1.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.03 84.63 3.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.576 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.7 p -80.32 172.19 14.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 1.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.6 -43.34 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 1.0 109.447 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . 0.601 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.8 m-70 -68.68 -43.64 75.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 109.484 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.93 -36.59 84.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.0 -38.81 79.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 1.0 109.831 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.27 -49.03 78.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 1.0 109.63 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.22 -35.37 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -62.99 -40.36 97.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.301 -0.874 . . . . 1.0 109.24 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.43 -36.93 85.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.039 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.96 -43.0 99.76 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.25 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.448 ' NZ ' ' CD2' ' X' ' 28' ' ' TYR . 88.6 tttt -61.46 -36.94 81.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 1.0 109.417 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.25 -48.5 80.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.0 109.254 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -68.58 -40.3 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.446 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.65 -38.75 92.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 1.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.86 -39.7 95.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.306 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.2 p -61.77 -29.38 70.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 1.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.15 -17.51 63.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.588 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.13 44.55 0.67 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . 0.437 ' CG1' ' HE ' ' X' ' 58' ' ' ARG . 30.9 t -122.98 135.64 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.667 -0.902 . . . . 1.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -135.49 99.74 4.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 1.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.54 164.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.485 -0.76 . . . . 1.0 109.625 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.12 146.26 47.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.353 -0.842 . . . . 1.0 109.512 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.448 ' CD2' ' NZ ' ' X' ' 16' ' ' LYS . 94.7 m-85 -62.83 -37.39 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.05 -1.031 . . . . 1.0 109.371 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.49 -34.23 66.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -39.67 90.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 1.0 109.113 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.23 -43.55 98.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.0 109.526 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.71 -42.27 97.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 1.0 109.33 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.1 -30.86 71.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 1.0 109.18 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -61.39 -50.21 73.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 1.0 109.607 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -62.28 -46.56 88.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 1.0 109.547 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -65.52 -38.18 88.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.208 -0.932 . . . . 1.0 109.231 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.25 -45.64 93.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 1.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.27 -48.63 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 1.0 109.693 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -67.8 -28.46 67.61 Favored 'General case' 0 C--O 1.192 -1.94 0 O-C-N 121.171 -0.956 . . . . 1.0 108.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.562 ' OD1' ' CZ2' ' X' ' 44' ' ' TRP . 71.0 m-20 -77.93 -20.71 52.3 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 120.032 -1.667 . . . . 1.0 109.796 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 m -54.34 -60.91 2.71 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.99 -1.069 . . . . 1.0 111.275 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 42' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -101.84 -53.95 0.14 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.512 -0.743 . . . . 1.0 110.858 -178.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 43' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' X' ' 42' ' ' CYS . 89.1 Cg_exo -46.02 -43.0 20.68 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.514 2.143 . . . . 1.0 112.601 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 44' ' ' TRP . . . . . 0.562 ' CZ2' ' OD1' ' X' ' 40' ' ' ASP . 0.1 OUTLIER -176.56 131.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 1.0 109.207 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 45' ' ' PHE . . . . . 0.523 ' CE2' ' CD2' ' X' ' 82' ' ' TYR . 0.2 OUTLIER -104.69 105.95 52.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 1.0 109.775 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 46' ' ' PRO . . . . . 0.403 ' CG ' ' HE1' ' X' ' 44' ' ' TRP . 56.4 Cg_endo -83.2 -164.46 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.778 2.318 . . . . 1.0 111.918 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -90.57 122.36 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.363 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.01 154.76 17.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.461 -0.774 . . . . 1.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.19 -93.99 2.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 27.3 m -130.92 137.4 49.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -1.007 . . . . 1.0 109.434 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.457 HD13 HG22 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -112.67 139.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.543 -0.723 . . . . 1.0 109.381 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.435 ' H ' HD12 ' X' ' 51' ' ' ILE . 85.5 m-20 -68.85 136.61 52.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 1.0 109.76 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.57 -27.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -0.997 . . . . 1.0 109.537 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.68 -41.87 95.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.024 -1.047 . . . . 1.0 109.777 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -75.88 -17.03 59.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 1.0 109.839 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.9 t90 -60.61 -37.74 82.41 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.288 -0.883 . . . . 1.0 109.954 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -59.44 -44.51 92.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 1.0 109.673 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.437 ' HE ' ' CG1' ' X' ' 24' ' ' VAL . 19.0 mtt85 -64.79 -40.01 94.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.54 -43.67 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.85 -46.92 92.6 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -67.88 -42.1 81.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -1.2 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.98 -51.6 66.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 1.0 109.639 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.98 -44.21 87.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 1.0 109.527 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -56.41 -40.62 74.99 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.272 -0.892 . . . . 1.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.415 ' O ' ' OG1' ' X' ' 69' ' ' THR . 25.5 m-20 -66.69 -43.29 84.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 1.0 109.324 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -62.86 -35.7 80.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 1.0 109.269 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.515 ' CE2' ' OD1' ' X' ' 68' ' ' ASN . 3.4 t80 -59.26 -55.0 40.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.515 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 84.9 m-20 -65.13 -34.56 78.7 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.041 -1.037 . . . . 1.0 109.771 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 20.2 m -64.16 -48.93 74.08 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.288 -0.883 . . . . 1.0 110.012 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -114.7 -51.93 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.651 -0.655 . . . . 1.0 109.871 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 143.45 -168.87 26.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' X' ' 76' ' ' PRO . 7.4 Cg_exo -67.03 -21.76 48.9 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.998 2.465 . . . . 1.0 111.987 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.91 -51.01 69.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 1.0 109.457 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.53 -45.08 88.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 1.0 109.808 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 26.6 m -142.8 82.4 12.34 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.0 109.356 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' X' ' 72' ' ' PRO . 51.5 Cg_endo -79.59 -172.33 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.911 2.407 . . . . 1.0 112.31 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.46 -20.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.922 . . . . 1.0 109.524 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 22.2 p -62.63 -37.85 87.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 1.0 109.563 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.25 79.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 1.0 109.56 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -65.68 -37.06 85.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 1.0 109.416 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -61.6 -45.3 94.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 1.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.523 ' CD2' ' CE2' ' X' ' 45' ' ' PHE . 38.3 m-85 -63.74 -44.24 94.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 1.0 109.732 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.634 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.7 t-105 -64.43 -37.56 87.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.282 -0.886 . . . . 1.0 109.296 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -55.99 -41.73 75.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 1.0 108.829 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.57 -40.39 92.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 1.0 109.297 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -64.22 -42.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 1.0 109.485 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -54.81 -39.32 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 1.0 109.264 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -70.39 -39.46 74.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 1.0 109.478 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.45 -46.0 90.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 1.0 110.139 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.19 -31.98 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.518 -0.739 . . . . 1.0 109.566 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.56 -40.55 92.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 1.0 109.374 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.37 -40.19 93.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.0 109.454 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -94.63 115.16 27.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.189 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.97 122.1 28.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 1.0 109.457 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 1.0 109.409 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mtm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.1 9.76 84.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.49 149.96 51.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -1.164 . . . . 1.0 109.499 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.15 139.31 52.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 1.0 109.568 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 67.9 mt -90.86 104.08 16.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.855 . . . . 1.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.8 p -82.27 168.63 17.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 1.0 109.565 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -53.84 -41.39 67.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 1.0 109.489 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -66.39 -45.64 79.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 1.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -62.96 -35.99 81.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 1.0 109.428 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.43 -36.97 85.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 1.0 109.578 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -61.63 -41.74 97.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.404 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 t -59.63 -43.32 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.297 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -56.33 -46.92 79.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.228 -0.92 . . . . 1.0 109.347 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.98 -38.0 89.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 1.0 108.884 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.88 -41.51 99.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 1.0 108.772 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.77 -37.73 79.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 1.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -59.15 -44.98 92.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 1.0 109.099 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.51 -37.35 86.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 1.0 109.344 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.78 -39.1 93.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 1.0 109.338 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.26 -42.53 86.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 1.0 109.325 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.9 p -63.68 -31.73 72.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 1.0 109.342 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.58 -18.6 61.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 1.0 109.24 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.87 47.85 0.65 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.62 132.92 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 1.0 109.466 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.8 93.96 3.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.144 -0.973 . . . . 1.0 109.226 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.36 160.65 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 1.0 109.363 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -72.73 151.45 42.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 1.0 109.453 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.67 -40.17 92.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.872 . . . . 1.0 109.257 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.58 57.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.0 109.487 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -61.44 -37.5 83.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 1.0 109.409 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -62.23 -45.28 94.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 1.0 109.369 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.91 -41.41 97.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 1.0 109.405 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 1.0 109.415 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -56.63 -49.14 75.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 1.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -59.95 -42.23 93.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 1.0 109.419 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.22 -44.13 95.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.0 109.292 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -61.2 -45.48 94.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 1.0 109.548 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.93 -44.69 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 1.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 69.9 tttt -64.2 -31.51 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 1.0 109.436 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' X' ' 44' ' ' TRP . 99.0 m-20 -70.7 -19.32 62.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 1.0 109.587 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 30.9 m -53.89 -52.25 61.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 1.0 109.378 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.698 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -116.13 -60.73 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 1.0 109.504 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 74.0 Cg_exo -41.5 -54.58 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.868 2.379 . . . . 1.0 112.203 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.52 ' O ' ' O ' ' X' ' 40' ' ' ASP . 8.4 m0 -127.65 113.01 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 1.0 109.58 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -61.49 -44.52 92.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 1.0 109.81 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.4 Cg_exo -59.6 141.71 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.699 2.266 . . . . 1.0 112.378 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -97.99 159.21 15.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 1.0 109.665 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.43 133.7 12.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.846 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.94 155.23 22.74 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.794 -1.323 . . . . 1.0 109.794 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -91.91 135.08 34.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 1.0 109.303 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.447 HD12 HG21 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -102.21 134.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 1.0 109.518 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -75.55 137.94 41.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 1.0 109.756 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.95 -34.19 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 1.0 109.392 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.695 ' HZ1' ' H ' ' X' ' 99' ' ' VAL . 98.1 mttt -63.85 -38.05 89.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 1.0 109.452 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.18 -20.36 52.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 1.0 109.245 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.597 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 13.5 t90 -56.18 -33.95 65.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 1.0 109.719 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -59.89 -41.98 92.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 1.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.431 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 72.8 mtp180 -66.38 -39.68 89.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 1.0 109.515 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.76 -43.11 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.342 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.33 -46.61 93.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -70.02 -42.2 73.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 1.0 109.494 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.1 m -63.86 -48.41 76.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 1.0 109.544 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.84 -39.35 91.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 1.0 109.493 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -61.93 -39.67 92.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 1.0 109.456 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' X' ' 69' ' ' THR . 52.6 m-20 -63.07 -44.1 96.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 1.0 109.236 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -65.47 -35.15 80.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 1.0 109.475 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' X' ' 71' ' ' GLY . 5.1 t80 -59.05 -54.39 47.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.87 . . . . 1.0 109.45 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 95.0 m-20 -65.74 -36.57 83.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 1.0 109.311 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 17.0 m -62.93 -47.99 80.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 1.0 109.299 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.76 -52.36 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 1.0 109.209 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.26 -165.93 25.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.459 -1.457 . . . . 1.0 109.459 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -67.19 -16.56 48.99 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.953 2.435 . . . . 1.0 111.952 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.55 -54.6 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 1.0 109.198 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -63.74 -43.6 95.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 1.0 109.404 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 27.3 m -148.63 92.42 4.47 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 1.0 109.431 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.55 -166.55 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.873 2.382 . . . . 1.0 112.166 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.66 -12.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 1.0 109.416 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -66.17 -33.2 75.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 1.0 109.421 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.15 -47.18 81.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.446 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -64.92 -45.67 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 1.0 109.4 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -59.77 -47.12 86.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 1.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -63.15 -40.89 98.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 1.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.597 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.5 t-105 -61.69 -37.98 86.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.05 -42.57 76.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.882 . . . . 1.0 109.223 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.31 -41.59 98.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 1.0 109.586 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -63.75 -43.53 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -0.941 . . . . 1.0 109.412 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.54 -37.63 58.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.0 109.501 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.21 -42.3 72.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.0 109.309 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.32 -48.02 83.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 1.0 109.396 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -72.69 -36.74 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.914 . . . . 1.0 109.434 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -63.11 -39.74 95.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 1.0 109.536 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -63.62 -40.96 98.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 1.0 109.57 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -88.75 117.48 27.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 1.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.75 138.17 56.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 1.0 109.564 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.86 162.46 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 1.0 109.572 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -125.29 82.17 62.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 1.0 109.604 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.28 -147.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.875 2.383 . . . . 1.0 112.301 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -65.89 -49.67 67.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.893 . . . . 1.0 109.411 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.695 ' H ' ' HZ1' ' X' ' 54' ' ' LYS . 59.0 t -123.97 130.31 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 1.0 109.515 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.98 -1.01 . . . . 1.0 109.528 179.762 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.89 79.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -95.41 157.76 15.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.407 -1.055 . . . . 1.0 109.523 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.3 130.81 46.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 1.0 109.423 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 64.4 mt -91.93 104.66 17.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 1.0 109.717 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -82.46 168.37 17.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.434 -0.791 . . . . 1.0 109.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.96 -41.46 67.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 1.0 109.413 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.76 -45.13 79.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 1.0 109.606 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.85 -31.67 73.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.2 -0.938 . . . . 1.0 109.344 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -70.74 -40.65 72.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 1.0 109.925 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -60.66 -49.75 76.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 1.0 109.644 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -65.19 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 1.0 109.361 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.61 -40.96 93.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 1.0 109.019 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.22 -36.41 84.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 1.0 108.875 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.7 -41.42 99.12 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 109.126 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.6 -40.71 88.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 1.0 109.329 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -59.38 -44.57 92.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 1.0 109.046 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.08 -38.61 91.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.301 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.1 -40.98 87.02 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.021 -1.05 . . . . 1.0 109.207 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.41 -30.61 71.34 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.991 -1.068 . . . . 1.0 109.162 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 31.4 p -77.06 -31.46 56.12 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.346 -0.846 . . . . 1.0 109.535 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.429 ' HE ' ' CG2' ' X' ' 24' ' ' VAL . 15.9 ptt85 -75.57 -19.3 59.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.112 -0.993 . . . . 1.0 109.29 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.73 48.47 0.3 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . 0.429 ' CG2' ' HE ' ' X' ' 22' ' ' ARG . 69.7 t -123.11 139.47 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 1.0 109.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . 0.469 ' C ' HE22 ' X' ' 98' ' ' GLN . 99.1 mttt -125.39 98.2 5.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.743 . . . . 1.0 109.312 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -132.04 138.63 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 1.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.94 150.15 39.17 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.361 -0.837 . . . . 1.0 109.631 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.15 -35.36 80.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 1.0 109.128 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 1.0 109.305 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -62.88 -37.47 87.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.185 -0.947 . . . . 1.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.11 -44.77 94.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 1.0 109.631 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.67 -43.11 94.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 1.0 109.429 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 1.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.86 -48.45 78.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 1.0 109.571 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.82 -41.05 97.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 109.209 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.41 -44.93 95.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 1.0 109.271 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.48 -48.07 79.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.58 -45.03 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.908 . . . . 1.0 109.327 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 51.4 tttm -64.38 -34.22 77.66 Favored 'General case' 0 C--O 1.2 -1.516 0 CA-C-O 122.103 0.954 . . . . 1.0 108.938 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 2.9 m-20 -69.42 -20.73 63.79 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 120.242 -1.536 . . . . 1.0 109.646 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -54.28 -61.04 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.0 110.926 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.455 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -102.68 -59.09 0.09 OUTLIER Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.334 -0.854 . . . . 1.0 110.728 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.8 Cg_exo -41.7 -48.6 5.72 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.599 2.199 . . . . 1.0 112.697 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -125.53 -118.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.0 109.03 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.631 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.9 OUTLIER -177.58 -41.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.0 110.227 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.8 Cg_exo -60.84 141.41 94.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.728 2.286 . . . . 1.0 112.231 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.11 164.29 15.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 1.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.0 161.12 30.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 1.0 109.753 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.03 -2.86 58.1 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.086 -1.206 . . . . 1.0 110.086 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -119.63 116.12 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.978 . . . . 1.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' X' ' 51' ' ' ILE . 0.3 OUTLIER -135.84 132.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.156 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -72.46 131.34 42.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.83 -1.169 . . . . 1.0 109.884 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.26 -42.44 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 1.0 109.581 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -57.37 -42.07 81.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.159 . . . . 1.0 109.43 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . 0.519 ' CE2' ' CG2' ' X' ' 59' ' ' VAL . 86.2 t80 -77.08 -23.76 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 1.0 109.757 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.643 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -59.56 -38.8 82.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.975 . . . . 1.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -57.09 -44.42 83.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.218 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.5 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 77.8 mtp85 -66.69 -39.02 87.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 1.0 109.487 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . 0.519 ' CG2' ' CE2' ' X' ' 55' ' ' PHE . 59.2 t -62.4 -44.1 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 1.0 109.46 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.01 73.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -65.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -1.133 . . . . 1.0 109.498 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 74.0 m -66.33 -55.16 17.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 1.0 109.715 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.52 -37.83 85.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 1.0 109.548 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -38.35 90.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 1.0 109.303 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 1.0 109.438 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -64.8 -35.44 81.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.895 . . . . 1.0 109.579 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' X' ' 71' ' ' GLY . 0.9 OUTLIER -62.15 -54.06 46.54 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.261 -0.9 . . . . 1.0 109.834 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 35.0 t-20 -64.42 -35.52 81.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.909 -1.12 . . . . 1.0 109.674 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -67.24 -46.14 74.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.288 -0.883 . . . . 1.0 109.69 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -115.15 -52.05 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.691 -0.631 . . . . 1.0 109.901 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.76 -169.19 24.23 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' X' ' 76' ' ' PRO . 13.1 Cg_exo -63.33 -22.87 72.04 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.946 2.431 . . . . 1.0 111.99 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.79 -53.06 57.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 1.0 109.346 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -65.37 -43.91 89.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.299 -0.875 . . . . 1.0 109.751 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 m -138.79 84.52 17.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.612 -0.68 . . . . 1.0 109.285 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.592 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.5 Cg_exo -60.12 152.8 62.97 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.841 2.36 . . . . 1.0 112.153 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -52.03 -4.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.968 . . . . 1.0 109.707 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.592 ' H ' ' C ' ' X' ' 76' ' ' PRO . 51.5 p -65.49 -38.62 90.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.132 -0.98 . . . . 1.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.15 77.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 1.0 109.434 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -62.6 -45.83 91.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 1.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 65.9 m -61.05 -46.76 89.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.72 -37.48 87.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 1.0 109.431 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.643 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.2 t-105 -66.75 -35.17 79.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 1.0 109.214 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -58.07 -45.36 87.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 1.0 108.865 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.72 -42.02 99.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 1.0 109.413 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.6 -45.06 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 1.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -54.19 -44.27 71.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 1.0 109.508 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.98 -35.26 76.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.067 -1.02 . . . . 1.0 109.466 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.22 -49.09 71.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.089 -1.007 . . . . 1.0 110.014 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' X' ' 93' ' ' LYS . 6.0 pt -71.77 -43.07 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 1.0 109.517 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -62.01 -48.34 80.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.68 -44.7 92.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 1.0 109.712 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.5 tttt -81.34 143.25 32.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 1.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.08 138.4 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 1.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' X' ' 96' ' ' ASN . 9.2 p -136.1 164.42 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.775 . . . . 1.0 109.369 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.405 ' N ' ' CG2' ' X' ' 95' ' ' VAL . 15.5 t-20 -122.64 82.81 48.22 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.676 -0.64 . . . . 1.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.97 -166.09 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.022 2.481 . . . . 1.0 112.247 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . 0.469 HE22 ' C ' ' X' ' 25' ' ' LYS . 88.0 mt-30 -64.62 -43.65 93.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 1.0 109.48 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.9 t -124.18 129.05 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.525 -0.735 . . . . 1.0 109.387 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.9 mtp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.972 -1.013 . . . . 1.0 109.389 179.961 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 41.4 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.53 21.97 54.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -128.52 158.31 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.658 -0.907 . . . . 1.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' X' ' 4' ' ' GLU . 56.7 mp0 -58.61 144.22 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.231 -0.918 . . . . 1.0 109.436 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 60.4 mt -97.32 101.92 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 82.4 p -80.02 170.97 15.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 1.0 109.497 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.09 -42.02 79.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 1.0 109.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.31 -45.33 80.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 1.0 109.554 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 96.7 mt-10 -62.82 -36.68 83.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 1.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.32 -40.39 97.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 1.0 109.636 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.11 -37.82 81.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 1.0 109.069 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.32 -44.74 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 1.0 109.043 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -56.09 -47.79 77.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0 109.314 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 1.0 109.002 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.283 -0.885 . . . . 1.0 109.181 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.529 ' HZ1' ' C ' ' X' ' 27' ' ' LYS . 86.0 tttt -60.35 -42.01 94.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 1.0 109.063 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -55.05 -44.69 74.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 1.0 109.111 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.08 86.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 1.0 109.168 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.94 -39.26 94.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 1.0 109.086 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.82 -41.02 90.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.382 -0.824 . . . . 1.0 109.278 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 13.8 m -59.38 -39.06 82.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 1.0 109.225 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.81 -17.81 64.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 1.0 109.26 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.67 46.57 0.96 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.358 -1.497 . . . . 1.0 109.358 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.96 134.73 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.643 -0.916 . . . . 1.0 109.374 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . 0.405 ' O ' ' OE1' ' X' ' 98' ' ' GLN . 70.2 mmtt -124.46 106.75 10.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.637 -0.664 . . . . 1.0 109.231 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.518 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 53.7 t -135.9 159.14 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.657 -0.652 . . . . 1.0 109.531 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . 0.529 ' C ' ' HZ1' ' X' ' 16' ' ' LYS . 99.7 mttt -81.27 143.64 32.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.381 -0.825 . . . . 1.0 109.717 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.47 ' N ' ' NZ ' ' X' ' 16' ' ' LYS . 88.3 t80 -59.59 -39.2 83.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 1.0 109.354 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.17 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 1.0 109.543 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -64.42 -38.57 91.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 1.0 109.167 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.79 -46.06 89.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 1.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.4 -42.39 98.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 1.0 109.572 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 -36.02 82.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 1.0 109.357 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -60.48 -49.56 77.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 1.0 109.806 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.37 -44.61 90.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 1.0 109.787 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.92 -44.2 96.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 1.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . 0.468 ' O ' ' OG1' ' X' ' 41' ' ' THR . 84.2 t80 -64.11 -45.46 88.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 1.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.36 -43.41 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.275 -0.891 . . . . 1.0 109.95 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.55 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -76.24 -29.19 57.41 Favored 'General case' 0 C--O 1.187 -2.19 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' X' ' 44' ' ' TRP . 79.1 m-20 -78.17 -21.79 49.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.052 0.929 . . . . 1.0 109.83 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 41' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 37' ' ' PHE . 11.3 m -62.72 -51.27 67.83 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.363 -1.461 . . . . 1.0 111.669 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -65.11 -64.28 2.79 Favored Pre-proline 0 C--N 1.296 -1.74 0 O-C-N 121.448 -0.782 . . . . 1.0 110.998 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.55 ' CG ' ' O ' ' X' ' 39' ' ' LYS . 27.7 Cg_endo -61.23 -54.19 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.723 2.282 . . . . 1.0 112.792 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.65 ' CD2' ' O ' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -173.67 139.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.092 -1.005 . . . . 1.0 109.287 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.518 ' N ' ' HD3' ' X' ' 46' ' ' PRO . 11.8 p90 -154.42 54.93 1.15 Allowed Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 120.671 -1.268 . . . . 1.0 110.002 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 38.9 Cg_endo -78.97 -23.0 8.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.673 2.248 . . . . 1.0 112.53 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -75.97 156.16 34.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.905 . . . . 1.0 109.629 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -132.39 151.83 51.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.573 -0.704 . . . . 1.0 109.49 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' X' ' 86' ' ' ILE . . . -150.74 -176.67 23.9 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.2 m -77.37 144.05 38.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -1.18 . . . . 1.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.423 HG22 HD12 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -135.29 134.45 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.494 -0.753 . . . . 1.0 109.227 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' X' ' 53' ' ' ILE . 66.2 t0 -65.33 135.62 55.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.932 -1.105 . . . . 1.0 109.801 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 97.2 mt -69.54 -42.29 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.917 -1.115 . . . . 1.0 109.436 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.65 -39.84 77.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 1.0 109.171 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -70.5 -36.63 73.91 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.298 -0.876 . . . . 1.0 109.506 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.645 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 17.3 t90 -52.78 -37.79 60.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.163 -0.961 . . . . 1.0 109.458 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -57.32 -44.8 84.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 1.0 109.234 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 80.1 mtp85 -67.96 -43.15 79.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 1.0 109.514 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.5 -43.73 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 1.0 109.467 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.32 -48.81 77.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.49 -38.12 86.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -1.18 . . . . 1.0 109.645 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.4 m -66.73 -48.7 68.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 1.0 109.693 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.92 -46.19 88.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.333 -0.854 . . . . 1.0 109.545 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -57.13 -40.63 77.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 1.0 109.354 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -63.13 -45.97 89.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.0 109.353 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -64.84 -30.95 71.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 1.0 109.449 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.506 ' O ' ' N ' ' X' ' 71' ' ' GLY . 2.1 t80 -63.26 -54.78 31.92 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.357 -0.839 . . . . 1.0 109.847 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.418 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 76.4 m-20 -65.82 -38.97 90.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.876 -1.14 . . . . 1.0 109.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -62.5 -49.56 74.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.295 -0.878 . . . . 1.0 109.958 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.69 -51.76 2.85 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.996 -0.682 . . . . 1.0 109.97 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.41 -169.46 24.79 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.1 -20.06 50.57 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.985 2.456 . . . . 1.0 112.014 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -57.24 -51.91 67.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.97 . . . . 1.0 109.366 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.94 -46.21 82.52 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 1.0 110.004 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 29.8 m -146.01 86.84 6.94 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.537 -0.727 . . . . 1.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.42 -166.51 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.865 2.376 . . . . 1.0 112.41 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.71 -15.97 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.0 109.662 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 36.9 p -61.73 -34.14 75.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 1.0 109.277 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.55 -45.45 75.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.62 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -63.91 -46.15 86.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -61.53 -46.47 89.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 1.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.05 -42.13 98.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 1.0 109.538 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.645 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.8 t-105 -64.53 -36.73 85.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 1.0 109.163 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -55.85 -44.98 78.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 1.0 108.933 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.99 -42.94 99.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0 109.498 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' X' ' 49' ' ' GLY . 1.5 mm -61.46 -41.83 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 1.0 109.49 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.66 -36.87 67.54 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.372 -0.83 . . . . 1.0 109.181 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.86 -41.29 71.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 1.0 109.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.89 -46.98 87.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 1.0 110.403 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 6.4 pt -71.54 -41.91 72.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -0.821 . . . . 1.0 109.704 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.78 -46.71 89.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.888 . . . . 1.0 109.326 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -45.81 90.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 1.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.17 133.0 39.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 1.0 109.453 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.78 126.46 31.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 1.0 109.437 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' X' ' 96' ' ' ASN . 9.3 p -133.43 168.76 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.521 -0.737 . . . . 1.0 109.329 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.454 ' N ' ' CG2' ' X' ' 95' ' ' VAL . 17.6 t-20 -125.11 81.61 62.86 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.708 -0.62 . . . . 1.0 109.471 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -81.74 -168.67 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.965 2.444 . . . . 1.0 112.265 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . 0.405 ' OE1' ' O ' ' X' ' 25' ' ' LYS . 86.2 mt-30 -66.59 -43.52 84.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 1.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 53.8 t -125.0 133.57 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 1.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.065 -0.969 . . . . 1.0 109.479 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.03 4.63 86.76 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.532 -1.427 . . . . 1.0 109.532 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -129.24 159.87 34.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -1.136 . . . . 1.0 109.451 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.467 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.7 mt-10 -56.46 141.77 41.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 1.0 109.555 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 86.3 mt -96.89 105.37 17.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 1.0 109.506 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -83.44 172.46 12.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 1.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -56.56 -46.58 80.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 1.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . 0.58 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 3.2 m-70 -66.59 -44.01 83.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 1.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 81.5 mt-10 -60.17 -38.75 84.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 1.0 109.425 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -63.64 -38.48 91.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 1.0 109.555 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.14 -40.22 89.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 1.0 109.468 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.68 -44.37 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 1.0 109.307 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.15 -41.67 75.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 1.0 109.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -66.22 -36.27 82.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 1.0 108.896 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.47 -41.11 98.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.228 -0.92 . . . . 1.0 108.815 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -40.9 98.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.0 109.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.49 -45.27 85.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 1.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.77 85.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 1.0 109.377 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.77 -38.66 91.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 1.0 109.364 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.42 -35.54 76.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 1.0 109.316 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -66.16 -39.53 89.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 1.0 109.351 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -68.55 -19.12 64.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.845 . . . . 1.0 109.255 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.22 50.01 0.48 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.97 129.84 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -1.151 . . . . 1.0 109.436 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -126.74 101.73 6.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 1.0 109.145 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.78 162.46 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 1.0 109.36 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.34 145.07 39.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.886 . . . . 1.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -59.94 -39.28 85.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.237 -0.914 . . . . 1.0 109.34 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.55 68.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 1.0 109.414 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.0 -39.62 86.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 1.0 109.392 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -63.01 -43.76 97.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 1.0 109.393 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.47 -41.52 98.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 1.0 109.435 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.31 -38.53 91.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 1.0 109.42 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.97 -49.06 78.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 1.0 109.412 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -64.01 -45.81 87.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.0 109.365 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -58.52 -43.06 89.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 1.0 109.317 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -66.4 -43.49 85.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 1.0 109.523 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.42 -45.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 1.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' CH2' ' X' ' 44' ' ' TRP . 44.5 tttm -66.62 -32.85 74.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.43 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.9 m-20 -68.85 -19.53 64.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 1.0 109.688 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 41' ' ' THR . . . . . 0.407 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 6.4 m -54.01 -61.37 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.0 109.418 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.63 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.71 -60.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 -177.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 71.4 Cg_exo -41.67 -51.81 4.16 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.891 2.394 . . . . 1.0 112.232 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.585 ' CH2' ' NZ ' ' X' ' 39' ' ' LYS . 6.5 m0 -132.95 -149.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 1.0 109.551 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.621 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.45 -44.91 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 1.0 109.877 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 36.1 Cg_exo -56.47 -31.74 86.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.725 2.283 . . . . 1.0 112.367 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.09 125.01 24.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 1.0 109.65 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -132.18 159.51 38.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.43 156.42 27.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -64.09 142.8 58.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.178 . . . . 1.0 109.382 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' X' ' 51' ' ' ILE . 0.3 OUTLIER -126.73 133.28 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 1.0 109.548 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.414 ' N ' ' CD1' ' X' ' 51' ' ' ILE . 83.8 m-20 -72.12 135.61 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 1.0 109.756 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 1.0 109.423 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.28 -41.15 97.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 1.0 109.373 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -81.51 -17.48 48.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.0 109.299 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.544 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -58.44 -37.45 75.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.997 . . . . 1.0 109.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.16 -43.47 92.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 1.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -67.09 -37.03 83.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 1.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.65 -43.22 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 1.0 109.33 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.56 -47.46 90.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.504 -1.439 . . . . 1.0 109.504 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.01 -40.34 82.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 1.0 109.44 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.0 m -65.78 -50.28 65.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 1.0 109.439 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.79 -43.2 94.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 1.0 109.519 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -61.99 -33.41 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.0 109.517 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -65.12 -43.01 93.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 1.0 109.335 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.87 -34.96 74.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 1.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' X' ' 71' ' ' GLY . 19.9 t80 -60.26 -54.85 40.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.61 -36.53 82.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.0 109.351 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -64.59 -47.14 79.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 1.0 109.313 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.68 -52.68 2.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 1.0 109.264 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.81 -164.53 26.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -73.45 -14.27 25.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.928 2.418 . . . . 1.0 111.983 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -61.49 -49.76 75.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.0 109.284 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.55 -46.3 73.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 1.0 109.324 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.453 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 35.5 m -147.24 89.28 5.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 1.0 109.484 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.23 -170.23 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.83 2.353 . . . . 1.0 112.186 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.82 -18.23 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 1.0 109.406 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.6 p -58.55 -30.86 67.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.413 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 1.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.85 -39.66 93.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 1.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 64.7 m -61.79 -46.02 91.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 1.0 109.403 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' CZ ' ' X' ' 45' ' ' PHE . 36.7 m-85 -66.64 -42.38 86.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.877 . . . . 1.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.544 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t-105 -63.86 -34.63 78.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.0 109.289 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.3 -41.05 83.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 1.0 109.202 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.61 -42.44 98.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 1.0 109.577 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.3 -41.38 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 1.0 109.394 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.515 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 47.5 mttt -53.62 -41.36 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 1.0 109.424 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.56 -37.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 1.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.72 -48.69 76.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 1.0 109.378 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -73.31 -41.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 1.0 109.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.09 -42.29 98.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 1.0 109.454 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -64.76 -42.5 95.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 1.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.18 130.28 35.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 1.0 109.459 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.71 114.88 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 1.0 109.524 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p -141.33 151.08 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 1.0 109.62 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.513 HD22 ' H ' ' X' ' 100' ' ' MET . 12.6 t-20 -125.13 83.85 60.09 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 1.0 109.506 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.42 -40.36 85.98 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.878 2.385 . . . . 1.0 112.303 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -151.87 -81.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 1.0 109.439 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.86 101.69 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.548 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 100' ' ' MET . . . . . 0.513 ' H ' HD22 ' X' ' 96' ' ' ASN . 94.1 mtp . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.003 -0.998 . . . . 1.0 109.515 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.9 ttp . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.31 8.51 81.18 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -91.15 158.26 16.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 1.0 109.487 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.73 132.34 36.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.97 102.78 15.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.87 . . . . 1.0 109.506 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -82.95 175.66 9.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.0 109.616 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -54.11 -45.55 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 1.0 109.483 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.98 -43.59 87.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.565 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -60.07 -39.46 86.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 1.0 109.387 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.8 -38.18 89.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 1.0 109.606 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -61.79 -35.85 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.911 . . . . 1.0 109.437 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.01 -43.71 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 1.0 109.318 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.55 -44.69 93.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 1.0 109.312 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.6 -37.95 83.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.179 -0.95 . . . . 1.0 108.91 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.74 -40.3 94.6 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.279 -0.888 . . . . 1.0 108.747 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.577 ' HZ3' ' N ' ' X' ' 28' ' ' TYR . 88.6 tttt -62.58 -41.1 98.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 1.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.62 -44.65 85.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.922 . . . . 1.0 109.139 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.4 -41.06 98.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.445 -0.785 . . . . 1.0 109.412 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.81 -38.03 89.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 1.0 109.251 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -58.62 -43.08 89.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.0 109.228 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.4 p -63.16 -31.26 72.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 1.0 109.384 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.83 -15.79 61.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 1.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.31 47.16 0.82 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.3 134.28 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -1.123 . . . . 1.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.7 92.98 3.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.937 . . . . 1.0 109.209 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.84 160.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 1.0 109.298 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.0 143.43 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 1.0 109.486 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.577 ' N ' ' HZ3' ' X' ' 16' ' ' LYS . 89.6 t80 -61.68 -38.48 87.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 1.0 109.296 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.81 65.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 1.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.0 m-20 -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 1.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.62 -44.58 96.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 1.0 109.391 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.37 -43.74 96.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 1.0 109.329 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.07 -37.45 85.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 1.0 109.378 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.66 -48.13 75.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 1.0 109.376 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -60.95 -41.59 96.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 1.0 109.391 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -65.14 -40.34 94.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 1.0 109.214 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.83 -42.71 99.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 1.0 109.51 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.37 -46.13 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 1.0 109.575 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 1.0 109.404 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' X' ' 44' ' ' TRP . 85.5 m-20 -70.64 -19.3 62.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 1.0 109.694 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 41' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 22.2 m -54.9 -52.92 61.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.0 109.445 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.617 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -112.89 -63.65 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 1.0 109.466 -177.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.617 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.09 -40.61 4.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.904 2.403 . . . . 1.0 112.15 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.4 m-90 -146.08 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 1.0 109.537 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 172.29 -45.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 1.0 109.889 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.5 Cg_exo -56.1 -35.37 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.693 2.262 . . . . 1.0 112.368 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -64.4 127.98 33.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 1.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -142.15 168.85 18.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 109.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.88 165.63 37.69 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 15.6 m -64.31 141.3 58.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -1.217 . . . . 1.0 109.371 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.443 HG22 HD12 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -130.0 135.12 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 30' ' ' ASP . 38.8 m-20 -68.85 138.25 54.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 1.0 109.779 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.91 -25.02 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 1.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.97 -40.49 95.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 1.0 109.358 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -76.21 -18.74 58.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 1.0 109.258 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.3 t90 -54.64 -39.09 67.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -62.66 -41.31 99.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.0 109.496 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.416 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 79.0 mtp85 -66.61 -38.46 87.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 1.0 109.477 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.31 -43.98 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 1.0 109.441 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.7 84.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 1.0 109.511 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -66.18 -37.27 85.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -1.197 . . . . 1.0 109.512 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 82.5 m -69.95 -50.43 42.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 1.0 109.522 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.11 -43.09 99.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 1.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.6 -40.14 86.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 1.0 109.439 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.68 -45.91 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 1.0 109.373 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -64.53 -35.06 79.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.485 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' X' ' 71' ' ' GLY . 1.9 t80 -59.29 -54.71 43.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 1.0 109.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.442 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 38.7 t30 -64.41 -36.71 85.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 1.0 109.281 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -67.72 -45.19 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 1.0 109.277 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.27 -52.23 2.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 1.0 109.312 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.74 -168.32 24.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.439 -1.464 . . . . 1.0 109.439 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -65.71 -20.07 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.914 2.409 . . . . 1.0 111.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.66 -54.84 39.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 1.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -64.21 -42.98 96.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 1.0 109.352 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 34.8 m -150.44 91.38 4.15 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 1.0 109.432 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -82.83 179.97 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.862 2.375 . . . . 1.0 112.213 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.62 -23.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 1.0 109.486 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 6.5 p -60.85 -34.95 75.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 1.0 109.423 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.38 72.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -69.86 -37.78 76.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -59.88 -46.98 87.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 1.0 109.403 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -61.9 -40.14 94.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.513 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.668 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.6 t-105 -66.0 -36.18 82.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -58.05 -41.67 83.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 1.0 109.255 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.49 -38.26 90.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.41 -0.806 . . . . 1.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.57 -42.7 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 1.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -57.71 -43.35 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0 109.395 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.25 -36.65 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 1.0 109.383 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.8 -51.95 59.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 1.0 109.352 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 pt -71.41 -41.09 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.0 109.411 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.33 -51.65 67.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.501 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.78 -40.68 92.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 1.0 109.541 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.16 138.77 39.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 1.0 109.533 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.69 93.85 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 1.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.757 ' CG2' ' H ' ' X' ' 96' ' ' ASN . 9.9 p -124.64 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.757 ' H ' ' CG2' ' X' ' 95' ' ' VAL . 20.8 t-20 -124.96 81.77 62.03 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 1.0 109.605 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -83.93 -40.87 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.821 2.347 . . . . 1.0 112.333 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.15 172.87 6.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 1.0 109.437 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 86.4 t -78.41 78.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 1.0 109.539 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.964 -1.017 . . . . 1.0 109.419 179.738 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.17 63.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -129.46 162.07 28.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -1.171 . . . . 1.0 109.543 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.26 131.28 41.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 1.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -96.91 104.54 16.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 1.0 109.486 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -77.64 170.19 17.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.868 . . . . 1.0 109.575 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -50.79 -43.17 58.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 1.0 109.379 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -68.14 -49.0 63.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 1.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.89 -35.87 77.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 1.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -60.86 -41.28 95.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 1.0 109.562 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.7 -36.04 79.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 1.0 109.464 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.41 -45.31 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 1.0 109.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.74 -45.97 81.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 1.0 109.398 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.95 -38.92 90.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 1.0 108.911 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.77 -43.14 99.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 1.0 108.765 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.545 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.26 -38.6 87.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 1.0 109.486 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.46 -46.95 87.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 1.0 109.145 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.15 93.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.313 -0.867 . . . . 1.0 109.44 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.08 -40.69 87.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 1.0 109.23 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.19 -42.07 80.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.903 . . . . 1.0 109.242 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 70.3 p -64.96 -33.93 77.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.845 . . . . 1.0 109.299 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.95 -17.64 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 1.0 109.169 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.17 48.24 0.53 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.28 -1.528 . . . . 1.0 109.28 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.92 133.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 1.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -132.0 99.0 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 1.0 109.224 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.23 163.22 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 1.0 109.357 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.92 148.81 32.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 1.0 109.499 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.545 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 59.0 m-85 -63.75 -42.93 97.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.224 -0.923 . . . . 1.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.95 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 1.0 109.455 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.25 -40.34 93.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 1.0 109.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.1 -45.93 91.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 1.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.13 -41.68 99.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 1.0 109.394 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . 0.655 ' HZ1' ' H ' ' X' ' 50' ' ' THR . 98.4 mttt -67.24 -35.83 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.34 -50.26 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 1.0 109.493 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -61.03 -41.49 96.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.0 109.417 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.56 -39.74 95.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 1.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.37 -45.58 91.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -0.802 . . . . 1.0 109.508 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 76.7 t -58.27 -49.21 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 1.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.5 mttt -64.0 -31.5 72.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.8 m-20 -67.67 -19.14 65.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.85 . . . . 1.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 9.8 m -53.78 -48.43 69.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 1.0 109.403 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.747 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -122.73 -59.6 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.747 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.5 Cg_exo -41.47 -45.69 6.03 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.88 2.386 . . . . 1.0 112.219 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.7 m-90 -139.02 113.67 9.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.152 -0.967 . . . . 1.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -64.91 -43.72 69.4 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 1.0 109.875 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -55.93 130.77 42.13 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.79 2.327 . . . . 1.0 112.373 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -119.05 133.45 55.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 1.0 109.707 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -142.51 127.72 18.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.887 . . . . 1.0 109.789 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.74 147.73 5.38 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.655 ' H ' ' HZ1' ' X' ' 33' ' ' LYS . 31.4 m -88.68 143.26 27.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.099 -1.236 . . . . 1.0 109.414 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' X' ' 51' ' ' ILE . 0.3 OUTLIER -117.14 130.27 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 1.0 109.538 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -71.88 136.79 47.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 1.0 109.784 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.74 -25.4 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 1.0 109.464 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.96 -38.66 91.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 1.0 109.396 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -82.74 -18.88 39.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 1.0 109.296 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 11.9 t90 -60.13 -38.38 82.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.0 109.64 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.563 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 31.8 mmt180 -56.88 -43.64 81.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 109.478 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.498 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.8 mtp180 -68.75 -39.4 80.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 1.0 109.479 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -61.62 -46.55 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 1.0 109.372 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.49 -48.66 68.92 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.14 -33.99 77.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 1.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.5 m -69.23 -54.04 16.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 1.0 109.454 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -64.14 -43.37 95.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 1.0 109.482 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.4 -32.2 72.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 1.0 109.467 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.43 -45.87 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 1.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -72.67 -28.86 62.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 1.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' X' ' 71' ' ' GLY . 45.1 t80 -60.03 -53.4 58.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 1.0 109.402 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -69.48 -35.67 75.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 1.0 109.336 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.1 m -62.08 -45.86 91.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 1.0 109.258 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.19 -51.25 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 1.0 109.2 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.85 -158.5 24.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.8 -13.89 17.59 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.89 2.393 . . . . 1.0 111.953 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.93 -51.6 66.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 1.0 109.213 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -64.36 -40.82 96.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 1.0 109.309 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.78 83.92 9.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 1.0 109.418 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' X' ' 78' ' ' THR . 43.5 Cg_exo -55.46 154.41 24.63 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.827 2.352 . . . . 1.0 112.265 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -53.39 -6.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 1.0 109.438 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.549 ' H ' ' C ' ' X' ' 76' ' ' PRO . 63.1 p -61.19 -41.21 96.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.87 . . . . 1.0 109.391 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.62 75.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 1.0 109.385 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -61.13 -42.8 99.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 1.0 109.425 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -63.22 -46.63 86.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -63.19 -41.74 99.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.576 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.599 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.6 t-105 -61.42 -37.53 83.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 1.0 109.367 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.95 -44.14 78.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 1.0 109.191 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.66 -40.09 92.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 1.0 109.552 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -61.6 -41.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.243 -0.91 . . . . 1.0 109.395 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.93 -39.95 79.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 1.0 109.481 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -71.09 -36.73 72.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.389 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.501 ' N ' HD12 ' X' ' 89' ' ' LEU . 7.9 mp -65.72 -43.27 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 1.0 109.386 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.5 pt -78.92 -20.74 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 1.0 109.335 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.34 -50.07 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.485 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -41.23 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 1.0 109.54 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.54 139.54 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 1.0 109.573 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -75.86 92.27 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.0 109.538 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' X' ' 97' ' ' PRO . 11.2 p -111.14 167.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 1.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.43 ' N ' ' CG2' ' X' ' 95' ' ' VAL . 0.2 OUTLIER -58.61 108.46 1.33 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 1.0 109.612 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' X' ' 95' ' ' VAL . 29.1 Cg_exo -62.3 -164.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.793 2.328 . . . . 1.0 112.336 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -63.93 -40.82 97.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 1.0 109.481 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.42 132.6 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 109.437 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.992 -1.004 . . . . 1.0 109.4 179.558 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.54 80.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -130.0 157.29 42.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 1.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.46 145.04 47.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 1.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.89 94.79 10.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 1.0 109.511 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -78.41 176.22 9.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.593 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -54.28 -45.84 72.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 1.0 109.436 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.35 -42.49 92.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.46 -39.69 88.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 1.0 109.469 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.61 -42.23 92.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 1.0 109.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -59.33 -35.37 73.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 1.0 109.415 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.4 -44.72 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.0 109.305 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' X' ' 28' ' ' TYR . 46.1 tp10 -55.92 -47.7 77.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 1.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -66.53 -37.13 84.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 1.0 108.868 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.24 -42.65 98.98 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 1.0 108.803 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.56 ' HZ1' ' C ' ' X' ' 27' ' ' LYS . 88.5 tttt -61.85 -42.06 98.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 1.0 109.555 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -52.52 -49.91 63.87 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.177 -0.952 . . . . 1.0 109.158 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.57 80.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.0 109.422 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.19 -40.38 93.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 1.0 109.251 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.68 -40.71 80.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.303 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -58.61 -33.88 70.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.449 -0.782 . . . . 1.0 109.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.87 -9.97 56.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 1.0 109.19 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.31 44.33 2.2 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.32 135.24 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 1.0 109.387 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -131.36 94.81 3.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.0 109.22 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.471 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 35.3 m -132.8 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 1.0 109.366 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . 0.56 ' C ' ' HZ1' ' X' ' 16' ' ' LYS . 68.2 mttm -73.33 147.89 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 109.47 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.554 ' N ' ' HZ1' ' X' ' 16' ' ' LYS . 51.8 t80 -59.07 -39.28 81.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.203 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.55 59.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 1.0 109.493 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.516 ' CG ' ' CG ' ' X' ' 55' ' ' PHE . 30.2 t0 -61.15 -43.56 98.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 1.0 109.404 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.0 mm? -61.62 -45.35 94.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 1.0 109.409 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.7 -42.11 98.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 1.0 109.351 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -36.0 82.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 1.0 109.415 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.53 -46.65 83.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 1.0 109.413 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.1 -41.77 90.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 1.0 109.308 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -63.34 -44.07 95.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 109.266 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 38.8 t80 -61.34 -43.59 98.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.46 -47.46 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.0 109.535 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.82 -36.76 80.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 1.0 109.425 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' X' ' 44' ' ' TRP . 84.6 m-20 -69.11 -19.65 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 1.0 109.639 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 96.4 m -54.44 -47.78 72.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 1.0 109.41 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.646 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -119.16 -64.34 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 1.0 109.461 -178.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.0 Cg_exo -40.69 -33.82 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.89 2.393 . . . . 1.0 112.174 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 6.2 m-90 -155.94 100.95 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 1.0 109.468 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.684 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -71.22 -39.92 8.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 1.0 109.901 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 26.0 Cg_exo -60.87 -34.32 91.39 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.703 2.269 . . . . 1.0 112.369 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.427 ' OE1' ' OD1' ' X' ' 40' ' ' ASP . 84.4 mt-30 -65.65 124.77 23.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 1.0 109.656 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -144.4 175.16 10.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 1.0 109.847 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.82 165.58 34.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.1 m -69.92 137.52 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -1.187 . . . . 1.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.58 139.68 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 1.0 109.504 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -94.26 133.84 37.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 1.0 109.751 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mm -48.71 -23.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 1.0 109.481 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.725 ' HZ2' ' H ' ' X' ' 99' ' ' VAL . 98.7 mttt -65.47 -43.25 90.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 109.353 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' X' ' 55' ' ' PHE . 1.0 OUTLIER -79.79 -16.35 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 1.0 109.296 -178.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 18.1 t90 -59.32 -43.05 92.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 1.0 109.646 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.599 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 32.9 mmt180 -59.72 -42.08 92.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 1.0 109.493 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 63.4 mtp85 -71.55 -46.34 59.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 1.0 109.437 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.29 -47.92 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 1.0 109.282 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.15 -47.02 84.1 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -66.15 -37.71 86.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.172 . . . . 1.0 109.462 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 98.7 m -64.11 -56.24 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 1.0 109.48 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.6 m-85 -61.15 -44.77 96.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 1.0 109.459 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.71 -36.94 84.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 1.0 109.49 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.451 ' O ' ' OG1' ' X' ' 69' ' ' THR . 74.7 m-20 -61.73 -47.15 86.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.0 109.344 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.22 -29.54 68.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.458 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' X' ' 71' ' ' GLY . 39.9 t80 -62.42 -55.05 31.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 1.0 109.429 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -67.52 -34.91 78.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 1.0 109.33 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 15.9 m -66.34 -51.38 57.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 1.0 109.331 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -108.93 -52.44 2.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.85 -162.17 26.29 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' ' N ' ' X' ' 76' ' ' PRO . 18.9 Cg_endo -74.77 -17.88 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.946 2.431 . . . . 1.0 111.956 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.89 -52.12 66.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 1.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -64.78 -39.32 93.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 1.0 109.371 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.91 79.69 13.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 1.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.539 ' C ' ' H ' ' X' ' 78' ' ' THR . 45.8 Cg_exo -55.33 155.0 21.55 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.772 2.315 . . . . 1.0 112.222 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.79 -5.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.539 ' H ' ' C ' ' X' ' 76' ' ' PRO . 62.2 p -61.11 -33.88 74.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 1.0 109.44 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.42 ' N ' ' HG1' ' X' ' 78' ' ' THR . . . -68.3 -36.87 79.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 1.0 109.372 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.89 . . . . 1.0 109.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -61.85 -49.12 77.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 1.0 109.4 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.85 -41.97 95.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 1.0 109.524 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.539 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.4 t-105 -67.07 -34.66 78.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.89 -43.28 85.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.0 109.243 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.47 -38.14 83.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.592 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.24 -44.07 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 1.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.41 -43.78 84.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 1.0 109.441 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.89 -36.54 72.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 1.0 109.355 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.56 -50.69 66.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 1.0 109.35 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.42 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.1 pt -70.45 -42.29 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.42 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 86.2 m-20 -61.53 -47.45 85.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.0 109.475 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.03 -38.85 92.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 1.0 109.614 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.93 135.65 49.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.0 109.508 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -88.74 113.21 24.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 1.0 109.638 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.76 154.7 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.0 109.626 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -126.28 85.64 59.57 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 109.564 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.57 -152.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.881 2.387 . . . . 1.0 112.296 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -62.87 -40.12 96.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.0 109.43 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.725 ' H ' ' HZ2' ' X' ' 54' ' ' LYS . 41.6 t -126.31 131.17 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.518 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.99 -1.005 . . . . 1.0 109.473 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 16.56 80.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -130.16 161.12 31.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 1.0 109.497 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 80.1 mm-40 -59.87 134.41 57.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 1.0 109.545 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.87 99.76 12.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 1.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -79.61 171.68 14.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 1.0 109.563 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -55.59 -42.96 75.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 1.0 109.436 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -66.36 -44.41 83.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 1.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 90.7 mt-10 -63.3 -33.34 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 1.0 109.427 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -70.52 -39.41 74.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 1.0 109.607 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.95 -49.12 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 1.0 109.364 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.16 -34.18 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 1.0 109.324 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.2 -43.1 92.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.261 -0.9 . . . . 1.0 109.289 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.67 -34.2 77.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 1.0 108.916 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.8 -41.12 99.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.356 -0.84 . . . . 1.0 108.847 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.415 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 87.6 tttt -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.756 . . . . 1.0 109.566 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.44 -45.19 84.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 1.0 109.195 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.69 -39.75 91.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 1.0 109.403 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.77 -38.88 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 1.0 109.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 1.0 109.238 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 45.8 p -62.92 -31.37 72.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.09 -17.57 61.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 1.0 109.145 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.29 47.18 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -119.06 130.46 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.429 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.19 98.43 4.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.94 . . . . 1.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.96 160.12 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 109.288 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -74.4 143.99 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 1.0 109.489 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.415 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 63.9 m-85 -61.74 -41.42 97.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.204 -0.935 . . . . 1.0 109.26 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.77 53.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 1.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' CG ' ' X' ' 55' ' ' PHE . 15.4 t70 -63.18 -39.5 94.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 1.0 109.448 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.39 -45.56 92.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 1.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.03 -42.95 99.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 1.0 109.364 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . 0.571 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.6 mttt -65.02 -38.86 92.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 1.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -58.31 -49.62 76.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 1.0 109.391 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -63.08 -44.14 96.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 1.0 109.404 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.23 -37.54 80.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 1.0 109.265 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.76 -46.78 88.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.918 . . . . 1.0 109.533 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.44 -44.34 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 1.0 109.548 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.29 -25.58 64.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.5 m-20 -73.56 -19.58 60.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.867 . . . . 1.0 109.658 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -54.11 -41.29 68.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 1.0 109.418 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.642 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -128.06 -64.4 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.473 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.642 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 53.9 Cg_exo -40.84 -40.1 3.45 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.879 2.386 . . . . 1.0 112.183 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.517 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -142.66 116.34 9.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 1.0 109.527 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.656 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -66.5 -41.72 42.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 1.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 27.1 Cg_exo -60.82 137.72 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.768 2.312 . . . . 1.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.92 147.74 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 1.0 109.654 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -141.33 157.19 45.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 1.0 109.807 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 164.3 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.571 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 41.6 m -114.5 129.82 56.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 1.0 109.311 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.0 136.08 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 1.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.67 137.54 36.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 1.0 109.757 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.13 -23.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 1.0 109.437 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -64.68 -39.29 93.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 1.0 109.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . 0.544 ' CG ' ' OD1' ' X' ' 30' ' ' ASP . 3.1 t80 -85.2 -9.98 57.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.955 . . . . 1.0 109.283 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t90 -57.64 -38.24 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 1.0 109.646 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -61.41 -38.95 88.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 1.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 76.9 mtp180 -70.19 -36.88 74.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 1.0 109.418 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.32 -42.16 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 1.0 109.315 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.53 -48.77 84.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -66.08 -40.14 90.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -1.141 . . . . 1.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 89.3 m -64.56 -54.28 34.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 1.0 109.509 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.96 -44.46 94.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 1.0 109.446 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -60.1 -37.87 81.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 1.0 109.478 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' X' ' 69' ' ' THR . 44.9 m-20 -63.38 -41.44 98.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 1.0 109.284 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -66.24 -38.6 88.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.3 -52.45 65.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 1.0 109.402 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.61 -30.14 69.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 1.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 98.1 m -61.65 -48.14 82.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 1.0 109.257 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 -52.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 1.0 109.269 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.68 29.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' X' ' 76' ' ' PRO . 23.2 Cg_exo -60.17 -23.71 74.64 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.969 2.446 . . . . 1.0 111.899 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -52.44 -51.95 56.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.164 -0.96 . . . . 1.0 109.231 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.0 -42.43 99.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.354 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.4 81.09 14.1 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 1.0 109.485 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.7 Cg_exo -59.62 161.75 17.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.818 2.345 . . . . 1.0 112.277 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -50.19 -9.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 1.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.537 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.1 p -60.21 -35.85 76.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 1.0 109.413 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.94 94.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 1.0 109.414 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.22 -42.8 93.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 1.0 109.411 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -62.77 -45.91 90.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.426 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.513 ' OH ' ' CD2' ' X' ' 45' ' ' PHE . 18.7 m-85 -63.72 -43.25 97.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 1.0 109.475 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -63.45 -36.87 85.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 1.0 109.389 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.78 -43.54 80.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.4 -0.813 . . . . 1.0 109.223 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.27 -40.59 86.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 1.0 109.613 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -61.5 -42.48 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 1.0 109.241 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -43.2 88.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 1.0 109.508 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 97.0 mt-10 -70.91 -24.61 62.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 1.0 109.347 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.13 -49.3 12.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 6.5 pt -70.47 -42.4 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 1.0 109.426 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 16.6 p-10 -67.69 -9.51 44.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 1.0 109.491 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.428 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 88.5 tttt -62.48 -48.1 81.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 1.0 109.556 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -115.23 125.46 53.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 1.0 109.452 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -71.03 125.69 27.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 1.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.77 155.29 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.619 ' ND2' ' H ' ' X' ' 100' ' ' MET . 8.2 t-20 -121.69 84.76 43.51 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 1.0 109.55 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.47 -42.2 62.83 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.86 2.373 . . . . 1.0 112.295 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -144.48 -92.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 1.0 109.433 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.86 95.13 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 1.0 109.507 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 100' ' ' MET . . . . . 0.619 ' H ' ' ND2' ' X' ' 96' ' ' ASN . 31.0 ttm . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.998 -1.001 . . . . 1.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.9 79.96 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.661 -1.376 . . . . 1.0 109.661 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -130.1 161.97 29.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.97 . . . . 1.0 109.468 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 131.24 49.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 1.0 109.551 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.97 89.61 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 1.0 109.626 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.1 p -82.88 174.99 10.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 1.0 109.554 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -53.14 -41.02 64.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.237 -0.914 . . . . 1.0 109.282 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 5.1 m-70 -69.25 -43.69 73.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 1.0 109.415 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.96 -39.25 93.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 1.0 109.602 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.93 -36.83 84.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 109.567 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -61.06 -49.73 76.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 1.0 109.925 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.24 -34.25 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 1.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.57 -35.43 80.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.459 -0.776 . . . . 1.0 109.226 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -68.24 -39.16 82.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 1.0 108.959 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -61.43 -41.24 96.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 1.0 108.961 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.47 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.28 -40.5 94.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 1.0 109.395 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -56.2 -44.74 79.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 1.0 109.067 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -36.73 82.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 1.0 109.227 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.27 -38.74 92.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 1.0 109.068 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.53 -41.38 85.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 1.0 109.092 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -60.14 -39.14 85.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 1.0 109.103 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.41 -16.92 63.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 1.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.58 53.15 0.73 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . 0.531 ' CG2' HH21 ' X' ' 58' ' ' ARG . 38.2 t -122.06 133.4 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.583 -0.951 . . . . 1.0 109.325 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.18 96.52 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.31 163.99 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 1.0 109.503 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.45 147.78 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.47 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 96.9 m-85 -63.9 -39.95 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 1.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.26 -31.69 63.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.0 109.358 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -59.96 -42.2 93.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 1.0 109.227 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 1.0 109.359 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.26 -41.27 97.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.797 . . . . 1.0 109.28 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.27 -34.74 79.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 1.0 109.394 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.97 -48.86 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 1.0 109.693 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.18 -45.33 93.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.249 -0.907 . . . . 1.0 109.621 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -64.13 -37.85 88.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.0 109.13 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.14 -45.67 92.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 1.0 109.428 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.03 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 1.0 109.595 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.46 -32.69 74.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.011 0.91 . . . . 1.0 109.629 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.4 m-20 -68.26 -20.38 64.79 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.766 -1.209 . . . . 1.0 109.757 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 m -55.15 -57.46 11.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.878 -1.138 . . . . 1.0 110.708 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.525 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.1 OUTLIER -109.85 -59.6 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.042 0 O-C-N 121.514 -0.741 . . . . 1.0 110.634 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.1 Cg_exo -42.2 -42.25 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.494 2.129 . . . . 1.0 112.701 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.8 m-90 -142.62 -158.91 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 1.0 109.361 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.535 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 2.2 t80 -171.84 49.37 0.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 1.0 109.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 29.3 Cg_endo -67.32 -166.42 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.709 2.273 . . . . 1.0 112.132 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.08 140.6 35.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 1.0 109.581 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.4 134.99 42.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 1.0 109.758 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.03 -178.43 43.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.791 -1.324 . . . . 1.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 14.4 m -71.2 141.7 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -1.193 . . . . 1.0 109.275 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.421 HG21 HD13 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -127.77 133.58 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.761 0.791 . . . . 1.0 109.212 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' X' ' 53' ' ' ILE . 56.5 t0 -71.82 136.97 47.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.64 -1.287 . . . . 1.0 110.012 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 63.7 mt -66.56 -21.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.79 -1.194 . . . . 1.0 109.259 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -64.95 -40.05 94.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 1.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -84.39 -9.64 58.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 1.0 109.616 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.595 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 11.0 t90 -53.67 -39.88 65.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 1.0 109.795 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.24 -37.23 84.62 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.172 -0.955 . . . . 1.0 109.486 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.531 HH21 ' CG2' ' X' ' 24' ' ' VAL . 85.6 mmt-85 -68.31 -42.89 78.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.351 -0.843 . . . . 1.0 109.781 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.38 -45.13 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.29 -0.882 . . . . 1.0 109.26 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.55 97.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.68 -42.2 91.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.255 -1.144 . . . . 1.0 109.671 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.92 -50.67 61.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 1.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.48 -44.75 96.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.0 109.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.96 -35.58 75.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.181 -0.949 . . . . 1.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -64.7 -46.16 83.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 1.0 109.412 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 1.0 109.428 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' X' ' 71' ' ' GLY . 9.1 t80 -59.37 -53.29 59.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 1.0 109.716 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' X' ' 68' ' ' ASN . 51.6 t-20 -64.5 -35.92 82.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.856 -1.153 . . . . 1.0 109.473 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -65.02 -45.35 85.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.213 -0.929 . . . . 1.0 109.99 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.34 -51.87 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.141 -0.623 . . . . 1.0 109.893 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 138.74 -164.05 25.78 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 1.0 109.388 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' X' ' 76' ' ' PRO . 8.6 Cg_exo -66.41 -20.65 54.53 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.97 2.446 . . . . 1.0 111.948 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.37 -53.81 52.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 1.0 109.474 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.44 -37.27 86.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.361 -0.837 . . . . 1.0 109.667 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 34.5 m -143.59 81.21 12.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.566 -0.709 . . . . 1.0 109.198 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.502 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.0 Cg_exo -59.03 155.11 40.83 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 123.057 2.504 . . . . 1.0 112.287 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.91 -10.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 1.0 109.303 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.494 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.4 t -62.28 -33.44 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.94 -45.08 91.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.324 -0.86 . . . . 1.0 109.129 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.33 -43.43 97.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 1.0 109.479 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -61.94 -45.69 92.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 1.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -64.41 -37.22 86.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 1.0 109.433 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.448 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.1 t-105 -64.59 -35.54 81.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.87 . . . . 1.0 109.092 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.14 -43.52 95.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 1.0 109.092 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.07 -39.1 93.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.422 -0.799 . . . . 1.0 109.133 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.24 -42.47 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.0 109.552 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.595 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 63.4 mttt -55.96 -43.26 77.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.71 -35.65 79.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.923 -1.11 . . . . 1.0 109.485 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.72 -49.18 71.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.935 . . . . 1.0 109.835 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.8 pt -71.96 -40.95 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 1.0 109.308 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.32 -44.61 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.406 -0.809 . . . . 1.0 109.481 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.51 -43.19 94.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 1.0 109.401 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.0 126.17 30.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.139 -0.976 . . . . 1.0 109.498 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.81 127.91 34.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 1.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' X' ' 96' ' ' ASN . 13.8 p -132.0 170.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 1.0 109.465 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.438 ' N ' ' CG2' ' X' ' 95' ' ' VAL . 8.3 t-20 -124.01 84.64 54.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.605 -0.684 . . . . 1.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.43 148.38 80.65 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 123.091 2.528 . . . . 1.0 112.096 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.02 -41.27 62.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -0.929 . . . . 1.0 109.203 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' X' ' 99' ' ' VAL . 9.1 p -126.47 106.03 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.513 -0.742 . . . . 1.0 109.619 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.986 -1.007 . . . . 1.0 109.572 179.642 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.79 17.38 77.4 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -128.88 160.51 32.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -1.182 . . . . 1.0 109.503 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -58.42 138.3 56.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 1.0 109.584 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.82 103.57 15.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 1.0 109.495 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.2 p -79.29 171.3 15.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 1.0 109.571 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.5 -40.9 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 1.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.64 -46.2 76.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 1.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -62.51 -38.35 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 1.0 109.405 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -61.49 -40.91 96.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 1.0 109.551 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.95 -36.45 77.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.195 -0.941 . . . . 1.0 109.475 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.03 -44.15 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 1.0 109.34 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.95 -48.06 73.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.286 -0.884 . . . . 1.0 109.317 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -65.62 -36.31 83.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 1.0 108.805 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.05 -41.76 99.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.291 -0.881 . . . . 1.0 108.834 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 1.0 109.499 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -55.99 -46.88 78.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.19 -0.944 . . . . 1.0 109.122 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.38 -41.01 96.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.378 -0.827 . . . . 1.0 109.343 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.87 -36.44 84.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 1.0 109.287 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.89 -38.27 87.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 1.0 109.229 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 76.0 p -65.79 -33.47 75.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 1.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -70.78 -19.36 62.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 1.0 109.243 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.29 47.14 0.39 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.325 -1.51 . . . . 1.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -121.55 133.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -1.105 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.99 91.38 2.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.268 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.73 162.15 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 1.0 109.311 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.12 147.05 32.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 1.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -62.68 -34.5 77.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 1.0 109.225 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.35 69.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 1.0 109.403 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 1.0 109.386 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -60.35 -44.39 95.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 1.0 109.361 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -42.14 99.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.409 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.03 -33.57 76.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.359 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -59.39 -46.01 89.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 1.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.26 -44.51 96.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 1.0 109.402 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.63 -44.32 94.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 1.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -63.17 -46.19 88.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 1.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 69.7 t -60.39 -44.58 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 1.0 109.569 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 1.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 7.1 m-20 -68.32 -19.84 64.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 1.0 109.667 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 99.6 m -54.48 -51.48 64.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 1.0 109.393 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.683 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -118.82 -63.16 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 1.0 109.508 -177.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.3 Cg_exo -40.79 -54.22 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.897 2.398 . . . . 1.0 112.168 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -118.36 -128.25 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 1.0 109.503 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.683 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.8 OUTLIER -175.28 -41.62 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 1.0 109.908 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 34.5 Cg_exo -58.17 132.72 50.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 1.0 112.307 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -119.01 159.27 24.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 109.71 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -74.16 158.59 33.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 1.0 109.758 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.74 -4.18 63.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.855 -1.298 . . . . 1.0 109.855 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -119.7 118.28 30.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 1.0 109.308 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.465 HD12 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -136.31 135.1 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 109.497 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.465 ' H ' HD12 ' X' ' 51' ' ' ILE . 67.4 t0 -67.27 130.68 43.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.14 -38.61 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 1.0 109.417 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -61.57 -37.72 84.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 1.0 109.4 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -76.36 -24.21 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 1.0 109.305 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.659 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -57.48 -36.46 71.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.612 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.424 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 14.0 mmm180 -60.69 -41.45 95.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 1.0 109.501 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.63 -37.47 79.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 1.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.15 -44.37 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 1.0 109.306 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.35 -48.57 84.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -65.35 -41.12 94.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.163 . . . . 1.0 109.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.24 -42.87 92.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 1.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -65.76 -40.02 91.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.21 -37.95 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 1.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' X' ' 69' ' ' THR . 93.1 m-20 -63.25 -43.93 96.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 1.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.96 -31.73 71.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.477 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' X' ' 71' ' ' GLY . 17.4 t80 -59.65 -55.02 39.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 1.0 109.357 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -68.38 -34.94 76.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 1.0 109.303 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.0 m -65.01 -48.03 75.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 1.0 109.283 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -111.75 -52.37 2.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 1.0 109.329 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.97 -165.68 26.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.58 -14.46 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.911 2.407 . . . . 1.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.1 -49.79 74.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.274 -0.891 . . . . 1.0 109.302 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -66.91 -43.98 81.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 1.0 109.347 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 35.3 m -148.46 88.69 5.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 1.0 109.455 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -81.02 -176.0 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.832 2.354 . . . . 1.0 112.267 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -19.67 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 1.0 109.397 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.1 p -59.67 -33.73 71.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 1.0 109.42 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.39 73.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 1.0 109.463 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -61.63 -41.09 96.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.0 t -59.23 -46.01 89.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 1.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.28 -43.88 93.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.659 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.5 t-105 -64.32 -36.16 83.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -55.38 -43.08 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.0 109.207 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.52 -40.83 93.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 1.0 109.565 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.27 -42.28 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 1.0 109.346 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.76 -41.3 70.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 1.0 109.41 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.73 -38.75 73.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.948 . . . . 1.0 109.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.31 -49.59 73.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 1.0 109.372 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.2 pt -70.29 -41.18 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 1.0 109.436 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 69.5 m-20 -59.84 -47.08 87.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.95 . . . . 1.0 109.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.83 -41.82 97.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.61 137.48 38.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.918 . . . . 1.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 1.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.55 160.29 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.0 109.537 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.82 81.66 26.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 1.0 109.597 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' X' ' 99' ' ' VAL . 59.5 Cg_endo -81.97 65.88 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.879 2.386 . . . . 1.0 112.264 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 54.3 -80.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.164 -0.96 . . . . 1.0 109.419 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' X' ' 97' ' ' PRO . 58.0 t -94.18 129.85 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 1.0 109.577 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.052 -0.975 . . . . 1.0 109.493 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.23 3.16 90.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -129.08 160.99 31.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -1.16 . . . . 1.0 109.582 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mt-10 -62.41 146.51 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.517 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.12 101.84 14.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 109.484 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 6' ' ' SER . . . . . 0.424 ' H ' ' HG ' ' X' ' 6' ' ' SER . 13.3 p -83.48 170.28 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 1.0 109.431 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -54.09 -43.19 70.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 1.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -64.65 -43.49 93.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.878 . . . . 1.0 109.543 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 99.2 mt-10 -67.78 -34.91 77.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 1.0 109.371 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.3 -38.28 84.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.882 . . . . 1.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.08 -51.16 69.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.41 -33.29 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 1.0 109.261 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.21 -42.3 85.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.893 . . . . 1.0 109.177 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -63.75 -39.74 95.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.94 . . . . 1.0 108.766 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.45 -40.25 86.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.482 ' NZ ' ' CD2' ' X' ' 28' ' ' TYR . 88.0 tttt -61.39 -43.7 98.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 1.0 109.579 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -44.11 77.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 1.0 109.024 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.8 96.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 1.0 109.276 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.11 -38.04 89.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -0.899 . . . . 1.0 109.22 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -60.11 -41.39 92.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 1.0 109.297 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.5 p -63.06 -31.95 73.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.865 . . . . 1.0 109.233 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.29 -17.96 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.0 109.19 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.65 46.61 0.52 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.22 133.33 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.353 -1.086 . . . . 1.0 109.358 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.92 93.57 2.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 1.0 109.215 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.12 161.21 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 1.0 109.342 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -70.36 146.97 50.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.917 . . . . 1.0 109.491 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.482 ' CD2' ' NZ ' ' X' ' 16' ' ' LYS . 97.0 m-85 -63.67 -35.46 80.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 1.0 109.235 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.9 -34.48 69.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 1.0 109.409 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.16 -44.19 92.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 1.0 109.341 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -62.04 -45.96 91.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 1.0 109.436 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.49 -42.65 98.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 1.0 109.395 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.75 -34.36 75.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 1.0 109.384 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.76 -48.46 81.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 1.0 109.471 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -62.03 -43.72 98.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.99 -42.14 99.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 1.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.4 -43.66 96.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.43 -44.5 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.0 109.299 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -36.34 83.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 1.0 109.351 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.5 m-20 -68.3 -20.56 64.76 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.089 -1.007 . . . . 1.0 109.588 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -54.44 -52.83 60.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.19 -0.944 . . . . 1.0 109.763 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.624 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -112.35 -62.76 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.283 -0.886 . . . . 1.0 109.914 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.624 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 77.1 Cg_exo -42.33 -39.05 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.57 2.18 . . . . 1.0 112.062 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 -145.61 -146.16 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 1.0 109.435 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.603 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 174.74 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 1.0 109.902 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -54.9 -34.81 87.35 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.793 2.329 . . . . 1.0 112.396 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.89 124.07 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 1.0 109.675 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.66 158.78 43.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 1.0 109.736 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.76 163.59 31.81 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.328 . . . . 1.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.6 m -63.3 140.05 58.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.0 109.345 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -129.98 134.79 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 1.0 109.334 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' X' ' 53' ' ' ILE . 55.9 t0 -72.79 134.36 44.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 1.0 109.811 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.606 ' CG2' HH12 ' X' ' 57' ' ' ARG . 80.2 mt -64.13 -28.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 1.0 109.55 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.3 -40.05 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 1.0 109.503 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.18 -22.69 52.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.8 t90 -55.96 -37.61 69.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.142 -0.974 . . . . 1.0 109.728 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.606 HH12 ' CG2' ' X' ' 53' ' ' ILE . 28.6 mmt-85 -58.05 -38.86 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 1.0 109.46 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.48 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.4 mmt-85 -68.79 -39.62 80.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.61 -44.34 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 1.0 109.469 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.92 -48.15 74.82 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.93 -37.07 83.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 1.0 109.434 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.8 m -67.71 -51.16 52.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 1.0 109.675 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.07 -41.19 99.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 1.0 109.421 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.11 -38.72 83.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 1.0 109.445 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.425 ' O ' ' OG1' ' X' ' 69' ' ' THR . 96.0 m-20 -60.91 -44.44 97.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 1.0 109.36 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -64.74 -37.85 89.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 1.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' X' ' 71' ' ' GLY . 6.5 t80 -60.13 -53.81 53.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 1.0 109.535 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.4 -33.81 76.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 1.0 109.286 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 18.1 m -68.37 -44.23 75.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 1.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -122.36 -51.76 1.96 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 1.0 109.673 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.74 -164.29 25.2 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.8 Cg_exo -65.35 -21.51 61.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.941 2.428 . . . . 1.0 112.182 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.44 -53.03 61.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.216 -0.928 . . . . 1.0 109.314 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -66.2 -38.52 88.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 1.0 109.401 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.4 78.63 14.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' X' ' 78' ' ' THR . 35.9 Cg_exo -56.41 156.12 22.83 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.855 2.37 . . . . 1.0 112.362 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.03 -11.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 1.0 109.397 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.508 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.0 p -59.9 -38.1 81.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.0 109.44 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.425 ' N ' ' HG1' ' X' ' 78' ' ' THR . . . -55.5 -46.61 76.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 1.0 109.397 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -63.67 -44.14 94.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 1.0 109.564 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 50.7 m -61.63 -51.68 67.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 1.0 109.553 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -60.56 -41.84 95.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 1.0 109.484 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.676 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 14.2 t-105 -63.13 -40.36 97.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 1.0 109.289 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -56.27 -38.86 71.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 1.0 108.843 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.14 -42.69 99.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.532 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -61.46 -42.33 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 1.0 109.499 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.604 ' HZ2' ' CB ' ' X' ' 56' ' ' TRP . 60.8 mmtt -55.69 -40.08 71.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 1.0 109.538 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.2 -37.96 84.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.893 . . . . 1.0 109.544 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.89 -41.91 95.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.217 -0.927 . . . . 1.0 109.843 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.89 -43.14 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.0 109.658 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.91 -48.28 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.0 109.537 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.9 -43.96 94.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 1.0 109.646 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.75 130.53 35.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 1.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.97 130.04 40.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.875 . . . . 1.0 109.55 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p -129.78 160.6 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 1.0 109.604 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.36 83.96 40.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.612 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.08 -162.39 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.924 2.416 . . . . 1.0 112.293 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -61.02 -43.39 98.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 1.0 109.471 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.33 133.67 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 1.0 109.546 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.944 -1.027 . . . . 1.0 109.415 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mtp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.289 0.566 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.2 89.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -127.64 151.02 49.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -1.18 . . . . 1.0 109.418 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' X' ' 6' ' ' SER . 95.4 mt-10 -53.03 121.69 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 1.0 109.5 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 92.7 mt -55.37 85.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 1.0 109.484 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 6' ' ' SER . . . . . 0.531 ' N ' ' O ' ' X' ' 4' ' ' GLU . 10.0 p -81.76 171.68 14.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 1.0 109.599 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . 0.443 ' CG ' HH21 ' X' ' 10' ' ' ARG . 96.4 mt-30 -54.86 -45.86 74.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 1.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -66.55 -41.8 88.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 1.0 109.485 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -37.42 84.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 1.0 109.408 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . 0.443 HH21 ' CG ' ' X' ' 7' ' ' GLN . 86.6 mtm180 -70.54 -38.05 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 1.0 109.62 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.58 -49.72 76.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 1.0 109.441 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.94 -27.63 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.0 109.366 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.1 -40.7 90.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 1.0 109.395 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.41 -39.18 88.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.993 . . . . 1.0 108.92 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.52 -40.56 97.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.275 -0.891 . . . . 1.0 108.855 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.519 ' HZ2' ' C ' ' X' ' 27' ' ' LYS . 88.8 tttt -61.48 -38.66 88.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 1.0 109.498 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -57.87 -46.61 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 1.0 109.144 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.819 . . . . 1.0 109.43 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.35 -38.99 93.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 1.0 109.275 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.19 -44.7 92.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 1.0 109.246 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -56.27 -39.81 73.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 1.0 109.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -68.77 -17.14 63.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 1.0 109.222 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.06 0.66 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 50.1 t -122.72 136.78 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -1.109 . . . . 1.0 109.381 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.71 88.5 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 1.0 109.205 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.7 165.0 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 1.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . 0.519 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 99.7 mttt -77.01 153.74 34.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 1.0 109.45 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -61.44 -35.22 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 1.0 109.261 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.812 . . . . 1.0 109.432 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 56.5 t0 -58.52 -45.24 89.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 1.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.2 mm? -63.11 -45.26 92.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 1.0 109.4 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.39 -43.73 93.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.338 -0.851 . . . . 1.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.3 -33.41 73.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.39 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -58.89 -48.75 80.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 1.0 109.448 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -64.85 -42.22 95.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.2 -43.2 98.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.283 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.04 -45.11 94.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.366 -0.834 . . . . 1.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.2 -47.49 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 1.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -66.64 -35.71 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 109.395 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' X' ' 44' ' ' TRP . 91.6 m-20 -65.05 -19.38 65.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.673 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -54.29 -61.68 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.972 . . . . 1.0 109.362 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.631 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.77 -60.2 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 1.0 109.509 -178.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.631 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.6 Cg_exo -41.36 -44.57 5.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.883 2.389 . . . . 1.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.4 m-90 -143.17 -144.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 1.0 109.504 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.585 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.39 -46.04 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.95 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.3 Cg_exo -54.94 -33.77 83.77 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.713 2.276 . . . . 1.0 112.411 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.21 129.08 38.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 1.0 109.672 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.55 163.36 34.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 1.0 109.87 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.87 166.89 31.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.79 -1.324 . . . . 1.0 109.79 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 28.4 m -64.16 129.78 41.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 1.0 109.3 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.45 131.64 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 1.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' X' ' 54' ' ' LYS . 20.3 t0 -94.23 126.09 39.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.885 . . . . 1.0 109.697 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -44.83 -16.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -0.986 . . . . 1.0 109.482 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' X' ' 52' ' ' ASP . 98.9 mttt -67.31 -35.77 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.398 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . 0.569 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 2.3 m-85 -84.33 -10.99 57.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 1.0 109.285 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -58.24 -46.0 86.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 1.0 109.646 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 1.0 109.544 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.507 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 34.0 mmt180 -63.2 -47.9 80.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 1.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.06 -44.4 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 1.0 109.367 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.38 -48.65 82.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -66.16 -40.4 90.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -1.125 . . . . 1.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 90.0 m -62.6 -49.42 75.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.915 . . . . 1.0 109.461 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.17 -42.0 99.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 1.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -58.68 -36.46 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 1.0 109.536 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' X' ' 69' ' ' THR . 89.2 m-20 -62.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 1.0 109.326 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -67.98 -34.23 76.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.31 -0.869 . . . . 1.0 109.483 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' X' ' 71' ' ' GLY . 10.0 t80 -61.55 -54.81 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.355 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -63.34 -34.11 77.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 1.0 109.342 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.1 m -68.59 -48.26 64.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.0 109.285 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.23 -52.57 2.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 1.0 109.301 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.52 -163.65 25.18 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.5 Cg_exo -66.06 -23.38 53.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.86 2.373 . . . . 1.0 111.967 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.07 -54.76 34.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 1.0 109.24 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -65.45 -36.0 82.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.403 -0.811 . . . . 1.0 109.331 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.26 81.4 10.42 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 1.0 109.445 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.521 ' N ' ' O ' ' X' ' 72' ' ' PRO . 38.2 Cg_exo -60.27 154.36 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.868 2.379 . . . . 1.0 112.228 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 52.0 t -49.93 -11.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 1.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.519 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.3 t -63.94 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 1.0 109.356 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.03 96.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 1.0 109.418 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -64.92 -44.37 89.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 1.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.9 t -59.09 -45.47 90.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 1.0 109.408 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -65.27 -38.07 89.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 1.0 109.535 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -66.25 -37.9 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 1.0 109.411 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -55.99 -43.97 78.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 1.0 109.212 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.75 -40.39 96.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.535 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.35 -42.85 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 1.0 109.397 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -59.02 -41.32 87.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 1.0 109.492 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.92 -36.92 72.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 1.0 109.338 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.41 -45.15 88.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 1.0 109.33 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.01 -38.27 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.0 109.448 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.58 -45.14 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 1.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.95 -42.72 99.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.549 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -72.4 146.77 46.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.88 . . . . 1.0 109.498 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -101.9 93.62 5.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 1.0 109.535 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' X' ' 96' ' ' ASN . 7.5 p -95.91 167.53 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 1.0 109.557 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.458 ' N ' ' CG2' ' X' ' 95' ' ' VAL . 47.9 t30 -126.19 81.1 67.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 1.0 109.603 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -82.16 -159.82 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.818 2.345 . . . . 1.0 112.258 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.53 -43.14 94.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 1.0 109.426 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.534 ' H ' ' HZ2' ' X' ' 54' ' ' LYS . 51.1 t -125.25 130.95 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.0 109.516 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 46.9 ttp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.965 -1.017 . . . . 1.0 109.508 179.831 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' X' X ' 1' ' ' MET . . . . . 0.42 ' HG2' ' H ' ' X' ' 3' ' ' GLN . 56.9 ttp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.89 82.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' X' ' 1' ' ' MET . 99.2 mm-40 -128.38 155.93 43.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 1.0 109.521 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.1 mt-10 -60.72 136.7 58.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 1.0 109.58 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.47 100.88 13.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 109.477 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.2 p -77.56 169.63 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.0 109.565 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -52.49 -43.78 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.63 -47.89 71.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 1.0 109.527 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 94.5 mt-10 -60.27 -36.68 78.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 1.0 109.461 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -61.1 -42.62 98.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 1.0 109.63 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -59.7 -35.54 74.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 1.0 109.442 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.54 -44.51 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 109.316 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.38 -48.61 78.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.311 -0.868 . . . . 1.0 109.401 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -62.25 -38.3 88.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.23 -0.919 . . . . 1.0 108.92 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.28 -43.34 99.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 1.0 108.762 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.85 -37.38 81.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.498 -0.751 . . . . 1.0 109.523 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -57.87 -48.49 79.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 1.0 109.121 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.41 79.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 1.0 109.412 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.35 -40.28 95.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -0.843 . . . . 1.0 109.299 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.59 -38.16 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 1.0 109.217 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 68.4 p -64.13 -13.66 49.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 1.0 109.279 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.12 7.06 42.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 1.0 109.227 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 38.17 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.0 133.19 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.04 96.84 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 1.0 109.166 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.74 161.71 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 1.0 109.41 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.08 144.99 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 1.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -61.98 -37.49 85.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 1.0 109.296 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -33.78 64.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.0 109.492 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.07 -38.43 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.427 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -61.09 -43.89 98.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 1.0 109.456 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.17 -42.11 96.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 1.0 109.39 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 99.2 mttt -62.63 -38.27 89.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 1.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.56 -50.06 75.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0 109.477 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.65 -42.17 99.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 1.0 109.382 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' X' ' 40' ' ' ASP . 66.2 t0 -63.44 -39.61 94.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 1.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.43 -45.31 88.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 1.0 109.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.43 -47.58 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.96 -33.47 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 1.0 109.367 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.7 m-20 -69.78 -19.95 63.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 1.0 109.7 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 7.5 m -54.96 -61.05 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.0 109.481 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.569 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -103.04 -62.86 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.56 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.569 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.5 Cg_exo -41.32 -50.09 4.62 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.867 2.378 . . . . 1.0 112.175 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.497 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.6 m-90 -135.06 -147.19 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 1.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.14 -44.52 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 1.0 109.851 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.0 Cg_exo -58.1 -32.7 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.711 2.274 . . . . 1.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.01 124.14 18.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 1.0 109.735 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' X' ' 82' ' ' TYR . 97.0 mt-10 -141.28 161.64 37.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 1.0 109.789 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.04 169.15 41.23 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.475 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 34.7 m -64.17 138.51 58.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.116 -1.226 . . . . 1.0 109.334 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.448 HD13 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.22 135.84 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 1.0 109.479 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.448 ' H ' HD13 ' X' ' 51' ' ' ILE . 85.4 m-20 -71.83 136.29 46.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.854 . . . . 1.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -24.41 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 1.0 109.468 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -65.28 -38.96 91.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.0 109.361 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -80.57 -17.79 50.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 1.0 109.25 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.611 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.6 t90 -54.06 -37.42 64.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 1.0 109.665 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -61.53 -39.85 92.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 1.0 109.479 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -66.39 -40.36 89.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 1.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.36 -45.91 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 1.0 109.35 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -44.11 98.46 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -65.75 -40.13 91.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -1.162 . . . . 1.0 109.462 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.26 -53.66 23.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 109.534 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -61.41 -42.61 99.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 1.0 109.485 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -59.46 -36.92 76.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -62.96 -45.2 93.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 1.0 109.28 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -65.48 -38.06 88.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 1.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' X' ' 71' ' ' GLY . 8.9 t80 -60.14 -53.47 57.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 1.0 109.364 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.28 -38.86 92.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 1.0 109.282 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.8 m -64.13 -49.82 70.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.0 109.281 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.64 -52.24 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 1.0 109.329 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.09 -165.13 24.97 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' X' ' 76' ' ' PRO . 12.6 Cg_exo -65.36 -19.89 61.63 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.911 2.408 . . . . 1.0 111.968 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.86 -54.71 41.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.239 -0.913 . . . . 1.0 109.204 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.86 -37.24 85.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.88 80.15 15.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 1.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.1 Cg_exo -58.01 157.68 24.04 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.895 2.397 . . . . 1.0 112.214 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -51.66 -6.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 1.0 109.462 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.571 ' H ' ' C ' ' X' ' 76' ' ' PRO . 77.0 p -61.78 -32.97 73.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 1.0 109.371 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.07 -49.96 73.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 1.0 109.405 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 67.6 m -59.87 -43.77 94.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 1.0 109.442 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' X' ' 48' ' ' GLU . 1.2 t80 -61.43 -43.25 99.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0 109.491 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.611 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.0 t-105 -65.9 -36.0 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 1.0 109.373 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -56.78 -42.59 79.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 1.0 109.272 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.92 -42.6 97.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 1.0 109.587 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.12 -41.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 1.0 109.403 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.33 -39.21 72.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -71.08 -37.42 72.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 1.0 109.394 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.73 -46.12 83.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.895 . . . . 1.0 109.412 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -74.65 -39.55 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -61.16 -48.99 79.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 1.0 109.512 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.88 -45.0 79.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 1.0 109.596 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.52 127.11 32.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 1.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.42 132.19 51.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.56 167.02 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 1.0 109.602 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -126.81 83.38 65.58 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 1.0 109.6 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 -153.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.881 2.387 . . . . 1.0 112.261 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.38 -40.49 93.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 1.0 109.476 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.09 131.62 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 1.0 109.525 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.964 -1.017 . . . . 1.0 109.477 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.35 0.595 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.78 -8.09 80.35 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.691 -1.364 . . . . 1.0 109.691 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -90.37 161.71 15.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -1.105 . . . . 1.0 109.47 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.45 138.83 12.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 1.0 109.44 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.08 102.46 15.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.739 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.9 p -83.98 168.85 15.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 1.0 109.528 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -52.07 -40.94 61.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 1.0 109.325 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.0 -44.94 83.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 1.0 109.396 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.36 -34.26 76.93 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 1.0 109.427 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.078 -1.014 . . . . 1.0 109.49 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -60.87 -50.26 74.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.97 . . . . 1.0 109.779 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.01 -32.81 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 1.0 109.244 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.05 -44.49 87.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 1.0 109.191 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . 0.472 ' NE2' ' OE1' ' X' ' 17' ' ' GLN . 72.6 tp60 -63.25 -37.46 87.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.918 . . . . 1.0 108.807 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.07 -39.46 89.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -0.904 . . . . 1.0 108.751 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.59 -43.12 97.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 1.0 109.095 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . 0.472 ' OE1' ' NE2' ' X' ' 14' ' ' GLN . 87.0 mt-30 -54.97 -42.26 72.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 1.0 108.77 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.457 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.26 -44.26 92.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 1.0 109.192 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.536 ' CD2' HH21 ' X' ' 22' ' ' ARG . 8.8 mt -63.15 -41.37 99.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.083 -1.01 . . . . 1.0 109.366 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.32 -38.94 91.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.278 -0.889 . . . . 1.0 109.507 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 52.4 p -64.46 -29.83 70.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.433 -0.792 . . . . 1.0 109.345 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.536 HH21 ' CD2' ' X' ' 19' ' ' LEU . 77.7 mtm180 -78.48 -13.46 59.82 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 1.0 109.554 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.03 48.21 0.73 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.52 135.58 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.715 -0.874 . . . . 1.0 109.041 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -130.09 97.3 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.406 -0.808 . . . . 1.0 109.252 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.41 160.36 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.596 -0.69 . . . . 1.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.17 152.32 32.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 1.0 109.675 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -63.99 -34.66 78.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 1.0 108.939 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -29.28 70.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 1.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.555 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 41.9 t0 -59.37 -48.48 81.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.0 109.179 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.544 ' CD2' HH22 ' X' ' 58' ' ' ARG . 10.6 mt -62.36 -42.96 99.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.937 . . . . 1.0 108.912 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.76 -42.66 99.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.265 -0.897 . . . . 1.0 108.972 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . 0.53 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.0 mttt -67.55 -35.04 78.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 1.0 109.178 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.05 -48.92 79.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 1.0 109.879 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -63.51 -43.47 97.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 1.0 109.647 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -63.38 -40.79 98.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 1.0 109.274 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . 0.632 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 53.5 t80 -61.6 -46.22 90.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.665 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.64 -39.36 69.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.048 -1.032 . . . . 1.0 109.039 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.21 -20.01 45.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 1.0 109.543 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' NE2' ' X' ' 47' ' ' GLN . 95.9 m-20 -68.13 -19.95 64.86 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.959 -1.088 . . . . 1.0 109.409 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 18.9 m -55.31 -43.51 74.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 1.0 110.332 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.528 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.7 OUTLIER -126.04 -63.12 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.538 -0.726 . . . . 1.0 109.929 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.528 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 50.3 Cg_exo -42.02 -44.07 7.22 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.662 2.242 . . . . 1.0 112.394 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.9 m0 -139.72 -146.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 109.216 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -174.42 -45.24 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 1.0 109.769 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.2 Cg_exo -58.66 140.27 94.21 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.612 2.208 . . . . 1.0 112.252 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.459 ' NE2' ' OD2' ' X' ' 40' ' ' ASP . 88.7 mm-40 -105.7 158.0 17.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.592 -0.693 . . . . 1.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.69 146.04 47.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 1.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.55 -155.92 29.9 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.331 -1.507 . . . . 1.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.53 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 91.4 m -128.42 131.81 48.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.565 -0.962 . . . . 1.0 109.567 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.98 131.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.944 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' X' ' 54' ' ' LYS . 24.7 t0 -93.97 127.36 39.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 1.0 109.141 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -46.87 -16.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 1.0 109.495 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' X' ' 52' ' ' ASP . 65.1 mmtt -66.19 -35.51 80.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 1.0 109.635 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . 0.555 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 1.0 OUTLIER -83.25 -11.6 57.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 1.0 109.636 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.441 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.7 t90 -59.42 -42.94 93.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.88 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -63.85 -40.97 97.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 1.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.544 HH22 ' CD2' ' X' ' 31' ' ' LEU . 82.3 mtp180 -69.67 -47.19 64.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.0 109.568 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.62 -46.25 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 1.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.03 -45.31 96.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -67.12 -36.66 82.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -1.175 . . . . 1.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 91.7 m -67.37 -47.01 71.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.659 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . 0.632 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.0 m-85 -64.35 -40.07 95.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 1.0 109.535 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -60.23 -37.68 81.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.311 -0.868 . . . . 1.0 109.331 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.09 -48.21 77.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 1.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -62.07 -36.42 81.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.84 . . . . 1.0 109.435 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' X' ' 71' ' ' GLY . 3.0 t80 -61.86 -55.31 31.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.226 -0.921 . . . . 1.0 109.886 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.61 -36.21 83.52 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.973 -1.079 . . . . 1.0 109.711 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -64.44 -45.72 86.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 110.195 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.35 -51.96 2.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.685 -0.635 . . . . 1.0 109.967 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 141.59 -169.7 25.06 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.3 Cg_exo -65.36 -22.31 60.07 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.894 2.396 . . . . 1.0 112.102 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.13 -54.63 42.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 1.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -61.58 -39.21 90.37 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.261 -0.899 . . . . 1.0 109.614 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.29 82.01 8.48 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.449 -0.782 . . . . 1.0 109.346 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.2 Cg_exo -57.55 151.7 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.851 2.367 . . . . 1.0 112.333 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 m -49.53 -11.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.388 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.516 ' H ' ' C ' ' X' ' 76' ' ' PRO . 2.0 t -62.64 -33.12 74.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 1.0 109.371 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.28 -41.84 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.9 . . . . 1.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 1.0 109.404 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -61.43 -44.16 97.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -0.855 . . . . 1.0 109.263 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.95 -42.47 94.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.997 . . . . 1.0 109.681 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.441 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 10.2 t-105 -62.76 -36.19 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 1.0 109.315 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -58.5 -43.25 89.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 1.0 108.861 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.54 -40.53 97.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 1.0 109.271 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.0 109.619 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.48 -37.61 70.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.365 -0.835 . . . . 1.0 109.509 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -70.99 -39.79 72.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 1.0 109.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.49 -48.41 77.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 1.0 110.458 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.5 pt -72.43 -42.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.565 -0.709 . . . . 1.0 109.619 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 62.9 t0 -62.56 -37.17 85.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 1.0 109.312 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 1.0 109.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -82.2 135.15 35.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 1.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.99 123.08 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 1.0 109.426 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p -133.53 164.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.705 . . . . 1.0 109.365 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.514 ' C ' HD21 ' X' ' 96' ' ' ASN . 0.2 OUTLIER -128.63 81.56 70.45 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.647 -0.658 . . . . 1.0 109.555 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.05 -150.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.97 2.447 . . . . 1.0 112.075 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.47 -42.37 87.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 1.0 109.504 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.7 128.47 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.649 -0.657 . . . . 1.0 109.323 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.4 mtm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.062 -0.97 . . . . 1.0 109.31 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.46 -0.02 89.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 1.0 109.598 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -130.12 161.67 30.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 1.0 109.531 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.71 136.33 57.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 1.0 109.578 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.94 99.49 12.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 1.0 109.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.4 p -79.54 167.31 20.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -51.06 -42.34 60.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 1.0 109.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.6 -48.7 71.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 1.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.96 -38.92 87.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 1.0 109.4 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.49 -36.68 84.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.532 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -59.94 -42.04 93.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 1.0 109.417 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.97 -43.33 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.95 . . . . 1.0 109.304 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.36 -43.23 78.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 1.0 109.35 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.31 -35.18 80.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 1.0 108.867 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.82 -42.16 99.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0 108.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.86 -42.43 99.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 1.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -56.07 -46.49 78.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 1.0 109.144 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.0 97.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 1.0 109.407 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 1.0 109.319 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.04 -39.36 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 1.0 109.243 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 46.8 p -65.65 -29.92 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.0 109.29 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.92 -18.44 59.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 1.0 109.142 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.58 48.52 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.08 135.29 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -1.138 . . . . 1.0 109.397 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.65 101.41 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 1.0 109.125 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 161.5 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.835 . . . . 1.0 109.352 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.89 145.83 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 109.435 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.24 -41.24 99.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 1.0 109.281 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.04 64.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.426 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' CG ' ' X' ' 55' ' ' PHE . 20.6 t70 -59.12 -39.33 81.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.0 109.417 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.52 -43.08 99.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 1.0 109.417 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.29 -41.55 85.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 1.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.5 -38.37 89.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 1.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.02 -48.65 79.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 1.0 109.419 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -61.88 -42.61 99.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 1.0 109.4 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.51 -34.46 77.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.0 109.332 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.55 -46.25 86.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.539 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.91 -50.92 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.589 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' X' ' 43' ' ' PRO . 68.3 mttm -66.35 -29.88 70.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 1.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.0 m-20 -78.25 -18.59 55.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0 109.675 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 41' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 3.0 m -53.92 -61.28 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 1.0 109.396 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.558 ' N ' ' CD ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -108.98 -50.91 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 1.0 109.568 -176.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' X' ' 42' ' ' CYS . 52.7 Cg_exo -52.7 -39.34 76.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.885 2.39 . . . . 1.0 112.2 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.485 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -147.49 -150.4 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 1.0 109.544 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' X' ' 41' ' ' THR . 0.2 OUTLIER 172.9 69.31 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.877 . . . . 1.0 109.877 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 3.3 Cg_exo -75.72 159.8 38.37 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.693 2.262 . . . . 1.0 112.369 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.25 130.24 45.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 1.0 109.733 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.96 179.8 7.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 1.0 109.763 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.98 -93.43 0.17 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 29.5 m -125.92 144.79 50.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.174 . . . . 1.0 109.35 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.462 HD12 ' H ' ' X' ' 52' ' ' ASP . 0.2 OUTLIER -131.64 132.49 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 1.0 109.544 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.462 ' H ' HD12 ' X' ' 51' ' ' ILE . 65.5 m-20 -66.53 134.04 51.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 109.757 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.31 -29.07 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 1.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -44.61 93.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 1.0 109.44 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . 0.559 ' CG ' ' OD2' ' X' ' 30' ' ' ASP . 4.7 t80 -77.99 -23.22 48.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 1.0 109.285 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.609 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -55.64 -38.08 69.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 1.0 109.639 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.39 -42.1 98.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.933 . . . . 1.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 78.5 mtp85 -67.41 -37.2 82.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 1.0 109.429 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.59 -42.79 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.907 . . . . 1.0 109.356 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.29 91.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -66.82 -37.07 83.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -1.159 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 97.7 m -71.91 -44.62 63.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 1.0 109.553 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 1.0 109.472 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.87 -37.43 79.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 1.0 109.472 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -63.06 -46.25 88.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 1.0 109.32 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -65.77 -31.75 72.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 1.0 109.458 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' X' ' 71' ' ' GLY . 11.2 t80 -59.15 -54.89 41.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 1.0 109.391 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -67.6 -35.65 79.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.853 . . . . 1.0 109.335 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -65.87 -44.02 86.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 1.0 109.345 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.48 -52.55 2.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 1.0 109.275 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -164.47 26.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -73.5 -15.1 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.874 2.383 . . . . 1.0 111.913 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -61.92 -50.22 73.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 1.0 109.198 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -65.62 -43.68 88.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.878 . . . . 1.0 109.396 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 32.7 m -150.08 89.03 4.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 1.0 109.406 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.35 -175.03 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.871 2.381 . . . . 1.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 m -62.32 -18.19 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 109.383 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.1 p -62.05 -31.8 72.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 1.0 109.382 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.79 97.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -67.98 -38.64 82.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.431 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -61.29 -51.3 69.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 1.0 109.356 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -60.8 -44.34 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 1.0 109.417 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.609 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.9 t-105 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 109.351 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -56.35 -44.68 80.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 1.0 109.295 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.27 -40.41 97.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 1.0 109.559 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.25 -42.54 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 1.0 109.327 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.27 -39.94 67.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.495 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.8 -39.09 73.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 1.0 109.413 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.401 ' N ' HD22 ' X' ' 89' ' ' LEU . 3.5 mm? -64.48 -43.96 92.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 1.0 109.356 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' X' ' 93' ' ' LYS . 10.2 pt -76.17 -38.74 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 1.0 109.508 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.2 -45.0 96.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 1.0 109.509 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.88 -41.74 77.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 1.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.3 tttt -85.46 137.82 32.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.0 109.441 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.97 140.86 47.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 1.0 109.531 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.737 ' CG2' ' H ' ' X' ' 96' ' ' ASN . 9.5 p -150.0 -147.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 1.0 109.579 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.737 ' H ' ' CG2' ' X' ' 95' ' ' VAL . 36.0 t-20 -129.99 81.49 68.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 1.0 109.597 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.39 -168.13 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.811 2.34 . . . . 1.0 112.268 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -63.44 -38.59 91.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 1.0 109.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.3 129.64 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 1.0 109.534 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.3 mtp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.022 -0.99 . . . . 1.0 109.457 179.741 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.17 75.11 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -91.08 156.65 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 1.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -64.23 133.48 52.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 1.0 109.519 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.73 105.22 16.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 1.0 109.473 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.3 p -87.38 175.13 8.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 1.0 109.58 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.71 -43.63 65.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 1.0 109.435 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . 0.551 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.2 m-70 -67.88 -44.92 75.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 1.0 109.522 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.57 -39.45 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 1.0 109.369 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -62.04 -38.32 88.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.0 109.61 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.1 -41.59 88.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 1.0 109.502 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.65 -44.41 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 1.0 109.33 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -51.02 -46.0 61.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.258 -0.901 . . . . 1.0 109.392 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -66.21 -37.5 85.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 1.0 108.881 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.73 -40.22 96.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.266 -0.896 . . . . 1.0 108.826 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -62.83 -42.4 99.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 1.0 109.544 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -53.61 -45.2 69.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.146 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.23 -38.22 88.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 1.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.39 -38.46 89.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.172 -0.955 . . . . 1.0 109.275 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -57.31 -43.25 83.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.0 109.301 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.6 p -65.17 -24.44 67.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 1.0 109.284 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -82.15 -6.03 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 1.0 109.197 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.7 47.86 1.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.24 -1.544 . . . . 1.0 109.24 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.4 131.82 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -1.101 . . . . 1.0 109.356 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -132.35 88.44 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.98 . . . . 1.0 109.175 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.78 161.99 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 1.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -78.31 148.43 33.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 1.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.83 -35.05 77.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 1.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.39 65.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 1.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' X' ' 52' ' ' ASP . 89.2 m-20 -62.24 -39.62 93.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.1 mm? -62.01 -44.54 96.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 1.0 109.382 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.93 -41.5 99.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 1.0 109.449 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 98.9 mttt -66.27 -31.44 72.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.483 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.28 -46.77 87.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 1.0 109.449 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.15 -44.28 96.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 1.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.77 -47.3 84.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 1.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.71 -47.04 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 1.0 109.565 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.22 -32.23 73.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 1.0 109.379 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.0 m-20 -67.08 -19.59 65.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 1.0 109.663 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.4 m -54.52 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 1.0 109.371 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.65 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -106.95 -61.06 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 109.467 -177.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.65 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.2 Cg_exo -41.25 -45.12 5.63 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.887 2.391 . . . . 1.0 112.218 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.548 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.9 m-90 -135.66 -167.63 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 1.0 109.487 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.72 ' H ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -135.11 -46.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 109.885 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.72 ' CD ' ' H ' ' X' ' 45' ' ' PHE . 28.0 Cg_exo -60.74 142.67 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.73 2.287 . . . . 1.0 112.301 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -117.99 150.67 38.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 1.0 109.643 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -137.77 155.24 49.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.903 . . . . 1.0 109.743 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.55 176.66 47.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 88.3 m -119.39 135.29 54.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 1.0 109.313 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.94 141.15 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 1.0 109.515 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.43 ' OD2' ' OD1' ' X' ' 30' ' ' ASP . 91.4 m-20 -87.44 138.22 31.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 1.0 109.77 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.95 -40.82 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.081 -1.012 . . . . 1.0 109.445 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.99 -39.31 81.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.0 109.388 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -81.75 -18.06 45.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 1.0 109.277 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.632 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 8.1 t90 -63.73 -37.26 86.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.0 109.638 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -56.81 -43.07 80.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 1.0 109.508 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.493 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 17.2 mtt85 -67.83 -36.44 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 1.0 109.468 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.67 -44.01 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.382 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.47 95.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -67.77 -37.52 82.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 1.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.0 m -64.62 -52.57 56.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 109.448 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.77 -42.51 99.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 1.0 109.479 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.54 -38.95 78.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 1.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OG1' ' X' ' 69' ' ' THR . 98.0 m-20 -62.33 -44.46 96.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 1.0 109.311 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -69.29 -32.99 72.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 1.0 109.379 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' X' ' 71' ' ' GLY . 25.6 t80 -64.07 -55.21 23.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 1.0 109.411 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -70.47 -35.92 73.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 1.0 109.323 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 86.2 m -64.58 -47.16 79.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 1.0 109.301 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.48 -52.51 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 1.0 109.195 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -168.57 25.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' X' ' 76' ' ' PRO . 21.3 Cg_endo -70.08 -18.75 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.985 2.456 . . . . 1.0 111.97 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.92 -51.55 69.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 1.0 109.224 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -65.35 -38.94 91.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 1.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.6 82.49 8.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.8 Cg_exo -56.32 161.11 9.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.885 2.39 . . . . 1.0 112.302 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.44 -5.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 1.0 109.455 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.502 ' H ' ' C ' ' X' ' 76' ' ' PRO . 73.0 p -63.9 -33.48 75.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.873 . . . . 1.0 109.396 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 1.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.94 -46.79 80.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 1.0 109.377 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 75.7 m -59.42 -47.96 83.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 1.0 109.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -62.45 -40.23 95.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.0 109.501 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.632 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.6 t-105 -66.53 -36.03 81.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 1.0 109.441 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -56.24 -44.76 79.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 1.0 109.194 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.94 -39.82 95.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.635 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.0 -43.29 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.344 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.32 -43.3 83.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 1.0 109.438 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -69.45 -35.37 75.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 1.0 109.365 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.42 -47.78 75.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.357 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -74.25 -39.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 1.0 109.402 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -59.37 -46.43 88.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 1.0 109.521 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.91 -41.67 95.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 1.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -69.77 122.6 19.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 1.0 109.483 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.12 102.33 12.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 1.0 109.565 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.45 156.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -128.16 80.31 72.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 1.0 109.57 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.89 -42.82 65.31 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.899 2.399 . . . . 1.0 112.286 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -144.13 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.413 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.1 104.01 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 1.0 109.455 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.969 -1.015 . . . . 1.0 109.409 179.774 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.07 8.4 83.97 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -128.86 158.86 37.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -1.149 . . . . 1.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 96.0 mt-10 -64.39 146.44 54.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 1.0 109.541 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.58 102.58 15.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 1.0 109.508 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.1 p -84.84 171.58 12.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 1.0 109.579 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -57.13 -41.49 79.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 1.0 109.435 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -66.14 -42.26 89.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 1.0 109.511 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 92.5 mt-10 -66.92 -38.23 85.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 1.0 109.428 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.56 -35.04 75.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 1.0 109.583 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.28 -49.0 78.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 1.0 109.41 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -68.21 -32.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -0.972 . . . . 1.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.46 -45.8 90.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.868 . . . . 1.0 109.334 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -62.43 -37.42 85.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 1.0 108.878 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.67 -42.28 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 1.0 108.738 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.31 -44.18 79.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 1.0 109.523 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . 0.544 HE22 ' HZ2' ' X' ' 20' ' ' LYS . 98.5 mm-40 -55.13 -42.93 73.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 1.0 109.116 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.57 -37.77 88.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.78 . . . . 1.0 109.392 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.6 -36.93 85.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.898 . . . . 1.0 109.273 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.544 ' HZ2' HE22 ' X' ' 17' ' ' GLN . 97.6 mttt -58.33 -40.68 82.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 1.0 109.218 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 77.0 p -66.42 -31.22 71.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 1.0 109.263 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.434 HH12 ' CB ' ' X' ' 18' ' ' ALA . 84.1 mtt85 -72.89 -18.26 61.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 1.0 109.212 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.78 46.37 0.78 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.309 -1.517 . . . . 1.0 109.309 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.82 132.98 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 1.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.67 95.82 3.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 1.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.02 158.11 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -0.86 . . . . 1.0 109.359 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.15 145.26 46.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.923 . . . . 1.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -57.17 -33.56 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 1.0 109.271 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.5 70.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 1.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.5 m-20 -59.72 -40.75 89.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 1.0 109.409 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.79 -44.53 96.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 1.0 109.345 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.97 -42.51 97.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 1.0 109.369 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.94 -37.13 85.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 1.0 109.356 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.04 -50.93 72.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 1.0 109.4 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.43 -42.2 98.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 1.0 109.41 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.62 -38.71 91.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.0 109.277 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -62.51 -46.47 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 1.0 109.52 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.2 -50.11 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 1.0 109.373 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' X' ' 44' ' ' TRP . 21.1 m-20 -69.98 -19.86 63.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 1.0 109.686 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -54.72 -59.34 4.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.967 . . . . 1.0 109.426 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.632 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -107.69 -62.02 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 1.0 109.487 -176.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.632 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.24 -41.75 4.87 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.919 2.413 . . . . 1.0 112.201 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.2 m-90 -141.83 -159.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 1.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.511 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -173.75 50.18 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 1.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_endo -70.58 166.69 27.79 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.753 2.302 . . . . 1.0 112.327 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.54 138.73 57.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 1.0 109.712 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.62 136.14 37.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 1.0 109.798 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.8 -173.72 37.96 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 141.37 57.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -1.206 . . . . 1.0 109.293 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.441 HG22 HD12 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -127.46 134.04 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 1.0 109.567 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 30' ' ' ASP . 98.5 m-20 -64.39 137.28 57.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 1.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.15 -23.02 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 1.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.31 -39.48 92.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 1.0 109.41 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -83.26 -10.13 58.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 1.0 109.247 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.626 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.8 t90 -58.76 -38.16 77.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 1.0 109.651 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -62.15 -40.54 96.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.0 109.466 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 74.8 mtp85 -66.08 -39.13 89.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 1.0 109.396 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.95 -43.82 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 1.0 109.39 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.31 -50.7 62.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.74 -41.67 97.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -1.164 . . . . 1.0 109.511 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 81.8 m -65.43 -52.29 54.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 1.0 109.518 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -60.98 -41.46 96.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 1.0 109.498 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -63.85 -38.72 92.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 1.0 109.465 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.95 -45.28 89.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.306 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -68.05 -30.56 69.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 1.0 109.461 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' X' ' 71' ' ' GLY . 14.9 t80 -60.44 -55.09 37.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 1.0 109.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -66.95 -36.51 82.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 1.0 109.345 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -63.85 -47.03 82.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 1.0 109.318 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.35 -52.45 2.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 1.0 109.302 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.47 -164.12 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.4 -15.45 31.17 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.928 2.419 . . . . 1.0 112.001 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.11 -54.44 44.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 1.0 109.16 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -63.27 -44.47 95.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 1.0 109.366 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 34.2 m -148.81 90.57 4.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 1.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.42 -173.84 1.96 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.85 2.367 . . . . 1.0 112.204 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.94 -16.56 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 1.0 109.431 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.422 HG21 ' N ' ' X' ' 79' ' ' ALA . 0.9 OUTLIER -57.71 -32.52 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 1.0 109.345 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.422 ' N ' HG21 ' X' ' 78' ' ' THR . . . -60.13 -42.78 95.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 1.0 109.376 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -65.04 -41.24 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 1.0 109.38 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -59.66 -48.02 83.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -65.51 -43.75 89.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 1.0 109.488 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.626 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.7 t-105 -61.67 -36.46 80.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 1.0 109.389 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -56.77 -43.19 80.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 1.0 109.277 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.48 -41.14 96.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 1.0 109.642 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.5 -41.29 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.927 . . . . 1.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -56.87 -40.04 75.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 1.0 109.497 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.01 -40.62 78.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 1.0 109.434 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.7 -46.11 86.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 1.0 109.33 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.64 -38.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.399 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.46 -45.07 92.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 1.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.95 -45.55 93.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 1.0 109.586 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.8 127.96 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 1.0 109.495 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -91.73 96.09 10.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 1.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' X' ' 96' ' ' ASN . 14.0 p -121.76 170.21 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 1.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.419 ' N ' ' CG2' ' X' ' 95' ' ' VAL . 36.1 t-20 -129.38 81.88 69.12 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.59 -151.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.839 2.359 . . . . 1.0 112.321 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -62.54 -69.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 1.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.01 129.09 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 1.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.038 -0.982 . . . . 1.0 109.476 179.909 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.53 83.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -128.95 159.06 37.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.536 -0.979 . . . . 1.0 109.436 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.07 138.43 58.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 1.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.03 84.63 3.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.576 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.7 p -80.32 172.19 14.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 1.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.6 -43.34 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 1.0 109.447 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . 0.601 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.8 m-70 -68.68 -43.64 75.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 109.484 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.93 -36.59 84.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.0 -38.81 79.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 1.0 109.831 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.27 -49.03 78.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 1.0 109.63 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.22 -35.37 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -62.99 -40.36 97.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.301 -0.874 . . . . 1.0 109.24 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.43 -36.93 85.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.039 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.96 -43.0 99.76 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.25 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.448 ' NZ ' ' CD2' ' X' ' 28' ' ' TYR . 88.6 tttt -61.46 -36.94 81.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 1.0 109.417 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.25 -48.5 80.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.0 109.254 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -68.58 -40.3 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.446 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.65 -38.75 92.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 1.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.86 -39.7 95.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.306 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.2 p -61.77 -29.38 70.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 1.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.15 -17.51 63.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.588 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.13 44.55 0.67 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . 0.437 ' CG1' ' HE ' ' X' ' 58' ' ' ARG . 30.9 t -122.98 135.64 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.667 -0.902 . . . . 1.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -135.49 99.74 4.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 1.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.54 164.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.485 -0.76 . . . . 1.0 109.625 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.12 146.26 47.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.353 -0.842 . . . . 1.0 109.512 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.448 ' CD2' ' NZ ' ' X' ' 16' ' ' LYS . 94.7 m-85 -62.83 -37.39 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.05 -1.031 . . . . 1.0 109.371 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.49 -34.23 66.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -39.67 90.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 1.0 109.113 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.23 -43.55 98.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.0 109.526 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.71 -42.27 97.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 1.0 109.33 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.1 -30.86 71.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 1.0 109.18 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -61.39 -50.21 73.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 1.0 109.607 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -62.28 -46.56 88.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 1.0 109.547 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -65.52 -38.18 88.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.208 -0.932 . . . . 1.0 109.231 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.25 -45.64 93.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 1.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.27 -48.63 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 1.0 109.693 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -67.8 -28.46 67.61 Favored 'General case' 0 C--O 1.192 -1.94 0 O-C-N 121.171 -0.956 . . . . 1.0 108.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.562 ' OD1' ' CZ2' ' X' ' 44' ' ' TRP . 71.0 m-20 -77.93 -20.71 52.3 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 120.032 -1.667 . . . . 1.0 109.796 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 m -54.34 -60.91 2.71 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.99 -1.069 . . . . 1.0 111.275 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -101.84 -53.95 0.14 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.512 -0.743 . . . . 1.0 110.858 -178.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' X' ' 42' ' ' CYS . 89.1 Cg_exo -46.02 -43.0 20.68 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.514 2.143 . . . . 1.0 112.601 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.562 ' CZ2' ' OD1' ' X' ' 40' ' ' ASP . 0.1 OUTLIER -176.56 131.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 1.0 109.207 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.523 ' CE2' ' CD2' ' X' ' 82' ' ' TYR . 0.2 OUTLIER -104.69 105.95 52.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 1.0 109.775 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.403 ' CG ' ' HE1' ' X' ' 44' ' ' TRP . 56.4 Cg_endo -83.2 -164.46 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.778 2.318 . . . . 1.0 111.918 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -90.57 122.36 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.363 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.01 154.76 17.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.461 -0.774 . . . . 1.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.19 -93.99 2.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 27.3 m -130.92 137.4 49.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -1.007 . . . . 1.0 109.434 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.457 HD13 HG22 ' X' ' 51' ' ' ILE . 0.3 OUTLIER -112.67 139.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.543 -0.723 . . . . 1.0 109.381 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.435 ' H ' HD12 ' X' ' 51' ' ' ILE . 85.5 m-20 -68.85 136.61 52.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 1.0 109.76 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.57 -27.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -0.997 . . . . 1.0 109.537 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' X' ' 98' ' ' GLN . 46.1 mtmt -64.68 -41.87 95.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.024 -1.047 . . . . 1.0 109.777 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -75.88 -17.03 59.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 1.0 109.839 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.9 t90 -60.61 -37.74 82.41 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.288 -0.883 . . . . 1.0 109.954 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -59.44 -44.51 92.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 1.0 109.673 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.437 ' HE ' ' CG1' ' X' ' 24' ' ' VAL . 19.0 mtt85 -64.79 -40.01 94.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.54 -43.67 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.85 -46.92 92.6 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -67.88 -42.1 81.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -1.2 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.98 -51.6 66.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 1.0 109.639 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.98 -44.21 87.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 1.0 109.527 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -56.41 -40.62 74.99 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.272 -0.892 . . . . 1.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.415 ' O ' ' OG1' ' X' ' 69' ' ' THR . 25.5 m-20 -66.69 -43.29 84.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 1.0 109.324 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -62.86 -35.7 80.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 1.0 109.269 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.515 ' CE2' ' OD1' ' X' ' 68' ' ' ASN . 3.4 t80 -59.26 -55.0 40.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.515 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 84.9 m-20 -65.13 -34.56 78.7 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.041 -1.037 . . . . 1.0 109.771 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 20.2 m -64.16 -48.93 74.08 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.288 -0.883 . . . . 1.0 110.012 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -114.7 -51.93 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.651 -0.655 . . . . 1.0 109.871 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 143.45 -168.87 26.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' X' ' 76' ' ' PRO . 7.4 Cg_exo -67.03 -21.76 48.9 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.998 2.465 . . . . 1.0 111.987 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.91 -51.01 69.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 1.0 109.457 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.53 -45.08 88.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 1.0 109.808 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' X' ' 75' ' ' VAL . 26.6 m -142.8 82.4 12.34 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.0 109.356 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' X' ' 72' ' ' PRO . 51.5 Cg_endo -79.59 -172.33 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.911 2.407 . . . . 1.0 112.31 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.46 -20.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.922 . . . . 1.0 109.524 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 22.2 p -62.63 -37.85 87.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 1.0 109.563 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.25 79.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 1.0 109.56 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -65.68 -37.06 85.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 1.0 109.416 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -61.6 -45.3 94.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 1.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.523 ' CD2' ' CE2' ' X' ' 45' ' ' PHE . 38.3 m-85 -63.74 -44.24 94.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 1.0 109.732 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.634 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.7 t-105 -64.43 -37.56 87.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.282 -0.886 . . . . 1.0 109.296 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -55.99 -41.73 75.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 1.0 108.829 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.57 -40.39 92.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 1.0 109.297 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -64.22 -42.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 1.0 109.485 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -54.81 -39.32 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 1.0 109.264 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -70.39 -39.46 74.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 1.0 109.478 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.45 -46.0 90.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 1.0 110.139 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.19 -31.98 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.518 -0.739 . . . . 1.0 109.566 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.56 -40.55 92.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 1.0 109.374 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.37 -40.19 93.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.0 109.454 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -94.63 115.16 27.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.189 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.97 122.1 28.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 1.0 109.457 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.02 150.84 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 1.0 109.409 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -121.48 85.0 42.62 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.7 -45.75 38.78 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.705 2.27 . . . . 1.0 112.468 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . 0.499 ' OE1' ' NZ ' ' X' ' 54' ' ' LYS . 86.1 mt-30 -145.31 -78.6 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.541 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.07 100.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.744 -0.598 . . . . 1.0 109.416 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.994 -1.003 . . . . 1.0 109.434 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.269 0.557 . . . . 1.0 109.499 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.15 139.31 52.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 1.0 109.568 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 5' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 5' ' ' LEU . 67.9 mt -90.86 104.08 16.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.855 . . . . 1.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.8 p -82.27 168.63 17.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 1.0 109.565 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -53.84 -41.39 67.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 1.0 109.489 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -66.39 -45.64 79.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 1.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -62.96 -35.99 81.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 1.0 109.428 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.43 -36.97 85.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 1.0 109.578 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -61.63 -41.74 97.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.404 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 t -59.63 -43.32 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.297 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -56.33 -46.92 79.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.228 -0.92 . . . . 1.0 109.347 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.98 -38.0 89.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 1.0 108.884 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.88 -41.51 99.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 1.0 108.772 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.513 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.5 tttt -59.77 -37.73 79.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 1.0 109.474 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -59.15 -44.98 92.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 1.0 109.099 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.51 -37.35 86.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 1.0 109.344 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.78 -39.1 93.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 1.0 109.338 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.26 -42.53 86.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 1.0 109.325 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.9 p -63.68 -31.73 72.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 1.0 109.342 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.58 -18.6 61.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 1.0 109.24 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.87 47.85 0.65 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.62 132.92 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 1.0 109.466 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.8 93.96 3.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.144 -0.973 . . . . 1.0 109.226 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.36 160.65 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 1.0 109.363 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -72.73 151.45 42.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 1.0 109.453 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.513 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 72.5 t80 -65.67 -40.17 92.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.872 . . . . 1.0 109.257 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.58 57.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.0 109.487 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -61.44 -37.5 83.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 1.0 109.409 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.504 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.23 -45.28 94.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 1.0 109.369 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' X' ' 32' ' ' LEU . 96.7 mt -63.91 -41.41 97.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 1.0 109.405 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 1.0 109.415 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -56.63 -49.14 75.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 1.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -59.95 -42.23 93.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 1.0 109.419 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.22 -44.13 95.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.0 109.292 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -61.2 -45.48 94.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 1.0 109.548 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.93 -44.69 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 1.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 69.9 tttt -64.2 -31.51 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 1.0 109.436 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' X' ' 44' ' ' TRP . 99.0 m-20 -70.7 -19.32 62.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 1.0 109.587 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 30.9 m -53.89 -52.25 61.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 1.0 109.378 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.772 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -116.13 -60.73 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 1.0 109.504 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.772 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 74.0 Cg_exo -41.5 -54.58 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.868 2.379 . . . . 1.0 112.203 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.52 ' O ' ' O ' ' X' ' 40' ' ' ASP . 8.4 m0 -127.65 113.01 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 1.0 109.58 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -61.49 -44.52 92.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 1.0 109.81 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.4 Cg_exo -59.6 141.71 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.699 2.266 . . . . 1.0 112.378 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -97.99 159.21 15.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 1.0 109.665 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.43 133.7 12.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.846 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.94 155.23 22.74 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.794 -1.323 . . . . 1.0 109.794 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 50' ' ' THR . . . . . 0.476 HG23 HG22 ' X' ' 90' ' ' ILE . 19.6 m -91.91 135.08 34.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 1.0 109.303 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.66 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -102.21 134.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 1.0 109.518 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.66 ' N ' HD13 ' X' ' 51' ' ' ILE . 70.0 m-20 -75.55 137.94 41.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 1.0 109.756 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.95 -34.19 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 1.0 109.392 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.85 -38.05 89.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 1.0 109.452 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.18 -20.36 52.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 1.0 109.245 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.597 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 13.5 t90 -56.18 -33.95 65.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 1.0 109.719 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -59.89 -41.98 92.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 1.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.416 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 72.8 mtp180 -66.38 -39.68 89.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 1.0 109.515 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.572 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 72.8 t -62.76 -43.11 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.33 -46.61 93.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -70.02 -42.2 73.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 1.0 109.494 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.1 m -63.86 -48.41 76.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 1.0 109.544 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.438 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.3 m-85 -61.84 -39.35 91.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 1.0 109.493 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -61.93 -39.67 92.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 1.0 109.456 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -63.07 -44.1 96.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 1.0 109.236 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -65.47 -35.15 80.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 1.0 109.475 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' X' ' 71' ' ' GLY . 5.1 t80 -59.05 -54.39 47.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.87 . . . . 1.0 109.45 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 95.0 m-20 -65.74 -36.57 83.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 1.0 109.311 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -62.93 -47.99 80.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 1.0 109.299 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.76 -52.36 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 1.0 109.209 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.26 -165.93 25.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.459 -1.457 . . . . 1.0 109.459 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -67.19 -16.56 48.99 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.953 2.435 . . . . 1.0 111.952 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.55 -54.6 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 1.0 109.198 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -63.74 -43.6 95.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 1.0 109.404 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.694 HG23 ' O ' ' X' ' 75' ' ' VAL . 27.3 m -148.63 92.42 4.47 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 1.0 109.431 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.55 -166.55 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.873 2.382 . . . . 1.0 112.166 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.66 -12.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 1.0 109.416 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -66.17 -33.2 75.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 1.0 109.421 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.15 -47.18 81.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.446 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -64.92 -45.67 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 1.0 109.4 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -59.77 -47.12 86.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 1.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -63.15 -40.89 98.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 1.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.597 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.5 t-105 -61.69 -37.98 86.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.05 -42.57 76.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.882 . . . . 1.0 109.223 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.31 -41.59 98.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 1.0 109.586 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -63.75 -43.53 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -0.941 . . . . 1.0 109.412 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.54 -37.63 58.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.0 109.501 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.21 -42.3 72.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.0 109.309 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.32 -48.02 83.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 1.0 109.396 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.476 HG22 HG23 ' X' ' 50' ' ' THR . 11.5 pt -72.69 -36.74 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.914 . . . . 1.0 109.434 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -63.11 -39.74 95.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 1.0 109.536 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -63.62 -40.96 98.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 1.0 109.57 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -88.75 117.48 27.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 1.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.75 138.17 56.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 1.0 109.564 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 1.0 109.572 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.256 0.55 . . . . 1.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.3 130.81 46.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 1.0 109.423 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 64.4 mt -91.93 104.66 17.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 1.0 109.717 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -82.46 168.37 17.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.434 -0.791 . . . . 1.0 109.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.96 -41.46 67.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 1.0 109.413 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.76 -45.13 79.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 1.0 109.606 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.85 -31.67 73.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.2 -0.938 . . . . 1.0 109.344 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -70.74 -40.65 72.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 1.0 109.925 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -60.66 -49.75 76.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 1.0 109.644 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -65.19 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 1.0 109.361 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.61 -40.96 93.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 1.0 109.019 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.22 -36.41 84.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 1.0 108.875 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.7 -41.42 99.12 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 109.126 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.6 -40.71 88.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 1.0 109.329 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -59.38 -44.57 92.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 1.0 109.046 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.08 -38.61 91.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.301 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.4 HD23 ' HD3' ' X' ' 22' ' ' ARG . 98.6 mt -67.1 -40.98 87.02 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.021 -1.05 . . . . 1.0 109.207 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.41 -30.61 71.34 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.991 -1.068 . . . . 1.0 109.162 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 31.4 p -77.06 -31.46 56.12 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.346 -0.846 . . . . 1.0 109.535 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' CG2' ' X' ' 24' ' ' VAL . 15.9 ptt85 -75.57 -19.3 59.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.112 -0.993 . . . . 1.0 109.29 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.73 48.47 0.3 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.455 ' CG2' ' HE ' ' X' ' 22' ' ' ARG . 69.7 t -123.11 139.47 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 1.0 109.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -125.39 98.2 5.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.743 . . . . 1.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -132.04 138.63 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 1.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.94 150.15 39.17 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.361 -0.837 . . . . 1.0 109.631 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.15 -35.36 80.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 1.0 109.128 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 1.0 109.305 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -62.88 -37.47 87.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.185 -0.947 . . . . 1.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -63.11 -44.77 94.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 1.0 109.631 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.67 -43.11 94.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 1.0 109.429 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 1.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.86 -48.45 78.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 1.0 109.571 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.82 -41.05 97.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 109.209 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.41 -44.93 95.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 1.0 109.271 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.48 -48.07 79.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.58 -45.03 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.908 . . . . 1.0 109.327 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 51.4 tttm -64.38 -34.22 77.66 Favored 'General case' 0 C--O 1.2 -1.516 0 CA-C-O 122.103 0.954 . . . . 1.0 108.938 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 2.9 m-20 -69.42 -20.73 63.79 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 120.242 -1.536 . . . . 1.0 109.646 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -54.28 -61.04 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.0 110.926 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.54 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -102.68 -59.09 0.09 OUTLIER Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.334 -0.854 . . . . 1.0 110.728 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.8 Cg_exo -41.7 -48.6 5.72 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.599 2.199 . . . . 1.0 112.697 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -125.53 -118.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.0 109.03 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.672 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.9 OUTLIER -177.58 -41.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.0 110.227 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 25.8 Cg_exo -60.84 141.41 94.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.728 2.286 . . . . 1.0 112.231 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.11 164.29 15.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 1.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.0 161.12 30.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 1.0 109.753 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.03 -2.86 58.1 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.086 -1.206 . . . . 1.0 110.086 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -119.63 116.12 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.978 . . . . 1.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.663 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.84 132.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.156 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.663 ' N ' HD13 ' X' ' 51' ' ' ILE . 87.7 m-20 -72.46 131.34 42.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.83 -1.169 . . . . 1.0 109.884 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.26 -42.44 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 1.0 109.581 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -57.37 -42.07 81.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.159 . . . . 1.0 109.43 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 55' ' ' PHE . . . . . 0.519 ' CE2' ' CG2' ' X' ' 59' ' ' VAL . 86.2 t80 -77.08 -23.76 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 1.0 109.757 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.643 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -59.56 -38.8 82.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.975 . . . . 1.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -57.09 -44.42 83.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.218 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.461 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 77.8 mtp85 -66.69 -39.02 87.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 1.0 109.487 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.519 ' CG2' ' CE2' ' X' ' 55' ' ' PHE . 59.2 t -62.4 -44.1 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 1.0 109.46 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.01 73.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -65.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -1.133 . . . . 1.0 109.498 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 74.0 m -66.33 -55.16 17.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 1.0 109.715 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.52 -37.83 85.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 1.0 109.548 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -38.35 90.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 1.0 109.303 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 1.0 109.438 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -64.8 -35.44 81.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.895 . . . . 1.0 109.579 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' X' ' 71' ' ' GLY . 0.9 OUTLIER -62.15 -54.06 46.54 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.261 -0.9 . . . . 1.0 109.834 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 35.0 t-20 -64.42 -35.52 81.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.909 -1.12 . . . . 1.0 109.674 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -67.24 -46.14 74.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.288 -0.883 . . . . 1.0 109.69 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -115.15 -52.05 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.691 -0.631 . . . . 1.0 109.901 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.76 -169.19 24.23 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' X' ' 76' ' ' PRO . 13.1 Cg_exo -63.33 -22.87 72.04 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.946 2.431 . . . . 1.0 111.99 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.79 -53.06 57.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 1.0 109.346 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -65.37 -43.91 89.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.299 -0.875 . . . . 1.0 109.751 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' X' ' 75' ' ' VAL . 7.3 m -138.79 84.52 17.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.612 -0.68 . . . . 1.0 109.285 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.553 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.5 Cg_exo -60.12 152.8 62.97 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.841 2.36 . . . . 1.0 112.153 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.522 ' O ' HG12 ' X' ' 77' ' ' VAL . 61.0 t -52.03 -4.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.968 . . . . 1.0 109.707 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.553 ' H ' ' C ' ' X' ' 76' ' ' PRO . 51.5 p -65.49 -38.62 90.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.132 -0.98 . . . . 1.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.15 77.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 1.0 109.434 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -62.6 -45.83 91.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 1.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 65.9 m -61.05 -46.76 89.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.72 -37.48 87.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 1.0 109.431 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.643 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.2 t-105 -66.75 -35.17 79.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 1.0 109.214 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -58.07 -45.36 87.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 1.0 108.865 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.72 -42.02 99.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 1.0 109.413 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.6 -45.06 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 1.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -54.19 -44.27 71.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 1.0 109.508 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.98 -35.26 76.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.067 -1.02 . . . . 1.0 109.466 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.22 -49.09 71.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.089 -1.007 . . . . 1.0 110.014 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' X' ' 93' ' ' LYS . 6.0 pt -71.77 -43.07 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 1.0 109.517 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -62.01 -48.34 80.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.68 -44.7 92.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 1.0 109.712 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 93' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.5 tttt -81.34 143.25 32.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 1.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.08 138.4 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 1.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.775 . . . . 1.0 109.369 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 4' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' X' ' 4' ' ' GLU . 56.7 mp0 -58.61 144.22 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.231 -0.918 . . . . 1.0 109.436 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 60.4 mt -97.32 101.92 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 82.4 p -80.02 170.97 15.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 1.0 109.497 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.09 -42.02 79.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 1.0 109.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.31 -45.33 80.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 1.0 109.554 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 96.7 mt-10 -62.82 -36.68 83.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 1.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.32 -40.39 97.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 1.0 109.636 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.11 -37.82 81.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 1.0 109.069 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.32 -44.74 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 1.0 109.043 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -56.09 -47.79 77.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0 109.314 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 1.0 109.002 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.283 -0.885 . . . . 1.0 109.181 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' X' ' 26' ' ' VAL . 86.0 tttt -60.35 -42.01 94.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 1.0 109.063 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -55.05 -44.69 74.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 1.0 109.111 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.08 86.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 1.0 109.168 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' X' ' 16' ' ' LYS . 95.9 mt -62.94 -39.26 94.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 1.0 109.086 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.82 -41.02 90.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.382 -0.824 . . . . 1.0 109.278 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 13.8 m -59.38 -39.06 82.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 1.0 109.225 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.81 -17.81 64.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 1.0 109.26 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.67 46.57 0.96 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.358 -1.497 . . . . 1.0 109.358 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.96 134.73 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.643 -0.916 . . . . 1.0 109.374 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.46 106.75 10.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.637 -0.664 . . . . 1.0 109.231 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.503 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 53.7 t -135.9 159.14 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.657 -0.652 . . . . 1.0 109.531 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 27' ' ' LYS . . . . . 0.465 ' N ' HG12 ' X' ' 26' ' ' VAL . 99.7 mttt -81.27 143.64 32.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.381 -0.825 . . . . 1.0 109.717 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.5 ' CE2' HD11 ' X' ' 32' ' ' LEU . 88.3 t80 -59.59 -39.2 83.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 1.0 109.354 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.17 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 1.0 109.543 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -64.42 -38.57 91.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 1.0 109.167 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.79 -46.06 89.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 1.0 109.676 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' X' ' 28' ' ' TYR . 94.9 mt -63.4 -42.39 98.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 1.0 109.572 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 -36.02 82.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 1.0 109.357 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -60.48 -49.56 77.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 1.0 109.806 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.37 -44.61 90.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 1.0 109.787 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.92 -44.2 96.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 1.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.468 ' O ' ' OG1' ' X' ' 41' ' ' THR . 84.2 t80 -64.11 -45.46 88.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 1.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.36 -43.41 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.275 -0.891 . . . . 1.0 109.95 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.55 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -76.24 -29.19 57.41 Favored 'General case' 0 C--O 1.187 -2.19 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' X' ' 44' ' ' TRP . 79.1 m-20 -78.17 -21.79 49.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.052 0.929 . . . . 1.0 109.83 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 41' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 37' ' ' PHE . 11.3 m -62.72 -51.27 67.83 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.363 -1.461 . . . . 1.0 111.669 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -65.11 -64.28 2.79 Favored Pre-proline 0 C--N 1.296 -1.74 0 O-C-N 121.448 -0.782 . . . . 1.0 110.998 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.55 ' CG ' ' O ' ' X' ' 39' ' ' LYS . 27.7 Cg_endo -61.23 -54.19 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.723 2.282 . . . . 1.0 112.792 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.65 ' O ' ' CD2' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -173.67 139.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.092 -1.005 . . . . 1.0 109.287 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.539 ' N ' ' HD3' ' X' ' 46' ' ' PRO . 11.8 p90 -154.42 54.93 1.15 Allowed Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 120.671 -1.268 . . . . 1.0 110.002 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 38.9 Cg_endo -78.97 -23.0 8.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.673 2.248 . . . . 1.0 112.53 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -75.97 156.16 34.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.905 . . . . 1.0 109.629 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -132.39 151.83 51.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.573 -0.704 . . . . 1.0 109.49 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 49' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' X' ' 86' ' ' ILE . . . -150.74 -176.67 23.9 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.2 m -77.37 144.05 38.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -1.18 . . . . 1.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.669 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.29 134.45 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.494 -0.753 . . . . 1.0 109.227 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.669 ' N ' HD13 ' X' ' 51' ' ' ILE . 66.2 t0 -65.33 135.62 55.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.932 -1.105 . . . . 1.0 109.801 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 97.2 mt -69.54 -42.29 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.917 -1.115 . . . . 1.0 109.436 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.65 -39.84 77.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 1.0 109.171 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 55' ' ' PHE . . . . . 0.401 ' CE2' HG23 ' X' ' 59' ' ' VAL . 46.9 t80 -70.5 -36.63 73.91 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.298 -0.876 . . . . 1.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.645 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 17.3 t90 -52.78 -37.79 60.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.163 -0.961 . . . . 1.0 109.458 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -57.32 -44.8 84.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 1.0 109.234 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.446 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 80.1 mtp85 -67.96 -43.15 79.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 1.0 109.514 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.401 HG23 ' CE2' ' X' ' 55' ' ' PHE . 39.7 t -62.5 -43.73 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 1.0 109.467 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.32 -48.81 77.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.49 -38.12 86.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -1.18 . . . . 1.0 109.645 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.4 m -66.73 -48.7 68.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 1.0 109.693 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.437 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.6 m-85 -58.92 -46.19 88.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.333 -0.854 . . . . 1.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -57.13 -40.63 77.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 1.0 109.354 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -63.13 -45.97 89.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.0 109.353 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -64.84 -30.95 71.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 1.0 109.449 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.506 ' O ' ' N ' ' X' ' 71' ' ' GLY . 2.1 t80 -63.26 -54.78 31.92 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.357 -0.839 . . . . 1.0 109.847 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.418 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 76.4 m-20 -65.82 -38.97 90.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.876 -1.14 . . . . 1.0 109.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -62.5 -49.56 74.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.295 -0.878 . . . . 1.0 109.958 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.69 -51.76 2.85 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.996 -0.682 . . . . 1.0 109.97 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.41 -169.46 24.79 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.1 -20.06 50.57 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.985 2.456 . . . . 1.0 112.014 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -57.24 -51.91 67.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.97 . . . . 1.0 109.366 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.94 -46.21 82.52 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 1.0 110.004 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.767 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.8 m -146.01 86.84 6.94 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.537 -0.727 . . . . 1.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.42 -166.51 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.865 2.376 . . . . 1.0 112.41 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.71 -15.97 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.0 109.662 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 36.9 p -61.73 -34.14 75.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 1.0 109.277 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.55 -45.45 75.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.62 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -63.91 -46.15 86.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -61.53 -46.47 89.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 1.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.05 -42.13 98.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 1.0 109.538 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.645 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.8 t-105 -64.53 -36.73 85.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 1.0 109.163 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -55.85 -44.98 78.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 1.0 108.933 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.99 -42.94 99.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0 109.498 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' X' ' 49' ' ' GLY . 1.5 mm -61.46 -41.83 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 1.0 109.49 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.66 -36.87 67.54 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.372 -0.83 . . . . 1.0 109.181 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.86 -41.29 71.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 1.0 109.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.89 -46.98 87.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 1.0 110.403 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 6.4 pt -71.54 -41.91 72.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -0.821 . . . . 1.0 109.704 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.78 -46.71 89.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.888 . . . . 1.0 109.326 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -45.81 90.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 1.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.17 133.0 39.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 1.0 109.453 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.78 126.46 31.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 1.0 109.437 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.521 -0.737 . . . . 1.0 109.329 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.451 -0.574 . . . . 1.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 4' ' ' GLU . . . . . 0.467 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.7 mt-10 -56.46 141.77 41.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 1.0 109.555 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 5' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' X' ' 5' ' ' LEU . 86.3 mt -96.89 105.37 17.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 1.0 109.506 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -83.44 172.46 12.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 1.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -56.56 -46.58 80.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 1.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -66.59 -44.01 83.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 1.0 109.564 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 81.5 mt-10 -60.17 -38.75 84.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 1.0 109.425 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -63.64 -38.48 91.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 1.0 109.555 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.14 -40.22 89.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 1.0 109.468 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.68 -44.37 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 1.0 109.307 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.15 -41.67 75.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 1.0 109.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -66.22 -36.27 82.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 1.0 108.896 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.47 -41.11 98.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.228 -0.92 . . . . 1.0 108.815 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -40.9 98.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.0 109.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.49 -45.27 85.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 1.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.77 85.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 1.0 109.377 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 19' ' ' LEU . 88.6 mt -63.77 -38.66 91.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 1.0 109.364 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.42 -35.54 76.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 1.0 109.316 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -66.16 -39.53 89.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 1.0 109.351 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -68.55 -19.12 64.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.845 . . . . 1.0 109.255 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.22 50.01 0.48 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.97 129.84 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -1.151 . . . . 1.0 109.436 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -126.74 101.73 6.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 1.0 109.145 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.78 162.46 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 1.0 109.36 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.34 145.07 39.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.886 . . . . 1.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -59.94 -39.28 85.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.237 -0.914 . . . . 1.0 109.34 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.55 68.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 1.0 109.414 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.0 -39.62 86.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 1.0 109.392 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.441 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -63.01 -43.76 97.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 1.0 109.393 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.47 -41.52 98.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 1.0 109.435 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.31 -38.53 91.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 1.0 109.42 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.409 ' O ' HG23 ' X' ' 38' ' ' VAL . 61.3 t80 -57.97 -49.06 78.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 1.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -64.01 -45.81 87.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.0 109.365 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -58.52 -43.06 89.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 1.0 109.317 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -66.4 -43.49 85.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 1.0 109.523 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.409 HG23 ' O ' ' X' ' 34' ' ' PHE . 54.7 t -60.42 -45.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 1.0 109.535 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.563 ' NZ ' ' CH2' ' X' ' 44' ' ' TRP . 44.5 tttm -66.62 -32.85 74.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.43 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.9 m-20 -68.85 -19.53 64.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 1.0 109.688 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 41' ' ' THR . . . . . 0.407 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 6.4 m -54.01 -61.37 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.0 109.418 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.689 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.71 -60.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 -177.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 71.4 Cg_exo -41.67 -51.81 4.16 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.891 2.394 . . . . 1.0 112.232 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' NZ ' ' X' ' 39' ' ' LYS . 6.5 m0 -132.95 -149.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 1.0 109.551 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.621 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.45 -44.91 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 1.0 109.877 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 36.1 Cg_exo -56.47 -31.74 86.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.725 2.283 . . . . 1.0 112.367 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 47' ' ' GLN . . . . . 0.512 ' NE2' ' CE3' ' X' ' 44' ' ' TRP . 32.7 mt-30 -66.09 125.01 24.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 1.0 109.65 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -132.18 159.51 38.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.43 156.42 27.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -64.09 142.8 58.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.178 . . . . 1.0 109.382 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.68 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.73 133.28 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 1.0 109.548 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.68 ' N ' HD13 ' X' ' 51' ' ' ILE . 83.8 m-20 -72.12 135.61 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 1.0 109.756 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 1.0 109.423 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.28 -41.15 97.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 1.0 109.373 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -81.51 -17.48 48.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.0 109.299 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.544 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -58.44 -37.45 75.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.997 . . . . 1.0 109.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.16 -43.47 92.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 1.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -67.09 -37.03 83.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 1.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.65 -43.22 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 1.0 109.33 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.56 -47.46 90.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.504 -1.439 . . . . 1.0 109.504 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.01 -40.34 82.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 1.0 109.44 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.0 m -65.78 -50.28 65.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 1.0 109.439 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.79 -43.2 94.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 1.0 109.519 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -61.99 -33.41 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.0 109.517 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -65.12 -43.01 93.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 1.0 109.335 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.87 -34.96 74.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 1.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' X' ' 71' ' ' GLY . 19.9 t80 -60.26 -54.85 40.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.61 -36.53 82.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.0 109.351 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -64.59 -47.14 79.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 1.0 109.313 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.68 -52.68 2.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 1.0 109.264 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.81 -164.53 26.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -73.45 -14.27 25.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.928 2.418 . . . . 1.0 111.983 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -61.49 -49.76 75.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.0 109.284 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.55 -46.3 73.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 1.0 109.324 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.703 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.5 m -147.24 89.28 5.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 1.0 109.484 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.23 -170.23 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.83 2.353 . . . . 1.0 112.186 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.82 -18.23 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 1.0 109.406 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.6 p -58.55 -30.86 67.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.413 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 1.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.85 -39.66 93.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 1.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 64.7 m -61.79 -46.02 91.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 1.0 109.403 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' CZ ' ' X' ' 45' ' ' PHE . 36.7 m-85 -66.64 -42.38 86.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.877 . . . . 1.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.544 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t-105 -63.86 -34.63 78.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.0 109.289 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.3 -41.05 83.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 1.0 109.202 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.61 -42.44 98.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 1.0 109.577 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.3 -41.38 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 1.0 109.394 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.492 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 47.5 mttt -53.62 -41.36 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 1.0 109.424 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.56 -37.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 1.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.72 -48.69 76.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 1.0 109.378 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -73.31 -41.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 1.0 109.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.09 -42.29 98.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 1.0 109.454 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -64.76 -42.5 95.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 1.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.18 130.28 35.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 1.0 109.459 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.71 114.88 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 1.0 109.524 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 1.0 109.62 179.496 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.73 132.34 36.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.97 102.78 15.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.87 . . . . 1.0 109.506 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -82.95 175.66 9.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.0 109.616 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -54.11 -45.55 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 1.0 109.483 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.98 -43.59 87.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.565 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -60.07 -39.46 86.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 1.0 109.387 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.8 -38.18 89.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 1.0 109.606 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -61.79 -35.85 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.911 . . . . 1.0 109.437 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.01 -43.71 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 1.0 109.318 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.55 -44.69 93.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 1.0 109.312 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.6 -37.95 83.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.179 -0.95 . . . . 1.0 108.91 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.74 -40.3 94.6 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.279 -0.888 . . . . 1.0 108.747 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.638 ' HZ2' ' CA ' ' X' ' 28' ' ' TYR . 88.6 tttt -62.58 -41.1 98.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 1.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.62 -44.65 85.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.922 . . . . 1.0 109.139 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.06 98.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.445 -0.785 . . . . 1.0 109.412 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' X' ' 58' ' ' ARG . 95.7 mt -63.81 -38.03 89.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 1.0 109.251 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -58.62 -43.08 89.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.0 109.228 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 67.4 p -63.16 -31.26 72.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 1.0 109.384 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.83 -15.79 61.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 1.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.31 47.16 0.82 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.3 134.28 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -1.123 . . . . 1.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.7 92.98 3.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.937 . . . . 1.0 109.209 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.84 160.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 1.0 109.298 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.0 143.43 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 1.0 109.486 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.638 ' CA ' ' HZ2' ' X' ' 16' ' ' LYS . 89.6 t80 -61.68 -38.48 87.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 1.0 109.296 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.81 65.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 1.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.0 m-20 -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 1.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.462 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -61.62 -44.58 96.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 1.0 109.391 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.37 -43.74 96.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 1.0 109.329 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.07 -37.45 85.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 1.0 109.378 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.66 -48.13 75.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 1.0 109.376 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -60.95 -41.59 96.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 1.0 109.391 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -65.14 -40.34 94.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 1.0 109.214 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.83 -42.71 99.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 1.0 109.51 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.37 -46.13 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 1.0 109.575 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 1.0 109.404 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' X' ' 44' ' ' TRP . 85.5 m-20 -70.64 -19.3 62.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 1.0 109.694 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 41' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 22.2 m -54.9 -52.92 61.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.0 109.445 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.672 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -112.89 -63.65 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 1.0 109.466 -177.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.09 -40.61 4.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.904 2.403 . . . . 1.0 112.15 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.4 m-90 -146.08 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 1.0 109.537 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 172.29 -45.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 1.0 109.889 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.5 Cg_exo -56.1 -35.37 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.693 2.262 . . . . 1.0 112.368 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -64.4 127.98 33.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 1.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -142.15 168.85 18.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 109.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.88 165.63 37.69 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 15.6 m -64.31 141.3 58.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -1.217 . . . . 1.0 109.371 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.652 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -130.0 135.12 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.652 ' N ' HD13 ' X' ' 51' ' ' ILE . 38.8 m-20 -68.85 138.25 54.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 1.0 109.779 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.91 -25.02 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 1.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.97 -40.49 95.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 1.0 109.358 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -76.21 -18.74 58.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 1.0 109.258 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.3 t90 -54.64 -39.09 67.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -62.66 -41.31 99.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.0 109.496 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.454 ' NH2' HD13 ' X' ' 19' ' ' LEU . 79.0 mtp85 -66.61 -38.46 87.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 1.0 109.477 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.525 HG21 ' CH2' ' X' ' 83' ' ' TRP . 51.1 t -63.31 -43.98 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 1.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.7 84.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 1.0 109.511 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -66.18 -37.27 85.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -1.197 . . . . 1.0 109.512 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 82.5 m -69.95 -50.43 42.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 1.0 109.522 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.471 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.5 m-85 -61.11 -43.09 99.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 1.0 109.492 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.6 -40.14 86.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 1.0 109.439 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.68 -45.91 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 1.0 109.373 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -64.53 -35.06 79.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.485 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' X' ' 71' ' ' GLY . 1.9 t80 -59.29 -54.71 43.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 1.0 109.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.442 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 38.7 t30 -64.41 -36.71 85.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 1.0 109.281 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -67.72 -45.19 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 1.0 109.277 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.27 -52.23 2.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 1.0 109.312 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.74 -168.32 24.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.439 -1.464 . . . . 1.0 109.439 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -65.71 -20.07 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.914 2.409 . . . . 1.0 111.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.66 -54.84 39.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 1.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -64.21 -42.98 96.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 1.0 109.352 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.73 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.8 m -150.44 91.38 4.15 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 1.0 109.432 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -82.83 179.97 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.862 2.375 . . . . 1.0 112.213 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.62 -23.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 1.0 109.486 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.464 ' H ' HG23 ' X' ' 78' ' ' THR . 6.5 p -60.85 -34.95 75.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 1.0 109.423 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.38 72.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -69.86 -37.78 76.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -59.88 -46.98 87.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 1.0 109.403 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -61.9 -40.14 94.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.513 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.668 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.6 t-105 -66.0 -36.18 82.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -58.05 -41.67 83.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 1.0 109.255 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.49 -38.26 90.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.41 -0.806 . . . . 1.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.57 -42.7 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 1.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -57.71 -43.35 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0 109.395 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.25 -36.65 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 1.0 109.383 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.8 -51.95 59.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 1.0 109.352 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 pt -71.41 -41.09 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.0 109.411 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.33 -51.65 67.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.501 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.78 -40.68 92.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 1.0 109.541 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.16 138.77 39.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 1.0 109.533 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.69 93.85 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 1.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.0 109.564 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.26 131.28 41.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 1.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -96.91 104.54 16.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 1.0 109.486 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -77.64 170.19 17.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.868 . . . . 1.0 109.575 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -50.79 -43.17 58.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 1.0 109.379 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -68.14 -49.0 63.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 1.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.89 -35.87 77.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 1.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -60.86 -41.28 95.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 1.0 109.562 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.7 -36.04 79.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 1.0 109.464 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.41 -45.31 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 1.0 109.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.74 -45.97 81.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 1.0 109.398 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.95 -38.92 90.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 1.0 108.911 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.77 -43.14 99.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 1.0 108.765 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.542 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.26 -38.6 87.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 1.0 109.486 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.46 -46.95 87.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 1.0 109.145 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.15 93.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.313 -0.867 . . . . 1.0 109.44 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' X' ' 19' ' ' LEU . 97.1 mt -67.08 -40.69 87.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 1.0 109.23 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.19 -42.07 80.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.903 . . . . 1.0 109.242 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 70.3 p -64.96 -33.93 77.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.845 . . . . 1.0 109.299 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.95 -17.64 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 1.0 109.169 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.17 48.24 0.53 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.28 -1.528 . . . . 1.0 109.28 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.92 133.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 1.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -132.0 99.0 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 1.0 109.224 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.23 163.22 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 1.0 109.357 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.92 148.81 32.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 1.0 109.499 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.542 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 59.0 m-85 -63.75 -42.93 97.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.224 -0.923 . . . . 1.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.95 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 1.0 109.455 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.25 -40.34 93.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 1.0 109.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.454 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.1 -45.93 91.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 1.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.13 -41.68 99.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 1.0 109.394 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.509 ' HZ3' ' H ' ' X' ' 50' ' ' THR . 98.4 mttt -67.24 -35.83 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.34 -50.26 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 1.0 109.493 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -61.03 -41.49 96.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.0 109.417 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.56 -39.74 95.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 1.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.37 -45.58 91.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -0.802 . . . . 1.0 109.508 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 76.7 t -58.27 -49.21 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 1.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.5 mttt -64.0 -31.5 72.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.8 m-20 -67.67 -19.14 65.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.85 . . . . 1.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 9.8 m -53.78 -48.43 69.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 1.0 109.403 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.821 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -122.73 -59.6 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.821 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.5 Cg_exo -41.47 -45.69 6.03 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.88 2.386 . . . . 1.0 112.219 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.7 m-90 -139.02 113.67 9.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.152 -0.967 . . . . 1.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -64.91 -43.72 69.4 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 1.0 109.875 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -55.93 130.77 42.13 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.79 2.327 . . . . 1.0 112.373 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -119.05 133.45 55.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 1.0 109.707 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -142.51 127.72 18.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.887 . . . . 1.0 109.789 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.74 147.73 5.38 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 50' ' ' THR . . . . . 0.509 ' H ' ' HZ3' ' X' ' 33' ' ' LYS . 31.4 m -88.68 143.26 27.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.099 -1.236 . . . . 1.0 109.414 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.679 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -117.14 130.27 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 1.0 109.538 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.679 ' N ' HD13 ' X' ' 51' ' ' ILE . 45.1 t0 -71.88 136.79 47.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 1.0 109.784 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.74 -25.4 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 1.0 109.464 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.96 -38.66 91.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 1.0 109.396 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -82.74 -18.88 39.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 1.0 109.296 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 11.9 t90 -60.13 -38.38 82.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.0 109.64 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.563 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 31.8 mmt180 -56.88 -43.64 81.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 109.478 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.476 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.8 mtp180 -68.75 -39.4 80.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 1.0 109.479 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -61.62 -46.55 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 1.0 109.372 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.49 -48.66 68.92 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.14 -33.99 77.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 1.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.5 m -69.23 -54.04 16.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 1.0 109.454 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -64.14 -43.37 95.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 1.0 109.482 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.4 -32.2 72.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 1.0 109.467 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.43 -45.87 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 1.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -72.67 -28.86 62.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 1.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' X' ' 71' ' ' GLY . 45.1 t80 -60.03 -53.4 58.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 1.0 109.402 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -69.48 -35.67 75.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 1.0 109.336 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.1 m -62.08 -45.86 91.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 1.0 109.258 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.19 -51.25 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 1.0 109.2 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.85 -158.5 24.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.8 -13.89 17.59 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.89 2.393 . . . . 1.0 111.953 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.93 -51.6 66.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 1.0 109.213 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -64.36 -40.82 96.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 1.0 109.309 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.78 83.92 9.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 1.0 109.418 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' X' ' 78' ' ' THR . 43.5 Cg_exo -55.46 154.41 24.63 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.827 2.352 . . . . 1.0 112.265 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.493 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.9 p -53.39 -6.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 1.0 109.438 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.518 ' H ' ' C ' ' X' ' 76' ' ' PRO . 63.1 p -61.19 -41.21 96.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.87 . . . . 1.0 109.391 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.62 75.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 1.0 109.385 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -61.13 -42.8 99.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 1.0 109.425 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -63.22 -46.63 86.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -63.19 -41.74 99.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.576 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.599 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.6 t-105 -61.42 -37.53 83.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 1.0 109.367 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.95 -44.14 78.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 1.0 109.191 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.578 ' O ' HD13 ' X' ' 89' ' ' LEU . 98.8 mt -65.66 -40.09 92.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 1.0 109.552 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -61.6 -41.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.243 -0.91 . . . . 1.0 109.395 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.93 -39.95 79.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 1.0 109.481 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -71.09 -36.73 72.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.389 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.578 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -65.72 -43.27 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 1.0 109.386 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.437 HG22 HG23 ' X' ' 50' ' ' THR . 7.5 pt -78.92 -20.74 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 1.0 109.335 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.34 -50.07 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.485 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -41.23 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 1.0 109.54 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.54 139.54 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 1.0 109.573 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -75.86 92.27 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.0 109.538 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 1.0 109.593 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.46 145.04 47.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 1.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.89 94.79 10.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 1.0 109.511 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -78.41 176.22 9.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.593 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -54.28 -45.84 72.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 1.0 109.436 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.35 -42.49 92.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.46 -39.69 88.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 1.0 109.469 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.61 -42.23 92.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 1.0 109.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -59.33 -35.37 73.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 1.0 109.415 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.4 -44.72 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.0 109.305 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' X' ' 28' ' ' TYR . 46.1 tp10 -55.92 -47.7 77.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 1.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -66.53 -37.13 84.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 1.0 108.868 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.24 -42.65 98.98 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 1.0 108.803 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.553 ' HZ2' ' N ' ' X' ' 28' ' ' TYR . 88.5 tttt -61.85 -42.06 98.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 1.0 109.555 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -52.52 -49.91 63.87 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.177 -0.952 . . . . 1.0 109.158 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.57 80.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.0 109.422 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.434 HD23 HG11 ' X' ' 24' ' ' VAL . 9.8 tp -61.19 -40.38 93.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 1.0 109.251 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.68 -40.71 80.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.303 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -58.61 -33.88 70.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.449 -0.782 . . . . 1.0 109.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.87 -9.97 56.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 1.0 109.19 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.31 44.33 2.2 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.434 HG11 HD23 ' X' ' 19' ' ' LEU . 25.1 t -122.32 135.24 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 1.0 109.387 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -131.36 94.81 3.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.0 109.22 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.471 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 35.3 m -132.8 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 1.0 109.366 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 27' ' ' LYS . . . . . 0.547 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 68.2 mttm -73.33 147.89 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 109.47 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.562 ' CE2' HD11 ' X' ' 32' ' ' LEU . 51.8 t80 -59.07 -39.28 81.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.203 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.55 59.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 1.0 109.493 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.516 ' CG ' ' CG ' ' X' ' 55' ' ' PHE . 30.2 t0 -61.15 -43.56 98.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 1.0 109.404 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.0 mm? -61.62 -45.35 94.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 1.0 109.409 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' X' ' 28' ' ' TYR . 97.2 mt -63.7 -42.11 98.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 1.0 109.351 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -36.0 82.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 1.0 109.415 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.779 ' O ' HG23 ' X' ' 38' ' ' VAL . 56.2 t80 -57.53 -46.65 83.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 1.0 109.413 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.1 -41.77 90.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 1.0 109.308 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -63.34 -44.07 95.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 109.266 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 38.8 t80 -61.34 -43.59 98.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.779 HG23 ' O ' ' X' ' 34' ' ' PHE . 50.5 t -59.46 -47.46 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.0 109.535 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.82 -36.76 80.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 1.0 109.425 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.553 ' OD1' ' NE2' ' X' ' 47' ' ' GLN . 84.6 m-20 -69.11 -19.65 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 1.0 109.639 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 96.4 m -54.44 -47.78 72.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 1.0 109.41 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.712 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -119.16 -64.34 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 1.0 109.461 -178.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.0 Cg_exo -40.69 -33.82 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.89 2.393 . . . . 1.0 112.174 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 6.2 m-90 -155.94 100.95 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 1.0 109.468 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.684 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -71.22 -39.92 8.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 1.0 109.901 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 26.0 Cg_exo -60.87 -34.32 91.39 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.703 2.269 . . . . 1.0 112.369 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 47' ' ' GLN . . . . . 0.553 ' NE2' ' OD1' ' X' ' 40' ' ' ASP . 24.1 mt-30 -65.65 124.77 23.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 1.0 109.656 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -144.4 175.16 10.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 1.0 109.847 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.82 165.58 34.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.1 m -69.92 137.52 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -1.187 . . . . 1.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.58 139.68 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 1.0 109.504 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -94.26 133.84 37.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 1.0 109.751 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mm -48.71 -23.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 1.0 109.481 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.47 -43.25 90.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 109.353 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 55' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' X' ' 55' ' ' PHE . 1.0 OUTLIER -79.79 -16.35 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 1.0 109.296 -178.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 18.1 t90 -59.32 -43.05 92.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 1.0 109.646 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.599 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 32.9 mmt180 -59.72 -42.08 92.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 1.0 109.493 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 63.4 mtp85 -71.55 -46.34 59.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 1.0 109.437 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.586 HG11 ' CH2' ' X' ' 83' ' ' TRP . 81.2 t -64.29 -47.92 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 1.0 109.282 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.15 -47.02 84.1 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -66.15 -37.71 86.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.172 . . . . 1.0 109.462 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 98.7 m -64.11 -56.24 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 1.0 109.48 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.6 m-85 -61.15 -44.77 96.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 1.0 109.459 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.71 -36.94 84.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 1.0 109.49 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.73 -47.15 86.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.0 109.344 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.22 -29.54 68.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.458 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' X' ' 71' ' ' GLY . 39.9 t80 -62.42 -55.05 31.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 1.0 109.429 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -67.52 -34.91 78.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 1.0 109.33 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -66.34 -51.38 57.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 1.0 109.331 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -108.93 -52.44 2.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.85 -162.17 26.29 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' ' N ' ' X' ' 76' ' ' PRO . 18.9 Cg_endo -74.77 -17.88 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.946 2.431 . . . . 1.0 111.956 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.89 -52.12 66.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 1.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -64.78 -39.32 93.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 1.0 109.371 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.91 79.69 13.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 1.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' X' ' 78' ' ' THR . 45.8 Cg_exo -55.33 155.0 21.55 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.772 2.315 . . . . 1.0 112.222 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.79 -5.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.519 ' H ' ' C ' ' X' ' 76' ' ' PRO . 62.2 p -61.11 -33.88 74.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 1.0 109.44 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.3 -36.87 79.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 1.0 109.372 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.89 . . . . 1.0 109.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -61.85 -49.12 77.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 1.0 109.4 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.85 -41.97 95.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 1.0 109.524 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.586 ' CH2' HG11 ' X' ' 59' ' ' VAL . 9.4 t-105 -67.07 -34.66 78.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.89 -43.28 85.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.0 109.243 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' X' ' 85' ' ' LEU . 98.5 mt -67.47 -38.14 83.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.592 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.24 -44.07 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 1.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.41 -43.78 84.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 1.0 109.441 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.89 -36.54 72.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 1.0 109.355 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.56 -50.69 66.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 1.0 109.35 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.42 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.1 pt -70.45 -42.29 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.42 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 86.2 m-20 -61.53 -47.45 85.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.0 109.475 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.03 -38.85 92.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 1.0 109.614 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.93 135.65 49.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.0 109.508 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -88.74 113.21 24.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 1.0 109.638 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.0 109.626 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 4' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 80.1 mm-40 -59.87 134.41 57.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 1.0 109.545 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.87 99.76 12.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 1.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -79.61 171.68 14.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 1.0 109.563 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -55.59 -42.96 75.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 1.0 109.436 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -66.36 -44.41 83.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 1.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 90.7 mt-10 -63.3 -33.34 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 1.0 109.427 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -70.52 -39.41 74.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 1.0 109.607 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.95 -49.12 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 1.0 109.364 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' X' ' 35' ' ' PHE . 27.6 m -69.16 -34.18 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 1.0 109.324 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.2 -43.1 92.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.261 -0.9 . . . . 1.0 109.289 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.67 -34.2 77.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 1.0 108.916 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.8 -41.12 99.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.356 -0.84 . . . . 1.0 108.847 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.475 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 87.6 tttt -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.756 . . . . 1.0 109.566 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.44 -45.19 84.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 1.0 109.195 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.69 -39.75 91.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 1.0 109.403 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.77 -38.88 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 1.0 109.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 1.0 109.238 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 45.8 p -62.92 -31.37 72.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.09 -17.57 61.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 1.0 109.145 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.29 47.18 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -119.06 130.46 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.429 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.19 98.43 4.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.94 . . . . 1.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.96 160.12 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 109.288 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -74.4 143.99 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 1.0 109.489 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.475 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 63.9 m-85 -61.74 -41.42 97.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.204 -0.935 . . . . 1.0 109.26 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.77 53.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 1.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' CG ' ' X' ' 55' ' ' PHE . 15.4 t70 -63.18 -39.5 94.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 1.0 109.448 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' X' ' 31' ' ' LEU . 4.4 mm? -62.39 -45.56 92.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 1.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.03 -42.95 99.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 1.0 109.364 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.6 mttt -65.02 -38.86 92.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 1.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -58.31 -49.62 76.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 1.0 109.391 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG11 ' X' ' 12' ' ' VAL . 58.3 m-85 -63.08 -44.14 96.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 1.0 109.404 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.23 -37.54 80.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 1.0 109.265 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.76 -46.78 88.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.918 . . . . 1.0 109.533 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.44 -44.34 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 1.0 109.548 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.29 -25.58 64.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.5 m-20 -73.56 -19.58 60.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.867 . . . . 1.0 109.658 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -54.11 -41.29 68.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 1.0 109.418 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.699 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -128.06 -64.4 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.473 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.699 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 53.9 Cg_exo -40.84 -40.1 3.45 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.879 2.386 . . . . 1.0 112.183 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.517 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -142.66 116.34 9.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 1.0 109.527 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.656 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -66.5 -41.72 42.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 1.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 27.1 Cg_exo -60.82 137.72 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.768 2.312 . . . . 1.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.92 147.74 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 1.0 109.654 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -141.33 157.19 45.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 1.0 109.807 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 164.3 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 50' ' ' THR . . . . . 0.626 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 41.6 m -114.5 129.82 56.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 1.0 109.311 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.0 136.08 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 1.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.67 137.54 36.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 1.0 109.757 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.13 -23.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 1.0 109.437 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -64.68 -39.29 93.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 1.0 109.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 55' ' ' PHE . . . . . 0.544 ' CG ' ' OD1' ' X' ' 30' ' ' ASP . 3.1 t80 -85.2 -9.98 57.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.955 . . . . 1.0 109.283 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t90 -57.64 -38.24 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 1.0 109.646 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' X' ' 57' ' ' ARG . 14.3 mmm180 -61.41 -38.95 88.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 1.0 109.539 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 76.9 mtp180 -70.19 -36.88 74.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 1.0 109.418 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.535 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 79.4 t -65.32 -42.16 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 1.0 109.315 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.53 -48.77 84.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -66.08 -40.14 90.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -1.141 . . . . 1.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 89.3 m -64.56 -54.28 34.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 1.0 109.509 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.96 -44.46 94.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 1.0 109.446 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -60.1 -37.87 81.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 1.0 109.478 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.38 -41.44 98.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 1.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -66.24 -38.6 88.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.3 -52.45 65.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 1.0 109.402 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.61 -30.14 69.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 1.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.1 m -61.65 -48.14 82.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 1.0 109.257 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 -52.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 1.0 109.269 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.68 29.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' X' ' 76' ' ' PRO . 23.2 Cg_exo -60.17 -23.71 74.64 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.969 2.446 . . . . 1.0 111.899 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -52.44 -51.95 56.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.164 -0.96 . . . . 1.0 109.231 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.0 -42.43 99.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.354 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.4 81.09 14.1 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 1.0 109.485 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.7 Cg_exo -59.62 161.75 17.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.818 2.345 . . . . 1.0 112.277 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.491 ' O ' HG12 ' X' ' 77' ' ' VAL . 76.8 t -50.19 -9.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 1.0 109.444 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.513 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.1 p -60.21 -35.85 76.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 1.0 109.413 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.94 94.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 1.0 109.414 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.22 -42.8 93.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 1.0 109.411 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -62.77 -45.91 90.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.426 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.513 ' OH ' ' CD2' ' X' ' 45' ' ' PHE . 18.7 m-85 -63.72 -43.25 97.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 1.0 109.475 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.535 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 7.2 t-105 -63.45 -36.87 85.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 1.0 109.389 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -56.78 -43.54 80.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.4 -0.813 . . . . 1.0 109.223 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.27 -40.59 86.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 1.0 109.613 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -61.5 -42.48 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 1.0 109.241 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -43.2 88.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 1.0 109.508 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 88' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 97.0 mt-10 -70.91 -24.61 62.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 1.0 109.347 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.13 -49.3 12.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 6.5 pt -70.47 -42.4 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 1.0 109.426 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 16.6 p-10 -67.69 -9.51 44.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 1.0 109.491 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.428 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 88.5 tttt -62.48 -48.1 81.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 1.0 109.556 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -115.23 125.46 53.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 1.0 109.452 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -71.03 125.69 27.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 1.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 109.566 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 131.24 49.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 1.0 109.551 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.97 89.61 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 1.0 109.626 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.1 p -82.88 174.99 10.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 1.0 109.554 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -53.14 -41.02 64.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.237 -0.914 . . . . 1.0 109.282 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -69.25 -43.69 73.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 1.0 109.415 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.96 -39.25 93.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 1.0 109.602 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.93 -36.83 84.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 109.567 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -61.06 -49.73 76.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 1.0 109.925 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.24 -34.25 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 1.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.57 -35.43 80.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.459 -0.776 . . . . 1.0 109.226 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -68.24 -39.16 82.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 1.0 108.959 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -61.43 -41.24 96.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 1.0 108.961 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.28 -40.5 94.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 1.0 109.395 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -56.2 -44.74 79.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 1.0 109.067 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -36.73 82.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 1.0 109.227 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' X' ' 19' ' ' LEU . 93.8 mt -63.27 -38.74 92.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 1.0 109.068 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.53 -41.38 85.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 1.0 109.092 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -60.14 -39.14 85.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 1.0 109.103 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.41 -16.92 63.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 1.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.58 53.15 0.73 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.549 ' CG2' HH21 ' X' ' 58' ' ' ARG . 38.2 t -122.06 133.4 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.583 -0.951 . . . . 1.0 109.325 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.18 96.52 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' X' ' 54' ' ' LYS . 27.6 m -133.31 163.99 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 1.0 109.503 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.45 147.78 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.9 -39.95 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 1.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.26 -31.69 63.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.0 109.358 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -59.96 -42.2 93.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 1.0 109.227 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.427 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 1.0 109.359 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.26 -41.27 97.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.797 . . . . 1.0 109.28 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.27 -34.74 79.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 1.0 109.394 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.97 -48.86 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 1.0 109.693 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.18 -45.33 93.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.249 -0.907 . . . . 1.0 109.621 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -64.13 -37.85 88.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.0 109.13 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.14 -45.67 92.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 1.0 109.428 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.03 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 1.0 109.595 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.46 -32.69 74.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.011 0.91 . . . . 1.0 109.629 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.4 m-20 -68.26 -20.38 64.79 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.766 -1.209 . . . . 1.0 109.757 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 m -55.15 -57.46 11.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.878 -1.138 . . . . 1.0 110.708 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.636 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.1 OUTLIER -109.85 -59.6 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.042 0 O-C-N 121.514 -0.741 . . . . 1.0 110.634 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.636 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.1 Cg_exo -42.2 -42.25 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.494 2.129 . . . . 1.0 112.701 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.8 m-90 -142.62 -158.91 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 1.0 109.361 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.535 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 2.2 t80 -171.84 49.37 0.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 1.0 109.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 29.3 Cg_endo -67.32 -166.42 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.709 2.273 . . . . 1.0 112.132 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.08 140.6 35.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 1.0 109.581 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.4 134.99 42.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 1.0 109.758 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.03 -178.43 43.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.791 -1.324 . . . . 1.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 14.4 m -71.2 141.7 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -1.193 . . . . 1.0 109.275 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.685 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.77 133.58 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.761 0.791 . . . . 1.0 109.212 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.685 ' N ' HD13 ' X' ' 51' ' ' ILE . 56.5 t0 -71.82 136.97 47.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.64 -1.287 . . . . 1.0 110.012 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 63.7 mt -66.56 -21.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.79 -1.194 . . . . 1.0 109.259 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.572 ' HB2' HG12 ' X' ' 26' ' ' VAL . 65.4 mmtt -64.95 -40.05 94.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 1.0 109.595 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -84.39 -9.64 58.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 1.0 109.616 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.505 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 11.0 t90 -53.67 -39.88 65.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 1.0 109.795 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' X' ' 57' ' ' ARG . 24.5 mmm-85 -62.24 -37.23 84.62 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.172 -0.955 . . . . 1.0 109.486 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.549 HH21 ' CG2' ' X' ' 24' ' ' VAL . 85.6 mmt-85 -68.31 -42.89 78.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.351 -0.843 . . . . 1.0 109.781 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.62 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 93.3 t -61.38 -45.13 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.29 -0.882 . . . . 1.0 109.26 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.55 97.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.68 -42.2 91.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.255 -1.144 . . . . 1.0 109.671 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.92 -50.67 61.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 1.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.48 -44.75 96.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.0 109.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.96 -35.58 75.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.181 -0.949 . . . . 1.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -64.7 -46.16 83.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 1.0 109.412 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 1.0 109.428 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' X' ' 71' ' ' GLY . 9.1 t80 -59.37 -53.29 59.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 1.0 109.716 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.448 ' O ' ' OD1' ' X' ' 68' ' ' ASN . 51.6 t-20 -64.5 -35.92 82.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.856 -1.153 . . . . 1.0 109.473 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -65.02 -45.35 85.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.213 -0.929 . . . . 1.0 109.99 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.34 -51.87 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.141 -0.623 . . . . 1.0 109.893 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 138.74 -164.05 25.78 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 1.0 109.388 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' X' ' 76' ' ' PRO . 8.6 Cg_exo -66.41 -20.65 54.53 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.97 2.446 . . . . 1.0 111.948 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.37 -53.81 52.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 1.0 109.474 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.44 -37.27 86.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.361 -0.837 . . . . 1.0 109.667 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.706 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.5 m -143.59 81.21 12.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.566 -0.709 . . . . 1.0 109.198 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.502 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.0 Cg_exo -59.03 155.11 40.83 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 123.057 2.504 . . . . 1.0 112.287 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.473 ' O ' HG12 ' X' ' 77' ' ' VAL . 72.3 t -51.91 -10.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 1.0 109.303 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.453 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.4 t -62.28 -33.44 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.94 -45.08 91.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.324 -0.86 . . . . 1.0 109.129 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.33 -43.43 97.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 1.0 109.479 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -61.94 -45.69 92.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 1.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -64.41 -37.22 86.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 1.0 109.433 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.62 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 9.1 t-105 -64.59 -35.54 81.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.87 . . . . 1.0 109.092 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.14 -43.52 95.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 1.0 109.092 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.07 -39.1 93.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.422 -0.799 . . . . 1.0 109.133 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.24 -42.47 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.0 109.552 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.505 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 63.4 mttt -55.96 -43.26 77.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.71 -35.65 79.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.923 -1.11 . . . . 1.0 109.485 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.72 -49.18 71.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.935 . . . . 1.0 109.835 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.8 pt -71.96 -40.95 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 1.0 109.308 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.32 -44.61 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.406 -0.809 . . . . 1.0 109.481 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.51 -43.19 94.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 1.0 109.401 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.0 126.17 30.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.139 -0.976 . . . . 1.0 109.498 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.81 127.91 34.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 1.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 1.0 109.465 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.319 0.58 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -58.42 138.3 56.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 1.0 109.584 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 5' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' X' ' 5' ' ' LEU . 74.6 mt -98.82 103.57 15.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 1.0 109.495 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.2 p -79.29 171.3 15.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 1.0 109.571 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.5 -40.9 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 1.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.64 -46.2 76.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 1.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -62.51 -38.35 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 1.0 109.405 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -61.49 -40.91 96.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 1.0 109.551 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.95 -36.45 77.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.195 -0.941 . . . . 1.0 109.475 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.03 -44.15 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 1.0 109.34 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.95 -48.06 73.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.286 -0.884 . . . . 1.0 109.317 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -65.62 -36.31 83.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 1.0 108.805 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' X' ' 15' ' ' LEU . 60.3 tp -63.05 -41.76 99.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.291 -0.881 . . . . 1.0 108.834 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 1.0 109.499 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -55.99 -46.88 78.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.19 -0.944 . . . . 1.0 109.122 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.38 -41.01 96.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.378 -0.827 . . . . 1.0 109.343 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' X' ' 19' ' ' LEU . 90.7 mt -64.87 -36.44 84.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 1.0 109.287 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.89 -38.27 87.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 1.0 109.229 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 76.0 p -65.79 -33.47 75.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 1.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -70.78 -19.36 62.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 1.0 109.243 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.29 47.14 0.39 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.325 -1.51 . . . . 1.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -121.55 133.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -1.105 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.99 91.38 2.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.268 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.73 162.15 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 1.0 109.311 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.12 147.05 32.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 1.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -62.68 -34.5 77.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 1.0 109.225 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.35 69.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 1.0 109.403 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 1.0 109.386 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.519 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -60.35 -44.39 95.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 1.0 109.361 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -42.14 99.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.409 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.03 -33.57 76.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.359 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.482 ' O ' HG23 ' X' ' 38' ' ' VAL . 51.2 t80 -59.39 -46.01 89.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 1.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.26 -44.51 96.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 1.0 109.402 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.63 -44.32 94.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 1.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -63.17 -46.19 88.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 1.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.482 HG23 ' O ' ' X' ' 34' ' ' PHE . 69.7 t -60.39 -44.58 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 1.0 109.569 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 1.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 7.1 m-20 -68.32 -19.84 64.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 1.0 109.667 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 41' ' ' THR . . . . . 0.409 HG21 ' O ' ' X' ' 74' ' ' LYS . 99.6 m -54.48 -51.48 64.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 1.0 109.393 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.753 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -118.82 -63.16 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 1.0 109.508 -177.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.753 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.3 Cg_exo -40.79 -54.22 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.897 2.398 . . . . 1.0 112.168 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -118.36 -128.25 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 1.0 109.503 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.754 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.8 OUTLIER -175.28 -41.62 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 1.0 109.908 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.754 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 34.5 Cg_exo -58.17 132.72 50.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 1.0 112.307 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -119.01 159.27 24.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 109.71 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -74.16 158.59 33.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 1.0 109.758 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.74 -4.18 63.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.855 -1.298 . . . . 1.0 109.855 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -119.7 118.28 30.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 1.0 109.308 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.711 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -136.31 135.1 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 109.497 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.711 ' N ' HD13 ' X' ' 51' ' ' ILE . 67.4 t0 -67.27 130.68 43.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.14 -38.61 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 1.0 109.417 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -61.57 -37.72 84.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 1.0 109.4 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -76.36 -24.21 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 1.0 109.305 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.659 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -57.48 -36.46 71.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.612 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.424 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 14.0 mmm180 -60.69 -41.45 95.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 1.0 109.501 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.63 -37.47 79.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 1.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.15 -44.37 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 1.0 109.306 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.35 -48.57 84.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -65.35 -41.12 94.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.163 . . . . 1.0 109.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.24 -42.87 92.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 1.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.44 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.2 m-85 -65.76 -40.02 91.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 1.0 109.483 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.21 -37.95 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 1.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -63.25 -43.93 96.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 1.0 109.307 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.96 -31.73 71.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.477 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' X' ' 71' ' ' GLY . 17.4 t80 -59.65 -55.02 39.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 1.0 109.357 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -68.38 -34.94 76.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 1.0 109.303 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -65.01 -48.03 75.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 1.0 109.283 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -111.75 -52.37 2.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 1.0 109.329 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.97 -165.68 26.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.58 -14.46 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.911 2.407 . . . . 1.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.1 -49.79 74.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.274 -0.891 . . . . 1.0 109.302 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.409 ' O ' HG21 ' X' ' 41' ' ' THR . 59.7 mmtt -66.91 -43.98 81.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 1.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.717 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.3 m -148.46 88.69 5.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 1.0 109.455 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -81.02 -176.0 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.832 2.354 . . . . 1.0 112.267 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -19.67 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 1.0 109.397 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.4 ' H ' HG23 ' X' ' 78' ' ' THR . 19.1 p -59.67 -33.73 71.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 1.0 109.42 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.39 73.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 1.0 109.463 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -61.63 -41.09 96.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.0 t -59.23 -46.01 89.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 1.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.28 -43.88 93.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.659 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.5 t-105 -64.32 -36.16 83.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -55.38 -43.08 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.0 109.207 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 85' ' ' LEU . 96.5 mt -65.52 -40.83 93.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 1.0 109.565 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.27 -42.28 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 1.0 109.346 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.76 -41.3 70.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 1.0 109.41 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.73 -38.75 73.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.948 . . . . 1.0 109.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.31 -49.59 73.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 1.0 109.372 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.409 HD13 HG21 ' X' ' 90' ' ' ILE . 7.2 pt -70.29 -41.18 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 1.0 109.436 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 69.5 m-20 -59.84 -47.08 87.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.95 . . . . 1.0 109.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.83 -41.82 97.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.61 137.48 38.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.918 . . . . 1.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 1.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.0 109.537 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' X' X ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mt-10 -62.41 146.51 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.517 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.12 101.84 14.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 109.484 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.3 p -83.48 170.28 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 1.0 109.431 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -54.09 -43.19 70.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 1.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -64.65 -43.49 93.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.878 . . . . 1.0 109.543 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 99.2 mt-10 -67.78 -34.91 77.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 1.0 109.371 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.3 -38.28 84.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.882 . . . . 1.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.08 -51.16 69.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.41 -33.29 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 1.0 109.261 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.21 -42.3 85.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.893 . . . . 1.0 109.177 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -63.75 -39.74 95.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.94 . . . . 1.0 108.766 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.45 -40.25 86.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.39 -43.7 98.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 1.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.424 ' O ' HG23 ' X' ' 21' ' ' THR . 99.4 mm-40 -55.91 -44.11 77.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 1.0 109.024 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.8 96.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 1.0 109.276 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' X' ' 19' ' ' LEU . 95.6 mt -65.11 -38.04 89.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -0.899 . . . . 1.0 109.22 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -60.11 -41.39 92.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 1.0 109.297 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.424 HG23 ' O ' ' X' ' 17' ' ' GLN . 69.5 p -63.06 -31.95 73.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.865 . . . . 1.0 109.233 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.29 -17.96 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.0 109.19 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.65 46.61 0.52 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.584 HG22 HH21 ' X' ' 58' ' ' ARG . 55.4 t -121.22 133.33 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.353 -1.086 . . . . 1.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.92 93.57 2.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 1.0 109.215 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.12 161.21 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 1.0 109.342 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -70.36 146.97 50.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.917 . . . . 1.0 109.491 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.67 -35.46 80.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 1.0 109.235 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.9 -34.48 69.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 1.0 109.409 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.16 -44.19 92.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 1.0 109.341 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.496 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.04 -45.96 91.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 1.0 109.436 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.49 -42.65 98.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 1.0 109.395 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.75 -34.36 75.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 1.0 109.384 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.438 ' O ' HG23 ' X' ' 38' ' ' VAL . 41.1 t80 -58.76 -48.46 81.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 1.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -62.03 -43.72 98.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.99 -42.14 99.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 1.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.4 -43.66 96.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' X' ' 34' ' ' PHE . 84.3 t -56.43 -44.5 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -36.34 83.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 1.0 109.351 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.5 m-20 -68.3 -20.56 64.76 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.089 -1.007 . . . . 1.0 109.588 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -54.44 -52.83 60.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.19 -0.944 . . . . 1.0 109.763 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -112.35 -62.76 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.283 -0.886 . . . . 1.0 109.914 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 77.1 Cg_exo -42.33 -39.05 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.57 2.18 . . . . 1.0 112.062 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 -145.61 -146.16 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 1.0 109.435 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.603 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 174.74 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 1.0 109.902 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -54.9 -34.81 87.35 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.793 2.329 . . . . 1.0 112.396 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.89 124.07 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 1.0 109.675 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.66 158.78 43.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 1.0 109.736 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.76 163.59 31.81 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.328 . . . . 1.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.6 m -63.3 140.05 58.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.0 109.345 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.706 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -129.98 134.79 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 1.0 109.334 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.706 ' N ' HD13 ' X' ' 51' ' ' ILE . 55.9 t0 -72.79 134.36 44.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 1.0 109.811 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.932 HG22 HH12 ' X' ' 57' ' ' ARG . 80.2 mt -64.13 -28.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 1.0 109.55 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.3 -40.05 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 1.0 109.503 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.18 -22.69 52.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.8 t90 -55.96 -37.61 69.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.142 -0.974 . . . . 1.0 109.728 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.932 HH12 HG22 ' X' ' 53' ' ' ILE . 28.6 mmt-85 -58.05 -38.86 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 1.0 109.46 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.584 HH21 HG22 ' X' ' 24' ' ' VAL . 81.4 mmt-85 -68.79 -39.62 80.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.61 -44.34 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 1.0 109.469 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.92 -48.15 74.82 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.93 -37.07 83.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 1.0 109.434 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.8 m -67.71 -51.16 52.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 1.0 109.675 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.07 -41.19 99.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 1.0 109.421 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.11 -38.72 83.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 1.0 109.445 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.91 -44.44 97.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 1.0 109.36 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -64.74 -37.85 89.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 1.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' X' ' 71' ' ' GLY . 6.5 t80 -60.13 -53.81 53.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 1.0 109.535 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.4 -33.81 76.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 1.0 109.286 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -68.37 -44.23 75.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 1.0 109.565 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -122.36 -51.76 1.96 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 1.0 109.673 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.74 -164.29 25.2 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.8 Cg_exo -65.35 -21.51 61.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.941 2.428 . . . . 1.0 112.182 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.44 -53.03 61.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.216 -0.928 . . . . 1.0 109.314 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -66.2 -38.52 88.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 1.0 109.401 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.602 HG23 ' O ' ' X' ' 75' ' ' VAL . 30.5 m -143.4 78.63 14.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.0 109.433 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' X' ' 78' ' ' THR . 35.9 Cg_exo -56.41 156.12 22.83 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.855 2.37 . . . . 1.0 112.362 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.8 p -49.03 -11.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 1.0 109.397 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.507 ' N ' ' O ' ' X' ' 76' ' ' PRO . 68.0 p -59.9 -38.1 81.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.0 109.44 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.61 76.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 1.0 109.397 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -63.67 -44.14 94.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 1.0 109.564 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 50.7 m -61.63 -51.68 67.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 1.0 109.553 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -60.56 -41.84 95.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 1.0 109.484 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.676 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 14.2 t-105 -63.13 -40.36 97.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 1.0 109.289 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -56.27 -38.86 71.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 1.0 108.843 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.14 -42.69 99.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.532 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -61.46 -42.33 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 1.0 109.499 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.753 ' HZ2' HG23 ' X' ' 53' ' ' ILE . 60.8 mmtt -55.69 -40.08 71.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 1.0 109.538 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.2 -37.96 84.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.893 . . . . 1.0 109.544 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.89 -41.91 95.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.217 -0.927 . . . . 1.0 109.843 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.89 -43.14 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.0 109.658 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.91 -48.28 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.0 109.537 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.9 -43.96 94.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 1.0 109.646 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.75 130.53 35.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 1.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.97 130.04 40.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.875 . . . . 1.0 109.55 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 1.0 109.604 -179.746 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 4' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' X' ' 6' ' ' SER . 95.4 mt-10 -53.03 121.69 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 1.0 109.5 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 92.7 mt -55.37 85.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 1.0 109.484 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 6' ' ' SER . . . . . 0.531 ' N ' ' O ' ' X' ' 4' ' ' GLU . 10.0 p -81.76 171.68 14.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 1.0 109.599 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 7' ' ' GLN . . . . . 0.457 ' CG ' HH21 ' X' ' 10' ' ' ARG . 96.4 mt-30 -54.86 -45.86 74.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 1.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -66.55 -41.8 88.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 1.0 109.485 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -37.42 84.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 1.0 109.408 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 10' ' ' ARG . . . . . 0.457 HH21 ' CG ' ' X' ' 7' ' ' GLN . 86.6 mtm180 -70.54 -38.05 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 1.0 109.62 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.58 -49.72 76.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 1.0 109.441 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.94 -27.63 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.0 109.366 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.1 -40.7 90.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 1.0 109.395 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.41 -39.18 88.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.993 . . . . 1.0 108.92 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.52 -40.56 97.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.275 -0.891 . . . . 1.0 108.855 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.508 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.8 tttt -61.48 -38.66 88.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 1.0 109.498 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -57.87 -46.61 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 1.0 109.144 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.819 . . . . 1.0 109.43 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' X' ' 16' ' ' LYS . 92.1 mt -63.35 -38.99 93.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 1.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.19 -44.7 92.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 1.0 109.246 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -56.27 -39.81 73.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 1.0 109.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -68.77 -17.14 63.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 1.0 109.222 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.06 0.66 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 50.1 t -122.72 136.78 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -1.109 . . . . 1.0 109.381 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.71 88.5 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 1.0 109.205 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.7 165.0 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 1.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -77.01 153.74 34.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 1.0 109.45 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.508 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 99.5 m-85 -61.44 -35.22 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 1.0 109.261 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.812 . . . . 1.0 109.432 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 56.5 t0 -58.52 -45.24 89.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 1.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.505 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.2 mm? -63.11 -45.26 92.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 1.0 109.4 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.39 -43.73 93.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.338 -0.851 . . . . 1.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.3 -33.41 73.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.39 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.501 ' O ' HG23 ' X' ' 38' ' ' VAL . 39.0 t80 -58.89 -48.75 80.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 1.0 109.448 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -64.85 -42.22 95.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.2 -43.2 98.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.283 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.04 -45.11 94.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.366 -0.834 . . . . 1.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 34' ' ' PHE . 96.9 t -59.2 -47.49 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 1.0 109.518 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -66.64 -35.71 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 109.395 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' X' ' 44' ' ' TRP . 91.6 m-20 -65.05 -19.38 65.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.673 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -54.29 -61.68 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.972 . . . . 1.0 109.362 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.681 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.77 -60.2 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 1.0 109.509 -178.195 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.6 Cg_exo -41.36 -44.57 5.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.883 2.389 . . . . 1.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.4 m-90 -143.17 -144.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 1.0 109.504 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.588 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.39 -46.04 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.95 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 31.3 Cg_exo -54.94 -33.77 83.77 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.713 2.276 . . . . 1.0 112.411 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.21 129.08 38.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 1.0 109.672 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.55 163.36 34.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 1.0 109.87 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.87 166.89 31.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.79 -1.324 . . . . 1.0 109.79 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 28.4 m -64.16 129.78 41.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 1.0 109.3 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.45 131.64 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 1.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' X' ' 54' ' ' LYS . 20.3 t0 -94.23 126.09 39.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.885 . . . . 1.0 109.697 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -44.83 -16.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -0.986 . . . . 1.0 109.482 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' X' ' 52' ' ' ASP . 98.9 mttt -67.31 -35.77 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.398 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 55' ' ' PHE . . . . . 0.569 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 2.3 m-85 -84.33 -10.99 57.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 1.0 109.285 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 56' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -58.24 -46.0 86.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 1.0 109.646 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 1.0 109.544 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 34.0 mmt180 -63.2 -47.9 80.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 1.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.706 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 77.7 t -65.06 -44.4 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 1.0 109.367 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.38 -48.65 82.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -66.16 -40.4 90.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -1.125 . . . . 1.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 90.0 m -62.6 -49.42 75.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.915 . . . . 1.0 109.461 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.17 -42.0 99.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 1.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -58.68 -36.46 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 1.0 109.536 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 65' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' X' ' 69' ' ' THR . 89.2 m-20 -62.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 1.0 109.326 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -67.98 -34.23 76.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.31 -0.869 . . . . 1.0 109.483 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' X' ' 71' ' ' GLY . 10.0 t80 -61.55 -54.81 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.355 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -63.34 -34.11 77.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 1.0 109.342 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 69' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.1 m -68.59 -48.26 64.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.0 109.285 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.23 -52.57 2.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 1.0 109.301 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.52 -163.65 25.18 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.5 Cg_exo -66.06 -23.38 53.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.86 2.373 . . . . 1.0 111.967 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.07 -54.76 34.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 1.0 109.24 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -65.45 -36.0 82.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.403 -0.811 . . . . 1.0 109.331 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.447 HG23 ' O ' ' X' ' 75' ' ' VAL . 11.6 m -145.26 81.4 10.42 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.521 ' N ' ' O ' ' X' ' 72' ' ' PRO . 38.2 Cg_exo -60.27 154.36 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.868 2.379 . . . . 1.0 112.228 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.478 ' O ' HG12 ' X' ' 77' ' ' VAL . 52.0 t -49.93 -11.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 1.0 109.446 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.49 ' N ' ' O ' ' X' ' 76' ' ' PRO . 1.3 t -63.94 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 1.0 109.356 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.03 96.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 1.0 109.418 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -64.92 -44.37 89.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 1.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.9 t -59.09 -45.47 90.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 1.0 109.408 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -65.27 -38.07 89.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 1.0 109.535 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.706 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 8.6 t-105 -66.25 -37.9 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 1.0 109.411 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -55.99 -43.97 78.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 1.0 109.212 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.75 -40.39 96.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.535 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.35 -42.85 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 1.0 109.397 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -59.02 -41.32 87.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 1.0 109.492 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.92 -36.92 72.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 1.0 109.338 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.41 -45.15 88.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 1.0 109.33 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.01 -38.27 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.0 109.448 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.58 -45.14 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 1.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.95 -42.72 99.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.549 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -72.4 146.77 46.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.88 . . . . 1.0 109.498 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -101.9 93.62 5.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 1.0 109.535 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 1.0 109.557 179.8 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' X' X ' 4' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.1 mt-10 -60.72 136.7 58.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 1.0 109.58 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.47 100.88 13.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 109.477 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.2 p -77.56 169.63 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.0 109.565 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -52.49 -43.78 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.63 -47.89 71.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 1.0 109.527 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 94.5 mt-10 -60.27 -36.68 78.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 1.0 109.461 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -61.1 -42.62 98.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 1.0 109.63 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -59.7 -35.54 74.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 1.0 109.442 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.54 -44.51 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 109.316 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.38 -48.61 78.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.311 -0.868 . . . . 1.0 109.401 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -62.25 -38.3 88.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.23 -0.919 . . . . 1.0 108.92 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' X' ' 15' ' ' LEU . 62.2 tp -61.28 -43.34 99.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 1.0 108.762 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.85 -37.38 81.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.498 -0.751 . . . . 1.0 109.523 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.654 ' O ' HG23 ' X' ' 21' ' ' THR . 86.8 mt-30 -57.87 -48.49 79.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 1.0 109.121 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.41 79.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 1.0 109.412 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.35 -40.28 95.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -0.843 . . . . 1.0 109.299 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.59 -38.16 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 1.0 109.217 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.654 HG23 ' O ' ' X' ' 17' ' ' GLN . 68.4 p -64.13 -13.66 49.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 1.0 109.279 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.12 7.06 42.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 1.0 109.227 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 38.17 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.0 133.19 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.04 96.84 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 1.0 109.166 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.74 161.71 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 1.0 109.41 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.08 144.99 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 1.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.439 ' HE2' HD11 ' X' ' 32' ' ' LEU . 90.0 t80 -61.98 -37.49 85.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 1.0 109.296 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -33.78 64.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.0 109.492 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.07 -38.43 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.427 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.484 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -61.09 -43.89 98.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 1.0 109.456 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.439 HD11 ' HE2' ' X' ' 28' ' ' TYR . 97.1 mt -64.17 -42.11 96.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 1.0 109.39 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 99.2 mttt -62.63 -38.27 89.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 1.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.56 -50.06 75.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0 109.477 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.65 -42.17 99.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 1.0 109.382 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' X' ' 40' ' ' ASP . 66.2 t0 -63.44 -39.61 94.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 1.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.43 -45.31 88.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 1.0 109.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.43 -47.58 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.96 -33.47 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 1.0 109.367 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.7 m-20 -69.78 -19.95 63.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 1.0 109.7 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 7.5 m -54.96 -61.05 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.0 109.481 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.63 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -103.04 -62.86 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.56 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.5 Cg_exo -41.32 -50.09 4.62 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.867 2.378 . . . . 1.0 112.175 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.497 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.6 m-90 -135.06 -147.19 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 1.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.14 -44.52 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 1.0 109.851 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.0 Cg_exo -58.1 -32.7 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.711 2.274 . . . . 1.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.01 124.14 18.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 1.0 109.735 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 48' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' X' ' 82' ' ' TYR . 97.0 mt-10 -141.28 161.64 37.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 1.0 109.789 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.04 169.15 41.23 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 50' ' ' THR . . . . . 0.475 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 34.7 m -64.17 138.51 58.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.116 -1.226 . . . . 1.0 109.334 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.69 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.22 135.84 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 1.0 109.479 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.69 ' N ' HD13 ' X' ' 51' ' ' ILE . 85.4 m-20 -71.83 136.29 46.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.854 . . . . 1.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -24.41 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 1.0 109.468 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -65.28 -38.96 91.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.0 109.361 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -80.57 -17.79 50.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 1.0 109.25 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.611 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.6 t90 -54.06 -37.42 64.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 1.0 109.665 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -61.53 -39.85 92.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 1.0 109.479 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -66.39 -40.36 89.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 1.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' X' ' 83' ' ' TRP . 71.4 t -61.36 -45.91 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 1.0 109.35 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -44.11 98.46 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -65.75 -40.13 91.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -1.162 . . . . 1.0 109.462 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.26 -53.66 23.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 109.534 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -61.41 -42.61 99.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 1.0 109.485 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -59.46 -36.92 76.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -62.96 -45.2 93.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 1.0 109.28 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -65.48 -38.06 88.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 1.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' X' ' 71' ' ' GLY . 8.9 t80 -60.14 -53.47 57.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 1.0 109.364 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.28 -38.86 92.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 1.0 109.282 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.8 m -64.13 -49.82 70.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.0 109.281 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.64 -52.24 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 1.0 109.329 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.09 -165.13 24.97 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' X' ' 76' ' ' PRO . 12.6 Cg_exo -65.36 -19.89 61.63 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.911 2.408 . . . . 1.0 111.968 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.86 -54.71 41.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.239 -0.913 . . . . 1.0 109.204 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.86 -37.24 85.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.88 80.15 15.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 1.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.1 Cg_exo -58.01 157.68 24.04 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.895 2.397 . . . . 1.0 112.214 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -51.66 -6.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 1.0 109.462 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.549 ' H ' ' C ' ' X' ' 76' ' ' PRO . 77.0 p -61.78 -32.97 73.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 1.0 109.371 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.07 -49.96 73.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 1.0 109.405 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 67.6 m -59.87 -43.77 94.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 1.0 109.442 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' X' ' 48' ' ' GLU . 1.2 t80 -61.43 -43.25 99.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0 109.491 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.611 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.0 t-105 -65.9 -36.0 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 1.0 109.373 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -56.78 -42.59 79.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 1.0 109.272 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.452 ' O ' HD13 ' X' ' 89' ' ' LEU . 93.0 mt -63.92 -42.6 97.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 1.0 109.587 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.12 -41.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 1.0 109.403 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.33 -39.21 72.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -71.08 -37.42 72.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 1.0 109.394 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.452 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.5 mp -64.73 -46.12 83.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.895 . . . . 1.0 109.412 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -74.65 -39.55 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -61.16 -48.99 79.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 1.0 109.512 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.88 -45.0 79.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 1.0 109.596 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.52 127.11 32.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 1.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.42 132.19 51.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 1.0 109.602 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.47 -0.566 . . . . 1.0 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.45 138.83 12.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 1.0 109.44 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.08 102.46 15.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.739 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.9 p -83.98 168.85 15.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 1.0 109.528 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -52.07 -40.94 61.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 1.0 109.325 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.0 -44.94 83.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 1.0 109.396 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.36 -34.26 76.93 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 1.0 109.427 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.078 -1.014 . . . . 1.0 109.49 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -60.87 -50.26 74.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.97 . . . . 1.0 109.779 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' X' ' 35' ' ' PHE . 17.1 m -64.01 -32.81 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 1.0 109.244 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.05 -44.49 87.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 1.0 109.191 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 14' ' ' GLN . . . . . 0.472 ' NE2' ' OE1' ' X' ' 17' ' ' GLN . 72.6 tp60 -63.25 -37.46 87.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.918 . . . . 1.0 108.807 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.07 -39.46 89.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -0.904 . . . . 1.0 108.751 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.59 -43.12 97.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 1.0 109.095 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.537 ' O ' HG23 ' X' ' 21' ' ' THR . 87.0 mt-30 -54.97 -42.26 72.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 1.0 108.77 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.26 -44.26 92.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 1.0 109.192 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.547 ' CD2' HH21 ' X' ' 22' ' ' ARG . 8.8 mt -63.15 -41.37 99.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.083 -1.01 . . . . 1.0 109.366 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.32 -38.94 91.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.278 -0.889 . . . . 1.0 109.507 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.537 HG23 ' O ' ' X' ' 17' ' ' GLN . 52.4 p -64.46 -29.83 70.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.433 -0.792 . . . . 1.0 109.345 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.547 HH21 ' CD2' ' X' ' 19' ' ' LEU . 77.7 mtm180 -78.48 -13.46 59.82 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 1.0 109.554 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.03 48.21 0.73 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.52 135.58 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.715 -0.874 . . . . 1.0 109.041 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -130.09 97.3 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.406 -0.808 . . . . 1.0 109.252 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.651 HG11 HH11 ' X' ' 58' ' ' ARG . 27.7 m -134.41 160.36 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.596 -0.69 . . . . 1.0 109.559 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.17 152.32 32.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 1.0 109.675 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -63.99 -34.66 78.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 1.0 108.939 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -29.28 70.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 1.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.555 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 41.9 t0 -59.37 -48.48 81.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.0 109.179 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.562 ' CD2' HH22 ' X' ' 58' ' ' ARG . 10.6 mt -62.36 -42.96 99.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.937 . . . . 1.0 108.912 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.76 -42.66 99.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.265 -0.897 . . . . 1.0 108.972 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.719 ' HZ1' ' H ' ' X' ' 50' ' ' THR . 98.0 mttt -67.55 -35.04 78.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 1.0 109.178 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.593 ' O ' HG23 ' X' ' 38' ' ' VAL . 30.1 t80 -59.05 -48.92 79.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 1.0 109.879 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' X' ' 12' ' ' VAL . 46.0 m-85 -63.51 -43.47 97.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 1.0 109.647 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -63.38 -40.79 98.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 1.0 109.274 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.632 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 53.5 t80 -61.6 -46.22 90.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.665 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.593 HG23 ' O ' ' X' ' 34' ' ' PHE . 58.6 t -57.64 -39.36 69.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.048 -1.032 . . . . 1.0 109.039 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.21 -20.01 45.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 1.0 109.543 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' NE2' ' X' ' 47' ' ' GLN . 95.9 m-20 -68.13 -19.95 64.86 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.959 -1.088 . . . . 1.0 109.409 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 18.9 m -55.31 -43.51 74.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 1.0 110.332 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.649 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.7 OUTLIER -126.04 -63.12 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.538 -0.726 . . . . 1.0 109.929 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 50.3 Cg_exo -42.02 -44.07 7.22 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.662 2.242 . . . . 1.0 112.394 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.9 m0 -139.72 -146.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 109.216 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -174.42 -45.24 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 1.0 109.769 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 39.2 Cg_exo -58.66 140.27 94.21 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.612 2.208 . . . . 1.0 112.252 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 47' ' ' GLN . . . . . 0.459 ' NE2' ' OD2' ' X' ' 40' ' ' ASP . 88.7 mm-40 -105.7 158.0 17.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.592 -0.693 . . . . 1.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.69 146.04 47.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 1.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.55 -155.92 29.9 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.331 -1.507 . . . . 1.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 50' ' ' THR . . . . . 0.719 ' H ' ' HZ1' ' X' ' 33' ' ' LYS . 91.4 m -128.42 131.81 48.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.565 -0.962 . . . . 1.0 109.567 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.98 131.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.944 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' X' ' 54' ' ' LYS . 24.7 t0 -93.97 127.36 39.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 1.0 109.141 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -46.87 -16.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 1.0 109.495 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' X' ' 52' ' ' ASP . 65.1 mmtt -66.19 -35.51 80.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 1.0 109.635 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 55' ' ' PHE . . . . . 0.555 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 1.0 OUTLIER -83.25 -11.6 57.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 1.0 109.636 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.441 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.7 t90 -59.42 -42.94 93.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.88 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -63.85 -40.97 97.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 1.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.651 HH11 HG11 ' X' ' 26' ' ' VAL . 82.3 mtp180 -69.67 -47.19 64.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.0 109.568 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.731 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 85.9 t -64.62 -46.25 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 1.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.03 -45.31 96.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -67.12 -36.66 82.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -1.175 . . . . 1.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 91.7 m -67.37 -47.01 71.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.659 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.632 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.0 m-85 -64.35 -40.07 95.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 1.0 109.535 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -60.23 -37.68 81.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.311 -0.868 . . . . 1.0 109.331 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.09 -48.21 77.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 1.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -62.07 -36.42 81.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.84 . . . . 1.0 109.435 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' X' ' 71' ' ' GLY . 3.0 t80 -61.86 -55.31 31.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.226 -0.921 . . . . 1.0 109.886 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.61 -36.21 83.52 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.973 -1.079 . . . . 1.0 109.711 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -64.44 -45.72 86.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 110.195 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.35 -51.96 2.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.685 -0.635 . . . . 1.0 109.967 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 141.59 -169.7 25.06 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.3 Cg_exo -65.36 -22.31 60.07 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.894 2.396 . . . . 1.0 112.102 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.13 -54.63 42.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 1.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -61.58 -39.21 90.37 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.261 -0.899 . . . . 1.0 109.614 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.29 82.01 8.48 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.449 -0.782 . . . . 1.0 109.346 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.2 Cg_exo -57.55 151.7 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.851 2.367 . . . . 1.0 112.333 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 m -49.53 -11.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.388 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.496 ' N ' ' O ' ' X' ' 76' ' ' PRO . 2.0 t -62.64 -33.12 74.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 1.0 109.371 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.28 -41.84 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.9 . . . . 1.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 1.0 109.404 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -61.43 -44.16 97.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -0.855 . . . . 1.0 109.263 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.95 -42.47 94.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.997 . . . . 1.0 109.681 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.731 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 10.2 t-105 -62.76 -36.19 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 1.0 109.315 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -58.5 -43.25 89.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 1.0 108.861 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.415 ' O ' HD13 ' X' ' 89' ' ' LEU . 89.7 mt -63.54 -40.53 97.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 1.0 109.271 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.0 109.619 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.48 -37.61 70.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.365 -0.835 . . . . 1.0 109.509 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -70.99 -39.79 72.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 1.0 109.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.415 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -63.49 -48.41 77.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 1.0 110.458 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.5 pt -72.43 -42.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.565 -0.709 . . . . 1.0 109.619 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 62.9 t0 -62.56 -37.17 85.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 1.0 109.312 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 1.0 109.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -82.2 135.15 35.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 1.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.99 123.08 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 1.0 109.426 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.705 . . . . 1.0 109.365 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.71 136.33 57.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 1.0 109.578 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.94 99.49 12.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 1.0 109.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.4 p -79.54 167.31 20.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -51.06 -42.34 60.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 1.0 109.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.6 -48.7 71.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 1.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.96 -38.92 87.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 1.0 109.4 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.49 -36.68 84.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.532 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -59.94 -42.04 93.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 1.0 109.417 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.97 -43.33 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.95 . . . . 1.0 109.304 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.36 -43.23 78.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 1.0 109.35 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.31 -35.18 80.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 1.0 108.867 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.82 -42.16 99.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0 108.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.86 -42.43 99.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 1.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.54 ' O ' HG23 ' X' ' 21' ' ' THR . 89.0 mt-30 -56.07 -46.49 78.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 1.0 109.144 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.0 97.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 1.0 109.407 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' X' ' 19' ' ' LEU . 82.5 mt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 1.0 109.319 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.04 -39.36 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 1.0 109.243 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.54 HG23 ' O ' ' X' ' 17' ' ' GLN . 46.8 p -65.65 -29.92 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.0 109.29 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.92 -18.44 59.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 1.0 109.142 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.58 48.52 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.08 135.29 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -1.138 . . . . 1.0 109.397 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.65 101.41 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 1.0 109.125 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 161.5 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.835 . . . . 1.0 109.352 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.89 145.83 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 109.435 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.24 -41.24 99.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 1.0 109.281 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.04 64.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.426 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' CG ' ' X' ' 55' ' ' PHE . 20.6 t70 -59.12 -39.33 81.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.0 109.417 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.52 -43.08 99.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 1.0 109.417 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.29 -41.55 85.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 1.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.5 -38.37 89.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 1.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.02 -48.65 79.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 1.0 109.419 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -61.88 -42.61 99.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 1.0 109.4 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.51 -34.46 77.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.0 109.332 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.55 -46.25 86.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.539 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.91 -50.92 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.589 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' X' ' 43' ' ' PRO . 68.3 mttm -66.35 -29.88 70.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 1.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.0 m-20 -78.25 -18.59 55.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0 109.675 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 41' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 3.0 m -53.92 -61.28 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 1.0 109.396 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.624 ' H ' ' CD ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -108.98 -50.91 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 1.0 109.568 -176.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.624 ' CD ' ' H ' ' X' ' 42' ' ' CYS . 52.7 Cg_exo -52.7 -39.34 76.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.885 2.39 . . . . 1.0 112.2 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.485 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -147.49 -150.4 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 1.0 109.544 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' X' ' 41' ' ' THR . 0.2 OUTLIER 172.9 69.31 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.877 . . . . 1.0 109.877 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.72 159.8 38.37 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.693 2.262 . . . . 1.0 112.369 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.25 130.24 45.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 1.0 109.733 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.96 179.8 7.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 1.0 109.763 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.98 -93.43 0.17 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 29.5 m -125.92 144.79 50.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.174 . . . . 1.0 109.35 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.716 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.2 OUTLIER -131.64 132.49 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 1.0 109.544 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.716 ' N ' HD13 ' X' ' 51' ' ' ILE . 65.5 m-20 -66.53 134.04 51.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 109.757 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.31 -29.07 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 1.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -44.61 93.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 1.0 109.44 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 55' ' ' PHE . . . . . 0.559 ' CG ' ' OD2' ' X' ' 30' ' ' ASP . 4.7 t80 -77.99 -23.22 48.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 1.0 109.285 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.609 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -55.64 -38.08 69.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 1.0 109.639 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.39 -42.1 98.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.933 . . . . 1.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 78.5 mtp85 -67.41 -37.2 82.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 1.0 109.429 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.59 -42.79 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.907 . . . . 1.0 109.356 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.29 91.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -66.82 -37.07 83.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -1.159 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 97.7 m -71.91 -44.62 63.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 1.0 109.553 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.458 ' O ' HG21 ' X' ' 75' ' ' VAL . 3.0 m-85 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 1.0 109.472 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.87 -37.43 79.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 1.0 109.472 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -63.06 -46.25 88.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 1.0 109.32 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -65.77 -31.75 72.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 1.0 109.458 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' X' ' 71' ' ' GLY . 11.2 t80 -59.15 -54.89 41.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 1.0 109.391 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -67.6 -35.65 79.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.853 . . . . 1.0 109.335 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -65.87 -44.02 86.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 1.0 109.345 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.48 -52.55 2.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 1.0 109.275 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -164.47 26.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -73.5 -15.1 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.874 2.383 . . . . 1.0 111.913 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -61.92 -50.22 73.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 1.0 109.198 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -65.62 -43.68 88.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.878 . . . . 1.0 109.396 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.746 HG23 ' O ' ' X' ' 75' ' ' VAL . 32.7 m -150.08 89.03 4.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 1.0 109.406 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.35 -175.03 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.871 2.381 . . . . 1.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.453 ' H ' HG22 ' X' ' 77' ' ' VAL . 5.1 m -62.32 -18.19 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 109.383 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.1 p -62.05 -31.8 72.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 1.0 109.382 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.79 97.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -67.98 -38.64 82.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.431 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -61.29 -51.3 69.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 1.0 109.356 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -60.8 -44.34 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 1.0 109.417 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.609 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.9 t-105 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 109.351 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -56.35 -44.68 80.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 1.0 109.295 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' X' ' 85' ' ' LEU . 89.7 mt -63.27 -40.41 97.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 1.0 109.559 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.25 -42.54 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 1.0 109.327 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.27 -39.94 67.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.495 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.8 -39.09 73.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 1.0 109.413 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.48 -43.96 92.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 1.0 109.356 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' X' ' 93' ' ' LYS . 10.2 pt -76.17 -38.74 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 1.0 109.508 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.2 -45.0 96.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 1.0 109.509 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.88 -41.74 77.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 1.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 93' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.3 tttt -85.46 137.82 32.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.0 109.441 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.97 140.86 47.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 1.0 109.531 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 1.0 109.579 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -64.23 133.48 52.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 1.0 109.519 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.73 105.22 16.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 1.0 109.473 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.3 p -87.38 175.13 8.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 1.0 109.58 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.71 -43.63 65.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 1.0 109.435 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.88 -44.92 75.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 1.0 109.522 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.57 -39.45 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 1.0 109.369 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -62.04 -38.32 88.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.0 109.61 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.1 -41.59 88.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 1.0 109.502 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.65 -44.41 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 1.0 109.33 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -51.02 -46.0 61.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.258 -0.901 . . . . 1.0 109.392 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -66.21 -37.5 85.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 1.0 108.881 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.73 -40.22 96.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.266 -0.896 . . . . 1.0 108.826 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.53 ' HG2' ' HZ2' ' X' ' 20' ' ' LYS . 89.1 tttt -62.83 -42.4 99.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 1.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -53.61 -45.2 69.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.146 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.23 -38.22 88.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 1.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.39 -38.46 89.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.172 -0.955 . . . . 1.0 109.275 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.53 ' HZ2' ' HG2' ' X' ' 16' ' ' LYS . 50.2 mttp -57.31 -43.25 83.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.0 109.301 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.6 p -65.17 -24.44 67.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 1.0 109.284 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -82.15 -6.03 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 1.0 109.197 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.7 47.86 1.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.24 -1.544 . . . . 1.0 109.24 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.674 HG13 ' HE ' ' X' ' 58' ' ' ARG . 54.8 t -122.4 131.82 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -1.101 . . . . 1.0 109.356 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -132.35 88.44 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.98 . . . . 1.0 109.175 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.78 161.99 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 1.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -78.31 148.43 33.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 1.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.451 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 76.5 t80 -61.83 -35.05 77.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 1.0 109.218 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.39 65.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 1.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' X' ' 52' ' ' ASP . 89.2 m-20 -62.24 -39.62 93.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.476 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.01 -44.54 96.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 1.0 109.382 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.93 -41.5 99.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 1.0 109.449 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.27 -31.44 72.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.483 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.45 ' O ' HG23 ' X' ' 38' ' ' VAL . 58.6 t80 -59.28 -46.77 87.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 1.0 109.449 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.15 -44.28 96.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 1.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.77 -47.3 84.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 1.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.45 HG23 ' O ' ' X' ' 34' ' ' PHE . 98.2 t -60.71 -47.04 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 1.0 109.565 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.22 -32.23 73.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 1.0 109.379 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.0 m-20 -67.08 -19.59 65.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 1.0 109.663 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.4 m -54.52 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 1.0 109.371 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.711 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -106.95 -61.06 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 109.467 -177.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.2 Cg_exo -41.25 -45.12 5.63 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.887 2.391 . . . . 1.0 112.218 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.548 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.9 m-90 -135.66 -167.63 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 1.0 109.487 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.808 ' H ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -135.11 -46.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 109.885 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.808 ' CD ' ' H ' ' X' ' 45' ' ' PHE . 28.0 Cg_exo -60.74 142.67 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.73 2.287 . . . . 1.0 112.301 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -117.99 150.67 38.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 1.0 109.643 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -137.77 155.24 49.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.903 . . . . 1.0 109.743 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.55 176.66 47.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 88.3 m -119.39 135.29 54.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 1.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.94 141.15 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 1.0 109.515 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.43 ' OD2' ' OD1' ' X' ' 30' ' ' ASP . 91.4 m-20 -87.44 138.22 31.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 1.0 109.77 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.95 -40.82 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.081 -1.012 . . . . 1.0 109.445 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.99 -39.31 81.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.0 109.388 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -81.75 -18.06 45.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 1.0 109.277 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.632 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 8.1 t90 -63.73 -37.26 86.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.0 109.638 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -56.81 -43.07 80.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 1.0 109.508 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.674 ' HE ' HG13 ' X' ' 24' ' ' VAL . 17.2 mtt85 -67.83 -36.44 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 1.0 109.468 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.497 HG11 ' CH2' ' X' ' 83' ' ' TRP . 39.1 t -65.67 -44.01 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.382 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.47 95.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -67.77 -37.52 82.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 1.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.0 m -64.62 -52.57 56.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 109.448 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.77 -42.51 99.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 1.0 109.479 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.54 -38.95 78.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 1.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.33 -44.46 96.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 1.0 109.311 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -69.29 -32.99 72.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 1.0 109.379 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' X' ' 71' ' ' GLY . 25.6 t80 -64.07 -55.21 23.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 1.0 109.411 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -70.47 -35.92 73.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 1.0 109.323 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -64.58 -47.16 79.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 1.0 109.301 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.48 -52.51 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 1.0 109.195 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -168.57 25.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' X' ' 76' ' ' PRO . 21.3 Cg_endo -70.08 -18.75 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.985 2.456 . . . . 1.0 111.97 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.92 -51.55 69.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 1.0 109.224 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -65.35 -38.94 91.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 1.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.6 82.49 8.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.8 Cg_exo -56.32 161.11 9.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.885 2.39 . . . . 1.0 112.302 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.44 -5.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 1.0 109.455 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.463 ' H ' ' C ' ' X' ' 76' ' ' PRO . 73.0 p -63.9 -33.48 75.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.873 . . . . 1.0 109.396 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 1.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.94 -46.79 80.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 1.0 109.377 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 75.7 m -59.42 -47.96 83.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 1.0 109.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -62.45 -40.23 95.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.0 109.501 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.632 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.6 t-105 -66.53 -36.03 81.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 1.0 109.441 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -56.24 -44.76 79.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 1.0 109.194 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.6 mt -62.94 -39.82 95.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.635 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.0 -43.29 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.344 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.32 -43.3 83.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 1.0 109.438 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -69.45 -35.37 75.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 1.0 109.365 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.42 -47.78 75.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.357 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -74.25 -39.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 1.0 109.402 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -59.37 -46.43 88.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 1.0 109.521 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.91 -41.67 95.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 1.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -69.77 122.6 19.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 1.0 109.483 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.12 102.33 12.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 1.0 109.565 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 4' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 96.0 mt-10 -64.39 146.44 54.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 1.0 109.541 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 5' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' X' ' 5' ' ' LEU . 76.3 mt -92.58 102.58 15.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 1.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.1 p -84.84 171.58 12.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 1.0 109.579 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -57.13 -41.49 79.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 1.0 109.435 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -66.14 -42.26 89.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 1.0 109.511 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 92.5 mt-10 -66.92 -38.23 85.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 1.0 109.428 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.56 -35.04 75.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 1.0 109.583 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.28 -49.0 78.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 1.0 109.41 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -68.21 -32.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -0.972 . . . . 1.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.46 -45.8 90.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.868 . . . . 1.0 109.334 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -62.43 -37.42 85.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 1.0 108.878 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.67 -42.28 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 1.0 108.738 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.527 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.2 tttt -56.31 -44.18 79.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 1.0 109.523 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -55.13 -42.93 73.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 1.0 109.116 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.582 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -63.57 -37.77 88.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.78 . . . . 1.0 109.392 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' X' ' 19' ' ' LEU . 97.2 mt -63.6 -36.93 85.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.898 . . . . 1.0 109.273 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.33 -40.68 82.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 1.0 109.218 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.0 p -66.42 -31.22 71.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 1.0 109.263 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.582 HH12 ' HB1' ' X' ' 18' ' ' ALA . 84.1 mtt85 -72.89 -18.26 61.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 1.0 109.212 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.78 46.37 0.78 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.309 -1.517 . . . . 1.0 109.309 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.82 132.98 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 1.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.67 95.82 3.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 1.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.02 158.11 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -0.86 . . . . 1.0 109.359 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.15 145.26 46.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.923 . . . . 1.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.527 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 82.3 t80 -57.17 -33.56 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 1.0 109.271 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.5 70.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 1.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 30' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.5 m-20 -59.72 -40.75 89.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 1.0 109.409 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.79 -44.53 96.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 1.0 109.345 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 32' ' ' LEU . 90.3 mt -63.97 -42.51 97.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 1.0 109.369 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.94 -37.13 85.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 1.0 109.356 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.04 -50.93 72.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 1.0 109.4 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.43 -42.2 98.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 1.0 109.41 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.62 -38.71 91.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.0 109.277 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -62.51 -46.47 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 1.0 109.52 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.2 -50.11 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 1.0 109.373 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' X' ' 44' ' ' TRP . 21.1 m-20 -69.98 -19.86 63.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 1.0 109.686 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -54.72 -59.34 4.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.967 . . . . 1.0 109.426 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -107.69 -62.02 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 1.0 109.487 -176.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.24 -41.75 4.87 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.919 2.413 . . . . 1.0 112.201 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.2 m-90 -141.83 -159.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 1.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.511 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -173.75 50.18 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 1.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_endo -70.58 166.69 27.79 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.753 2.302 . . . . 1.0 112.327 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.54 138.73 57.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 1.0 109.712 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.62 136.14 37.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 1.0 109.798 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.8 -173.72 37.96 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 141.37 57.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -1.206 . . . . 1.0 109.293 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.691 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.46 134.04 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 1.0 109.567 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.691 ' N ' HD13 ' X' ' 51' ' ' ILE . 98.5 m-20 -64.39 137.28 57.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 1.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.15 -23.02 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 1.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.31 -39.48 92.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 1.0 109.41 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -83.26 -10.13 58.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 1.0 109.247 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.626 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.8 t90 -58.76 -38.16 77.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 1.0 109.651 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -62.15 -40.54 96.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.0 109.466 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 74.8 mtp85 -66.08 -39.13 89.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 1.0 109.396 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.452 HG21 ' CH2' ' X' ' 83' ' ' TRP . 53.7 t -61.95 -43.82 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 1.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.31 -50.7 62.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.74 -41.67 97.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -1.164 . . . . 1.0 109.511 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 81.8 m -65.43 -52.29 54.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 1.0 109.518 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.521 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.8 m-85 -60.98 -41.46 96.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 1.0 109.498 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -63.85 -38.72 92.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 1.0 109.465 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.95 -45.28 89.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.306 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -68.05 -30.56 69.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 1.0 109.461 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' X' ' 71' ' ' GLY . 14.9 t80 -60.44 -55.09 37.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 1.0 109.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -66.95 -36.51 82.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 1.0 109.345 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -63.85 -47.03 82.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 1.0 109.318 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.35 -52.45 2.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 1.0 109.302 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.47 -164.12 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.4 -15.45 31.17 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.928 2.419 . . . . 1.0 112.001 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.11 -54.44 44.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 1.0 109.16 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -63.27 -44.47 95.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 1.0 109.366 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.699 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.2 m -148.81 90.57 4.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 1.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.42 -173.84 1.96 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.85 2.367 . . . . 1.0 112.204 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.94 -16.56 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 1.0 109.431 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.71 -32.52 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 1.0 109.345 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.78 95.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 1.0 109.376 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -65.04 -41.24 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 1.0 109.38 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -59.66 -48.02 83.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -65.51 -43.75 89.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 1.0 109.488 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.626 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.7 t-105 -61.67 -36.46 80.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 1.0 109.389 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -56.77 -43.19 80.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 1.0 109.277 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' X' ' 85' ' ' LEU . 94.6 mt -64.48 -41.14 96.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 1.0 109.642 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.5 -41.29 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.927 . . . . 1.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -56.87 -40.04 75.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 1.0 109.497 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.01 -40.62 78.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 1.0 109.434 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.7 -46.11 86.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 1.0 109.33 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.64 -38.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.399 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.46 -45.07 92.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 1.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.95 -45.55 93.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 1.0 109.586 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.8 127.96 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 1.0 109.495 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -91.73 96.09 10.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 1.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 1.0 109.541 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.359 0.599 . . . . 1.0 109.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.07 138.43 58.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 1.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 5' ' ' LEU . . . . . 0.49 HD22 ' OE1' ' X' ' 13' ' ' GLU . 95.7 mt -77.03 84.63 3.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.576 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.7 p -80.32 172.19 14.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 1.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.6 -43.34 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 1.0 109.447 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -68.68 -43.64 75.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 109.484 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.93 -36.59 84.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.0 -38.81 79.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 1.0 109.831 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.27 -49.03 78.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 1.0 109.63 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.22 -35.37 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 13' ' ' GLU . . . . . 0.49 ' OE1' HD22 ' X' ' 5' ' ' LEU . 79.3 tt0 -62.99 -40.36 97.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.301 -0.874 . . . . 1.0 109.24 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.43 -36.93 85.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.039 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.96 -43.0 99.76 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.25 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.46 -36.94 81.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 1.0 109.417 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.544 ' O ' HG23 ' X' ' 21' ' ' THR . 89.4 mt-30 -58.25 -48.5 80.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.0 109.254 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.3 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.446 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.65 -38.75 92.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 1.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.86 -39.7 95.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.306 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.544 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.2 p -61.77 -29.38 70.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 1.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.15 -17.51 63.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.588 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.13 44.55 0.67 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.738 HG13 ' HE ' ' X' ' 58' ' ' ARG . 30.9 t -122.98 135.64 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.667 -0.902 . . . . 1.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -135.49 99.74 4.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 1.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.54 164.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.485 -0.76 . . . . 1.0 109.625 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.12 146.26 47.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.353 -0.842 . . . . 1.0 109.512 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -62.83 -37.39 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.05 -1.031 . . . . 1.0 109.371 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.49 -34.23 66.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -39.67 90.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 1.0 109.113 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.465 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.23 -43.55 98.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.0 109.526 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' X' ' 32' ' ' LEU . 99.1 mt -63.71 -42.27 97.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 1.0 109.33 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.1 -30.86 71.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 1.0 109.18 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -61.39 -50.21 73.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 1.0 109.607 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -62.28 -46.56 88.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 1.0 109.547 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -65.52 -38.18 88.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.208 -0.932 . . . . 1.0 109.231 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.25 -45.64 93.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 1.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.27 -48.63 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 1.0 109.693 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -67.8 -28.46 67.61 Favored 'General case' 0 C--O 1.192 -1.94 0 O-C-N 121.171 -0.956 . . . . 1.0 108.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.562 ' OD1' ' CZ2' ' X' ' 44' ' ' TRP . 71.0 m-20 -77.93 -20.71 52.3 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 120.032 -1.667 . . . . 1.0 109.796 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 m -54.34 -60.91 2.71 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.99 -1.069 . . . . 1.0 111.275 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 42' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -101.84 -53.95 0.14 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.512 -0.743 . . . . 1.0 110.858 -178.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 43' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' X' ' 42' ' ' CYS . 89.1 Cg_exo -46.02 -43.0 20.68 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.514 2.143 . . . . 1.0 112.601 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 44' ' ' TRP . . . . . 0.562 ' CZ2' ' OD1' ' X' ' 40' ' ' ASP . 0.1 OUTLIER -176.56 131.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 1.0 109.207 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 45' ' ' PHE . . . . . 0.523 ' CE2' ' CD2' ' X' ' 82' ' ' TYR . 0.2 OUTLIER -104.69 105.95 52.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 1.0 109.775 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 46' ' ' PRO . . . . . 0.427 ' CG ' ' HE1' ' X' ' 44' ' ' TRP . 56.4 Cg_endo -83.2 -164.46 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.778 2.318 . . . . 1.0 111.918 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -90.57 122.36 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.363 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.01 154.76 17.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.461 -0.774 . . . . 1.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.19 -93.99 2.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 50' ' ' THR . . . . . 0.489 HG23 HG22 ' X' ' 90' ' ' ILE . 27.3 m -130.92 137.4 49.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -1.007 . . . . 1.0 109.434 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.73 HD13 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -112.67 139.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.543 -0.723 . . . . 1.0 109.381 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.73 ' H ' HD13 ' X' ' 51' ' ' ILE . 85.5 m-20 -68.85 136.61 52.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 1.0 109.76 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.57 -27.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -0.997 . . . . 1.0 109.537 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.68 -41.87 95.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.024 -1.047 . . . . 1.0 109.777 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -75.88 -17.03 59.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 1.0 109.839 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.9 t90 -60.61 -37.74 82.41 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.288 -0.883 . . . . 1.0 109.954 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -59.44 -44.51 92.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 1.0 109.673 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.738 ' HE ' HG13 ' X' ' 24' ' ' VAL . 19.0 mtt85 -64.79 -40.01 94.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.54 -43.67 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.85 -46.92 92.6 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -67.88 -42.1 81.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -1.2 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.98 -51.6 66.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 1.0 109.639 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.98 -44.21 87.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 1.0 109.527 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -56.41 -40.62 74.99 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.272 -0.892 . . . . 1.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.69 -43.29 84.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 1.0 109.324 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -62.86 -35.7 80.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 1.0 109.269 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.515 ' CE2' ' OD1' ' X' ' 68' ' ' ASN . 3.4 t80 -59.26 -55.0 40.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.515 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 84.9 m-20 -65.13 -34.56 78.7 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.041 -1.037 . . . . 1.0 109.771 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -64.16 -48.93 74.08 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.288 -0.883 . . . . 1.0 110.012 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -114.7 -51.93 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.651 -0.655 . . . . 1.0 109.871 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 143.45 -168.87 26.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' X' ' 76' ' ' PRO . 7.4 Cg_exo -67.03 -21.76 48.9 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.998 2.465 . . . . 1.0 111.987 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.91 -51.01 69.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 1.0 109.457 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.53 -45.08 88.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 1.0 109.808 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.759 HG23 ' O ' ' X' ' 75' ' ' VAL . 26.6 m -142.8 82.4 12.34 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.0 109.356 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' X' ' 72' ' ' PRO . 51.5 Cg_endo -79.59 -172.33 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.911 2.407 . . . . 1.0 112.31 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.46 -20.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.922 . . . . 1.0 109.524 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 22.2 p -62.63 -37.85 87.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 1.0 109.563 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.25 79.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 1.0 109.56 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -65.68 -37.06 85.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 1.0 109.416 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -61.6 -45.3 94.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 1.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.523 ' CD2' ' CE2' ' X' ' 45' ' ' PHE . 38.3 m-85 -63.74 -44.24 94.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 1.0 109.732 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.634 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.7 t-105 -64.43 -37.56 87.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.282 -0.886 . . . . 1.0 109.296 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -55.99 -41.73 75.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 1.0 108.829 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.445 ' O ' HD13 ' X' ' 89' ' ' LEU . 95.1 mt -65.57 -40.39 92.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 1.0 109.297 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -64.22 -42.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 1.0 109.485 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -54.81 -39.32 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 1.0 109.264 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -70.39 -39.46 74.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 1.0 109.478 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.445 HD13 ' O ' ' X' ' 85' ' ' LEU . 8.1 mp -62.45 -46.0 90.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 1.0 110.139 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.489 HG22 HG23 ' X' ' 50' ' ' THR . 9.9 pt -74.19 -31.98 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.518 -0.739 . . . . 1.0 109.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.56 -40.55 92.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 1.0 109.374 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.37 -40.19 93.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.0 109.454 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -94.63 115.16 27.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.189 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.97 122.1 28.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 1.0 109.457 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 1.0 109.409 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mtm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.1 9.76 84.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.49 149.96 51.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -1.164 . . . . 1.0 109.499 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.15 139.31 52.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 1.0 109.568 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 5' ' ' LEU . 67.9 mt -90.86 104.08 16.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.855 . . . . 1.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.8 p -82.27 168.63 17.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 1.0 109.565 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -53.84 -41.39 67.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 1.0 109.489 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -66.39 -45.64 79.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 1.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -62.96 -35.99 81.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 1.0 109.428 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.43 -36.97 85.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 1.0 109.578 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -61.63 -41.74 97.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.404 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 t -59.63 -43.32 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.297 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -56.33 -46.92 79.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.228 -0.92 . . . . 1.0 109.347 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.98 -38.0 89.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 1.0 108.884 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.88 -41.51 99.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 1.0 108.772 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.513 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.5 tttt -59.77 -37.73 79.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 1.0 109.474 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -59.15 -44.98 92.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 1.0 109.099 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.51 -37.35 86.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 1.0 109.344 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.78 -39.1 93.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 1.0 109.338 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.26 -42.53 86.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 1.0 109.325 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.9 p -63.68 -31.73 72.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 1.0 109.342 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.58 -18.6 61.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 1.0 109.24 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.87 47.85 0.65 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.62 132.92 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 1.0 109.466 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.8 93.96 3.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.144 -0.973 . . . . 1.0 109.226 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.36 160.65 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 1.0 109.363 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 27' ' ' LYS . . . . . 0.411 ' HZ3' ' HA ' ' X' ' 97' ' ' PRO . 64.0 mttp -72.73 151.45 42.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 1.0 109.453 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.513 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 72.5 t80 -65.67 -40.17 92.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.872 . . . . 1.0 109.257 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.58 57.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.0 109.487 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -61.44 -37.5 83.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 1.0 109.409 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.504 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.23 -45.28 94.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 1.0 109.369 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' X' ' 32' ' ' LEU . 96.7 mt -63.91 -41.41 97.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 1.0 109.405 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 1.0 109.415 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -56.63 -49.14 75.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 1.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -59.95 -42.23 93.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 1.0 109.419 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.22 -44.13 95.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.0 109.292 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -61.2 -45.48 94.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 1.0 109.548 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.93 -44.69 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 1.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 69.9 tttt -64.2 -31.51 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 1.0 109.436 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' X' ' 44' ' ' TRP . 99.0 m-20 -70.7 -19.32 62.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 1.0 109.587 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 30.9 m -53.89 -52.25 61.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 1.0 109.378 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.772 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -116.13 -60.73 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 1.0 109.504 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.772 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 74.0 Cg_exo -41.5 -54.58 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.868 2.379 . . . . 1.0 112.203 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.52 ' O ' ' O ' ' X' ' 40' ' ' ASP . 8.4 m0 -127.65 113.01 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 1.0 109.58 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -61.49 -44.52 92.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 1.0 109.81 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.4 Cg_exo -59.6 141.71 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.699 2.266 . . . . 1.0 112.378 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -97.99 159.21 15.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 1.0 109.665 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.43 133.7 12.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.846 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.94 155.23 22.74 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.794 -1.323 . . . . 1.0 109.794 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.476 HG23 HG22 ' X' ' 90' ' ' ILE . 19.6 m -91.91 135.08 34.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 1.0 109.303 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.66 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -102.21 134.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 1.0 109.518 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.66 ' N ' HD13 ' X' ' 51' ' ' ILE . 70.0 m-20 -75.55 137.94 41.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 1.0 109.756 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.95 -34.19 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 1.0 109.392 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.742 ' HZ1' ' H ' ' X' ' 99' ' ' VAL . 98.1 mttt -63.85 -38.05 89.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 1.0 109.452 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.18 -20.36 52.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 1.0 109.245 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.597 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 13.5 t90 -56.18 -33.95 65.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 1.0 109.719 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -59.89 -41.98 92.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 1.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.416 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 72.8 mtp180 -66.38 -39.68 89.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 1.0 109.515 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.572 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 72.8 t -62.76 -43.11 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.33 -46.61 93.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -70.02 -42.2 73.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 1.0 109.494 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.1 m -63.86 -48.41 76.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 1.0 109.544 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.438 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.3 m-85 -61.84 -39.35 91.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 1.0 109.493 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -61.93 -39.67 92.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 1.0 109.456 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -63.07 -44.1 96.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 1.0 109.236 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -65.47 -35.15 80.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 1.0 109.475 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' X' ' 71' ' ' GLY . 5.1 t80 -59.05 -54.39 47.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.87 . . . . 1.0 109.45 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 95.0 m-20 -65.74 -36.57 83.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 1.0 109.311 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -62.93 -47.99 80.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 1.0 109.299 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.76 -52.36 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 1.0 109.209 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.26 -165.93 25.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.459 -1.457 . . . . 1.0 109.459 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -67.19 -16.56 48.99 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.953 2.435 . . . . 1.0 111.952 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.55 -54.6 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 1.0 109.198 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -63.74 -43.6 95.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 1.0 109.404 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.694 HG23 ' O ' ' X' ' 75' ' ' VAL . 27.3 m -148.63 92.42 4.47 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 1.0 109.431 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.55 -166.55 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.873 2.382 . . . . 1.0 112.166 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.66 -12.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 1.0 109.416 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -66.17 -33.2 75.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 1.0 109.421 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.15 -47.18 81.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.446 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -64.92 -45.67 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 1.0 109.4 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -59.77 -47.12 86.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 1.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -63.15 -40.89 98.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 1.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.597 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.5 t-105 -61.69 -37.98 86.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.05 -42.57 76.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.882 . . . . 1.0 109.223 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.31 -41.59 98.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 1.0 109.586 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -63.75 -43.53 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -0.941 . . . . 1.0 109.412 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.54 -37.63 58.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.0 109.501 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.21 -42.3 72.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.0 109.309 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.32 -48.02 83.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 1.0 109.396 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.476 HG22 HG23 ' X' ' 50' ' ' THR . 11.5 pt -72.69 -36.74 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.914 . . . . 1.0 109.434 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -63.11 -39.74 95.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 1.0 109.536 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -63.62 -40.96 98.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 1.0 109.57 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -88.75 117.48 27.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 1.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.75 138.17 56.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 1.0 109.564 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.531 HG22 ' N ' ' X' ' 96' ' ' ASN . 7.8 p -136.86 162.46 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 1.0 109.572 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' X' ' 100' ' ' MET . 8.2 t-20 -125.29 82.17 62.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 1.0 109.604 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.411 ' HA ' ' HZ3' ' X' ' 27' ' ' LYS . 34.7 Cg_exo -59.28 -147.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.875 2.383 . . . . 1.0 112.301 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -65.89 -49.67 67.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.893 . . . . 1.0 109.411 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.742 ' H ' ' HZ1' ' X' ' 54' ' ' LYS . 59.0 t -123.97 130.31 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 1.0 109.515 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 100' ' ' MET . . . . . 0.538 ' O ' ' ND2' ' X' ' 96' ' ' ASN . 72.2 mtm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.98 -1.01 . . . . 1.0 109.528 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.89 79.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -95.41 157.76 15.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.407 -1.055 . . . . 1.0 109.523 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.3 130.81 46.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 1.0 109.423 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 64.4 mt -91.93 104.66 17.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 1.0 109.717 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -82.46 168.37 17.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.434 -0.791 . . . . 1.0 109.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.96 -41.46 67.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 1.0 109.413 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.76 -45.13 79.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 1.0 109.606 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.85 -31.67 73.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.2 -0.938 . . . . 1.0 109.344 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -70.74 -40.65 72.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 1.0 109.925 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -60.66 -49.75 76.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 1.0 109.644 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -65.19 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 1.0 109.361 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.61 -40.96 93.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 1.0 109.019 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.22 -36.41 84.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 1.0 108.875 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.7 -41.42 99.12 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 109.126 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.6 -40.71 88.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 1.0 109.329 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -59.38 -44.57 92.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 1.0 109.046 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.08 -38.61 91.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.301 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.4 HD23 ' HD3' ' X' ' 22' ' ' ARG . 98.6 mt -67.1 -40.98 87.02 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.021 -1.05 . . . . 1.0 109.207 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.41 -30.61 71.34 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.991 -1.068 . . . . 1.0 109.162 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 31.4 p -77.06 -31.46 56.12 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.346 -0.846 . . . . 1.0 109.535 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' CG2' ' X' ' 24' ' ' VAL . 15.9 ptt85 -75.57 -19.3 59.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.112 -0.993 . . . . 1.0 109.29 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.73 48.47 0.3 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.455 ' CG2' ' HE ' ' X' ' 22' ' ' ARG . 69.7 t -123.11 139.47 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 1.0 109.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 25' ' ' LYS . . . . . 0.508 ' C ' HE22 ' X' ' 98' ' ' GLN . 99.1 mttt -125.39 98.2 5.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.743 . . . . 1.0 109.312 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -132.04 138.63 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 1.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.94 150.15 39.17 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.361 -0.837 . . . . 1.0 109.631 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.15 -35.36 80.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 1.0 109.128 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 1.0 109.305 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -62.88 -37.47 87.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.185 -0.947 . . . . 1.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -63.11 -44.77 94.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 1.0 109.631 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.67 -43.11 94.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 1.0 109.429 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 1.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.86 -48.45 78.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 1.0 109.571 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.82 -41.05 97.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 109.209 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.41 -44.93 95.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 1.0 109.271 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.48 -48.07 79.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.58 -45.03 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.908 . . . . 1.0 109.327 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 51.4 tttm -64.38 -34.22 77.66 Favored 'General case' 0 C--O 1.2 -1.516 0 CA-C-O 122.103 0.954 . . . . 1.0 108.938 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 2.9 m-20 -69.42 -20.73 63.79 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 120.242 -1.536 . . . . 1.0 109.646 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -54.28 -61.04 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.0 110.926 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.54 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -102.68 -59.09 0.09 OUTLIER Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.334 -0.854 . . . . 1.0 110.728 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.8 Cg_exo -41.7 -48.6 5.72 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.599 2.199 . . . . 1.0 112.697 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -125.53 -118.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.0 109.03 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.672 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.9 OUTLIER -177.58 -41.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.0 110.227 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 25.8 Cg_exo -60.84 141.41 94.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.728 2.286 . . . . 1.0 112.231 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.11 164.29 15.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 1.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.0 161.12 30.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 1.0 109.753 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.03 -2.86 58.1 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.086 -1.206 . . . . 1.0 110.086 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -119.63 116.12 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.978 . . . . 1.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.663 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.84 132.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.156 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.663 ' N ' HD13 ' X' ' 51' ' ' ILE . 87.7 m-20 -72.46 131.34 42.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.83 -1.169 . . . . 1.0 109.884 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.26 -42.44 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 1.0 109.581 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -57.37 -42.07 81.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.159 . . . . 1.0 109.43 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 55' ' ' PHE . . . . . 0.519 ' CE2' ' CG2' ' X' ' 59' ' ' VAL . 86.2 t80 -77.08 -23.76 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 1.0 109.757 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.643 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -59.56 -38.8 82.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.975 . . . . 1.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -57.09 -44.42 83.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.218 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.461 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 77.8 mtp85 -66.69 -39.02 87.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 1.0 109.487 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.519 ' CG2' ' CE2' ' X' ' 55' ' ' PHE . 59.2 t -62.4 -44.1 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 1.0 109.46 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.01 73.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -65.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -1.133 . . . . 1.0 109.498 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 74.0 m -66.33 -55.16 17.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 1.0 109.715 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.52 -37.83 85.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 1.0 109.548 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -38.35 90.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 1.0 109.303 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 1.0 109.438 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -64.8 -35.44 81.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.895 . . . . 1.0 109.579 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' X' ' 71' ' ' GLY . 0.9 OUTLIER -62.15 -54.06 46.54 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.261 -0.9 . . . . 1.0 109.834 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 35.0 t-20 -64.42 -35.52 81.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.909 -1.12 . . . . 1.0 109.674 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -67.24 -46.14 74.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.288 -0.883 . . . . 1.0 109.69 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -115.15 -52.05 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.691 -0.631 . . . . 1.0 109.901 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.76 -169.19 24.23 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' X' ' 76' ' ' PRO . 13.1 Cg_exo -63.33 -22.87 72.04 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.946 2.431 . . . . 1.0 111.99 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.79 -53.06 57.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 1.0 109.346 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -65.37 -43.91 89.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.299 -0.875 . . . . 1.0 109.751 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' X' ' 75' ' ' VAL . 7.3 m -138.79 84.52 17.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.612 -0.68 . . . . 1.0 109.285 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.553 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.5 Cg_exo -60.12 152.8 62.97 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.841 2.36 . . . . 1.0 112.153 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.522 ' O ' HG12 ' X' ' 77' ' ' VAL . 61.0 t -52.03 -4.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.968 . . . . 1.0 109.707 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.553 ' H ' ' C ' ' X' ' 76' ' ' PRO . 51.5 p -65.49 -38.62 90.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.132 -0.98 . . . . 1.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.15 77.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 1.0 109.434 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -62.6 -45.83 91.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 1.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 65.9 m -61.05 -46.76 89.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.72 -37.48 87.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 1.0 109.431 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.643 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.2 t-105 -66.75 -35.17 79.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 1.0 109.214 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -58.07 -45.36 87.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 1.0 108.865 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.72 -42.02 99.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 1.0 109.413 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.6 -45.06 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 1.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -54.19 -44.27 71.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 1.0 109.508 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.98 -35.26 76.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.067 -1.02 . . . . 1.0 109.466 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.22 -49.09 71.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.089 -1.007 . . . . 1.0 110.014 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' X' ' 93' ' ' LYS . 6.0 pt -71.77 -43.07 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 1.0 109.517 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -62.01 -48.34 80.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.68 -44.7 92.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 1.0 109.712 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.5 tttt -81.34 143.25 32.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 1.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.08 138.4 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 1.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.568 HG22 ' N ' ' X' ' 96' ' ' ASN . 9.2 p -136.1 164.42 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.775 . . . . 1.0 109.369 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.568 ' N ' HG22 ' X' ' 95' ' ' VAL . 15.5 t-20 -122.64 82.81 48.22 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.676 -0.64 . . . . 1.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.46 ' HD3' HG13 ' X' ' 95' ' ' VAL . 55.6 Cg_endo -83.97 -166.09 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.022 2.481 . . . . 1.0 112.247 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 98' ' ' GLN . . . . . 0.508 HE22 ' C ' ' X' ' 25' ' ' LYS . 88.0 mt-30 -64.62 -43.65 93.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 1.0 109.48 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.454 HG12 ' OXT' ' X' ' 100' ' ' MET . 55.9 t -124.18 129.05 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.525 -0.735 . . . . 1.0 109.387 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 100' ' ' MET . . . . . 0.454 ' OXT' HG12 ' X' ' 99' ' ' VAL . 97.9 mtp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.972 -1.013 . . . . 1.0 109.389 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 41.4 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.53 21.97 54.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -128.52 158.31 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.658 -0.907 . . . . 1.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' X' ' 4' ' ' GLU . 56.7 mp0 -58.61 144.22 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.231 -0.918 . . . . 1.0 109.436 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 60.4 mt -97.32 101.92 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 82.4 p -80.02 170.97 15.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 1.0 109.497 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.09 -42.02 79.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 1.0 109.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.31 -45.33 80.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 1.0 109.554 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 96.7 mt-10 -62.82 -36.68 83.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 1.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.32 -40.39 97.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 1.0 109.636 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.11 -37.82 81.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 1.0 109.069 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.32 -44.74 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 1.0 109.043 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -56.09 -47.79 77.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0 109.314 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 1.0 109.002 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.283 -0.885 . . . . 1.0 109.181 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' X' ' 26' ' ' VAL . 86.0 tttt -60.35 -42.01 94.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 1.0 109.063 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -55.05 -44.69 74.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 1.0 109.111 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.08 86.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 1.0 109.168 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' X' ' 16' ' ' LYS . 95.9 mt -62.94 -39.26 94.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 1.0 109.086 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.82 -41.02 90.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.382 -0.824 . . . . 1.0 109.278 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 13.8 m -59.38 -39.06 82.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 1.0 109.225 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.81 -17.81 64.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 1.0 109.26 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.67 46.57 0.96 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.358 -1.497 . . . . 1.0 109.358 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.96 134.73 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.643 -0.916 . . . . 1.0 109.374 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 25' ' ' LYS . . . . . 0.405 ' O ' ' OE1' ' X' ' 98' ' ' GLN . 70.2 mmtt -124.46 106.75 10.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.637 -0.664 . . . . 1.0 109.231 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.503 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 53.7 t -135.9 159.14 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.657 -0.652 . . . . 1.0 109.531 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 27' ' ' LYS . . . . . 0.465 ' N ' HG12 ' X' ' 26' ' ' VAL . 99.7 mttt -81.27 143.64 32.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.381 -0.825 . . . . 1.0 109.717 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.5 ' CE2' HD11 ' X' ' 32' ' ' LEU . 88.3 t80 -59.59 -39.2 83.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 1.0 109.354 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.17 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 1.0 109.543 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -64.42 -38.57 91.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 1.0 109.167 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.79 -46.06 89.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 1.0 109.676 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' X' ' 28' ' ' TYR . 94.9 mt -63.4 -42.39 98.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 1.0 109.572 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 -36.02 82.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 1.0 109.357 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -60.48 -49.56 77.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 1.0 109.806 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.37 -44.61 90.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 1.0 109.787 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.92 -44.2 96.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 1.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.468 ' O ' ' OG1' ' X' ' 41' ' ' THR . 84.2 t80 -64.11 -45.46 88.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 1.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.36 -43.41 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.275 -0.891 . . . . 1.0 109.95 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.55 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -76.24 -29.19 57.41 Favored 'General case' 0 C--O 1.187 -2.19 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' X' ' 44' ' ' TRP . 79.1 m-20 -78.17 -21.79 49.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.052 0.929 . . . . 1.0 109.83 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 41' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 37' ' ' PHE . 11.3 m -62.72 -51.27 67.83 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.363 -1.461 . . . . 1.0 111.669 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -65.11 -64.28 2.79 Favored Pre-proline 0 C--N 1.296 -1.74 0 O-C-N 121.448 -0.782 . . . . 1.0 110.998 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.55 ' CG ' ' O ' ' X' ' 39' ' ' LYS . 27.7 Cg_endo -61.23 -54.19 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.723 2.282 . . . . 1.0 112.792 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.65 ' O ' ' CD2' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -173.67 139.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.092 -1.005 . . . . 1.0 109.287 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.539 ' N ' ' HD3' ' X' ' 46' ' ' PRO . 11.8 p90 -154.42 54.93 1.15 Allowed Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 120.671 -1.268 . . . . 1.0 110.002 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 38.9 Cg_endo -78.97 -23.0 8.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.673 2.248 . . . . 1.0 112.53 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -75.97 156.16 34.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.905 . . . . 1.0 109.629 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -132.39 151.83 51.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.573 -0.704 . . . . 1.0 109.49 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 49' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' X' ' 86' ' ' ILE . . . -150.74 -176.67 23.9 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.2 m -77.37 144.05 38.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -1.18 . . . . 1.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.669 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.29 134.45 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.494 -0.753 . . . . 1.0 109.227 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.669 ' N ' HD13 ' X' ' 51' ' ' ILE . 66.2 t0 -65.33 135.62 55.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.932 -1.105 . . . . 1.0 109.801 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 97.2 mt -69.54 -42.29 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.917 -1.115 . . . . 1.0 109.436 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.65 -39.84 77.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 1.0 109.171 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 55' ' ' PHE . . . . . 0.401 ' CE2' HG23 ' X' ' 59' ' ' VAL . 46.9 t80 -70.5 -36.63 73.91 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.298 -0.876 . . . . 1.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.645 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 17.3 t90 -52.78 -37.79 60.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.163 -0.961 . . . . 1.0 109.458 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -57.32 -44.8 84.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 1.0 109.234 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.446 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 80.1 mtp85 -67.96 -43.15 79.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 1.0 109.514 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.401 HG23 ' CE2' ' X' ' 55' ' ' PHE . 39.7 t -62.5 -43.73 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 1.0 109.467 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.32 -48.81 77.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.49 -38.12 86.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -1.18 . . . . 1.0 109.645 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.4 m -66.73 -48.7 68.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 1.0 109.693 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.437 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.6 m-85 -58.92 -46.19 88.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.333 -0.854 . . . . 1.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -57.13 -40.63 77.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 1.0 109.354 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -63.13 -45.97 89.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.0 109.353 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -64.84 -30.95 71.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 1.0 109.449 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.506 ' O ' ' N ' ' X' ' 71' ' ' GLY . 2.1 t80 -63.26 -54.78 31.92 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.357 -0.839 . . . . 1.0 109.847 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.418 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 76.4 m-20 -65.82 -38.97 90.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.876 -1.14 . . . . 1.0 109.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -62.5 -49.56 74.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.295 -0.878 . . . . 1.0 109.958 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.69 -51.76 2.85 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.996 -0.682 . . . . 1.0 109.97 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.41 -169.46 24.79 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.1 -20.06 50.57 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.985 2.456 . . . . 1.0 112.014 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -57.24 -51.91 67.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.97 . . . . 1.0 109.366 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.94 -46.21 82.52 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 1.0 110.004 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.767 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.8 m -146.01 86.84 6.94 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.537 -0.727 . . . . 1.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.42 -166.51 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.865 2.376 . . . . 1.0 112.41 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.71 -15.97 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.0 109.662 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 36.9 p -61.73 -34.14 75.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 1.0 109.277 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.55 -45.45 75.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.62 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -63.91 -46.15 86.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -61.53 -46.47 89.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 1.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.05 -42.13 98.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 1.0 109.538 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.645 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.8 t-105 -64.53 -36.73 85.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 1.0 109.163 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -55.85 -44.98 78.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 1.0 108.933 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.99 -42.94 99.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0 109.498 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' X' ' 49' ' ' GLY . 1.5 mm -61.46 -41.83 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 1.0 109.49 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.66 -36.87 67.54 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.372 -0.83 . . . . 1.0 109.181 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.86 -41.29 71.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 1.0 109.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.89 -46.98 87.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 1.0 110.403 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 6.4 pt -71.54 -41.91 72.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -0.821 . . . . 1.0 109.704 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.78 -46.71 89.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.888 . . . . 1.0 109.326 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -45.81 90.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 1.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.17 133.0 39.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 1.0 109.453 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.78 126.46 31.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 1.0 109.437 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.639 HG22 ' N ' ' X' ' 96' ' ' ASN . 9.3 p -133.43 168.76 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.521 -0.737 . . . . 1.0 109.329 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.639 ' N ' HG22 ' X' ' 95' ' ' VAL . 17.6 t-20 -125.11 81.61 62.86 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.708 -0.62 . . . . 1.0 109.471 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.537 ' HD3' HG13 ' X' ' 95' ' ' VAL . 58.7 Cg_endo -81.74 -168.67 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.965 2.444 . . . . 1.0 112.265 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 98' ' ' GLN . . . . . 0.405 ' OE1' ' O ' ' X' ' 25' ' ' LYS . 86.2 mt-30 -66.59 -43.52 84.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 1.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 53.8 t -125.0 133.57 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 1.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.065 -0.969 . . . . 1.0 109.479 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.03 4.63 86.76 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.532 -1.427 . . . . 1.0 109.532 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -129.24 159.87 34.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -1.136 . . . . 1.0 109.451 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.467 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.7 mt-10 -56.46 141.77 41.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 1.0 109.555 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' X' ' 5' ' ' LEU . 86.3 mt -96.89 105.37 17.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 1.0 109.506 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -83.44 172.46 12.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 1.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -56.56 -46.58 80.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 1.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -66.59 -44.01 83.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 1.0 109.564 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 81.5 mt-10 -60.17 -38.75 84.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 1.0 109.425 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -63.64 -38.48 91.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 1.0 109.555 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.14 -40.22 89.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 1.0 109.468 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.68 -44.37 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 1.0 109.307 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.15 -41.67 75.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 1.0 109.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -66.22 -36.27 82.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 1.0 108.896 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.47 -41.11 98.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.228 -0.92 . . . . 1.0 108.815 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -40.9 98.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.0 109.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.49 -45.27 85.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 1.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.77 85.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 1.0 109.377 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 19' ' ' LEU . 88.6 mt -63.77 -38.66 91.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 1.0 109.364 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.42 -35.54 76.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 1.0 109.316 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -66.16 -39.53 89.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 1.0 109.351 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -68.55 -19.12 64.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.845 . . . . 1.0 109.255 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.22 50.01 0.48 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.97 129.84 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -1.151 . . . . 1.0 109.436 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -126.74 101.73 6.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 1.0 109.145 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.78 162.46 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 1.0 109.36 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.34 145.07 39.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.886 . . . . 1.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -59.94 -39.28 85.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.237 -0.914 . . . . 1.0 109.34 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.55 68.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 1.0 109.414 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.0 -39.62 86.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 1.0 109.392 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.441 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -63.01 -43.76 97.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 1.0 109.393 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.47 -41.52 98.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 1.0 109.435 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.31 -38.53 91.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 1.0 109.42 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.409 ' O ' HG23 ' X' ' 38' ' ' VAL . 61.3 t80 -57.97 -49.06 78.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 1.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -64.01 -45.81 87.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.0 109.365 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -58.52 -43.06 89.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 1.0 109.317 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -66.4 -43.49 85.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 1.0 109.523 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.409 HG23 ' O ' ' X' ' 34' ' ' PHE . 54.7 t -60.42 -45.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 1.0 109.535 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.563 ' NZ ' ' CH2' ' X' ' 44' ' ' TRP . 44.5 tttm -66.62 -32.85 74.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.43 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.9 m-20 -68.85 -19.53 64.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 1.0 109.688 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 41' ' ' THR . . . . . 0.407 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 6.4 m -54.01 -61.37 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.0 109.418 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.689 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.71 -60.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 -177.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 71.4 Cg_exo -41.67 -51.81 4.16 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.891 2.394 . . . . 1.0 112.232 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' NZ ' ' X' ' 39' ' ' LYS . 6.5 m0 -132.95 -149.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 1.0 109.551 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.621 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.45 -44.91 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 1.0 109.877 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 36.1 Cg_exo -56.47 -31.74 86.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.725 2.283 . . . . 1.0 112.367 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.512 ' NE2' ' CE3' ' X' ' 44' ' ' TRP . 32.7 mt-30 -66.09 125.01 24.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 1.0 109.65 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -132.18 159.51 38.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.43 156.42 27.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -64.09 142.8 58.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.178 . . . . 1.0 109.382 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.68 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.73 133.28 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 1.0 109.548 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.68 ' N ' HD13 ' X' ' 51' ' ' ILE . 83.8 m-20 -72.12 135.61 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 1.0 109.756 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 1.0 109.423 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.28 -41.15 97.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 1.0 109.373 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -81.51 -17.48 48.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.0 109.299 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.544 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -58.44 -37.45 75.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.997 . . . . 1.0 109.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.16 -43.47 92.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 1.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -67.09 -37.03 83.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 1.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.65 -43.22 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 1.0 109.33 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.56 -47.46 90.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.504 -1.439 . . . . 1.0 109.504 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.01 -40.34 82.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 1.0 109.44 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.0 m -65.78 -50.28 65.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 1.0 109.439 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.79 -43.2 94.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 1.0 109.519 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -61.99 -33.41 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.0 109.517 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -65.12 -43.01 93.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 1.0 109.335 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.87 -34.96 74.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 1.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' X' ' 71' ' ' GLY . 19.9 t80 -60.26 -54.85 40.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.61 -36.53 82.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.0 109.351 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -64.59 -47.14 79.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 1.0 109.313 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.68 -52.68 2.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 1.0 109.264 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.81 -164.53 26.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -73.45 -14.27 25.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.928 2.418 . . . . 1.0 111.983 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -61.49 -49.76 75.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.0 109.284 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.55 -46.3 73.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 1.0 109.324 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.703 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.5 m -147.24 89.28 5.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 1.0 109.484 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.23 -170.23 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.83 2.353 . . . . 1.0 112.186 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.82 -18.23 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 1.0 109.406 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.6 p -58.55 -30.86 67.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.413 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 1.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.85 -39.66 93.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 1.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 64.7 m -61.79 -46.02 91.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 1.0 109.403 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' CZ ' ' X' ' 45' ' ' PHE . 36.7 m-85 -66.64 -42.38 86.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.877 . . . . 1.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.544 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t-105 -63.86 -34.63 78.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.0 109.289 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.3 -41.05 83.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 1.0 109.202 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.61 -42.44 98.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 1.0 109.577 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.3 -41.38 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 1.0 109.394 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.492 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 47.5 mttt -53.62 -41.36 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 1.0 109.424 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.56 -37.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 1.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.72 -48.69 76.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 1.0 109.378 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -73.31 -41.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 1.0 109.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.09 -42.29 98.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 1.0 109.454 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -64.76 -42.5 95.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 1.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.18 130.28 35.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 1.0 109.459 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.71 114.88 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 1.0 109.524 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p -141.33 151.08 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 1.0 109.62 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -125.13 83.85 60.09 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 1.0 109.506 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.42 -40.36 85.98 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.878 2.385 . . . . 1.0 112.303 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -151.87 -81.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 1.0 109.439 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.86 101.69 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.548 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.003 -0.998 . . . . 1.0 109.515 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.9 ttp . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.31 8.51 81.18 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -91.15 158.26 16.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 1.0 109.487 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.73 132.34 36.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.97 102.78 15.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.87 . . . . 1.0 109.506 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -82.95 175.66 9.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.0 109.616 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -54.11 -45.55 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 1.0 109.483 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.98 -43.59 87.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.565 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -60.07 -39.46 86.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 1.0 109.387 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.8 -38.18 89.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 1.0 109.606 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -61.79 -35.85 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.911 . . . . 1.0 109.437 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.01 -43.71 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 1.0 109.318 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.55 -44.69 93.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 1.0 109.312 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.6 -37.95 83.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.179 -0.95 . . . . 1.0 108.91 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.74 -40.3 94.6 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.279 -0.888 . . . . 1.0 108.747 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.638 ' HZ2' ' CA ' ' X' ' 28' ' ' TYR . 88.6 tttt -62.58 -41.1 98.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 1.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.62 -44.65 85.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.922 . . . . 1.0 109.139 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.06 98.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.445 -0.785 . . . . 1.0 109.412 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' X' ' 58' ' ' ARG . 95.7 mt -63.81 -38.03 89.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 1.0 109.251 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -58.62 -43.08 89.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.0 109.228 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 67.4 p -63.16 -31.26 72.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 1.0 109.384 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.83 -15.79 61.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 1.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.31 47.16 0.82 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.3 134.28 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -1.123 . . . . 1.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.7 92.98 3.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.937 . . . . 1.0 109.209 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.84 160.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 1.0 109.298 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.0 143.43 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 1.0 109.486 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.638 ' CA ' ' HZ2' ' X' ' 16' ' ' LYS . 89.6 t80 -61.68 -38.48 87.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 1.0 109.296 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.81 65.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 1.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.0 m-20 -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 1.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.462 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -61.62 -44.58 96.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 1.0 109.391 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.37 -43.74 96.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 1.0 109.329 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.07 -37.45 85.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 1.0 109.378 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.66 -48.13 75.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 1.0 109.376 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -60.95 -41.59 96.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 1.0 109.391 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -65.14 -40.34 94.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 1.0 109.214 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.83 -42.71 99.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 1.0 109.51 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.37 -46.13 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 1.0 109.575 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 1.0 109.404 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' X' ' 44' ' ' TRP . 85.5 m-20 -70.64 -19.3 62.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 1.0 109.694 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 41' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 22.2 m -54.9 -52.92 61.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.0 109.445 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.672 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -112.89 -63.65 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 1.0 109.466 -177.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.09 -40.61 4.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.904 2.403 . . . . 1.0 112.15 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.4 m-90 -146.08 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 1.0 109.537 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 172.29 -45.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 1.0 109.889 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.5 Cg_exo -56.1 -35.37 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.693 2.262 . . . . 1.0 112.368 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -64.4 127.98 33.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 1.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -142.15 168.85 18.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 109.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.88 165.63 37.69 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 15.6 m -64.31 141.3 58.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -1.217 . . . . 1.0 109.371 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.652 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -130.0 135.12 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.652 ' N ' HD13 ' X' ' 51' ' ' ILE . 38.8 m-20 -68.85 138.25 54.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 1.0 109.779 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.91 -25.02 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 1.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.97 -40.49 95.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 1.0 109.358 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -76.21 -18.74 58.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 1.0 109.258 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.3 t90 -54.64 -39.09 67.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -62.66 -41.31 99.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.0 109.496 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.454 ' NH2' HD13 ' X' ' 19' ' ' LEU . 79.0 mtp85 -66.61 -38.46 87.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 1.0 109.477 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.525 HG21 ' CH2' ' X' ' 83' ' ' TRP . 51.1 t -63.31 -43.98 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 1.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.7 84.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 1.0 109.511 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -66.18 -37.27 85.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -1.197 . . . . 1.0 109.512 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 82.5 m -69.95 -50.43 42.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 1.0 109.522 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.471 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.5 m-85 -61.11 -43.09 99.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 1.0 109.492 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.6 -40.14 86.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 1.0 109.439 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.68 -45.91 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 1.0 109.373 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -64.53 -35.06 79.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.485 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' X' ' 71' ' ' GLY . 1.9 t80 -59.29 -54.71 43.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 1.0 109.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.442 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 38.7 t30 -64.41 -36.71 85.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 1.0 109.281 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -67.72 -45.19 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 1.0 109.277 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.27 -52.23 2.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 1.0 109.312 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.74 -168.32 24.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.439 -1.464 . . . . 1.0 109.439 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -65.71 -20.07 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.914 2.409 . . . . 1.0 111.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.66 -54.84 39.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 1.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -64.21 -42.98 96.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 1.0 109.352 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.73 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.8 m -150.44 91.38 4.15 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 1.0 109.432 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -82.83 179.97 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.862 2.375 . . . . 1.0 112.213 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.62 -23.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 1.0 109.486 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.464 ' H ' HG23 ' X' ' 78' ' ' THR . 6.5 p -60.85 -34.95 75.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 1.0 109.423 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.38 72.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -69.86 -37.78 76.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -59.88 -46.98 87.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 1.0 109.403 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -61.9 -40.14 94.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.513 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.668 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.6 t-105 -66.0 -36.18 82.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -58.05 -41.67 83.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 1.0 109.255 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.49 -38.26 90.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.41 -0.806 . . . . 1.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.57 -42.7 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 1.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -57.71 -43.35 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0 109.395 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.25 -36.65 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 1.0 109.383 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.8 -51.95 59.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 1.0 109.352 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 pt -71.41 -41.09 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.0 109.411 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.33 -51.65 67.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.501 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.78 -40.68 92.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 1.0 109.541 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.16 138.77 39.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 1.0 109.533 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.69 93.85 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 1.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 1.078 HG22 ' H ' ' X' ' 96' ' ' ASN . 9.9 p -124.64 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 1.078 ' H ' HG22 ' X' ' 95' ' ' VAL . 20.8 t-20 -124.96 81.77 62.03 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 1.0 109.605 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -83.93 -40.87 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.821 2.347 . . . . 1.0 112.333 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.15 172.87 6.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 1.0 109.437 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 86.4 t -78.41 78.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 1.0 109.539 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.964 -1.017 . . . . 1.0 109.419 179.738 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.17 63.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -129.46 162.07 28.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -1.171 . . . . 1.0 109.543 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.26 131.28 41.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 1.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -96.91 104.54 16.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 1.0 109.486 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -77.64 170.19 17.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.868 . . . . 1.0 109.575 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -50.79 -43.17 58.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 1.0 109.379 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -68.14 -49.0 63.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 1.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.89 -35.87 77.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 1.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -60.86 -41.28 95.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 1.0 109.562 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.7 -36.04 79.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 1.0 109.464 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.41 -45.31 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 1.0 109.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.74 -45.97 81.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 1.0 109.398 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.95 -38.92 90.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 1.0 108.911 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.77 -43.14 99.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 1.0 108.765 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.542 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.26 -38.6 87.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 1.0 109.486 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.46 -46.95 87.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 1.0 109.145 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.15 93.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.313 -0.867 . . . . 1.0 109.44 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' X' ' 19' ' ' LEU . 97.1 mt -67.08 -40.69 87.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 1.0 109.23 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.19 -42.07 80.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.903 . . . . 1.0 109.242 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 70.3 p -64.96 -33.93 77.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.845 . . . . 1.0 109.299 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.95 -17.64 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 1.0 109.169 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.17 48.24 0.53 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.28 -1.528 . . . . 1.0 109.28 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.92 133.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 1.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -132.0 99.0 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 1.0 109.224 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.23 163.22 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 1.0 109.357 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.92 148.81 32.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 1.0 109.499 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.542 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 59.0 m-85 -63.75 -42.93 97.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.224 -0.923 . . . . 1.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.95 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 1.0 109.455 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.25 -40.34 93.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 1.0 109.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.454 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.1 -45.93 91.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 1.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.13 -41.68 99.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 1.0 109.394 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.509 ' HZ3' ' H ' ' X' ' 50' ' ' THR . 98.4 mttt -67.24 -35.83 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.34 -50.26 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 1.0 109.493 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -61.03 -41.49 96.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.0 109.417 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.56 -39.74 95.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 1.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.37 -45.58 91.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -0.802 . . . . 1.0 109.508 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 76.7 t -58.27 -49.21 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 1.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.5 mttt -64.0 -31.5 72.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.8 m-20 -67.67 -19.14 65.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.85 . . . . 1.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 9.8 m -53.78 -48.43 69.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 1.0 109.403 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.821 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -122.73 -59.6 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.821 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.5 Cg_exo -41.47 -45.69 6.03 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.88 2.386 . . . . 1.0 112.219 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.7 m-90 -139.02 113.67 9.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.152 -0.967 . . . . 1.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -64.91 -43.72 69.4 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 1.0 109.875 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -55.93 130.77 42.13 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.79 2.327 . . . . 1.0 112.373 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -119.05 133.45 55.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 1.0 109.707 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -142.51 127.72 18.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.887 . . . . 1.0 109.789 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.74 147.73 5.38 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.509 ' H ' ' HZ3' ' X' ' 33' ' ' LYS . 31.4 m -88.68 143.26 27.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.099 -1.236 . . . . 1.0 109.414 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.679 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -117.14 130.27 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 1.0 109.538 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.679 ' N ' HD13 ' X' ' 51' ' ' ILE . 45.1 t0 -71.88 136.79 47.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 1.0 109.784 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.74 -25.4 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 1.0 109.464 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.96 -38.66 91.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 1.0 109.396 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -82.74 -18.88 39.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 1.0 109.296 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 11.9 t90 -60.13 -38.38 82.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.0 109.64 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.563 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 31.8 mmt180 -56.88 -43.64 81.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 109.478 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.476 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.8 mtp180 -68.75 -39.4 80.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 1.0 109.479 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -61.62 -46.55 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 1.0 109.372 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.49 -48.66 68.92 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.14 -33.99 77.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 1.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.5 m -69.23 -54.04 16.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 1.0 109.454 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -64.14 -43.37 95.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 1.0 109.482 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.4 -32.2 72.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 1.0 109.467 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.43 -45.87 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 1.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -72.67 -28.86 62.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 1.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' X' ' 71' ' ' GLY . 45.1 t80 -60.03 -53.4 58.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 1.0 109.402 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -69.48 -35.67 75.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 1.0 109.336 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.1 m -62.08 -45.86 91.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 1.0 109.258 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.19 -51.25 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 1.0 109.2 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.85 -158.5 24.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.8 -13.89 17.59 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.89 2.393 . . . . 1.0 111.953 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.93 -51.6 66.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 1.0 109.213 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -64.36 -40.82 96.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 1.0 109.309 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.78 83.92 9.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 1.0 109.418 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' X' ' 78' ' ' THR . 43.5 Cg_exo -55.46 154.41 24.63 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.827 2.352 . . . . 1.0 112.265 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.493 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.9 p -53.39 -6.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 1.0 109.438 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.518 ' H ' ' C ' ' X' ' 76' ' ' PRO . 63.1 p -61.19 -41.21 96.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.87 . . . . 1.0 109.391 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.62 75.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 1.0 109.385 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -61.13 -42.8 99.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 1.0 109.425 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -63.22 -46.63 86.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -63.19 -41.74 99.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.576 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.599 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.6 t-105 -61.42 -37.53 83.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 1.0 109.367 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.95 -44.14 78.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 1.0 109.191 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.578 ' O ' HD13 ' X' ' 89' ' ' LEU . 98.8 mt -65.66 -40.09 92.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 1.0 109.552 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -61.6 -41.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.243 -0.91 . . . . 1.0 109.395 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.93 -39.95 79.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 1.0 109.481 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -71.09 -36.73 72.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.389 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.578 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -65.72 -43.27 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 1.0 109.386 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.437 HG22 HG23 ' X' ' 50' ' ' THR . 7.5 pt -78.92 -20.74 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 1.0 109.335 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.34 -50.07 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.485 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -41.23 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 1.0 109.54 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.54 139.54 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 1.0 109.573 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -75.86 92.27 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.0 109.538 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.604 HG22 ' N ' ' X' ' 96' ' ' ASN . 11.2 p -111.14 167.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 1.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.604 ' N ' HG22 ' X' ' 95' ' ' VAL . 6.1 t-20 -58.61 108.46 1.33 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 1.0 109.612 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' X' ' 95' ' ' VAL . 29.1 Cg_exo -62.3 -164.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.793 2.328 . . . . 1.0 112.336 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -63.93 -40.82 97.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 1.0 109.481 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.42 132.6 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 109.437 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.992 -1.004 . . . . 1.0 109.4 179.558 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.54 80.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -130.0 157.29 42.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 1.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.46 145.04 47.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 1.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.89 94.79 10.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 1.0 109.511 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -78.41 176.22 9.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.593 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -54.28 -45.84 72.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 1.0 109.436 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.35 -42.49 92.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.46 -39.69 88.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 1.0 109.469 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.61 -42.23 92.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 1.0 109.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -59.33 -35.37 73.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 1.0 109.415 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.4 -44.72 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.0 109.305 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' X' ' 28' ' ' TYR . 46.1 tp10 -55.92 -47.7 77.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 1.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -66.53 -37.13 84.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 1.0 108.868 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.24 -42.65 98.98 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 1.0 108.803 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.553 ' HZ2' ' N ' ' X' ' 28' ' ' TYR . 88.5 tttt -61.85 -42.06 98.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 1.0 109.555 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -52.52 -49.91 63.87 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.177 -0.952 . . . . 1.0 109.158 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.57 80.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.0 109.422 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.434 HD23 HG11 ' X' ' 24' ' ' VAL . 9.8 tp -61.19 -40.38 93.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 1.0 109.251 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.68 -40.71 80.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.303 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -58.61 -33.88 70.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.449 -0.782 . . . . 1.0 109.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.87 -9.97 56.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 1.0 109.19 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.31 44.33 2.2 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.434 HG11 HD23 ' X' ' 19' ' ' LEU . 25.1 t -122.32 135.24 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 1.0 109.387 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -131.36 94.81 3.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.0 109.22 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.471 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 35.3 m -132.8 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 1.0 109.366 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 27' ' ' LYS . . . . . 0.547 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 68.2 mttm -73.33 147.89 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 109.47 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.562 ' CE2' HD11 ' X' ' 32' ' ' LEU . 51.8 t80 -59.07 -39.28 81.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.203 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.55 59.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 1.0 109.493 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.516 ' CG ' ' CG ' ' X' ' 55' ' ' PHE . 30.2 t0 -61.15 -43.56 98.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 1.0 109.404 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.0 mm? -61.62 -45.35 94.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 1.0 109.409 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' X' ' 28' ' ' TYR . 97.2 mt -63.7 -42.11 98.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 1.0 109.351 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -36.0 82.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 1.0 109.415 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.779 ' O ' HG23 ' X' ' 38' ' ' VAL . 56.2 t80 -57.53 -46.65 83.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 1.0 109.413 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.1 -41.77 90.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 1.0 109.308 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -63.34 -44.07 95.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 109.266 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 38.8 t80 -61.34 -43.59 98.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.779 HG23 ' O ' ' X' ' 34' ' ' PHE . 50.5 t -59.46 -47.46 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.0 109.535 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.82 -36.76 80.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 1.0 109.425 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.553 ' OD1' ' NE2' ' X' ' 47' ' ' GLN . 84.6 m-20 -69.11 -19.65 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 1.0 109.639 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 96.4 m -54.44 -47.78 72.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 1.0 109.41 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.712 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -119.16 -64.34 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 1.0 109.461 -178.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.0 Cg_exo -40.69 -33.82 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.89 2.393 . . . . 1.0 112.174 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 6.2 m-90 -155.94 100.95 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 1.0 109.468 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.684 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -71.22 -39.92 8.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 1.0 109.901 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 26.0 Cg_exo -60.87 -34.32 91.39 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.703 2.269 . . . . 1.0 112.369 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.553 ' NE2' ' OD1' ' X' ' 40' ' ' ASP . 24.1 mt-30 -65.65 124.77 23.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 1.0 109.656 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -144.4 175.16 10.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 1.0 109.847 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.82 165.58 34.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.1 m -69.92 137.52 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -1.187 . . . . 1.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.58 139.68 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 1.0 109.504 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -94.26 133.84 37.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 1.0 109.751 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mm -48.71 -23.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 1.0 109.481 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.825 ' HZ1' ' H ' ' X' ' 99' ' ' VAL . 98.7 mttt -65.47 -43.25 90.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 109.353 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 55' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' X' ' 55' ' ' PHE . 1.0 OUTLIER -79.79 -16.35 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 1.0 109.296 -178.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 18.1 t90 -59.32 -43.05 92.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 1.0 109.646 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.599 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 32.9 mmt180 -59.72 -42.08 92.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 1.0 109.493 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 63.4 mtp85 -71.55 -46.34 59.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 1.0 109.437 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.586 HG11 ' CH2' ' X' ' 83' ' ' TRP . 81.2 t -64.29 -47.92 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 1.0 109.282 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.15 -47.02 84.1 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -66.15 -37.71 86.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.172 . . . . 1.0 109.462 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 98.7 m -64.11 -56.24 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 1.0 109.48 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.6 m-85 -61.15 -44.77 96.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 1.0 109.459 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.71 -36.94 84.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 1.0 109.49 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.73 -47.15 86.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.0 109.344 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.22 -29.54 68.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.458 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' X' ' 71' ' ' GLY . 39.9 t80 -62.42 -55.05 31.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 1.0 109.429 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -67.52 -34.91 78.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 1.0 109.33 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -66.34 -51.38 57.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 1.0 109.331 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -108.93 -52.44 2.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.85 -162.17 26.29 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' ' N ' ' X' ' 76' ' ' PRO . 18.9 Cg_endo -74.77 -17.88 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.946 2.431 . . . . 1.0 111.956 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.89 -52.12 66.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 1.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -64.78 -39.32 93.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 1.0 109.371 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.91 79.69 13.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 1.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' X' ' 78' ' ' THR . 45.8 Cg_exo -55.33 155.0 21.55 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.772 2.315 . . . . 1.0 112.222 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.79 -5.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.519 ' H ' ' C ' ' X' ' 76' ' ' PRO . 62.2 p -61.11 -33.88 74.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 1.0 109.44 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.3 -36.87 79.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 1.0 109.372 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.89 . . . . 1.0 109.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -61.85 -49.12 77.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 1.0 109.4 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.85 -41.97 95.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 1.0 109.524 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.586 ' CH2' HG11 ' X' ' 59' ' ' VAL . 9.4 t-105 -67.07 -34.66 78.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.89 -43.28 85.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.0 109.243 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' X' ' 85' ' ' LEU . 98.5 mt -67.47 -38.14 83.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.592 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.24 -44.07 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 1.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.41 -43.78 84.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 1.0 109.441 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.89 -36.54 72.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 1.0 109.355 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.56 -50.69 66.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 1.0 109.35 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.42 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.1 pt -70.45 -42.29 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.42 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 86.2 m-20 -61.53 -47.45 85.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.0 109.475 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.03 -38.85 92.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 1.0 109.614 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.93 135.65 49.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.0 109.508 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -88.74 113.21 24.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 1.0 109.638 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.444 HG13 ' HD3' ' X' ' 97' ' ' PRO . 9.8 p -134.76 154.7 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.0 109.626 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -126.28 85.64 59.57 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 109.564 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.444 ' HD3' HG13 ' X' ' 95' ' ' VAL . 28.1 Cg_exo -62.57 -152.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.881 2.387 . . . . 1.0 112.296 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -62.87 -40.12 96.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.0 109.43 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.825 ' H ' ' HZ1' ' X' ' 54' ' ' LYS . 41.6 t -126.31 131.17 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.518 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.99 -1.005 . . . . 1.0 109.473 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 16.56 80.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -130.16 161.12 31.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 1.0 109.497 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 80.1 mm-40 -59.87 134.41 57.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 1.0 109.545 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.87 99.76 12.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 1.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -79.61 171.68 14.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 1.0 109.563 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -55.59 -42.96 75.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 1.0 109.436 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -66.36 -44.41 83.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 1.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 90.7 mt-10 -63.3 -33.34 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 1.0 109.427 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -70.52 -39.41 74.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 1.0 109.607 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.95 -49.12 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 1.0 109.364 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' X' ' 35' ' ' PHE . 27.6 m -69.16 -34.18 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 1.0 109.324 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.2 -43.1 92.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.261 -0.9 . . . . 1.0 109.289 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.67 -34.2 77.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 1.0 108.916 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.8 -41.12 99.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.356 -0.84 . . . . 1.0 108.847 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.475 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 87.6 tttt -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.756 . . . . 1.0 109.566 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.44 -45.19 84.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 1.0 109.195 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.69 -39.75 91.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 1.0 109.403 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.77 -38.88 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 1.0 109.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 1.0 109.238 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 45.8 p -62.92 -31.37 72.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.09 -17.57 61.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 1.0 109.145 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.29 47.18 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -119.06 130.46 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.429 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.19 98.43 4.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.94 . . . . 1.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.96 160.12 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 109.288 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -74.4 143.99 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 1.0 109.489 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.475 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 63.9 m-85 -61.74 -41.42 97.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.204 -0.935 . . . . 1.0 109.26 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.77 53.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 1.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' CG ' ' X' ' 55' ' ' PHE . 15.4 t70 -63.18 -39.5 94.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 1.0 109.448 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' X' ' 31' ' ' LEU . 4.4 mm? -62.39 -45.56 92.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 1.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.03 -42.95 99.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 1.0 109.364 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.6 mttt -65.02 -38.86 92.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 1.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -58.31 -49.62 76.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 1.0 109.391 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG11 ' X' ' 12' ' ' VAL . 58.3 m-85 -63.08 -44.14 96.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 1.0 109.404 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.23 -37.54 80.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 1.0 109.265 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.76 -46.78 88.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.918 . . . . 1.0 109.533 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.44 -44.34 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 1.0 109.548 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.29 -25.58 64.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.5 m-20 -73.56 -19.58 60.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.867 . . . . 1.0 109.658 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -54.11 -41.29 68.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 1.0 109.418 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.699 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -128.06 -64.4 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.473 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.699 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 53.9 Cg_exo -40.84 -40.1 3.45 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.879 2.386 . . . . 1.0 112.183 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.517 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -142.66 116.34 9.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 1.0 109.527 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.656 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -66.5 -41.72 42.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 1.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 27.1 Cg_exo -60.82 137.72 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.768 2.312 . . . . 1.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.92 147.74 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 1.0 109.654 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -141.33 157.19 45.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 1.0 109.807 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 164.3 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.626 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 41.6 m -114.5 129.82 56.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 1.0 109.311 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.0 136.08 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 1.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.67 137.54 36.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 1.0 109.757 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.13 -23.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 1.0 109.437 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -64.68 -39.29 93.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 1.0 109.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 55' ' ' PHE . . . . . 0.544 ' CG ' ' OD1' ' X' ' 30' ' ' ASP . 3.1 t80 -85.2 -9.98 57.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.955 . . . . 1.0 109.283 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t90 -57.64 -38.24 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 1.0 109.646 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' X' ' 57' ' ' ARG . 14.3 mmm180 -61.41 -38.95 88.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 1.0 109.539 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 76.9 mtp180 -70.19 -36.88 74.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 1.0 109.418 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.535 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 79.4 t -65.32 -42.16 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 1.0 109.315 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.53 -48.77 84.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -66.08 -40.14 90.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -1.141 . . . . 1.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 89.3 m -64.56 -54.28 34.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 1.0 109.509 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.96 -44.46 94.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 1.0 109.446 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -60.1 -37.87 81.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 1.0 109.478 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.38 -41.44 98.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 1.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -66.24 -38.6 88.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.3 -52.45 65.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 1.0 109.402 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.61 -30.14 69.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 1.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.1 m -61.65 -48.14 82.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 1.0 109.257 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 -52.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 1.0 109.269 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.68 29.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' X' ' 76' ' ' PRO . 23.2 Cg_exo -60.17 -23.71 74.64 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.969 2.446 . . . . 1.0 111.899 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -52.44 -51.95 56.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.164 -0.96 . . . . 1.0 109.231 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.0 -42.43 99.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.354 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.4 81.09 14.1 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 1.0 109.485 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.7 Cg_exo -59.62 161.75 17.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.818 2.345 . . . . 1.0 112.277 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.491 ' O ' HG12 ' X' ' 77' ' ' VAL . 76.8 t -50.19 -9.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 1.0 109.444 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.513 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.1 p -60.21 -35.85 76.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 1.0 109.413 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.94 94.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 1.0 109.414 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.22 -42.8 93.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 1.0 109.411 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -62.77 -45.91 90.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.426 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.513 ' OH ' ' CD2' ' X' ' 45' ' ' PHE . 18.7 m-85 -63.72 -43.25 97.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 1.0 109.475 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.535 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 7.2 t-105 -63.45 -36.87 85.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 1.0 109.389 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -56.78 -43.54 80.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.4 -0.813 . . . . 1.0 109.223 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.27 -40.59 86.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 1.0 109.613 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -61.5 -42.48 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 1.0 109.241 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -43.2 88.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 1.0 109.508 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 88' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 97.0 mt-10 -70.91 -24.61 62.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 1.0 109.347 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.13 -49.3 12.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 6.5 pt -70.47 -42.4 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 1.0 109.426 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 16.6 p-10 -67.69 -9.51 44.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 1.0 109.491 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.428 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 88.5 tttt -62.48 -48.1 81.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 1.0 109.556 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -115.23 125.46 53.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 1.0 109.452 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -71.03 125.69 27.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 1.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.414 HG22 ' N ' ' X' ' 96' ' ' ASN . 7.6 p -137.77 155.29 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 109.566 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.414 ' N ' HG22 ' X' ' 95' ' ' VAL . 5.9 t30 -121.69 84.76 43.51 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 1.0 109.55 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.47 -42.2 62.83 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.86 2.373 . . . . 1.0 112.295 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -144.48 -92.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 1.0 109.433 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.86 95.13 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 1.0 109.507 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 31.0 ttm . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.998 -1.001 . . . . 1.0 109.484 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.9 79.96 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.661 -1.376 . . . . 1.0 109.661 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -130.1 161.97 29.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.97 . . . . 1.0 109.468 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 131.24 49.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 1.0 109.551 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.97 89.61 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 1.0 109.626 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.1 p -82.88 174.99 10.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 1.0 109.554 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -53.14 -41.02 64.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.237 -0.914 . . . . 1.0 109.282 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -69.25 -43.69 73.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 1.0 109.415 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.96 -39.25 93.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 1.0 109.602 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.93 -36.83 84.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 109.567 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -61.06 -49.73 76.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 1.0 109.925 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.24 -34.25 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 1.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.57 -35.43 80.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.459 -0.776 . . . . 1.0 109.226 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -68.24 -39.16 82.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 1.0 108.959 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -61.43 -41.24 96.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 1.0 108.961 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.28 -40.5 94.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 1.0 109.395 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -56.2 -44.74 79.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 1.0 109.067 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -36.73 82.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 1.0 109.227 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' X' ' 19' ' ' LEU . 93.8 mt -63.27 -38.74 92.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 1.0 109.068 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.53 -41.38 85.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 1.0 109.092 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -60.14 -39.14 85.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 1.0 109.103 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.41 -16.92 63.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 1.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.58 53.15 0.73 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.549 ' CG2' HH21 ' X' ' 58' ' ' ARG . 38.2 t -122.06 133.4 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.583 -0.951 . . . . 1.0 109.325 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.18 96.52 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' X' ' 54' ' ' LYS . 27.6 m -133.31 163.99 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 1.0 109.503 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.45 147.78 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.9 -39.95 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 1.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.26 -31.69 63.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.0 109.358 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -59.96 -42.2 93.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 1.0 109.227 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.427 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 1.0 109.359 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.26 -41.27 97.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.797 . . . . 1.0 109.28 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.27 -34.74 79.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 1.0 109.394 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.97 -48.86 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 1.0 109.693 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.18 -45.33 93.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.249 -0.907 . . . . 1.0 109.621 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -64.13 -37.85 88.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.0 109.13 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.14 -45.67 92.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 1.0 109.428 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.03 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 1.0 109.595 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.46 -32.69 74.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.011 0.91 . . . . 1.0 109.629 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.4 m-20 -68.26 -20.38 64.79 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.766 -1.209 . . . . 1.0 109.757 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 m -55.15 -57.46 11.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.878 -1.138 . . . . 1.0 110.708 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.636 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.1 OUTLIER -109.85 -59.6 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.042 0 O-C-N 121.514 -0.741 . . . . 1.0 110.634 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.636 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.1 Cg_exo -42.2 -42.25 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.494 2.129 . . . . 1.0 112.701 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.8 m-90 -142.62 -158.91 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 1.0 109.361 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.535 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 2.2 t80 -171.84 49.37 0.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 1.0 109.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 29.3 Cg_endo -67.32 -166.42 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.709 2.273 . . . . 1.0 112.132 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.08 140.6 35.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 1.0 109.581 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.4 134.99 42.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 1.0 109.758 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.03 -178.43 43.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.791 -1.324 . . . . 1.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 14.4 m -71.2 141.7 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -1.193 . . . . 1.0 109.275 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.685 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.77 133.58 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.761 0.791 . . . . 1.0 109.212 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.685 ' N ' HD13 ' X' ' 51' ' ' ILE . 56.5 t0 -71.82 136.97 47.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.64 -1.287 . . . . 1.0 110.012 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 63.7 mt -66.56 -21.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.79 -1.194 . . . . 1.0 109.259 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.572 ' HB2' HG12 ' X' ' 26' ' ' VAL . 65.4 mmtt -64.95 -40.05 94.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 1.0 109.595 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -84.39 -9.64 58.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 1.0 109.616 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.505 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 11.0 t90 -53.67 -39.88 65.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 1.0 109.795 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' X' ' 57' ' ' ARG . 24.5 mmm-85 -62.24 -37.23 84.62 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.172 -0.955 . . . . 1.0 109.486 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.549 HH21 ' CG2' ' X' ' 24' ' ' VAL . 85.6 mmt-85 -68.31 -42.89 78.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.351 -0.843 . . . . 1.0 109.781 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.62 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 93.3 t -61.38 -45.13 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.29 -0.882 . . . . 1.0 109.26 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.55 97.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.68 -42.2 91.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.255 -1.144 . . . . 1.0 109.671 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.92 -50.67 61.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 1.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.48 -44.75 96.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.0 109.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.96 -35.58 75.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.181 -0.949 . . . . 1.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -64.7 -46.16 83.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 1.0 109.412 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 1.0 109.428 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' X' ' 71' ' ' GLY . 9.1 t80 -59.37 -53.29 59.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 1.0 109.716 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.448 ' O ' ' OD1' ' X' ' 68' ' ' ASN . 51.6 t-20 -64.5 -35.92 82.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.856 -1.153 . . . . 1.0 109.473 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -65.02 -45.35 85.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.213 -0.929 . . . . 1.0 109.99 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.34 -51.87 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.141 -0.623 . . . . 1.0 109.893 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 138.74 -164.05 25.78 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 1.0 109.388 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' X' ' 76' ' ' PRO . 8.6 Cg_exo -66.41 -20.65 54.53 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.97 2.446 . . . . 1.0 111.948 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.37 -53.81 52.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 1.0 109.474 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.44 -37.27 86.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.361 -0.837 . . . . 1.0 109.667 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.706 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.5 m -143.59 81.21 12.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.566 -0.709 . . . . 1.0 109.198 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.502 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.0 Cg_exo -59.03 155.11 40.83 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 123.057 2.504 . . . . 1.0 112.287 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.473 ' O ' HG12 ' X' ' 77' ' ' VAL . 72.3 t -51.91 -10.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 1.0 109.303 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.453 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.4 t -62.28 -33.44 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.94 -45.08 91.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.324 -0.86 . . . . 1.0 109.129 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.33 -43.43 97.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 1.0 109.479 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -61.94 -45.69 92.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 1.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -64.41 -37.22 86.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 1.0 109.433 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.62 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 9.1 t-105 -64.59 -35.54 81.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.87 . . . . 1.0 109.092 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.14 -43.52 95.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 1.0 109.092 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.07 -39.1 93.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.422 -0.799 . . . . 1.0 109.133 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.24 -42.47 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.0 109.552 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.505 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 63.4 mttt -55.96 -43.26 77.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.71 -35.65 79.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.923 -1.11 . . . . 1.0 109.485 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.72 -49.18 71.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.935 . . . . 1.0 109.835 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.8 pt -71.96 -40.95 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 1.0 109.308 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.32 -44.61 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.406 -0.809 . . . . 1.0 109.481 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.51 -43.19 94.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 1.0 109.401 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.0 126.17 30.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.139 -0.976 . . . . 1.0 109.498 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.81 127.91 34.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 1.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.631 HG22 ' N ' ' X' ' 96' ' ' ASN . 13.8 p -132.0 170.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 1.0 109.465 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.631 ' N ' HG22 ' X' ' 95' ' ' VAL . 8.3 t-20 -124.01 84.64 54.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.605 -0.684 . . . . 1.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.416 ' HD3' HG13 ' X' ' 95' ' ' VAL . 31.9 Cg_exo -58.43 148.38 80.65 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 123.091 2.528 . . . . 1.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.02 -41.27 62.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -0.929 . . . . 1.0 109.203 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.692 ' O ' HG13 ' X' ' 99' ' ' VAL . 9.1 p -126.47 106.03 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.513 -0.742 . . . . 1.0 109.619 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.986 -1.007 . . . . 1.0 109.572 179.642 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.79 17.38 77.4 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -128.88 160.51 32.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -1.182 . . . . 1.0 109.503 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -58.42 138.3 56.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 1.0 109.584 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' X' ' 5' ' ' LEU . 74.6 mt -98.82 103.57 15.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 1.0 109.495 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.2 p -79.29 171.3 15.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 1.0 109.571 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.5 -40.9 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 1.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.64 -46.2 76.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 1.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -62.51 -38.35 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 1.0 109.405 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -61.49 -40.91 96.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 1.0 109.551 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.95 -36.45 77.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.195 -0.941 . . . . 1.0 109.475 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.03 -44.15 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 1.0 109.34 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.95 -48.06 73.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.286 -0.884 . . . . 1.0 109.317 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -65.62 -36.31 83.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 1.0 108.805 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' X' ' 15' ' ' LEU . 60.3 tp -63.05 -41.76 99.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.291 -0.881 . . . . 1.0 108.834 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 1.0 109.499 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -55.99 -46.88 78.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.19 -0.944 . . . . 1.0 109.122 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.38 -41.01 96.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.378 -0.827 . . . . 1.0 109.343 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' X' ' 19' ' ' LEU . 90.7 mt -64.87 -36.44 84.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 1.0 109.287 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.89 -38.27 87.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 1.0 109.229 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 76.0 p -65.79 -33.47 75.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 1.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -70.78 -19.36 62.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 1.0 109.243 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.29 47.14 0.39 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.325 -1.51 . . . . 1.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -121.55 133.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -1.105 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.99 91.38 2.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.268 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.73 162.15 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 1.0 109.311 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.12 147.05 32.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 1.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -62.68 -34.5 77.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 1.0 109.225 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.35 69.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 1.0 109.403 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 1.0 109.386 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.519 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -60.35 -44.39 95.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 1.0 109.361 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -42.14 99.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.409 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.03 -33.57 76.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.359 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.482 ' O ' HG23 ' X' ' 38' ' ' VAL . 51.2 t80 -59.39 -46.01 89.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 1.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.26 -44.51 96.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 1.0 109.402 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.63 -44.32 94.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 1.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -63.17 -46.19 88.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 1.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.482 HG23 ' O ' ' X' ' 34' ' ' PHE . 69.7 t -60.39 -44.58 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 1.0 109.569 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 1.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 7.1 m-20 -68.32 -19.84 64.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 1.0 109.667 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 41' ' ' THR . . . . . 0.409 HG21 ' O ' ' X' ' 74' ' ' LYS . 99.6 m -54.48 -51.48 64.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 1.0 109.393 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.753 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -118.82 -63.16 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 1.0 109.508 -177.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.753 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.3 Cg_exo -40.79 -54.22 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.897 2.398 . . . . 1.0 112.168 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -118.36 -128.25 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 1.0 109.503 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.754 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.8 OUTLIER -175.28 -41.62 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 1.0 109.908 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.754 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 34.5 Cg_exo -58.17 132.72 50.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 1.0 112.307 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -119.01 159.27 24.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 109.71 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -74.16 158.59 33.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 1.0 109.758 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.74 -4.18 63.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.855 -1.298 . . . . 1.0 109.855 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -119.7 118.28 30.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 1.0 109.308 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.711 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -136.31 135.1 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 109.497 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.711 ' N ' HD13 ' X' ' 51' ' ' ILE . 67.4 t0 -67.27 130.68 43.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.14 -38.61 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 1.0 109.417 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -61.57 -37.72 84.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 1.0 109.4 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -76.36 -24.21 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 1.0 109.305 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.659 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -57.48 -36.46 71.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.612 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.424 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 14.0 mmm180 -60.69 -41.45 95.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 1.0 109.501 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.63 -37.47 79.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 1.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.15 -44.37 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 1.0 109.306 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.35 -48.57 84.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -65.35 -41.12 94.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.163 . . . . 1.0 109.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.24 -42.87 92.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 1.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.44 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.2 m-85 -65.76 -40.02 91.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 1.0 109.483 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.21 -37.95 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 1.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -63.25 -43.93 96.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 1.0 109.307 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.96 -31.73 71.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.477 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' X' ' 71' ' ' GLY . 17.4 t80 -59.65 -55.02 39.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 1.0 109.357 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -68.38 -34.94 76.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 1.0 109.303 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -65.01 -48.03 75.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 1.0 109.283 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -111.75 -52.37 2.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 1.0 109.329 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.97 -165.68 26.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.58 -14.46 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.911 2.407 . . . . 1.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.1 -49.79 74.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.274 -0.891 . . . . 1.0 109.302 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.409 ' O ' HG21 ' X' ' 41' ' ' THR . 59.7 mmtt -66.91 -43.98 81.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 1.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.717 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.3 m -148.46 88.69 5.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 1.0 109.455 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -81.02 -176.0 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.832 2.354 . . . . 1.0 112.267 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -19.67 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 1.0 109.397 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.4 ' H ' HG23 ' X' ' 78' ' ' THR . 19.1 p -59.67 -33.73 71.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 1.0 109.42 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.39 73.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 1.0 109.463 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -61.63 -41.09 96.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.0 t -59.23 -46.01 89.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 1.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.28 -43.88 93.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.659 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.5 t-105 -64.32 -36.16 83.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -55.38 -43.08 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.0 109.207 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 85' ' ' LEU . 96.5 mt -65.52 -40.83 93.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 1.0 109.565 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.27 -42.28 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 1.0 109.346 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.76 -41.3 70.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 1.0 109.41 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.73 -38.75 73.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.948 . . . . 1.0 109.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.31 -49.59 73.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 1.0 109.372 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.409 HD13 HG21 ' X' ' 90' ' ' ILE . 7.2 pt -70.29 -41.18 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 1.0 109.436 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 69.5 m-20 -59.84 -47.08 87.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.95 . . . . 1.0 109.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.83 -41.82 97.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.61 137.48 38.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.918 . . . . 1.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 1.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.52 HG13 ' HD3' ' X' ' 97' ' ' PRO . 9.8 p -131.55 160.29 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.496 ' N ' HG22 ' X' ' 95' ' ' VAL . 0.7 OUTLIER -119.82 81.66 26.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 1.0 109.597 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' X' ' 99' ' ' VAL . 59.5 Cg_endo -81.97 65.88 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.879 2.386 . . . . 1.0 112.264 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 54.3 -80.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.164 -0.96 . . . . 1.0 109.419 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' X' ' 97' ' ' PRO . 58.0 t -94.18 129.85 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 1.0 109.577 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.052 -0.975 . . . . 1.0 109.493 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.23 3.16 90.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -129.08 160.99 31.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -1.16 . . . . 1.0 109.582 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mt-10 -62.41 146.51 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.517 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.12 101.84 14.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 109.484 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.3 p -83.48 170.28 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 1.0 109.431 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -54.09 -43.19 70.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 1.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -64.65 -43.49 93.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.878 . . . . 1.0 109.543 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 99.2 mt-10 -67.78 -34.91 77.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 1.0 109.371 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.3 -38.28 84.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.882 . . . . 1.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.08 -51.16 69.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.41 -33.29 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 1.0 109.261 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.21 -42.3 85.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.893 . . . . 1.0 109.177 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -63.75 -39.74 95.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.94 . . . . 1.0 108.766 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.45 -40.25 86.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.39 -43.7 98.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 1.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.424 ' O ' HG23 ' X' ' 21' ' ' THR . 99.4 mm-40 -55.91 -44.11 77.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 1.0 109.024 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.8 96.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 1.0 109.276 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' X' ' 19' ' ' LEU . 95.6 mt -65.11 -38.04 89.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -0.899 . . . . 1.0 109.22 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -60.11 -41.39 92.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 1.0 109.297 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.424 HG23 ' O ' ' X' ' 17' ' ' GLN . 69.5 p -63.06 -31.95 73.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.865 . . . . 1.0 109.233 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.29 -17.96 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.0 109.19 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.65 46.61 0.52 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.584 HG22 HH21 ' X' ' 58' ' ' ARG . 55.4 t -121.22 133.33 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.353 -1.086 . . . . 1.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.92 93.57 2.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 1.0 109.215 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.12 161.21 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 1.0 109.342 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -70.36 146.97 50.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.917 . . . . 1.0 109.491 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.67 -35.46 80.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 1.0 109.235 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.9 -34.48 69.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 1.0 109.409 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.16 -44.19 92.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 1.0 109.341 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.496 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.04 -45.96 91.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 1.0 109.436 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.49 -42.65 98.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 1.0 109.395 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.75 -34.36 75.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 1.0 109.384 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.438 ' O ' HG23 ' X' ' 38' ' ' VAL . 41.1 t80 -58.76 -48.46 81.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 1.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -62.03 -43.72 98.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.99 -42.14 99.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 1.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.4 -43.66 96.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' X' ' 34' ' ' PHE . 84.3 t -56.43 -44.5 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -36.34 83.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 1.0 109.351 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.5 m-20 -68.3 -20.56 64.76 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.089 -1.007 . . . . 1.0 109.588 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -54.44 -52.83 60.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.19 -0.944 . . . . 1.0 109.763 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -112.35 -62.76 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.283 -0.886 . . . . 1.0 109.914 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 77.1 Cg_exo -42.33 -39.05 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.57 2.18 . . . . 1.0 112.062 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 -145.61 -146.16 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 1.0 109.435 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.603 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 174.74 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 1.0 109.902 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -54.9 -34.81 87.35 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.793 2.329 . . . . 1.0 112.396 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.89 124.07 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 1.0 109.675 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.66 158.78 43.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 1.0 109.736 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.76 163.59 31.81 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.328 . . . . 1.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.6 m -63.3 140.05 58.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.0 109.345 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.706 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -129.98 134.79 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 1.0 109.334 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.706 ' N ' HD13 ' X' ' 51' ' ' ILE . 55.9 t0 -72.79 134.36 44.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 1.0 109.811 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.932 HG22 HH12 ' X' ' 57' ' ' ARG . 80.2 mt -64.13 -28.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 1.0 109.55 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.3 -40.05 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 1.0 109.503 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.18 -22.69 52.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.8 t90 -55.96 -37.61 69.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.142 -0.974 . . . . 1.0 109.728 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.932 HH12 HG22 ' X' ' 53' ' ' ILE . 28.6 mmt-85 -58.05 -38.86 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 1.0 109.46 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.584 HH21 HG22 ' X' ' 24' ' ' VAL . 81.4 mmt-85 -68.79 -39.62 80.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.61 -44.34 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 1.0 109.469 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.92 -48.15 74.82 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.93 -37.07 83.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 1.0 109.434 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.8 m -67.71 -51.16 52.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 1.0 109.675 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.07 -41.19 99.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 1.0 109.421 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.11 -38.72 83.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 1.0 109.445 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.91 -44.44 97.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 1.0 109.36 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -64.74 -37.85 89.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 1.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' X' ' 71' ' ' GLY . 6.5 t80 -60.13 -53.81 53.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 1.0 109.535 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.4 -33.81 76.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 1.0 109.286 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -68.37 -44.23 75.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 1.0 109.565 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -122.36 -51.76 1.96 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 1.0 109.673 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.74 -164.29 25.2 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.8 Cg_exo -65.35 -21.51 61.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.941 2.428 . . . . 1.0 112.182 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.44 -53.03 61.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.216 -0.928 . . . . 1.0 109.314 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -66.2 -38.52 88.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 1.0 109.401 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.602 HG23 ' O ' ' X' ' 75' ' ' VAL . 30.5 m -143.4 78.63 14.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.0 109.433 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' X' ' 78' ' ' THR . 35.9 Cg_exo -56.41 156.12 22.83 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.855 2.37 . . . . 1.0 112.362 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.8 p -49.03 -11.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 1.0 109.397 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.507 ' N ' ' O ' ' X' ' 76' ' ' PRO . 68.0 p -59.9 -38.1 81.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.0 109.44 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.61 76.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 1.0 109.397 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -63.67 -44.14 94.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 1.0 109.564 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 50.7 m -61.63 -51.68 67.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 1.0 109.553 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -60.56 -41.84 95.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 1.0 109.484 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.676 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 14.2 t-105 -63.13 -40.36 97.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 1.0 109.289 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -56.27 -38.86 71.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 1.0 108.843 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.14 -42.69 99.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.532 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -61.46 -42.33 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 1.0 109.499 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.753 ' HZ2' HG23 ' X' ' 53' ' ' ILE . 60.8 mmtt -55.69 -40.08 71.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 1.0 109.538 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.2 -37.96 84.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.893 . . . . 1.0 109.544 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.89 -41.91 95.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.217 -0.927 . . . . 1.0 109.843 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.89 -43.14 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.0 109.658 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.91 -48.28 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.0 109.537 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.9 -43.96 94.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 1.0 109.646 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.75 130.53 35.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 1.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.97 130.04 40.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.875 . . . . 1.0 109.55 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.495 HG22 ' N ' ' X' ' 96' ' ' ASN . 9.8 p -129.78 160.6 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 1.0 109.604 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.495 ' N ' HG22 ' X' ' 95' ' ' VAL . 15.4 t-20 -121.36 83.96 40.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.612 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.412 ' HD3' HG13 ' X' ' 95' ' ' VAL . 50.1 Cg_endo -82.08 -162.39 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.924 2.416 . . . . 1.0 112.293 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.02 -43.39 98.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 1.0 109.471 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.33 133.67 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 1.0 109.546 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.944 -1.027 . . . . 1.0 109.415 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mtp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.289 0.566 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.2 89.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -127.64 151.02 49.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -1.18 . . . . 1.0 109.418 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' X' ' 6' ' ' SER . 95.4 mt-10 -53.03 121.69 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 1.0 109.5 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 92.7 mt -55.37 85.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 1.0 109.484 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 6' ' ' SER . . . . . 0.531 ' N ' ' O ' ' X' ' 4' ' ' GLU . 10.0 p -81.76 171.68 14.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 1.0 109.599 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 7' ' ' GLN . . . . . 0.457 ' CG ' HH21 ' X' ' 10' ' ' ARG . 96.4 mt-30 -54.86 -45.86 74.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 1.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -66.55 -41.8 88.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 1.0 109.485 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -37.42 84.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 1.0 109.408 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.457 HH21 ' CG ' ' X' ' 7' ' ' GLN . 86.6 mtm180 -70.54 -38.05 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 1.0 109.62 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.58 -49.72 76.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 1.0 109.441 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.94 -27.63 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.0 109.366 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.1 -40.7 90.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 1.0 109.395 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.41 -39.18 88.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.993 . . . . 1.0 108.92 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.52 -40.56 97.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.275 -0.891 . . . . 1.0 108.855 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.508 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.8 tttt -61.48 -38.66 88.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 1.0 109.498 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -57.87 -46.61 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 1.0 109.144 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.819 . . . . 1.0 109.43 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' X' ' 16' ' ' LYS . 92.1 mt -63.35 -38.99 93.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 1.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.19 -44.7 92.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 1.0 109.246 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -56.27 -39.81 73.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 1.0 109.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -68.77 -17.14 63.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 1.0 109.222 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.06 0.66 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 50.1 t -122.72 136.78 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -1.109 . . . . 1.0 109.381 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.71 88.5 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 1.0 109.205 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.7 165.0 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 1.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -77.01 153.74 34.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 1.0 109.45 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.508 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 99.5 m-85 -61.44 -35.22 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 1.0 109.261 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.812 . . . . 1.0 109.432 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 56.5 t0 -58.52 -45.24 89.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 1.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.505 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.2 mm? -63.11 -45.26 92.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 1.0 109.4 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.39 -43.73 93.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.338 -0.851 . . . . 1.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.3 -33.41 73.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.39 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.501 ' O ' HG23 ' X' ' 38' ' ' VAL . 39.0 t80 -58.89 -48.75 80.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 1.0 109.448 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -64.85 -42.22 95.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.2 -43.2 98.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.283 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.04 -45.11 94.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.366 -0.834 . . . . 1.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 34' ' ' PHE . 96.9 t -59.2 -47.49 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 1.0 109.518 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -66.64 -35.71 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 109.395 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' X' ' 44' ' ' TRP . 91.6 m-20 -65.05 -19.38 65.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.673 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -54.29 -61.68 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.972 . . . . 1.0 109.362 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.681 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.77 -60.2 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 1.0 109.509 -178.195 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.6 Cg_exo -41.36 -44.57 5.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.883 2.389 . . . . 1.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.4 m-90 -143.17 -144.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 1.0 109.504 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.588 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.39 -46.04 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.95 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 31.3 Cg_exo -54.94 -33.77 83.77 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.713 2.276 . . . . 1.0 112.411 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.21 129.08 38.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 1.0 109.672 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.55 163.36 34.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 1.0 109.87 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.87 166.89 31.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.79 -1.324 . . . . 1.0 109.79 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 28.4 m -64.16 129.78 41.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 1.0 109.3 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.45 131.64 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 1.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' X' ' 54' ' ' LYS . 20.3 t0 -94.23 126.09 39.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.885 . . . . 1.0 109.697 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -44.83 -16.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -0.986 . . . . 1.0 109.482 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' X' ' 52' ' ' ASP . 98.9 mttt -67.31 -35.77 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.398 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 55' ' ' PHE . . . . . 0.569 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 2.3 m-85 -84.33 -10.99 57.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 1.0 109.285 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 56' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -58.24 -46.0 86.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 1.0 109.646 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 1.0 109.544 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 34.0 mmt180 -63.2 -47.9 80.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 1.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.706 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 77.7 t -65.06 -44.4 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 1.0 109.367 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.38 -48.65 82.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -66.16 -40.4 90.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -1.125 . . . . 1.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 90.0 m -62.6 -49.42 75.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.915 . . . . 1.0 109.461 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.17 -42.0 99.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 1.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -58.68 -36.46 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 1.0 109.536 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 65' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' X' ' 69' ' ' THR . 89.2 m-20 -62.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 1.0 109.326 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -67.98 -34.23 76.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.31 -0.869 . . . . 1.0 109.483 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' X' ' 71' ' ' GLY . 10.0 t80 -61.55 -54.81 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.355 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -63.34 -34.11 77.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 1.0 109.342 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 69' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.1 m -68.59 -48.26 64.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.0 109.285 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.23 -52.57 2.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 1.0 109.301 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.52 -163.65 25.18 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.5 Cg_exo -66.06 -23.38 53.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.86 2.373 . . . . 1.0 111.967 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.07 -54.76 34.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 1.0 109.24 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -65.45 -36.0 82.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.403 -0.811 . . . . 1.0 109.331 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.447 HG23 ' O ' ' X' ' 75' ' ' VAL . 11.6 m -145.26 81.4 10.42 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.521 ' N ' ' O ' ' X' ' 72' ' ' PRO . 38.2 Cg_exo -60.27 154.36 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.868 2.379 . . . . 1.0 112.228 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.478 ' O ' HG12 ' X' ' 77' ' ' VAL . 52.0 t -49.93 -11.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 1.0 109.446 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.49 ' N ' ' O ' ' X' ' 76' ' ' PRO . 1.3 t -63.94 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 1.0 109.356 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.03 96.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 1.0 109.418 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -64.92 -44.37 89.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 1.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.9 t -59.09 -45.47 90.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 1.0 109.408 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -65.27 -38.07 89.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 1.0 109.535 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.706 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 8.6 t-105 -66.25 -37.9 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 1.0 109.411 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -55.99 -43.97 78.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 1.0 109.212 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.75 -40.39 96.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.535 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.35 -42.85 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 1.0 109.397 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -59.02 -41.32 87.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 1.0 109.492 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.92 -36.92 72.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 1.0 109.338 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.41 -45.15 88.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 1.0 109.33 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.01 -38.27 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.0 109.448 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.58 -45.14 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 1.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.95 -42.72 99.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.549 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -72.4 146.77 46.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.88 . . . . 1.0 109.498 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -101.9 93.62 5.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 1.0 109.535 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.615 HG22 ' N ' ' X' ' 96' ' ' ASN . 7.5 p -95.91 167.53 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 1.0 109.557 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.615 ' N ' HG22 ' X' ' 95' ' ' VAL . 47.9 t30 -126.19 81.1 67.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 1.0 109.603 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.507 ' HD3' HG13 ' X' ' 95' ' ' VAL . 56.0 Cg_endo -82.16 -159.82 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.818 2.345 . . . . 1.0 112.258 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.53 -43.14 94.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 1.0 109.426 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.25 130.95 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 46.9 ttp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.965 -1.017 . . . . 1.0 109.508 179.831 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' X' X ' 1' ' ' MET . . . . . 0.454 ' HG2' ' H ' ' X' ' 3' ' ' GLN . 56.9 ttp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.89 82.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 3' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' X' ' 1' ' ' MET . 99.2 mm-40 -128.38 155.93 43.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 1.0 109.521 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.1 mt-10 -60.72 136.7 58.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 1.0 109.58 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.47 100.88 13.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 109.477 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.2 p -77.56 169.63 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.0 109.565 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -52.49 -43.78 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.63 -47.89 71.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 1.0 109.527 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 94.5 mt-10 -60.27 -36.68 78.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 1.0 109.461 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -61.1 -42.62 98.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 1.0 109.63 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -59.7 -35.54 74.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 1.0 109.442 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.54 -44.51 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 109.316 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.38 -48.61 78.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.311 -0.868 . . . . 1.0 109.401 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -62.25 -38.3 88.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.23 -0.919 . . . . 1.0 108.92 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' X' ' 15' ' ' LEU . 62.2 tp -61.28 -43.34 99.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 1.0 108.762 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.85 -37.38 81.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.498 -0.751 . . . . 1.0 109.523 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.654 ' O ' HG23 ' X' ' 21' ' ' THR . 86.8 mt-30 -57.87 -48.49 79.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 1.0 109.121 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.41 79.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 1.0 109.412 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.35 -40.28 95.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -0.843 . . . . 1.0 109.299 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.59 -38.16 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 1.0 109.217 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.654 HG23 ' O ' ' X' ' 17' ' ' GLN . 68.4 p -64.13 -13.66 49.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 1.0 109.279 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.12 7.06 42.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 1.0 109.227 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 38.17 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.0 133.19 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.04 96.84 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 1.0 109.166 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.74 161.71 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 1.0 109.41 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.08 144.99 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 1.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.439 ' HE2' HD11 ' X' ' 32' ' ' LEU . 90.0 t80 -61.98 -37.49 85.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 1.0 109.296 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -33.78 64.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.0 109.492 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.07 -38.43 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.427 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.484 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -61.09 -43.89 98.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 1.0 109.456 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.439 HD11 ' HE2' ' X' ' 28' ' ' TYR . 97.1 mt -64.17 -42.11 96.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 1.0 109.39 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 99.2 mttt -62.63 -38.27 89.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 1.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.56 -50.06 75.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0 109.477 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.65 -42.17 99.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 1.0 109.382 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' X' ' 40' ' ' ASP . 66.2 t0 -63.44 -39.61 94.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 1.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.43 -45.31 88.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 1.0 109.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.43 -47.58 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.96 -33.47 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 1.0 109.367 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.7 m-20 -69.78 -19.95 63.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 1.0 109.7 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 7.5 m -54.96 -61.05 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.0 109.481 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.63 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -103.04 -62.86 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.56 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.5 Cg_exo -41.32 -50.09 4.62 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.867 2.378 . . . . 1.0 112.175 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.497 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.6 m-90 -135.06 -147.19 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 1.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.14 -44.52 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 1.0 109.851 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.0 Cg_exo -58.1 -32.7 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.711 2.274 . . . . 1.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.01 124.14 18.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 1.0 109.735 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 48' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' X' ' 82' ' ' TYR . 97.0 mt-10 -141.28 161.64 37.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 1.0 109.789 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.04 169.15 41.23 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.475 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 34.7 m -64.17 138.51 58.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.116 -1.226 . . . . 1.0 109.334 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.69 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.22 135.84 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 1.0 109.479 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.69 ' N ' HD13 ' X' ' 51' ' ' ILE . 85.4 m-20 -71.83 136.29 46.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.854 . . . . 1.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -24.41 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 1.0 109.468 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -65.28 -38.96 91.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.0 109.361 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -80.57 -17.79 50.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 1.0 109.25 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.611 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.6 t90 -54.06 -37.42 64.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 1.0 109.665 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -61.53 -39.85 92.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 1.0 109.479 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -66.39 -40.36 89.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 1.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' X' ' 83' ' ' TRP . 71.4 t -61.36 -45.91 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 1.0 109.35 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -44.11 98.46 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -65.75 -40.13 91.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -1.162 . . . . 1.0 109.462 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.26 -53.66 23.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 109.534 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -61.41 -42.61 99.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 1.0 109.485 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -59.46 -36.92 76.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -62.96 -45.2 93.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 1.0 109.28 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -65.48 -38.06 88.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 1.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' X' ' 71' ' ' GLY . 8.9 t80 -60.14 -53.47 57.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 1.0 109.364 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.28 -38.86 92.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 1.0 109.282 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.8 m -64.13 -49.82 70.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.0 109.281 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.64 -52.24 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 1.0 109.329 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.09 -165.13 24.97 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' X' ' 76' ' ' PRO . 12.6 Cg_exo -65.36 -19.89 61.63 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.911 2.408 . . . . 1.0 111.968 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.86 -54.71 41.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.239 -0.913 . . . . 1.0 109.204 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.86 -37.24 85.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.88 80.15 15.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 1.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.1 Cg_exo -58.01 157.68 24.04 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.895 2.397 . . . . 1.0 112.214 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -51.66 -6.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 1.0 109.462 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.549 ' H ' ' C ' ' X' ' 76' ' ' PRO . 77.0 p -61.78 -32.97 73.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 1.0 109.371 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.07 -49.96 73.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 1.0 109.405 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 67.6 m -59.87 -43.77 94.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 1.0 109.442 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' X' ' 48' ' ' GLU . 1.2 t80 -61.43 -43.25 99.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0 109.491 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.611 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.0 t-105 -65.9 -36.0 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 1.0 109.373 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -56.78 -42.59 79.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 1.0 109.272 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.452 ' O ' HD13 ' X' ' 89' ' ' LEU . 93.0 mt -63.92 -42.6 97.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 1.0 109.587 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.12 -41.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 1.0 109.403 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.33 -39.21 72.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -71.08 -37.42 72.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 1.0 109.394 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.452 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.5 mp -64.73 -46.12 83.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.895 . . . . 1.0 109.412 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -74.65 -39.55 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -61.16 -48.99 79.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 1.0 109.512 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.88 -45.0 79.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 1.0 109.596 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.52 127.11 32.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 1.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.42 132.19 51.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.589 HG22 ' N ' ' X' ' 96' ' ' ASN . 14.2 p -133.56 167.02 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 1.0 109.602 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.589 ' N ' HG22 ' X' ' 95' ' ' VAL . 20.2 t-20 -126.81 83.38 65.58 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 1.0 109.6 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.466 ' HD3' HG13 ' X' ' 95' ' ' VAL . 31.4 Cg_exo -58.84 -153.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.881 2.387 . . . . 1.0 112.261 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.38 -40.49 93.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 1.0 109.476 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.09 131.62 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 1.0 109.525 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.964 -1.017 . . . . 1.0 109.477 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.35 0.595 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.78 -8.09 80.35 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.691 -1.364 . . . . 1.0 109.691 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -90.37 161.71 15.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -1.105 . . . . 1.0 109.47 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.45 138.83 12.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 1.0 109.44 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.08 102.46 15.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.739 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.9 p -83.98 168.85 15.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 1.0 109.528 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -52.07 -40.94 61.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 1.0 109.325 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.0 -44.94 83.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 1.0 109.396 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.36 -34.26 76.93 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 1.0 109.427 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.078 -1.014 . . . . 1.0 109.49 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -60.87 -50.26 74.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.97 . . . . 1.0 109.779 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' X' ' 35' ' ' PHE . 17.1 m -64.01 -32.81 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 1.0 109.244 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.05 -44.49 87.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 1.0 109.191 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 14' ' ' GLN . . . . . 0.472 ' NE2' ' OE1' ' X' ' 17' ' ' GLN . 72.6 tp60 -63.25 -37.46 87.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.918 . . . . 1.0 108.807 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.07 -39.46 89.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -0.904 . . . . 1.0 108.751 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.59 -43.12 97.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 1.0 109.095 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.537 ' O ' HG23 ' X' ' 21' ' ' THR . 87.0 mt-30 -54.97 -42.26 72.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 1.0 108.77 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.26 -44.26 92.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 1.0 109.192 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.547 ' CD2' HH21 ' X' ' 22' ' ' ARG . 8.8 mt -63.15 -41.37 99.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.083 -1.01 . . . . 1.0 109.366 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.32 -38.94 91.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.278 -0.889 . . . . 1.0 109.507 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.537 HG23 ' O ' ' X' ' 17' ' ' GLN . 52.4 p -64.46 -29.83 70.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.433 -0.792 . . . . 1.0 109.345 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.547 HH21 ' CD2' ' X' ' 19' ' ' LEU . 77.7 mtm180 -78.48 -13.46 59.82 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 1.0 109.554 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.03 48.21 0.73 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.52 135.58 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.715 -0.874 . . . . 1.0 109.041 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -130.09 97.3 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.406 -0.808 . . . . 1.0 109.252 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.651 HG11 HH11 ' X' ' 58' ' ' ARG . 27.7 m -134.41 160.36 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.596 -0.69 . . . . 1.0 109.559 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.17 152.32 32.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 1.0 109.675 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -63.99 -34.66 78.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 1.0 108.939 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -29.28 70.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 1.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.555 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 41.9 t0 -59.37 -48.48 81.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.0 109.179 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.562 ' CD2' HH22 ' X' ' 58' ' ' ARG . 10.6 mt -62.36 -42.96 99.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.937 . . . . 1.0 108.912 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.76 -42.66 99.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.265 -0.897 . . . . 1.0 108.972 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.719 ' HZ1' ' H ' ' X' ' 50' ' ' THR . 98.0 mttt -67.55 -35.04 78.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 1.0 109.178 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.593 ' O ' HG23 ' X' ' 38' ' ' VAL . 30.1 t80 -59.05 -48.92 79.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 1.0 109.879 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' X' ' 12' ' ' VAL . 46.0 m-85 -63.51 -43.47 97.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 1.0 109.647 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -63.38 -40.79 98.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 1.0 109.274 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.632 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 53.5 t80 -61.6 -46.22 90.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.665 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.593 HG23 ' O ' ' X' ' 34' ' ' PHE . 58.6 t -57.64 -39.36 69.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.048 -1.032 . . . . 1.0 109.039 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.21 -20.01 45.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 1.0 109.543 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' NE2' ' X' ' 47' ' ' GLN . 95.9 m-20 -68.13 -19.95 64.86 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.959 -1.088 . . . . 1.0 109.409 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 18.9 m -55.31 -43.51 74.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 1.0 110.332 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.649 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.7 OUTLIER -126.04 -63.12 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.538 -0.726 . . . . 1.0 109.929 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 50.3 Cg_exo -42.02 -44.07 7.22 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.662 2.242 . . . . 1.0 112.394 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.9 m0 -139.72 -146.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 109.216 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -174.42 -45.24 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 1.0 109.769 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 39.2 Cg_exo -58.66 140.27 94.21 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.612 2.208 . . . . 1.0 112.252 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.459 ' NE2' ' OD2' ' X' ' 40' ' ' ASP . 88.7 mm-40 -105.7 158.0 17.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.592 -0.693 . . . . 1.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.69 146.04 47.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 1.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.55 -155.92 29.9 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.331 -1.507 . . . . 1.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.719 ' H ' ' HZ1' ' X' ' 33' ' ' LYS . 91.4 m -128.42 131.81 48.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.565 -0.962 . . . . 1.0 109.567 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.98 131.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.944 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' X' ' 54' ' ' LYS . 24.7 t0 -93.97 127.36 39.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 1.0 109.141 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -46.87 -16.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 1.0 109.495 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' X' ' 52' ' ' ASP . 65.1 mmtt -66.19 -35.51 80.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 1.0 109.635 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 55' ' ' PHE . . . . . 0.555 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 1.0 OUTLIER -83.25 -11.6 57.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 1.0 109.636 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.441 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.7 t90 -59.42 -42.94 93.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.88 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -63.85 -40.97 97.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 1.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.651 HH11 HG11 ' X' ' 26' ' ' VAL . 82.3 mtp180 -69.67 -47.19 64.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.0 109.568 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.731 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 85.9 t -64.62 -46.25 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 1.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.03 -45.31 96.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -67.12 -36.66 82.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -1.175 . . . . 1.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 91.7 m -67.37 -47.01 71.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.659 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.632 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.0 m-85 -64.35 -40.07 95.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 1.0 109.535 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -60.23 -37.68 81.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.311 -0.868 . . . . 1.0 109.331 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.09 -48.21 77.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 1.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -62.07 -36.42 81.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.84 . . . . 1.0 109.435 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' X' ' 71' ' ' GLY . 3.0 t80 -61.86 -55.31 31.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.226 -0.921 . . . . 1.0 109.886 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.61 -36.21 83.52 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.973 -1.079 . . . . 1.0 109.711 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -64.44 -45.72 86.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 110.195 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.35 -51.96 2.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.685 -0.635 . . . . 1.0 109.967 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 141.59 -169.7 25.06 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.3 Cg_exo -65.36 -22.31 60.07 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.894 2.396 . . . . 1.0 112.102 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.13 -54.63 42.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 1.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -61.58 -39.21 90.37 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.261 -0.899 . . . . 1.0 109.614 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.29 82.01 8.48 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.449 -0.782 . . . . 1.0 109.346 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.2 Cg_exo -57.55 151.7 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.851 2.367 . . . . 1.0 112.333 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 m -49.53 -11.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.388 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.496 ' N ' ' O ' ' X' ' 76' ' ' PRO . 2.0 t -62.64 -33.12 74.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 1.0 109.371 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.28 -41.84 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.9 . . . . 1.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 1.0 109.404 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -61.43 -44.16 97.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -0.855 . . . . 1.0 109.263 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.95 -42.47 94.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.997 . . . . 1.0 109.681 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.731 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 10.2 t-105 -62.76 -36.19 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 1.0 109.315 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -58.5 -43.25 89.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 1.0 108.861 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.415 ' O ' HD13 ' X' ' 89' ' ' LEU . 89.7 mt -63.54 -40.53 97.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 1.0 109.271 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.0 109.619 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.48 -37.61 70.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.365 -0.835 . . . . 1.0 109.509 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -70.99 -39.79 72.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 1.0 109.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.415 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -63.49 -48.41 77.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 1.0 110.458 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.5 pt -72.43 -42.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.565 -0.709 . . . . 1.0 109.619 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 62.9 t0 -62.56 -37.17 85.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 1.0 109.312 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 1.0 109.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -82.2 135.15 35.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 1.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.99 123.08 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 1.0 109.426 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.541 HG22 ' N ' ' X' ' 96' ' ' ASN . 14.9 p -133.53 164.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.705 . . . . 1.0 109.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.541 ' N ' HG22 ' X' ' 95' ' ' VAL . 0.2 OUTLIER -128.63 81.56 70.45 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.647 -0.658 . . . . 1.0 109.555 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.484 ' HD3' HG13 ' X' ' 95' ' ' VAL . 30.8 Cg_exo -61.05 -150.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.97 2.447 . . . . 1.0 112.075 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -66.47 -42.37 87.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 1.0 109.504 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.7 128.47 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.649 -0.657 . . . . 1.0 109.323 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.4 mtm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.062 -0.97 . . . . 1.0 109.31 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.46 -0.02 89.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 1.0 109.598 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -130.12 161.67 30.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 1.0 109.531 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.71 136.33 57.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 1.0 109.578 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.94 99.49 12.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 1.0 109.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.4 p -79.54 167.31 20.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -51.06 -42.34 60.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 1.0 109.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.6 -48.7 71.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 1.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.96 -38.92 87.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 1.0 109.4 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.49 -36.68 84.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.532 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -59.94 -42.04 93.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 1.0 109.417 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.97 -43.33 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.95 . . . . 1.0 109.304 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.36 -43.23 78.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 1.0 109.35 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.31 -35.18 80.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 1.0 108.867 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.82 -42.16 99.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0 108.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.86 -42.43 99.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 1.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.54 ' O ' HG23 ' X' ' 21' ' ' THR . 89.0 mt-30 -56.07 -46.49 78.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 1.0 109.144 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.0 97.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 1.0 109.407 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' X' ' 19' ' ' LEU . 82.5 mt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 1.0 109.319 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.04 -39.36 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 1.0 109.243 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.54 HG23 ' O ' ' X' ' 17' ' ' GLN . 46.8 p -65.65 -29.92 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.0 109.29 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.92 -18.44 59.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 1.0 109.142 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.58 48.52 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.08 135.29 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -1.138 . . . . 1.0 109.397 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.65 101.41 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 1.0 109.125 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 161.5 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.835 . . . . 1.0 109.352 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.89 145.83 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 109.435 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.24 -41.24 99.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 1.0 109.281 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.04 64.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.426 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' CG ' ' X' ' 55' ' ' PHE . 20.6 t70 -59.12 -39.33 81.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.0 109.417 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.52 -43.08 99.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 1.0 109.417 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.29 -41.55 85.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 1.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.5 -38.37 89.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 1.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.02 -48.65 79.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 1.0 109.419 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -61.88 -42.61 99.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 1.0 109.4 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.51 -34.46 77.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.0 109.332 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.55 -46.25 86.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.539 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.91 -50.92 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.589 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' X' ' 43' ' ' PRO . 68.3 mttm -66.35 -29.88 70.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 1.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.0 m-20 -78.25 -18.59 55.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0 109.675 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 41' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 3.0 m -53.92 -61.28 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 1.0 109.396 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.624 ' H ' ' CD ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -108.98 -50.91 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 1.0 109.568 -176.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.624 ' CD ' ' H ' ' X' ' 42' ' ' CYS . 52.7 Cg_exo -52.7 -39.34 76.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.885 2.39 . . . . 1.0 112.2 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.485 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -147.49 -150.4 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 1.0 109.544 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' X' ' 41' ' ' THR . 0.2 OUTLIER 172.9 69.31 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.877 . . . . 1.0 109.877 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.72 159.8 38.37 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.693 2.262 . . . . 1.0 112.369 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.25 130.24 45.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 1.0 109.733 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.96 179.8 7.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 1.0 109.763 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.98 -93.43 0.17 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 29.5 m -125.92 144.79 50.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.174 . . . . 1.0 109.35 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.716 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.2 OUTLIER -131.64 132.49 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 1.0 109.544 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.716 ' N ' HD13 ' X' ' 51' ' ' ILE . 65.5 m-20 -66.53 134.04 51.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 109.757 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.31 -29.07 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 1.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -44.61 93.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 1.0 109.44 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 55' ' ' PHE . . . . . 0.559 ' CG ' ' OD2' ' X' ' 30' ' ' ASP . 4.7 t80 -77.99 -23.22 48.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 1.0 109.285 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.609 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -55.64 -38.08 69.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 1.0 109.639 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.39 -42.1 98.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.933 . . . . 1.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 78.5 mtp85 -67.41 -37.2 82.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 1.0 109.429 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.59 -42.79 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.907 . . . . 1.0 109.356 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.29 91.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -66.82 -37.07 83.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -1.159 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 97.7 m -71.91 -44.62 63.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 1.0 109.553 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.458 ' O ' HG21 ' X' ' 75' ' ' VAL . 3.0 m-85 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 1.0 109.472 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.87 -37.43 79.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 1.0 109.472 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -63.06 -46.25 88.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 1.0 109.32 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -65.77 -31.75 72.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 1.0 109.458 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' X' ' 71' ' ' GLY . 11.2 t80 -59.15 -54.89 41.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 1.0 109.391 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -67.6 -35.65 79.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.853 . . . . 1.0 109.335 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -65.87 -44.02 86.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 1.0 109.345 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.48 -52.55 2.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 1.0 109.275 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -164.47 26.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -73.5 -15.1 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.874 2.383 . . . . 1.0 111.913 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -61.92 -50.22 73.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 1.0 109.198 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -65.62 -43.68 88.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.878 . . . . 1.0 109.396 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.746 HG23 ' O ' ' X' ' 75' ' ' VAL . 32.7 m -150.08 89.03 4.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 1.0 109.406 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.35 -175.03 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.871 2.381 . . . . 1.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.453 ' H ' HG22 ' X' ' 77' ' ' VAL . 5.1 m -62.32 -18.19 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 109.383 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.1 p -62.05 -31.8 72.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 1.0 109.382 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.79 97.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -67.98 -38.64 82.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.431 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -61.29 -51.3 69.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 1.0 109.356 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -60.8 -44.34 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 1.0 109.417 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.609 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.9 t-105 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 109.351 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -56.35 -44.68 80.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 1.0 109.295 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' X' ' 85' ' ' LEU . 89.7 mt -63.27 -40.41 97.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 1.0 109.559 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.25 -42.54 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 1.0 109.327 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.27 -39.94 67.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.495 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.8 -39.09 73.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 1.0 109.413 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.48 -43.96 92.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 1.0 109.356 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' X' ' 93' ' ' LYS . 10.2 pt -76.17 -38.74 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 1.0 109.508 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.2 -45.0 96.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 1.0 109.509 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.88 -41.74 77.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 1.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.3 tttt -85.46 137.82 32.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.0 109.441 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.97 140.86 47.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 1.0 109.531 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 1.06 HG22 ' H ' ' X' ' 96' ' ' ASN . 9.5 p -150.0 -147.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 1.0 109.579 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 1.06 ' H ' HG22 ' X' ' 95' ' ' VAL . 36.0 t-20 -129.99 81.49 68.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 1.0 109.597 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.39 -168.13 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.811 2.34 . . . . 1.0 112.268 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -63.44 -38.59 91.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 1.0 109.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.3 129.64 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 1.0 109.534 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.3 mtp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.022 -0.99 . . . . 1.0 109.457 179.741 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.17 75.11 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -91.08 156.65 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 1.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -64.23 133.48 52.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 1.0 109.519 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.73 105.22 16.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 1.0 109.473 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.3 p -87.38 175.13 8.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 1.0 109.58 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.71 -43.63 65.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 1.0 109.435 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.88 -44.92 75.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 1.0 109.522 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.57 -39.45 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 1.0 109.369 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -62.04 -38.32 88.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.0 109.61 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.1 -41.59 88.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 1.0 109.502 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.65 -44.41 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 1.0 109.33 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -51.02 -46.0 61.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.258 -0.901 . . . . 1.0 109.392 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -66.21 -37.5 85.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 1.0 108.881 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.73 -40.22 96.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.266 -0.896 . . . . 1.0 108.826 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.53 ' HG2' ' HZ2' ' X' ' 20' ' ' LYS . 89.1 tttt -62.83 -42.4 99.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 1.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -53.61 -45.2 69.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.146 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.23 -38.22 88.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 1.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.39 -38.46 89.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.172 -0.955 . . . . 1.0 109.275 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.53 ' HZ2' ' HG2' ' X' ' 16' ' ' LYS . 50.2 mttp -57.31 -43.25 83.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.0 109.301 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.6 p -65.17 -24.44 67.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 1.0 109.284 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -82.15 -6.03 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 1.0 109.197 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.7 47.86 1.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.24 -1.544 . . . . 1.0 109.24 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.674 HG13 ' HE ' ' X' ' 58' ' ' ARG . 54.8 t -122.4 131.82 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -1.101 . . . . 1.0 109.356 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -132.35 88.44 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.98 . . . . 1.0 109.175 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.78 161.99 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 1.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -78.31 148.43 33.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 1.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.451 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 76.5 t80 -61.83 -35.05 77.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 1.0 109.218 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.39 65.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 1.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' X' ' 52' ' ' ASP . 89.2 m-20 -62.24 -39.62 93.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.476 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.01 -44.54 96.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 1.0 109.382 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.93 -41.5 99.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 1.0 109.449 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.27 -31.44 72.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.483 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.45 ' O ' HG23 ' X' ' 38' ' ' VAL . 58.6 t80 -59.28 -46.77 87.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 1.0 109.449 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.15 -44.28 96.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 1.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.77 -47.3 84.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 1.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.45 HG23 ' O ' ' X' ' 34' ' ' PHE . 98.2 t -60.71 -47.04 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 1.0 109.565 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.22 -32.23 73.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 1.0 109.379 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.0 m-20 -67.08 -19.59 65.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 1.0 109.663 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.4 m -54.52 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 1.0 109.371 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.711 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -106.95 -61.06 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 109.467 -177.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.2 Cg_exo -41.25 -45.12 5.63 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.887 2.391 . . . . 1.0 112.218 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.548 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.9 m-90 -135.66 -167.63 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 1.0 109.487 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.808 ' H ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -135.11 -46.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 109.885 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.808 ' CD ' ' H ' ' X' ' 45' ' ' PHE . 28.0 Cg_exo -60.74 142.67 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.73 2.287 . . . . 1.0 112.301 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -117.99 150.67 38.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 1.0 109.643 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -137.77 155.24 49.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.903 . . . . 1.0 109.743 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.55 176.66 47.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 88.3 m -119.39 135.29 54.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 1.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.94 141.15 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 1.0 109.515 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.43 ' OD2' ' OD1' ' X' ' 30' ' ' ASP . 91.4 m-20 -87.44 138.22 31.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 1.0 109.77 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.95 -40.82 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.081 -1.012 . . . . 1.0 109.445 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.99 -39.31 81.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.0 109.388 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -81.75 -18.06 45.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 1.0 109.277 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.632 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 8.1 t90 -63.73 -37.26 86.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.0 109.638 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -56.81 -43.07 80.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 1.0 109.508 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.674 ' HE ' HG13 ' X' ' 24' ' ' VAL . 17.2 mtt85 -67.83 -36.44 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 1.0 109.468 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.497 HG11 ' CH2' ' X' ' 83' ' ' TRP . 39.1 t -65.67 -44.01 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.382 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.47 95.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -67.77 -37.52 82.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 1.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.0 m -64.62 -52.57 56.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 109.448 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.77 -42.51 99.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 1.0 109.479 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.54 -38.95 78.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 1.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.33 -44.46 96.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 1.0 109.311 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -69.29 -32.99 72.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 1.0 109.379 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' X' ' 71' ' ' GLY . 25.6 t80 -64.07 -55.21 23.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 1.0 109.411 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -70.47 -35.92 73.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 1.0 109.323 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -64.58 -47.16 79.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 1.0 109.301 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.48 -52.51 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 1.0 109.195 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -168.57 25.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' X' ' 76' ' ' PRO . 21.3 Cg_endo -70.08 -18.75 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.985 2.456 . . . . 1.0 111.97 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.92 -51.55 69.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 1.0 109.224 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -65.35 -38.94 91.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 1.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.6 82.49 8.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.8 Cg_exo -56.32 161.11 9.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.885 2.39 . . . . 1.0 112.302 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.44 -5.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 1.0 109.455 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.463 ' H ' ' C ' ' X' ' 76' ' ' PRO . 73.0 p -63.9 -33.48 75.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.873 . . . . 1.0 109.396 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 1.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.94 -46.79 80.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 1.0 109.377 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 75.7 m -59.42 -47.96 83.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 1.0 109.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -62.45 -40.23 95.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.0 109.501 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.632 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.6 t-105 -66.53 -36.03 81.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 1.0 109.441 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -56.24 -44.76 79.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 1.0 109.194 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.6 mt -62.94 -39.82 95.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.635 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.0 -43.29 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.344 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.32 -43.3 83.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 1.0 109.438 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -69.45 -35.37 75.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 1.0 109.365 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.42 -47.78 75.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.357 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -74.25 -39.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 1.0 109.402 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -59.37 -46.43 88.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 1.0 109.521 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.91 -41.67 95.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 1.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -69.77 122.6 19.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 1.0 109.483 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.12 102.33 12.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 1.0 109.565 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.416 HG22 ' N ' ' X' ' 96' ' ' ASN . 12.5 p -136.45 156.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.416 ' N ' HG22 ' X' ' 95' ' ' VAL . 43.7 t-20 -128.16 80.31 72.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 1.0 109.57 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.407 ' HD3' HG13 ' X' ' 95' ' ' VAL . 47.8 Cg_exo -54.89 -42.82 65.31 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.899 2.399 . . . . 1.0 112.286 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -144.13 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.413 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.1 104.01 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 1.0 109.455 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.969 -1.015 . . . . 1.0 109.409 179.774 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.07 8.4 83.97 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -128.86 158.86 37.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -1.149 . . . . 1.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 96.0 mt-10 -64.39 146.44 54.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 1.0 109.541 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' X' ' 5' ' ' LEU . 76.3 mt -92.58 102.58 15.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 1.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.1 p -84.84 171.58 12.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 1.0 109.579 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -57.13 -41.49 79.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 1.0 109.435 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -66.14 -42.26 89.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 1.0 109.511 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 92.5 mt-10 -66.92 -38.23 85.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 1.0 109.428 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.56 -35.04 75.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 1.0 109.583 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.28 -49.0 78.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 1.0 109.41 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -68.21 -32.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -0.972 . . . . 1.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.46 -45.8 90.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.868 . . . . 1.0 109.334 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -62.43 -37.42 85.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 1.0 108.878 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.67 -42.28 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 1.0 108.738 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.527 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.2 tttt -56.31 -44.18 79.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 1.0 109.523 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -55.13 -42.93 73.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 1.0 109.116 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.582 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -63.57 -37.77 88.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.78 . . . . 1.0 109.392 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' X' ' 19' ' ' LEU . 97.2 mt -63.6 -36.93 85.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.898 . . . . 1.0 109.273 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.33 -40.68 82.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 1.0 109.218 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.0 p -66.42 -31.22 71.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 1.0 109.263 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.582 HH12 ' HB1' ' X' ' 18' ' ' ALA . 84.1 mtt85 -72.89 -18.26 61.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 1.0 109.212 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.78 46.37 0.78 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.309 -1.517 . . . . 1.0 109.309 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.82 132.98 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 1.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.67 95.82 3.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 1.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.02 158.11 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -0.86 . . . . 1.0 109.359 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.15 145.26 46.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.923 . . . . 1.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.527 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 82.3 t80 -57.17 -33.56 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 1.0 109.271 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.5 70.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 1.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 30' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.5 m-20 -59.72 -40.75 89.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 1.0 109.409 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.79 -44.53 96.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 1.0 109.345 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 32' ' ' LEU . 90.3 mt -63.97 -42.51 97.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 1.0 109.369 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.94 -37.13 85.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 1.0 109.356 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.04 -50.93 72.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 1.0 109.4 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.43 -42.2 98.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 1.0 109.41 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.62 -38.71 91.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.0 109.277 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -62.51 -46.47 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 1.0 109.52 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.2 -50.11 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 1.0 109.373 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' X' ' 44' ' ' TRP . 21.1 m-20 -69.98 -19.86 63.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 1.0 109.686 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -54.72 -59.34 4.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.967 . . . . 1.0 109.426 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -107.69 -62.02 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 1.0 109.487 -176.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.24 -41.75 4.87 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.919 2.413 . . . . 1.0 112.201 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.2 m-90 -141.83 -159.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 1.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.511 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -173.75 50.18 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 1.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_endo -70.58 166.69 27.79 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.753 2.302 . . . . 1.0 112.327 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.54 138.73 57.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 1.0 109.712 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.62 136.14 37.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 1.0 109.798 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.8 -173.72 37.96 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 141.37 57.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -1.206 . . . . 1.0 109.293 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.691 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.46 134.04 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 1.0 109.567 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.691 ' N ' HD13 ' X' ' 51' ' ' ILE . 98.5 m-20 -64.39 137.28 57.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 1.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.15 -23.02 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 1.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.31 -39.48 92.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 1.0 109.41 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -83.26 -10.13 58.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 1.0 109.247 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.626 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.8 t90 -58.76 -38.16 77.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 1.0 109.651 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -62.15 -40.54 96.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.0 109.466 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 74.8 mtp85 -66.08 -39.13 89.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 1.0 109.396 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.452 HG21 ' CH2' ' X' ' 83' ' ' TRP . 53.7 t -61.95 -43.82 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 1.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.31 -50.7 62.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.74 -41.67 97.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -1.164 . . . . 1.0 109.511 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 81.8 m -65.43 -52.29 54.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 1.0 109.518 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.521 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.8 m-85 -60.98 -41.46 96.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 1.0 109.498 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -63.85 -38.72 92.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 1.0 109.465 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.95 -45.28 89.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.306 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -68.05 -30.56 69.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 1.0 109.461 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' X' ' 71' ' ' GLY . 14.9 t80 -60.44 -55.09 37.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 1.0 109.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -66.95 -36.51 82.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 1.0 109.345 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -63.85 -47.03 82.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 1.0 109.318 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.35 -52.45 2.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 1.0 109.302 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.47 -164.12 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.4 -15.45 31.17 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.928 2.419 . . . . 1.0 112.001 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.11 -54.44 44.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 1.0 109.16 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -63.27 -44.47 95.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 1.0 109.366 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.699 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.2 m -148.81 90.57 4.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 1.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.42 -173.84 1.96 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.85 2.367 . . . . 1.0 112.204 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.94 -16.56 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 1.0 109.431 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.71 -32.52 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 1.0 109.345 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.78 95.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 1.0 109.376 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -65.04 -41.24 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 1.0 109.38 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -59.66 -48.02 83.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -65.51 -43.75 89.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 1.0 109.488 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.626 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.7 t-105 -61.67 -36.46 80.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 1.0 109.389 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -56.77 -43.19 80.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 1.0 109.277 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' X' ' 85' ' ' LEU . 94.6 mt -64.48 -41.14 96.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 1.0 109.642 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.5 -41.29 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.927 . . . . 1.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -56.87 -40.04 75.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 1.0 109.497 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.01 -40.62 78.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 1.0 109.434 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.7 -46.11 86.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 1.0 109.33 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.64 -38.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.399 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.46 -45.07 92.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 1.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.95 -45.55 93.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 1.0 109.586 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.8 127.96 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 1.0 109.495 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -91.73 96.09 10.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 1.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.621 HG22 ' N ' ' X' ' 96' ' ' ASN . 14.0 p -121.76 170.21 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 1.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.621 ' N ' HG22 ' X' ' 95' ' ' VAL . 36.1 t-20 -129.38 81.88 69.12 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.559 ' HD3' HG13 ' X' ' 95' ' ' VAL . 32.2 Cg_exo -58.59 -151.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.839 2.359 . . . . 1.0 112.321 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -62.54 -69.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 1.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.01 129.09 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 1.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.038 -0.982 . . . . 1.0 109.476 179.909 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.53 83.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -128.95 159.06 37.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.536 -0.979 . . . . 1.0 109.436 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.07 138.43 58.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 1.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.49 HD22 ' OE1' ' X' ' 13' ' ' GLU . 95.7 mt -77.03 84.63 3.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.576 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.7 p -80.32 172.19 14.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 1.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.6 -43.34 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 1.0 109.447 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -68.68 -43.64 75.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 109.484 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.93 -36.59 84.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.0 -38.81 79.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 1.0 109.831 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.27 -49.03 78.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 1.0 109.63 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.22 -35.37 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 13' ' ' GLU . . . . . 0.49 ' OE1' HD22 ' X' ' 5' ' ' LEU . 79.3 tt0 -62.99 -40.36 97.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.301 -0.874 . . . . 1.0 109.24 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.43 -36.93 85.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.039 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.96 -43.0 99.76 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.25 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.46 -36.94 81.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 1.0 109.417 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.544 ' O ' HG23 ' X' ' 21' ' ' THR . 89.4 mt-30 -58.25 -48.5 80.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.0 109.254 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.3 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.446 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.65 -38.75 92.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 1.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.86 -39.7 95.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.306 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.544 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.2 p -61.77 -29.38 70.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 1.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.15 -17.51 63.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.588 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.13 44.55 0.67 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.738 HG13 ' HE ' ' X' ' 58' ' ' ARG . 30.9 t -122.98 135.64 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.667 -0.902 . . . . 1.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -135.49 99.74 4.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 1.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.54 164.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.485 -0.76 . . . . 1.0 109.625 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.12 146.26 47.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.353 -0.842 . . . . 1.0 109.512 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -62.83 -37.39 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.05 -1.031 . . . . 1.0 109.371 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.49 -34.23 66.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -39.67 90.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 1.0 109.113 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.465 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.23 -43.55 98.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.0 109.526 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' X' ' 32' ' ' LEU . 99.1 mt -63.71 -42.27 97.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 1.0 109.33 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.1 -30.86 71.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 1.0 109.18 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -61.39 -50.21 73.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 1.0 109.607 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -62.28 -46.56 88.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 1.0 109.547 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -65.52 -38.18 88.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.208 -0.932 . . . . 1.0 109.231 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.25 -45.64 93.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 1.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.27 -48.63 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 1.0 109.693 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -67.8 -28.46 67.61 Favored 'General case' 0 C--O 1.192 -1.94 0 O-C-N 121.171 -0.956 . . . . 1.0 108.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.562 ' OD1' ' CZ2' ' X' ' 44' ' ' TRP . 71.0 m-20 -77.93 -20.71 52.3 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 120.032 -1.667 . . . . 1.0 109.796 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 m -54.34 -60.91 2.71 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.99 -1.069 . . . . 1.0 111.275 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -101.84 -53.95 0.14 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.512 -0.743 . . . . 1.0 110.858 -178.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' X' ' 42' ' ' CYS . 89.1 Cg_exo -46.02 -43.0 20.68 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.514 2.143 . . . . 1.0 112.601 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.562 ' CZ2' ' OD1' ' X' ' 40' ' ' ASP . 0.1 OUTLIER -176.56 131.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 1.0 109.207 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.523 ' CE2' ' CD2' ' X' ' 82' ' ' TYR . 0.2 OUTLIER -104.69 105.95 52.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 1.0 109.775 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.427 ' CG ' ' HE1' ' X' ' 44' ' ' TRP . 56.4 Cg_endo -83.2 -164.46 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.778 2.318 . . . . 1.0 111.918 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -90.57 122.36 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.363 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.01 154.76 17.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.461 -0.774 . . . . 1.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.19 -93.99 2.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.489 HG23 HG22 ' X' ' 90' ' ' ILE . 27.3 m -130.92 137.4 49.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -1.007 . . . . 1.0 109.434 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.73 HD13 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -112.67 139.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.543 -0.723 . . . . 1.0 109.381 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.73 ' H ' HD13 ' X' ' 51' ' ' ILE . 85.5 m-20 -68.85 136.61 52.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 1.0 109.76 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.57 -27.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -0.997 . . . . 1.0 109.537 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.68 -41.87 95.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.024 -1.047 . . . . 1.0 109.777 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -75.88 -17.03 59.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 1.0 109.839 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.9 t90 -60.61 -37.74 82.41 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.288 -0.883 . . . . 1.0 109.954 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -59.44 -44.51 92.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 1.0 109.673 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.738 ' HE ' HG13 ' X' ' 24' ' ' VAL . 19.0 mtt85 -64.79 -40.01 94.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.54 -43.67 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.85 -46.92 92.6 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -67.88 -42.1 81.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -1.2 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.98 -51.6 66.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 1.0 109.639 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.98 -44.21 87.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 1.0 109.527 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -56.41 -40.62 74.99 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.272 -0.892 . . . . 1.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.69 -43.29 84.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 1.0 109.324 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -62.86 -35.7 80.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 1.0 109.269 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.515 ' CE2' ' OD1' ' X' ' 68' ' ' ASN . 3.4 t80 -59.26 -55.0 40.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.515 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 84.9 m-20 -65.13 -34.56 78.7 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.041 -1.037 . . . . 1.0 109.771 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -64.16 -48.93 74.08 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.288 -0.883 . . . . 1.0 110.012 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -114.7 -51.93 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.651 -0.655 . . . . 1.0 109.871 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 143.45 -168.87 26.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' X' ' 76' ' ' PRO . 7.4 Cg_exo -67.03 -21.76 48.9 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.998 2.465 . . . . 1.0 111.987 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.91 -51.01 69.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 1.0 109.457 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.53 -45.08 88.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 1.0 109.808 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.759 HG23 ' O ' ' X' ' 75' ' ' VAL . 26.6 m -142.8 82.4 12.34 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.0 109.356 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' X' ' 72' ' ' PRO . 51.5 Cg_endo -79.59 -172.33 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.911 2.407 . . . . 1.0 112.31 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.46 -20.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.922 . . . . 1.0 109.524 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 22.2 p -62.63 -37.85 87.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 1.0 109.563 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.25 79.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 1.0 109.56 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -65.68 -37.06 85.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 1.0 109.416 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -61.6 -45.3 94.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 1.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.523 ' CD2' ' CE2' ' X' ' 45' ' ' PHE . 38.3 m-85 -63.74 -44.24 94.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 1.0 109.732 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.634 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.7 t-105 -64.43 -37.56 87.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.282 -0.886 . . . . 1.0 109.296 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -55.99 -41.73 75.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 1.0 108.829 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.445 ' O ' HD13 ' X' ' 89' ' ' LEU . 95.1 mt -65.57 -40.39 92.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 1.0 109.297 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -64.22 -42.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 1.0 109.485 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -54.81 -39.32 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 1.0 109.264 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -70.39 -39.46 74.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 1.0 109.478 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.445 HD13 ' O ' ' X' ' 85' ' ' LEU . 8.1 mp -62.45 -46.0 90.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 1.0 110.139 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.489 HG22 HG23 ' X' ' 50' ' ' THR . 9.9 pt -74.19 -31.98 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.518 -0.739 . . . . 1.0 109.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.56 -40.55 92.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 1.0 109.374 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.37 -40.19 93.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.0 109.454 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -94.63 115.16 27.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.189 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.97 122.1 28.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 1.0 109.457 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.02 150.84 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 1.0 109.409 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -121.48 85.0 42.62 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.7 -45.75 38.78 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.705 2.27 . . . . 1.0 112.468 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -145.31 -78.6 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.541 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.07 100.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.744 -0.598 . . . . 1.0 109.416 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.994 -1.003 . . . . 1.0 109.434 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.269 0.557 . . . . 1.0 109.499 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.15 139.31 52.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 1.0 109.568 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 5' ' ' LEU . 67.9 mt -90.86 104.08 16.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.855 . . . . 1.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.8 p -82.27 168.63 17.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 1.0 109.565 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -53.84 -41.39 67.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 1.0 109.489 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -66.39 -45.64 79.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 1.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -62.96 -35.99 81.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 1.0 109.428 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.43 -36.97 85.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 1.0 109.578 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -61.63 -41.74 97.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.404 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 t -59.63 -43.32 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.297 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -56.33 -46.92 79.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.228 -0.92 . . . . 1.0 109.347 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.98 -38.0 89.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 1.0 108.884 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.88 -41.51 99.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 1.0 108.772 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.513 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.5 tttt -59.77 -37.73 79.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 1.0 109.474 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -59.15 -44.98 92.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 1.0 109.099 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.51 -37.35 86.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 1.0 109.344 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.78 -39.1 93.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 1.0 109.338 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.26 -42.53 86.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 1.0 109.325 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.9 p -63.68 -31.73 72.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 1.0 109.342 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.58 -18.6 61.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 1.0 109.24 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.87 47.85 0.65 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.62 132.92 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 1.0 109.466 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.8 93.96 3.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.144 -0.973 . . . . 1.0 109.226 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.36 160.65 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 1.0 109.363 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -72.73 151.45 42.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 1.0 109.453 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.513 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 72.5 t80 -65.67 -40.17 92.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.872 . . . . 1.0 109.257 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.58 57.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.0 109.487 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -61.44 -37.5 83.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 1.0 109.409 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.504 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.23 -45.28 94.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 1.0 109.369 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' X' ' 32' ' ' LEU . 96.7 mt -63.91 -41.41 97.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 1.0 109.405 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 1.0 109.415 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -56.63 -49.14 75.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 1.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -59.95 -42.23 93.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 1.0 109.419 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.22 -44.13 95.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.0 109.292 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -61.2 -45.48 94.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 1.0 109.548 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.93 -44.69 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 1.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 69.9 tttt -64.2 -31.51 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 1.0 109.436 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' X' ' 44' ' ' TRP . 99.0 m-20 -70.7 -19.32 62.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 1.0 109.587 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 30.9 m -53.89 -52.25 61.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 1.0 109.378 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.772 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -116.13 -60.73 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 1.0 109.504 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.772 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 74.0 Cg_exo -41.5 -54.58 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.868 2.379 . . . . 1.0 112.203 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.52 ' O ' ' O ' ' X' ' 40' ' ' ASP . 8.4 m0 -127.65 113.01 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 1.0 109.58 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -61.49 -44.52 92.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 1.0 109.81 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.4 Cg_exo -59.6 141.71 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.699 2.266 . . . . 1.0 112.378 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -97.99 159.21 15.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 1.0 109.665 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.43 133.7 12.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.846 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.94 155.23 22.74 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.794 -1.323 . . . . 1.0 109.794 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . 0.476 HG23 HG22 ' X' ' 90' ' ' ILE . 19.6 m -91.91 135.08 34.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 1.0 109.303 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.66 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -102.21 134.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 1.0 109.518 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.66 ' N ' HD13 ' X' ' 51' ' ' ILE . 70.0 m-20 -75.55 137.94 41.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 1.0 109.756 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.95 -34.19 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 1.0 109.392 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.85 -38.05 89.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 1.0 109.452 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.18 -20.36 52.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 1.0 109.245 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.597 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 13.5 t90 -56.18 -33.95 65.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 1.0 109.719 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -59.89 -41.98 92.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 1.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.416 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 72.8 mtp180 -66.38 -39.68 89.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 1.0 109.515 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.572 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 72.8 t -62.76 -43.11 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.33 -46.61 93.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -70.02 -42.2 73.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 1.0 109.494 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.1 m -63.86 -48.41 76.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 1.0 109.544 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.438 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.3 m-85 -61.84 -39.35 91.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 1.0 109.493 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -61.93 -39.67 92.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 1.0 109.456 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -63.07 -44.1 96.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 1.0 109.236 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -65.47 -35.15 80.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 1.0 109.475 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' X' ' 71' ' ' GLY . 5.1 t80 -59.05 -54.39 47.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.87 . . . . 1.0 109.45 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 95.0 m-20 -65.74 -36.57 83.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 1.0 109.311 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -62.93 -47.99 80.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 1.0 109.299 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.76 -52.36 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 1.0 109.209 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.26 -165.93 25.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.459 -1.457 . . . . 1.0 109.459 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -67.19 -16.56 48.99 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.953 2.435 . . . . 1.0 111.952 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.55 -54.6 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 1.0 109.198 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -63.74 -43.6 95.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 1.0 109.404 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.694 HG23 ' O ' ' X' ' 75' ' ' VAL . 27.3 m -148.63 92.42 4.47 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 1.0 109.431 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.55 -166.55 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.873 2.382 . . . . 1.0 112.166 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.66 -12.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 1.0 109.416 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -66.17 -33.2 75.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 1.0 109.421 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.15 -47.18 81.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.446 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -64.92 -45.67 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 1.0 109.4 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -59.77 -47.12 86.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 1.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -63.15 -40.89 98.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 1.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.597 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.5 t-105 -61.69 -37.98 86.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.05 -42.57 76.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.882 . . . . 1.0 109.223 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.31 -41.59 98.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 1.0 109.586 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -63.75 -43.53 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -0.941 . . . . 1.0 109.412 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.54 -37.63 58.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.0 109.501 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.21 -42.3 72.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.0 109.309 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.32 -48.02 83.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 1.0 109.396 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.476 HG22 HG23 ' X' ' 50' ' ' THR . 11.5 pt -72.69 -36.74 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.914 . . . . 1.0 109.434 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -63.11 -39.74 95.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 1.0 109.536 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -63.62 -40.96 98.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 1.0 109.57 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -88.75 117.48 27.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 1.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.75 138.17 56.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 1.0 109.564 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 1.0 109.572 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.256 0.55 . . . . 1.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.3 130.81 46.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 1.0 109.423 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 64.4 mt -91.93 104.66 17.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 1.0 109.717 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -82.46 168.37 17.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.434 -0.791 . . . . 1.0 109.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.96 -41.46 67.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 1.0 109.413 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.76 -45.13 79.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 1.0 109.606 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.85 -31.67 73.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.2 -0.938 . . . . 1.0 109.344 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -70.74 -40.65 72.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 1.0 109.925 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -60.66 -49.75 76.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 1.0 109.644 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -65.19 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 1.0 109.361 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.61 -40.96 93.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 1.0 109.019 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.22 -36.41 84.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 1.0 108.875 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.7 -41.42 99.12 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 109.126 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.6 -40.71 88.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 1.0 109.329 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -59.38 -44.57 92.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 1.0 109.046 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.08 -38.61 91.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.301 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.4 HD23 ' HD3' ' X' ' 22' ' ' ARG . 98.6 mt -67.1 -40.98 87.02 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.021 -1.05 . . . . 1.0 109.207 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.41 -30.61 71.34 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.991 -1.068 . . . . 1.0 109.162 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 31.4 p -77.06 -31.46 56.12 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.346 -0.846 . . . . 1.0 109.535 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' CG2' ' X' ' 24' ' ' VAL . 15.9 ptt85 -75.57 -19.3 59.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.112 -0.993 . . . . 1.0 109.29 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.73 48.47 0.3 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.455 ' CG2' ' HE ' ' X' ' 22' ' ' ARG . 69.7 t -123.11 139.47 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 1.0 109.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -125.39 98.2 5.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.743 . . . . 1.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -132.04 138.63 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 1.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.94 150.15 39.17 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.361 -0.837 . . . . 1.0 109.631 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.15 -35.36 80.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 1.0 109.128 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 1.0 109.305 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -62.88 -37.47 87.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.185 -0.947 . . . . 1.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -63.11 -44.77 94.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 1.0 109.631 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.67 -43.11 94.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 1.0 109.429 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 1.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.86 -48.45 78.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 1.0 109.571 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.82 -41.05 97.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 109.209 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.41 -44.93 95.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 1.0 109.271 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.48 -48.07 79.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.58 -45.03 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.908 . . . . 1.0 109.327 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 51.4 tttm -64.38 -34.22 77.66 Favored 'General case' 0 C--O 1.2 -1.516 0 CA-C-O 122.103 0.954 . . . . 1.0 108.938 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 2.9 m-20 -69.42 -20.73 63.79 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 120.242 -1.536 . . . . 1.0 109.646 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -54.28 -61.04 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.0 110.926 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.54 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -102.68 -59.09 0.09 OUTLIER Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.334 -0.854 . . . . 1.0 110.728 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.8 Cg_exo -41.7 -48.6 5.72 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.599 2.199 . . . . 1.0 112.697 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -125.53 -118.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.0 109.03 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.672 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.9 OUTLIER -177.58 -41.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.0 110.227 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 25.8 Cg_exo -60.84 141.41 94.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.728 2.286 . . . . 1.0 112.231 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.11 164.29 15.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 1.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.0 161.12 30.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 1.0 109.753 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.03 -2.86 58.1 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.086 -1.206 . . . . 1.0 110.086 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -119.63 116.12 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.978 . . . . 1.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.663 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.84 132.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.156 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.663 ' N ' HD13 ' X' ' 51' ' ' ILE . 87.7 m-20 -72.46 131.34 42.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.83 -1.169 . . . . 1.0 109.884 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.26 -42.44 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 1.0 109.581 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -57.37 -42.07 81.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.159 . . . . 1.0 109.43 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . 0.519 ' CE2' ' CG2' ' X' ' 59' ' ' VAL . 86.2 t80 -77.08 -23.76 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 1.0 109.757 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.643 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -59.56 -38.8 82.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.975 . . . . 1.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -57.09 -44.42 83.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.218 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.461 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 77.8 mtp85 -66.69 -39.02 87.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 1.0 109.487 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.519 ' CG2' ' CE2' ' X' ' 55' ' ' PHE . 59.2 t -62.4 -44.1 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 1.0 109.46 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.01 73.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -65.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -1.133 . . . . 1.0 109.498 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 74.0 m -66.33 -55.16 17.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 1.0 109.715 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.52 -37.83 85.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 1.0 109.548 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -38.35 90.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 1.0 109.303 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 1.0 109.438 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -64.8 -35.44 81.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.895 . . . . 1.0 109.579 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' X' ' 71' ' ' GLY . 0.9 OUTLIER -62.15 -54.06 46.54 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.261 -0.9 . . . . 1.0 109.834 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 35.0 t-20 -64.42 -35.52 81.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.909 -1.12 . . . . 1.0 109.674 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -67.24 -46.14 74.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.288 -0.883 . . . . 1.0 109.69 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -115.15 -52.05 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.691 -0.631 . . . . 1.0 109.901 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.76 -169.19 24.23 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' X' ' 76' ' ' PRO . 13.1 Cg_exo -63.33 -22.87 72.04 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.946 2.431 . . . . 1.0 111.99 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.79 -53.06 57.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 1.0 109.346 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -65.37 -43.91 89.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.299 -0.875 . . . . 1.0 109.751 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' X' ' 75' ' ' VAL . 7.3 m -138.79 84.52 17.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.612 -0.68 . . . . 1.0 109.285 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.553 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.5 Cg_exo -60.12 152.8 62.97 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.841 2.36 . . . . 1.0 112.153 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.522 ' O ' HG12 ' X' ' 77' ' ' VAL . 61.0 t -52.03 -4.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.968 . . . . 1.0 109.707 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.553 ' H ' ' C ' ' X' ' 76' ' ' PRO . 51.5 p -65.49 -38.62 90.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.132 -0.98 . . . . 1.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.15 77.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 1.0 109.434 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -62.6 -45.83 91.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 1.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 65.9 m -61.05 -46.76 89.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.72 -37.48 87.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 1.0 109.431 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.643 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.2 t-105 -66.75 -35.17 79.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 1.0 109.214 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -58.07 -45.36 87.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 1.0 108.865 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.72 -42.02 99.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 1.0 109.413 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.6 -45.06 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 1.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -54.19 -44.27 71.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 1.0 109.508 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.98 -35.26 76.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.067 -1.02 . . . . 1.0 109.466 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.22 -49.09 71.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.089 -1.007 . . . . 1.0 110.014 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' X' ' 93' ' ' LYS . 6.0 pt -71.77 -43.07 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 1.0 109.517 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -62.01 -48.34 80.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.68 -44.7 92.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 1.0 109.712 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.5 tttt -81.34 143.25 32.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 1.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.08 138.4 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 1.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.775 . . . . 1.0 109.369 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' X' ' 4' ' ' GLU . 56.7 mp0 -58.61 144.22 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.231 -0.918 . . . . 1.0 109.436 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 60.4 mt -97.32 101.92 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 82.4 p -80.02 170.97 15.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 1.0 109.497 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.09 -42.02 79.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 1.0 109.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.31 -45.33 80.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 1.0 109.554 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 96.7 mt-10 -62.82 -36.68 83.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 1.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.32 -40.39 97.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 1.0 109.636 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.11 -37.82 81.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 1.0 109.069 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.32 -44.74 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 1.0 109.043 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -56.09 -47.79 77.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0 109.314 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 1.0 109.002 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.283 -0.885 . . . . 1.0 109.181 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' X' ' 26' ' ' VAL . 86.0 tttt -60.35 -42.01 94.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 1.0 109.063 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -55.05 -44.69 74.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 1.0 109.111 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.08 86.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 1.0 109.168 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' X' ' 16' ' ' LYS . 95.9 mt -62.94 -39.26 94.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 1.0 109.086 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.82 -41.02 90.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.382 -0.824 . . . . 1.0 109.278 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 13.8 m -59.38 -39.06 82.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 1.0 109.225 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.81 -17.81 64.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 1.0 109.26 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.67 46.57 0.96 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.358 -1.497 . . . . 1.0 109.358 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.96 134.73 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.643 -0.916 . . . . 1.0 109.374 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.46 106.75 10.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.637 -0.664 . . . . 1.0 109.231 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.503 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 53.7 t -135.9 159.14 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.657 -0.652 . . . . 1.0 109.531 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . 0.465 ' N ' HG12 ' X' ' 26' ' ' VAL . 99.7 mttt -81.27 143.64 32.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.381 -0.825 . . . . 1.0 109.717 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.5 ' CE2' HD11 ' X' ' 32' ' ' LEU . 88.3 t80 -59.59 -39.2 83.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 1.0 109.354 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.17 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 1.0 109.543 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -64.42 -38.57 91.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 1.0 109.167 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.79 -46.06 89.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 1.0 109.676 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' X' ' 28' ' ' TYR . 94.9 mt -63.4 -42.39 98.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 1.0 109.572 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 -36.02 82.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 1.0 109.357 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -60.48 -49.56 77.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 1.0 109.806 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.37 -44.61 90.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 1.0 109.787 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.92 -44.2 96.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 1.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.468 ' O ' ' OG1' ' X' ' 41' ' ' THR . 84.2 t80 -64.11 -45.46 88.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 1.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.36 -43.41 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.275 -0.891 . . . . 1.0 109.95 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.55 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -76.24 -29.19 57.41 Favored 'General case' 0 C--O 1.187 -2.19 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' X' ' 44' ' ' TRP . 79.1 m-20 -78.17 -21.79 49.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.052 0.929 . . . . 1.0 109.83 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 37' ' ' PHE . 11.3 m -62.72 -51.27 67.83 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.363 -1.461 . . . . 1.0 111.669 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -65.11 -64.28 2.79 Favored Pre-proline 0 C--N 1.296 -1.74 0 O-C-N 121.448 -0.782 . . . . 1.0 110.998 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.55 ' CG ' ' O ' ' X' ' 39' ' ' LYS . 27.7 Cg_endo -61.23 -54.19 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.723 2.282 . . . . 1.0 112.792 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.65 ' O ' ' CD2' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -173.67 139.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.092 -1.005 . . . . 1.0 109.287 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.539 ' N ' ' HD3' ' X' ' 46' ' ' PRO . 11.8 p90 -154.42 54.93 1.15 Allowed Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 120.671 -1.268 . . . . 1.0 110.002 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 38.9 Cg_endo -78.97 -23.0 8.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.673 2.248 . . . . 1.0 112.53 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -75.97 156.16 34.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.905 . . . . 1.0 109.629 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -132.39 151.83 51.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.573 -0.704 . . . . 1.0 109.49 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' X' ' 86' ' ' ILE . . . -150.74 -176.67 23.9 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.2 m -77.37 144.05 38.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -1.18 . . . . 1.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.669 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.29 134.45 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.494 -0.753 . . . . 1.0 109.227 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.669 ' N ' HD13 ' X' ' 51' ' ' ILE . 66.2 t0 -65.33 135.62 55.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.932 -1.105 . . . . 1.0 109.801 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 97.2 mt -69.54 -42.29 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.917 -1.115 . . . . 1.0 109.436 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.65 -39.84 77.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 1.0 109.171 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . 0.401 ' CE2' HG23 ' X' ' 59' ' ' VAL . 46.9 t80 -70.5 -36.63 73.91 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.298 -0.876 . . . . 1.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.645 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 17.3 t90 -52.78 -37.79 60.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.163 -0.961 . . . . 1.0 109.458 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -57.32 -44.8 84.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 1.0 109.234 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.446 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 80.1 mtp85 -67.96 -43.15 79.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 1.0 109.514 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.401 HG23 ' CE2' ' X' ' 55' ' ' PHE . 39.7 t -62.5 -43.73 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 1.0 109.467 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.32 -48.81 77.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.49 -38.12 86.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -1.18 . . . . 1.0 109.645 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.4 m -66.73 -48.7 68.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 1.0 109.693 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.437 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.6 m-85 -58.92 -46.19 88.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.333 -0.854 . . . . 1.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -57.13 -40.63 77.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 1.0 109.354 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -63.13 -45.97 89.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.0 109.353 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -64.84 -30.95 71.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 1.0 109.449 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.506 ' O ' ' N ' ' X' ' 71' ' ' GLY . 2.1 t80 -63.26 -54.78 31.92 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.357 -0.839 . . . . 1.0 109.847 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.418 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 76.4 m-20 -65.82 -38.97 90.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.876 -1.14 . . . . 1.0 109.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -62.5 -49.56 74.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.295 -0.878 . . . . 1.0 109.958 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.69 -51.76 2.85 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.996 -0.682 . . . . 1.0 109.97 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.41 -169.46 24.79 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.1 -20.06 50.57 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.985 2.456 . . . . 1.0 112.014 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -57.24 -51.91 67.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.97 . . . . 1.0 109.366 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.94 -46.21 82.52 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 1.0 110.004 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.767 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.8 m -146.01 86.84 6.94 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.537 -0.727 . . . . 1.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.42 -166.51 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.865 2.376 . . . . 1.0 112.41 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.71 -15.97 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.0 109.662 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 36.9 p -61.73 -34.14 75.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 1.0 109.277 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.55 -45.45 75.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.62 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -63.91 -46.15 86.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -61.53 -46.47 89.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 1.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.05 -42.13 98.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 1.0 109.538 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.645 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.8 t-105 -64.53 -36.73 85.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 1.0 109.163 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -55.85 -44.98 78.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 1.0 108.933 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.99 -42.94 99.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0 109.498 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' X' ' 49' ' ' GLY . 1.5 mm -61.46 -41.83 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 1.0 109.49 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.66 -36.87 67.54 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.372 -0.83 . . . . 1.0 109.181 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.86 -41.29 71.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 1.0 109.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.89 -46.98 87.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 1.0 110.403 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 6.4 pt -71.54 -41.91 72.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -0.821 . . . . 1.0 109.704 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.78 -46.71 89.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.888 . . . . 1.0 109.326 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -45.81 90.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 1.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.17 133.0 39.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 1.0 109.453 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.78 126.46 31.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 1.0 109.437 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.521 -0.737 . . . . 1.0 109.329 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.451 -0.574 . . . . 1.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . 0.467 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.7 mt-10 -56.46 141.77 41.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 1.0 109.555 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' X' ' 5' ' ' LEU . 86.3 mt -96.89 105.37 17.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 1.0 109.506 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -83.44 172.46 12.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 1.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -56.56 -46.58 80.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 1.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . 0.653 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 3.2 m-70 -66.59 -44.01 83.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 1.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 81.5 mt-10 -60.17 -38.75 84.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 1.0 109.425 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -63.64 -38.48 91.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 1.0 109.555 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.14 -40.22 89.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 1.0 109.468 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.68 -44.37 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 1.0 109.307 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.15 -41.67 75.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 1.0 109.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -66.22 -36.27 82.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 1.0 108.896 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.47 -41.11 98.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.228 -0.92 . . . . 1.0 108.815 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -40.9 98.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.0 109.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.49 -45.27 85.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 1.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.77 85.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 1.0 109.377 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 19' ' ' LEU . 88.6 mt -63.77 -38.66 91.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 1.0 109.364 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.42 -35.54 76.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 1.0 109.316 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -66.16 -39.53 89.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 1.0 109.351 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -68.55 -19.12 64.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.845 . . . . 1.0 109.255 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.22 50.01 0.48 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.97 129.84 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -1.151 . . . . 1.0 109.436 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -126.74 101.73 6.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 1.0 109.145 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.78 162.46 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 1.0 109.36 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.34 145.07 39.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.886 . . . . 1.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -59.94 -39.28 85.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.237 -0.914 . . . . 1.0 109.34 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.55 68.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 1.0 109.414 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.0 -39.62 86.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 1.0 109.392 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.441 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -63.01 -43.76 97.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 1.0 109.393 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.47 -41.52 98.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 1.0 109.435 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.31 -38.53 91.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 1.0 109.42 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.409 ' O ' HG23 ' X' ' 38' ' ' VAL . 61.3 t80 -57.97 -49.06 78.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 1.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -64.01 -45.81 87.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.0 109.365 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -58.52 -43.06 89.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 1.0 109.317 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -66.4 -43.49 85.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 1.0 109.523 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.409 HG23 ' O ' ' X' ' 34' ' ' PHE . 54.7 t -60.42 -45.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 1.0 109.535 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.563 ' NZ ' ' CH2' ' X' ' 44' ' ' TRP . 44.5 tttm -66.62 -32.85 74.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.43 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.9 m-20 -68.85 -19.53 64.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 1.0 109.688 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . 0.407 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 6.4 m -54.01 -61.37 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.0 109.418 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.689 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.71 -60.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 -177.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 71.4 Cg_exo -41.67 -51.81 4.16 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.891 2.394 . . . . 1.0 112.232 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' NZ ' ' X' ' 39' ' ' LYS . 6.5 m0 -132.95 -149.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 1.0 109.551 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.621 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.45 -44.91 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 1.0 109.877 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 36.1 Cg_exo -56.47 -31.74 86.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.725 2.283 . . . . 1.0 112.367 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.09 125.01 24.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 1.0 109.65 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -132.18 159.51 38.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.43 156.42 27.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -64.09 142.8 58.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.178 . . . . 1.0 109.382 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.68 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.73 133.28 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 1.0 109.548 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.68 ' N ' HD13 ' X' ' 51' ' ' ILE . 83.8 m-20 -72.12 135.61 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 1.0 109.756 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 1.0 109.423 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.28 -41.15 97.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 1.0 109.373 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -81.51 -17.48 48.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.0 109.299 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.544 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -58.44 -37.45 75.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.997 . . . . 1.0 109.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.16 -43.47 92.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 1.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -67.09 -37.03 83.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 1.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.65 -43.22 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 1.0 109.33 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.56 -47.46 90.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.504 -1.439 . . . . 1.0 109.504 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.01 -40.34 82.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 1.0 109.44 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.0 m -65.78 -50.28 65.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 1.0 109.439 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.79 -43.2 94.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 1.0 109.519 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -61.99 -33.41 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.0 109.517 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -65.12 -43.01 93.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 1.0 109.335 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.87 -34.96 74.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 1.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' X' ' 71' ' ' GLY . 19.9 t80 -60.26 -54.85 40.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.61 -36.53 82.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.0 109.351 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -64.59 -47.14 79.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 1.0 109.313 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.68 -52.68 2.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 1.0 109.264 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.81 -164.53 26.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -73.45 -14.27 25.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.928 2.418 . . . . 1.0 111.983 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -61.49 -49.76 75.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.0 109.284 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.55 -46.3 73.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 1.0 109.324 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.703 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.5 m -147.24 89.28 5.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 1.0 109.484 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.23 -170.23 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.83 2.353 . . . . 1.0 112.186 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.82 -18.23 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 1.0 109.406 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.6 p -58.55 -30.86 67.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.413 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 1.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.85 -39.66 93.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 1.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 64.7 m -61.79 -46.02 91.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 1.0 109.403 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' CZ ' ' X' ' 45' ' ' PHE . 36.7 m-85 -66.64 -42.38 86.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.877 . . . . 1.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.544 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t-105 -63.86 -34.63 78.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.0 109.289 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.3 -41.05 83.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 1.0 109.202 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.61 -42.44 98.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 1.0 109.577 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.3 -41.38 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 1.0 109.394 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.492 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 47.5 mttt -53.62 -41.36 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 1.0 109.424 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.56 -37.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 1.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.72 -48.69 76.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 1.0 109.378 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -73.31 -41.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 1.0 109.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.09 -42.29 98.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 1.0 109.454 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -64.76 -42.5 95.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 1.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.18 130.28 35.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 1.0 109.459 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.71 114.88 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 1.0 109.524 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 1.0 109.62 179.496 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.73 132.34 36.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.97 102.78 15.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.87 . . . . 1.0 109.506 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -82.95 175.66 9.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.0 109.616 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -54.11 -45.55 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 1.0 109.483 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.98 -43.59 87.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.565 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -60.07 -39.46 86.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 1.0 109.387 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.8 -38.18 89.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 1.0 109.606 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -61.79 -35.85 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.911 . . . . 1.0 109.437 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.01 -43.71 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 1.0 109.318 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.55 -44.69 93.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 1.0 109.312 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.6 -37.95 83.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.179 -0.95 . . . . 1.0 108.91 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.74 -40.3 94.6 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.279 -0.888 . . . . 1.0 108.747 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.638 ' HZ2' ' CA ' ' X' ' 28' ' ' TYR . 88.6 tttt -62.58 -41.1 98.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 1.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.62 -44.65 85.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.922 . . . . 1.0 109.139 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.06 98.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.445 -0.785 . . . . 1.0 109.412 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' X' ' 58' ' ' ARG . 95.7 mt -63.81 -38.03 89.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 1.0 109.251 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -58.62 -43.08 89.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.0 109.228 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 67.4 p -63.16 -31.26 72.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 1.0 109.384 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.83 -15.79 61.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 1.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.31 47.16 0.82 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.3 134.28 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -1.123 . . . . 1.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.7 92.98 3.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.937 . . . . 1.0 109.209 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.84 160.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 1.0 109.298 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.0 143.43 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 1.0 109.486 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.638 ' CA ' ' HZ2' ' X' ' 16' ' ' LYS . 89.6 t80 -61.68 -38.48 87.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 1.0 109.296 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.81 65.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 1.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.0 m-20 -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 1.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.462 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -61.62 -44.58 96.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 1.0 109.391 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.37 -43.74 96.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 1.0 109.329 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.07 -37.45 85.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 1.0 109.378 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.66 -48.13 75.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 1.0 109.376 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -60.95 -41.59 96.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 1.0 109.391 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -65.14 -40.34 94.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 1.0 109.214 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.83 -42.71 99.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 1.0 109.51 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.37 -46.13 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 1.0 109.575 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 1.0 109.404 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' X' ' 44' ' ' TRP . 85.5 m-20 -70.64 -19.3 62.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 1.0 109.694 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 22.2 m -54.9 -52.92 61.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.0 109.445 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.672 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -112.89 -63.65 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 1.0 109.466 -177.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.09 -40.61 4.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.904 2.403 . . . . 1.0 112.15 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.4 m-90 -146.08 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 1.0 109.537 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 172.29 -45.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 1.0 109.889 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.5 Cg_exo -56.1 -35.37 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.693 2.262 . . . . 1.0 112.368 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -64.4 127.98 33.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 1.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -142.15 168.85 18.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 109.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.88 165.63 37.69 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 15.6 m -64.31 141.3 58.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -1.217 . . . . 1.0 109.371 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.652 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -130.0 135.12 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.652 ' N ' HD13 ' X' ' 51' ' ' ILE . 38.8 m-20 -68.85 138.25 54.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 1.0 109.779 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.91 -25.02 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 1.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.97 -40.49 95.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 1.0 109.358 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -76.21 -18.74 58.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 1.0 109.258 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.3 t90 -54.64 -39.09 67.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -62.66 -41.31 99.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.0 109.496 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.454 ' NH2' HD13 ' X' ' 19' ' ' LEU . 79.0 mtp85 -66.61 -38.46 87.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 1.0 109.477 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.525 HG21 ' CH2' ' X' ' 83' ' ' TRP . 51.1 t -63.31 -43.98 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 1.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.7 84.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 1.0 109.511 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -66.18 -37.27 85.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -1.197 . . . . 1.0 109.512 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 82.5 m -69.95 -50.43 42.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 1.0 109.522 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.471 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.5 m-85 -61.11 -43.09 99.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 1.0 109.492 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.6 -40.14 86.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 1.0 109.439 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.68 -45.91 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 1.0 109.373 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -64.53 -35.06 79.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.485 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' X' ' 71' ' ' GLY . 1.9 t80 -59.29 -54.71 43.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 1.0 109.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.442 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 38.7 t30 -64.41 -36.71 85.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 1.0 109.281 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -67.72 -45.19 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 1.0 109.277 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.27 -52.23 2.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 1.0 109.312 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.74 -168.32 24.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.439 -1.464 . . . . 1.0 109.439 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -65.71 -20.07 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.914 2.409 . . . . 1.0 111.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.66 -54.84 39.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 1.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -64.21 -42.98 96.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 1.0 109.352 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.73 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.8 m -150.44 91.38 4.15 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 1.0 109.432 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -82.83 179.97 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.862 2.375 . . . . 1.0 112.213 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.62 -23.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 1.0 109.486 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.464 ' H ' HG23 ' X' ' 78' ' ' THR . 6.5 p -60.85 -34.95 75.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 1.0 109.423 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.38 72.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -69.86 -37.78 76.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -59.88 -46.98 87.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 1.0 109.403 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -61.9 -40.14 94.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.513 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.668 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.6 t-105 -66.0 -36.18 82.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -58.05 -41.67 83.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 1.0 109.255 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.49 -38.26 90.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.41 -0.806 . . . . 1.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.57 -42.7 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 1.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -57.71 -43.35 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0 109.395 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.25 -36.65 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 1.0 109.383 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.8 -51.95 59.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 1.0 109.352 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 pt -71.41 -41.09 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.0 109.411 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.33 -51.65 67.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.501 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.78 -40.68 92.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 1.0 109.541 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.16 138.77 39.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 1.0 109.533 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.69 93.85 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 1.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.0 109.564 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.26 131.28 41.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 1.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -96.91 104.54 16.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 1.0 109.486 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -77.64 170.19 17.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.868 . . . . 1.0 109.575 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -50.79 -43.17 58.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 1.0 109.379 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -68.14 -49.0 63.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 1.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.89 -35.87 77.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 1.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -60.86 -41.28 95.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 1.0 109.562 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.7 -36.04 79.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 1.0 109.464 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.41 -45.31 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 1.0 109.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.74 -45.97 81.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 1.0 109.398 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.95 -38.92 90.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 1.0 108.911 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.77 -43.14 99.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 1.0 108.765 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.542 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.26 -38.6 87.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 1.0 109.486 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.46 -46.95 87.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 1.0 109.145 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.15 93.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.313 -0.867 . . . . 1.0 109.44 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' X' ' 19' ' ' LEU . 97.1 mt -67.08 -40.69 87.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 1.0 109.23 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.19 -42.07 80.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.903 . . . . 1.0 109.242 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 70.3 p -64.96 -33.93 77.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.845 . . . . 1.0 109.299 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.95 -17.64 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 1.0 109.169 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.17 48.24 0.53 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.28 -1.528 . . . . 1.0 109.28 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.92 133.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 1.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -132.0 99.0 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 1.0 109.224 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.23 163.22 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 1.0 109.357 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.92 148.81 32.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 1.0 109.499 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.542 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 59.0 m-85 -63.75 -42.93 97.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.224 -0.923 . . . . 1.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.95 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 1.0 109.455 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.25 -40.34 93.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 1.0 109.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.454 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.1 -45.93 91.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 1.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.13 -41.68 99.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 1.0 109.394 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.509 ' HZ3' ' H ' ' X' ' 50' ' ' THR . 98.4 mttt -67.24 -35.83 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.34 -50.26 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 1.0 109.493 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -61.03 -41.49 96.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.0 109.417 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.56 -39.74 95.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 1.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.37 -45.58 91.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -0.802 . . . . 1.0 109.508 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 76.7 t -58.27 -49.21 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 1.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.5 mttt -64.0 -31.5 72.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.8 m-20 -67.67 -19.14 65.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.85 . . . . 1.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 9.8 m -53.78 -48.43 69.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 1.0 109.403 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.821 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -122.73 -59.6 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.821 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.5 Cg_exo -41.47 -45.69 6.03 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.88 2.386 . . . . 1.0 112.219 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.7 m-90 -139.02 113.67 9.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.152 -0.967 . . . . 1.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -64.91 -43.72 69.4 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 1.0 109.875 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -55.93 130.77 42.13 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.79 2.327 . . . . 1.0 112.373 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -119.05 133.45 55.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 1.0 109.707 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -142.51 127.72 18.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.887 . . . . 1.0 109.789 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.74 147.73 5.38 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . 0.509 ' H ' ' HZ3' ' X' ' 33' ' ' LYS . 31.4 m -88.68 143.26 27.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.099 -1.236 . . . . 1.0 109.414 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.679 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -117.14 130.27 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 1.0 109.538 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.679 ' N ' HD13 ' X' ' 51' ' ' ILE . 45.1 t0 -71.88 136.79 47.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 1.0 109.784 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.74 -25.4 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 1.0 109.464 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.96 -38.66 91.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 1.0 109.396 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -82.74 -18.88 39.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 1.0 109.296 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 11.9 t90 -60.13 -38.38 82.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.0 109.64 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.563 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 31.8 mmt180 -56.88 -43.64 81.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 109.478 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.476 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.8 mtp180 -68.75 -39.4 80.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 1.0 109.479 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -61.62 -46.55 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 1.0 109.372 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.49 -48.66 68.92 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.14 -33.99 77.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 1.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.5 m -69.23 -54.04 16.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 1.0 109.454 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -64.14 -43.37 95.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 1.0 109.482 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.4 -32.2 72.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 1.0 109.467 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.43 -45.87 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 1.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -72.67 -28.86 62.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 1.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' X' ' 71' ' ' GLY . 45.1 t80 -60.03 -53.4 58.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 1.0 109.402 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -69.48 -35.67 75.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 1.0 109.336 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.1 m -62.08 -45.86 91.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 1.0 109.258 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.19 -51.25 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 1.0 109.2 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.85 -158.5 24.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.8 -13.89 17.59 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.89 2.393 . . . . 1.0 111.953 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.93 -51.6 66.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 1.0 109.213 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -64.36 -40.82 96.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 1.0 109.309 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.78 83.92 9.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 1.0 109.418 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' X' ' 78' ' ' THR . 43.5 Cg_exo -55.46 154.41 24.63 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.827 2.352 . . . . 1.0 112.265 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.493 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.9 p -53.39 -6.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 1.0 109.438 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.518 ' H ' ' C ' ' X' ' 76' ' ' PRO . 63.1 p -61.19 -41.21 96.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.87 . . . . 1.0 109.391 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.62 75.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 1.0 109.385 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -61.13 -42.8 99.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 1.0 109.425 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -63.22 -46.63 86.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -63.19 -41.74 99.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.576 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.599 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.6 t-105 -61.42 -37.53 83.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 1.0 109.367 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.95 -44.14 78.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 1.0 109.191 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.578 ' O ' HD13 ' X' ' 89' ' ' LEU . 98.8 mt -65.66 -40.09 92.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 1.0 109.552 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -61.6 -41.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.243 -0.91 . . . . 1.0 109.395 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.93 -39.95 79.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 1.0 109.481 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -71.09 -36.73 72.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.389 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.578 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -65.72 -43.27 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 1.0 109.386 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.437 HG22 HG23 ' X' ' 50' ' ' THR . 7.5 pt -78.92 -20.74 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 1.0 109.335 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.34 -50.07 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.485 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -41.23 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 1.0 109.54 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.54 139.54 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 1.0 109.573 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -75.86 92.27 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.0 109.538 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 1.0 109.593 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.46 145.04 47.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 1.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.89 94.79 10.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 1.0 109.511 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -78.41 176.22 9.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.593 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -54.28 -45.84 72.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 1.0 109.436 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.35 -42.49 92.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.46 -39.69 88.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 1.0 109.469 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.61 -42.23 92.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 1.0 109.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -59.33 -35.37 73.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 1.0 109.415 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.4 -44.72 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.0 109.305 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' X' ' 28' ' ' TYR . 46.1 tp10 -55.92 -47.7 77.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 1.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -66.53 -37.13 84.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 1.0 108.868 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.24 -42.65 98.98 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 1.0 108.803 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.553 ' HZ2' ' N ' ' X' ' 28' ' ' TYR . 88.5 tttt -61.85 -42.06 98.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 1.0 109.555 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -52.52 -49.91 63.87 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.177 -0.952 . . . . 1.0 109.158 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.57 80.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.0 109.422 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.434 HD23 HG11 ' X' ' 24' ' ' VAL . 9.8 tp -61.19 -40.38 93.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 1.0 109.251 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.68 -40.71 80.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.303 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -58.61 -33.88 70.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.449 -0.782 . . . . 1.0 109.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.87 -9.97 56.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 1.0 109.19 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.31 44.33 2.2 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.434 HG11 HD23 ' X' ' 19' ' ' LEU . 25.1 t -122.32 135.24 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 1.0 109.387 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -131.36 94.81 3.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.0 109.22 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.471 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 35.3 m -132.8 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 1.0 109.366 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . 0.547 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 68.2 mttm -73.33 147.89 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 109.47 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.562 ' CE2' HD11 ' X' ' 32' ' ' LEU . 51.8 t80 -59.07 -39.28 81.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.203 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.55 59.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 1.0 109.493 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.516 ' CG ' ' CG ' ' X' ' 55' ' ' PHE . 30.2 t0 -61.15 -43.56 98.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 1.0 109.404 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.0 mm? -61.62 -45.35 94.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 1.0 109.409 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' X' ' 28' ' ' TYR . 97.2 mt -63.7 -42.11 98.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 1.0 109.351 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -36.0 82.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 1.0 109.415 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.779 ' O ' HG23 ' X' ' 38' ' ' VAL . 56.2 t80 -57.53 -46.65 83.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 1.0 109.413 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.1 -41.77 90.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 1.0 109.308 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -63.34 -44.07 95.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 109.266 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 38.8 t80 -61.34 -43.59 98.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.779 HG23 ' O ' ' X' ' 34' ' ' PHE . 50.5 t -59.46 -47.46 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.0 109.535 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.82 -36.76 80.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 1.0 109.425 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' X' ' 44' ' ' TRP . 84.6 m-20 -69.11 -19.65 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 1.0 109.639 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 96.4 m -54.44 -47.78 72.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 1.0 109.41 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.712 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -119.16 -64.34 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 1.0 109.461 -178.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.0 Cg_exo -40.69 -33.82 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.89 2.393 . . . . 1.0 112.174 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 6.2 m-90 -155.94 100.95 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 1.0 109.468 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.684 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -71.22 -39.92 8.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 1.0 109.901 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 26.0 Cg_exo -60.87 -34.32 91.39 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.703 2.269 . . . . 1.0 112.369 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . 0.427 ' OE1' ' OD1' ' X' ' 40' ' ' ASP . 84.4 mt-30 -65.65 124.77 23.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 1.0 109.656 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -144.4 175.16 10.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 1.0 109.847 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.82 165.58 34.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.1 m -69.92 137.52 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -1.187 . . . . 1.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.58 139.68 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 1.0 109.504 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -94.26 133.84 37.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 1.0 109.751 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mm -48.71 -23.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 1.0 109.481 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.47 -43.25 90.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 109.353 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' X' ' 55' ' ' PHE . 1.0 OUTLIER -79.79 -16.35 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 1.0 109.296 -178.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 18.1 t90 -59.32 -43.05 92.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 1.0 109.646 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.599 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 32.9 mmt180 -59.72 -42.08 92.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 1.0 109.493 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 63.4 mtp85 -71.55 -46.34 59.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 1.0 109.437 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.586 HG11 ' CH2' ' X' ' 83' ' ' TRP . 81.2 t -64.29 -47.92 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 1.0 109.282 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.15 -47.02 84.1 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -66.15 -37.71 86.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.172 . . . . 1.0 109.462 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 98.7 m -64.11 -56.24 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 1.0 109.48 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.6 m-85 -61.15 -44.77 96.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 1.0 109.459 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.71 -36.94 84.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 1.0 109.49 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.73 -47.15 86.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.0 109.344 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.22 -29.54 68.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.458 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' X' ' 71' ' ' GLY . 39.9 t80 -62.42 -55.05 31.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 1.0 109.429 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -67.52 -34.91 78.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 1.0 109.33 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -66.34 -51.38 57.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 1.0 109.331 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -108.93 -52.44 2.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.85 -162.17 26.29 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' ' N ' ' X' ' 76' ' ' PRO . 18.9 Cg_endo -74.77 -17.88 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.946 2.431 . . . . 1.0 111.956 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.89 -52.12 66.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 1.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -64.78 -39.32 93.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 1.0 109.371 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.91 79.69 13.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 1.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' X' ' 78' ' ' THR . 45.8 Cg_exo -55.33 155.0 21.55 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.772 2.315 . . . . 1.0 112.222 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.79 -5.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.519 ' H ' ' C ' ' X' ' 76' ' ' PRO . 62.2 p -61.11 -33.88 74.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 1.0 109.44 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.3 -36.87 79.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 1.0 109.372 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.89 . . . . 1.0 109.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -61.85 -49.12 77.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 1.0 109.4 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.85 -41.97 95.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 1.0 109.524 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.586 ' CH2' HG11 ' X' ' 59' ' ' VAL . 9.4 t-105 -67.07 -34.66 78.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.89 -43.28 85.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.0 109.243 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' X' ' 85' ' ' LEU . 98.5 mt -67.47 -38.14 83.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.592 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.24 -44.07 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 1.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.41 -43.78 84.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 1.0 109.441 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.89 -36.54 72.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 1.0 109.355 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.56 -50.69 66.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 1.0 109.35 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.42 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.1 pt -70.45 -42.29 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.42 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 86.2 m-20 -61.53 -47.45 85.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.0 109.475 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.03 -38.85 92.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 1.0 109.614 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.93 135.65 49.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.0 109.508 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -88.74 113.21 24.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 1.0 109.638 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.0 109.626 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 80.1 mm-40 -59.87 134.41 57.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 1.0 109.545 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.87 99.76 12.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 1.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -79.61 171.68 14.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 1.0 109.563 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -55.59 -42.96 75.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 1.0 109.436 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -66.36 -44.41 83.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 1.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 90.7 mt-10 -63.3 -33.34 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 1.0 109.427 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -70.52 -39.41 74.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 1.0 109.607 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.95 -49.12 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 1.0 109.364 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' X' ' 35' ' ' PHE . 27.6 m -69.16 -34.18 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 1.0 109.324 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.2 -43.1 92.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.261 -0.9 . . . . 1.0 109.289 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.67 -34.2 77.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 1.0 108.916 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.8 -41.12 99.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.356 -0.84 . . . . 1.0 108.847 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.475 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 87.6 tttt -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.756 . . . . 1.0 109.566 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.44 -45.19 84.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 1.0 109.195 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.69 -39.75 91.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 1.0 109.403 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.77 -38.88 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 1.0 109.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 1.0 109.238 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 45.8 p -62.92 -31.37 72.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.09 -17.57 61.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 1.0 109.145 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.29 47.18 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -119.06 130.46 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.429 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.19 98.43 4.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.94 . . . . 1.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.96 160.12 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 109.288 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -74.4 143.99 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 1.0 109.489 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.475 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 63.9 m-85 -61.74 -41.42 97.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.204 -0.935 . . . . 1.0 109.26 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.77 53.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 1.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' CG ' ' X' ' 55' ' ' PHE . 15.4 t70 -63.18 -39.5 94.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 1.0 109.448 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' X' ' 31' ' ' LEU . 4.4 mm? -62.39 -45.56 92.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 1.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.03 -42.95 99.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 1.0 109.364 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.6 mttt -65.02 -38.86 92.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 1.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -58.31 -49.62 76.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 1.0 109.391 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG11 ' X' ' 12' ' ' VAL . 58.3 m-85 -63.08 -44.14 96.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 1.0 109.404 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.23 -37.54 80.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 1.0 109.265 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.76 -46.78 88.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.918 . . . . 1.0 109.533 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.44 -44.34 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 1.0 109.548 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.29 -25.58 64.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.5 m-20 -73.56 -19.58 60.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.867 . . . . 1.0 109.658 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -54.11 -41.29 68.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 1.0 109.418 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.699 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -128.06 -64.4 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.473 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.699 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 53.9 Cg_exo -40.84 -40.1 3.45 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.879 2.386 . . . . 1.0 112.183 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.517 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -142.66 116.34 9.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 1.0 109.527 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.656 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -66.5 -41.72 42.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 1.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 27.1 Cg_exo -60.82 137.72 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.768 2.312 . . . . 1.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.92 147.74 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 1.0 109.654 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -141.33 157.19 45.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 1.0 109.807 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 164.3 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . 0.626 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 41.6 m -114.5 129.82 56.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 1.0 109.311 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.0 136.08 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 1.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.67 137.54 36.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 1.0 109.757 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.13 -23.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 1.0 109.437 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -64.68 -39.29 93.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 1.0 109.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . 0.544 ' CG ' ' OD1' ' X' ' 30' ' ' ASP . 3.1 t80 -85.2 -9.98 57.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.955 . . . . 1.0 109.283 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t90 -57.64 -38.24 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 1.0 109.646 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' X' ' 57' ' ' ARG . 14.3 mmm180 -61.41 -38.95 88.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 1.0 109.539 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 76.9 mtp180 -70.19 -36.88 74.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 1.0 109.418 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.535 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 79.4 t -65.32 -42.16 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 1.0 109.315 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.53 -48.77 84.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -66.08 -40.14 90.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -1.141 . . . . 1.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 89.3 m -64.56 -54.28 34.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 1.0 109.509 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.96 -44.46 94.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 1.0 109.446 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -60.1 -37.87 81.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 1.0 109.478 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.38 -41.44 98.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 1.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -66.24 -38.6 88.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.3 -52.45 65.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 1.0 109.402 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.61 -30.14 69.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 1.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.1 m -61.65 -48.14 82.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 1.0 109.257 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 -52.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 1.0 109.269 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.68 29.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' X' ' 76' ' ' PRO . 23.2 Cg_exo -60.17 -23.71 74.64 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.969 2.446 . . . . 1.0 111.899 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -52.44 -51.95 56.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.164 -0.96 . . . . 1.0 109.231 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.0 -42.43 99.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.354 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.4 81.09 14.1 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 1.0 109.485 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.7 Cg_exo -59.62 161.75 17.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.818 2.345 . . . . 1.0 112.277 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.491 ' O ' HG12 ' X' ' 77' ' ' VAL . 76.8 t -50.19 -9.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 1.0 109.444 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.513 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.1 p -60.21 -35.85 76.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 1.0 109.413 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.94 94.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 1.0 109.414 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.22 -42.8 93.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 1.0 109.411 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -62.77 -45.91 90.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.426 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.513 ' OH ' ' CD2' ' X' ' 45' ' ' PHE . 18.7 m-85 -63.72 -43.25 97.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 1.0 109.475 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.535 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 7.2 t-105 -63.45 -36.87 85.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 1.0 109.389 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.78 -43.54 80.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.4 -0.813 . . . . 1.0 109.223 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.27 -40.59 86.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 1.0 109.613 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -61.5 -42.48 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 1.0 109.241 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -43.2 88.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 1.0 109.508 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 97.0 mt-10 -70.91 -24.61 62.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 1.0 109.347 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.13 -49.3 12.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 6.5 pt -70.47 -42.4 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 1.0 109.426 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 16.6 p-10 -67.69 -9.51 44.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 1.0 109.491 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.428 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 88.5 tttt -62.48 -48.1 81.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 1.0 109.556 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -115.23 125.46 53.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 1.0 109.452 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -71.03 125.69 27.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 1.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 109.566 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 131.24 49.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 1.0 109.551 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.97 89.61 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 1.0 109.626 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.1 p -82.88 174.99 10.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 1.0 109.554 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -53.14 -41.02 64.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.237 -0.914 . . . . 1.0 109.282 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . 0.547 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 5.1 m-70 -69.25 -43.69 73.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 1.0 109.415 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.96 -39.25 93.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 1.0 109.602 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.93 -36.83 84.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 109.567 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -61.06 -49.73 76.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 1.0 109.925 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.24 -34.25 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 1.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.57 -35.43 80.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.459 -0.776 . . . . 1.0 109.226 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -68.24 -39.16 82.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 1.0 108.959 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -61.43 -41.24 96.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 1.0 108.961 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.28 -40.5 94.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 1.0 109.395 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -56.2 -44.74 79.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 1.0 109.067 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -36.73 82.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 1.0 109.227 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' X' ' 19' ' ' LEU . 93.8 mt -63.27 -38.74 92.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 1.0 109.068 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.53 -41.38 85.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 1.0 109.092 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -60.14 -39.14 85.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 1.0 109.103 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.41 -16.92 63.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 1.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.58 53.15 0.73 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.549 ' CG2' HH21 ' X' ' 58' ' ' ARG . 38.2 t -122.06 133.4 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.583 -0.951 . . . . 1.0 109.325 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.18 96.52 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' X' ' 54' ' ' LYS . 27.6 m -133.31 163.99 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 1.0 109.503 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.45 147.78 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.9 -39.95 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 1.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.26 -31.69 63.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.0 109.358 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -59.96 -42.2 93.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 1.0 109.227 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.427 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 1.0 109.359 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.26 -41.27 97.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.797 . . . . 1.0 109.28 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.27 -34.74 79.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 1.0 109.394 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.97 -48.86 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 1.0 109.693 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.18 -45.33 93.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.249 -0.907 . . . . 1.0 109.621 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -64.13 -37.85 88.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.0 109.13 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.14 -45.67 92.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 1.0 109.428 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.03 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 1.0 109.595 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.46 -32.69 74.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.011 0.91 . . . . 1.0 109.629 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.4 m-20 -68.26 -20.38 64.79 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.766 -1.209 . . . . 1.0 109.757 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 m -55.15 -57.46 11.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.878 -1.138 . . . . 1.0 110.708 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.636 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.1 OUTLIER -109.85 -59.6 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.042 0 O-C-N 121.514 -0.741 . . . . 1.0 110.634 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.636 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.1 Cg_exo -42.2 -42.25 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.494 2.129 . . . . 1.0 112.701 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.8 m-90 -142.62 -158.91 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 1.0 109.361 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.535 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 2.2 t80 -171.84 49.37 0.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 1.0 109.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 29.3 Cg_endo -67.32 -166.42 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.709 2.273 . . . . 1.0 112.132 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.08 140.6 35.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 1.0 109.581 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.4 134.99 42.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 1.0 109.758 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.03 -178.43 43.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.791 -1.324 . . . . 1.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 14.4 m -71.2 141.7 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -1.193 . . . . 1.0 109.275 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.685 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.77 133.58 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.761 0.791 . . . . 1.0 109.212 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.685 ' N ' HD13 ' X' ' 51' ' ' ILE . 56.5 t0 -71.82 136.97 47.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.64 -1.287 . . . . 1.0 110.012 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 63.7 mt -66.56 -21.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.79 -1.194 . . . . 1.0 109.259 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.572 ' HB2' HG12 ' X' ' 26' ' ' VAL . 65.4 mmtt -64.95 -40.05 94.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 1.0 109.595 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -84.39 -9.64 58.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 1.0 109.616 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.505 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 11.0 t90 -53.67 -39.88 65.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 1.0 109.795 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' X' ' 57' ' ' ARG . 24.5 mmm-85 -62.24 -37.23 84.62 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.172 -0.955 . . . . 1.0 109.486 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.549 HH21 ' CG2' ' X' ' 24' ' ' VAL . 85.6 mmt-85 -68.31 -42.89 78.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.351 -0.843 . . . . 1.0 109.781 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.62 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 93.3 t -61.38 -45.13 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.29 -0.882 . . . . 1.0 109.26 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.55 97.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.68 -42.2 91.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.255 -1.144 . . . . 1.0 109.671 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.92 -50.67 61.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 1.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.48 -44.75 96.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.0 109.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.96 -35.58 75.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.181 -0.949 . . . . 1.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -64.7 -46.16 83.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 1.0 109.412 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 1.0 109.428 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' X' ' 71' ' ' GLY . 9.1 t80 -59.37 -53.29 59.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 1.0 109.716 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.448 ' O ' ' OD1' ' X' ' 68' ' ' ASN . 51.6 t-20 -64.5 -35.92 82.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.856 -1.153 . . . . 1.0 109.473 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -65.02 -45.35 85.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.213 -0.929 . . . . 1.0 109.99 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.34 -51.87 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.141 -0.623 . . . . 1.0 109.893 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 138.74 -164.05 25.78 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 1.0 109.388 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' X' ' 76' ' ' PRO . 8.6 Cg_exo -66.41 -20.65 54.53 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.97 2.446 . . . . 1.0 111.948 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.37 -53.81 52.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 1.0 109.474 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.44 -37.27 86.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.361 -0.837 . . . . 1.0 109.667 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.706 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.5 m -143.59 81.21 12.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.566 -0.709 . . . . 1.0 109.198 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.502 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.0 Cg_exo -59.03 155.11 40.83 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 123.057 2.504 . . . . 1.0 112.287 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.473 ' O ' HG12 ' X' ' 77' ' ' VAL . 72.3 t -51.91 -10.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 1.0 109.303 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.453 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.4 t -62.28 -33.44 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.94 -45.08 91.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.324 -0.86 . . . . 1.0 109.129 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.33 -43.43 97.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 1.0 109.479 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -61.94 -45.69 92.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 1.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -64.41 -37.22 86.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 1.0 109.433 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.62 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 9.1 t-105 -64.59 -35.54 81.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.87 . . . . 1.0 109.092 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.14 -43.52 95.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 1.0 109.092 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.07 -39.1 93.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.422 -0.799 . . . . 1.0 109.133 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.24 -42.47 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.0 109.552 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.505 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 63.4 mttt -55.96 -43.26 77.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.71 -35.65 79.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.923 -1.11 . . . . 1.0 109.485 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.72 -49.18 71.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.935 . . . . 1.0 109.835 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.8 pt -71.96 -40.95 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 1.0 109.308 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.32 -44.61 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.406 -0.809 . . . . 1.0 109.481 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.51 -43.19 94.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 1.0 109.401 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.0 126.17 30.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.139 -0.976 . . . . 1.0 109.498 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.81 127.91 34.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 1.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 1.0 109.465 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.319 0.58 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -58.42 138.3 56.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 1.0 109.584 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' X' ' 5' ' ' LEU . 74.6 mt -98.82 103.57 15.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 1.0 109.495 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.2 p -79.29 171.3 15.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 1.0 109.571 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.5 -40.9 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 1.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.64 -46.2 76.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 1.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -62.51 -38.35 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 1.0 109.405 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -61.49 -40.91 96.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 1.0 109.551 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.95 -36.45 77.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.195 -0.941 . . . . 1.0 109.475 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.03 -44.15 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 1.0 109.34 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.95 -48.06 73.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.286 -0.884 . . . . 1.0 109.317 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -65.62 -36.31 83.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 1.0 108.805 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' X' ' 15' ' ' LEU . 60.3 tp -63.05 -41.76 99.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.291 -0.881 . . . . 1.0 108.834 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 1.0 109.499 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -55.99 -46.88 78.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.19 -0.944 . . . . 1.0 109.122 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.38 -41.01 96.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.378 -0.827 . . . . 1.0 109.343 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' X' ' 19' ' ' LEU . 90.7 mt -64.87 -36.44 84.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 1.0 109.287 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.89 -38.27 87.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 1.0 109.229 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 76.0 p -65.79 -33.47 75.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 1.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -70.78 -19.36 62.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 1.0 109.243 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.29 47.14 0.39 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.325 -1.51 . . . . 1.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -121.55 133.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -1.105 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.99 91.38 2.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.268 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.73 162.15 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 1.0 109.311 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.12 147.05 32.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 1.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -62.68 -34.5 77.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 1.0 109.225 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.35 69.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 1.0 109.403 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 1.0 109.386 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.519 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -60.35 -44.39 95.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 1.0 109.361 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -42.14 99.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.409 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.03 -33.57 76.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.359 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.482 ' O ' HG23 ' X' ' 38' ' ' VAL . 51.2 t80 -59.39 -46.01 89.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 1.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.26 -44.51 96.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 1.0 109.402 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.63 -44.32 94.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 1.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -63.17 -46.19 88.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 1.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.482 HG23 ' O ' ' X' ' 34' ' ' PHE . 69.7 t -60.39 -44.58 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 1.0 109.569 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 1.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 7.1 m-20 -68.32 -19.84 64.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 1.0 109.667 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . 0.409 HG21 ' O ' ' X' ' 74' ' ' LYS . 99.6 m -54.48 -51.48 64.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 1.0 109.393 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.753 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -118.82 -63.16 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 1.0 109.508 -177.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.753 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.3 Cg_exo -40.79 -54.22 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.897 2.398 . . . . 1.0 112.168 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -118.36 -128.25 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 1.0 109.503 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.754 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.8 OUTLIER -175.28 -41.62 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 1.0 109.908 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.754 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 34.5 Cg_exo -58.17 132.72 50.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 1.0 112.307 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -119.01 159.27 24.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 109.71 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -74.16 158.59 33.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 1.0 109.758 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.74 -4.18 63.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.855 -1.298 . . . . 1.0 109.855 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -119.7 118.28 30.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 1.0 109.308 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.711 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -136.31 135.1 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 109.497 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.711 ' N ' HD13 ' X' ' 51' ' ' ILE . 67.4 t0 -67.27 130.68 43.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.14 -38.61 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 1.0 109.417 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -61.57 -37.72 84.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 1.0 109.4 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -76.36 -24.21 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 1.0 109.305 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.659 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -57.48 -36.46 71.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.612 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.424 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 14.0 mmm180 -60.69 -41.45 95.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 1.0 109.501 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.63 -37.47 79.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 1.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.15 -44.37 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 1.0 109.306 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.35 -48.57 84.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -65.35 -41.12 94.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.163 . . . . 1.0 109.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.24 -42.87 92.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 1.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.44 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.2 m-85 -65.76 -40.02 91.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 1.0 109.483 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.21 -37.95 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 1.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -63.25 -43.93 96.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 1.0 109.307 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.96 -31.73 71.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.477 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' X' ' 71' ' ' GLY . 17.4 t80 -59.65 -55.02 39.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 1.0 109.357 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -68.38 -34.94 76.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 1.0 109.303 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -65.01 -48.03 75.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 1.0 109.283 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -111.75 -52.37 2.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 1.0 109.329 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.97 -165.68 26.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.58 -14.46 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.911 2.407 . . . . 1.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.1 -49.79 74.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.274 -0.891 . . . . 1.0 109.302 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.409 ' O ' HG21 ' X' ' 41' ' ' THR . 59.7 mmtt -66.91 -43.98 81.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 1.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.717 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.3 m -148.46 88.69 5.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 1.0 109.455 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -81.02 -176.0 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.832 2.354 . . . . 1.0 112.267 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -19.67 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 1.0 109.397 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.4 ' H ' HG23 ' X' ' 78' ' ' THR . 19.1 p -59.67 -33.73 71.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 1.0 109.42 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.39 73.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 1.0 109.463 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -61.63 -41.09 96.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.0 t -59.23 -46.01 89.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 1.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.28 -43.88 93.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.659 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.5 t-105 -64.32 -36.16 83.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -55.38 -43.08 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.0 109.207 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 85' ' ' LEU . 96.5 mt -65.52 -40.83 93.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 1.0 109.565 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.27 -42.28 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 1.0 109.346 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.76 -41.3 70.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 1.0 109.41 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.73 -38.75 73.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.948 . . . . 1.0 109.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.31 -49.59 73.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 1.0 109.372 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.409 HD13 HG21 ' X' ' 90' ' ' ILE . 7.2 pt -70.29 -41.18 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 1.0 109.436 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 69.5 m-20 -59.84 -47.08 87.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.95 . . . . 1.0 109.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.83 -41.82 97.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.61 137.48 38.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.918 . . . . 1.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 1.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.0 109.537 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mt-10 -62.41 146.51 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.517 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.12 101.84 14.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 109.484 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.3 p -83.48 170.28 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 1.0 109.431 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -54.09 -43.19 70.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 1.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -64.65 -43.49 93.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.878 . . . . 1.0 109.543 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 99.2 mt-10 -67.78 -34.91 77.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 1.0 109.371 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.3 -38.28 84.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.882 . . . . 1.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.08 -51.16 69.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.41 -33.29 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 1.0 109.261 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.21 -42.3 85.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.893 . . . . 1.0 109.177 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -63.75 -39.74 95.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.94 . . . . 1.0 108.766 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.45 -40.25 86.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.39 -43.7 98.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 1.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.424 ' O ' HG23 ' X' ' 21' ' ' THR . 99.4 mm-40 -55.91 -44.11 77.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 1.0 109.024 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.8 96.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 1.0 109.276 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' X' ' 19' ' ' LEU . 95.6 mt -65.11 -38.04 89.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -0.899 . . . . 1.0 109.22 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -60.11 -41.39 92.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 1.0 109.297 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.424 HG23 ' O ' ' X' ' 17' ' ' GLN . 69.5 p -63.06 -31.95 73.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.865 . . . . 1.0 109.233 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.29 -17.96 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.0 109.19 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.65 46.61 0.52 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.584 HG22 HH21 ' X' ' 58' ' ' ARG . 55.4 t -121.22 133.33 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.353 -1.086 . . . . 1.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.92 93.57 2.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 1.0 109.215 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.12 161.21 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 1.0 109.342 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -70.36 146.97 50.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.917 . . . . 1.0 109.491 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.67 -35.46 80.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 1.0 109.235 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.9 -34.48 69.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 1.0 109.409 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.16 -44.19 92.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 1.0 109.341 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.496 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.04 -45.96 91.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 1.0 109.436 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.49 -42.65 98.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 1.0 109.395 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.75 -34.36 75.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 1.0 109.384 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.438 ' O ' HG23 ' X' ' 38' ' ' VAL . 41.1 t80 -58.76 -48.46 81.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 1.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -62.03 -43.72 98.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.99 -42.14 99.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 1.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.4 -43.66 96.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' X' ' 34' ' ' PHE . 84.3 t -56.43 -44.5 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -36.34 83.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 1.0 109.351 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.5 m-20 -68.3 -20.56 64.76 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.089 -1.007 . . . . 1.0 109.588 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -54.44 -52.83 60.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.19 -0.944 . . . . 1.0 109.763 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -112.35 -62.76 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.283 -0.886 . . . . 1.0 109.914 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 77.1 Cg_exo -42.33 -39.05 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.57 2.18 . . . . 1.0 112.062 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 -145.61 -146.16 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 1.0 109.435 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.603 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 174.74 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 1.0 109.902 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -54.9 -34.81 87.35 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.793 2.329 . . . . 1.0 112.396 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.89 124.07 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 1.0 109.675 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.66 158.78 43.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 1.0 109.736 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.76 163.59 31.81 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.328 . . . . 1.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.6 m -63.3 140.05 58.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.0 109.345 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.706 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -129.98 134.79 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 1.0 109.334 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.706 ' N ' HD13 ' X' ' 51' ' ' ILE . 55.9 t0 -72.79 134.36 44.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 1.0 109.811 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.932 HG22 HH12 ' X' ' 57' ' ' ARG . 80.2 mt -64.13 -28.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 1.0 109.55 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.3 -40.05 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 1.0 109.503 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.18 -22.69 52.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.8 t90 -55.96 -37.61 69.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.142 -0.974 . . . . 1.0 109.728 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.932 HH12 HG22 ' X' ' 53' ' ' ILE . 28.6 mmt-85 -58.05 -38.86 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 1.0 109.46 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.584 HH21 HG22 ' X' ' 24' ' ' VAL . 81.4 mmt-85 -68.79 -39.62 80.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.61 -44.34 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 1.0 109.469 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.92 -48.15 74.82 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.93 -37.07 83.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 1.0 109.434 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.8 m -67.71 -51.16 52.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 1.0 109.675 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.07 -41.19 99.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 1.0 109.421 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.11 -38.72 83.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 1.0 109.445 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.91 -44.44 97.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 1.0 109.36 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -64.74 -37.85 89.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 1.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' X' ' 71' ' ' GLY . 6.5 t80 -60.13 -53.81 53.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 1.0 109.535 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.4 -33.81 76.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 1.0 109.286 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -68.37 -44.23 75.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 1.0 109.565 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -122.36 -51.76 1.96 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 1.0 109.673 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.74 -164.29 25.2 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.8 Cg_exo -65.35 -21.51 61.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.941 2.428 . . . . 1.0 112.182 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.44 -53.03 61.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.216 -0.928 . . . . 1.0 109.314 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -66.2 -38.52 88.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 1.0 109.401 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.602 HG23 ' O ' ' X' ' 75' ' ' VAL . 30.5 m -143.4 78.63 14.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.0 109.433 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' X' ' 78' ' ' THR . 35.9 Cg_exo -56.41 156.12 22.83 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.855 2.37 . . . . 1.0 112.362 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.8 p -49.03 -11.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 1.0 109.397 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.507 ' N ' ' O ' ' X' ' 76' ' ' PRO . 68.0 p -59.9 -38.1 81.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.0 109.44 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.61 76.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 1.0 109.397 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -63.67 -44.14 94.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 1.0 109.564 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 50.7 m -61.63 -51.68 67.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 1.0 109.553 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -60.56 -41.84 95.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 1.0 109.484 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.676 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 14.2 t-105 -63.13 -40.36 97.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 1.0 109.289 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -56.27 -38.86 71.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 1.0 108.843 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.14 -42.69 99.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.532 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -61.46 -42.33 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 1.0 109.499 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.753 ' HZ2' HG23 ' X' ' 53' ' ' ILE . 60.8 mmtt -55.69 -40.08 71.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 1.0 109.538 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.2 -37.96 84.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.893 . . . . 1.0 109.544 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.89 -41.91 95.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.217 -0.927 . . . . 1.0 109.843 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.89 -43.14 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.0 109.658 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.91 -48.28 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.0 109.537 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.9 -43.96 94.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 1.0 109.646 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.75 130.53 35.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 1.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.97 130.04 40.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.875 . . . . 1.0 109.55 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 1.0 109.604 -179.746 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' X' ' 6' ' ' SER . 95.4 mt-10 -53.03 121.69 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 1.0 109.5 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 92.7 mt -55.37 85.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 1.0 109.484 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . 0.531 ' N ' ' O ' ' X' ' 4' ' ' GLU . 10.0 p -81.76 171.68 14.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 1.0 109.599 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . 0.457 ' CG ' HH21 ' X' ' 10' ' ' ARG . 96.4 mt-30 -54.86 -45.86 74.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 1.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -66.55 -41.8 88.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 1.0 109.485 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -37.42 84.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 1.0 109.408 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . 0.457 HH21 ' CG ' ' X' ' 7' ' ' GLN . 86.6 mtm180 -70.54 -38.05 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 1.0 109.62 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.58 -49.72 76.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 1.0 109.441 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.94 -27.63 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.0 109.366 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.1 -40.7 90.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 1.0 109.395 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.41 -39.18 88.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.993 . . . . 1.0 108.92 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.52 -40.56 97.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.275 -0.891 . . . . 1.0 108.855 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.508 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.8 tttt -61.48 -38.66 88.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 1.0 109.498 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -57.87 -46.61 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 1.0 109.144 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.819 . . . . 1.0 109.43 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' X' ' 16' ' ' LYS . 92.1 mt -63.35 -38.99 93.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 1.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.19 -44.7 92.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 1.0 109.246 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -56.27 -39.81 73.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 1.0 109.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -68.77 -17.14 63.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 1.0 109.222 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.06 0.66 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 50.1 t -122.72 136.78 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -1.109 . . . . 1.0 109.381 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.71 88.5 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 1.0 109.205 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.7 165.0 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 1.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -77.01 153.74 34.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 1.0 109.45 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.508 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 99.5 m-85 -61.44 -35.22 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 1.0 109.261 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.812 . . . . 1.0 109.432 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 56.5 t0 -58.52 -45.24 89.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 1.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.505 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.2 mm? -63.11 -45.26 92.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 1.0 109.4 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.39 -43.73 93.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.338 -0.851 . . . . 1.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.3 -33.41 73.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.39 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.501 ' O ' HG23 ' X' ' 38' ' ' VAL . 39.0 t80 -58.89 -48.75 80.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 1.0 109.448 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -64.85 -42.22 95.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.2 -43.2 98.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.283 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.04 -45.11 94.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.366 -0.834 . . . . 1.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 34' ' ' PHE . 96.9 t -59.2 -47.49 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 1.0 109.518 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -66.64 -35.71 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 109.395 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' X' ' 44' ' ' TRP . 91.6 m-20 -65.05 -19.38 65.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.673 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -54.29 -61.68 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.972 . . . . 1.0 109.362 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.681 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.77 -60.2 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 1.0 109.509 -178.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.6 Cg_exo -41.36 -44.57 5.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.883 2.389 . . . . 1.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.4 m-90 -143.17 -144.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 1.0 109.504 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.588 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.39 -46.04 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.95 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 31.3 Cg_exo -54.94 -33.77 83.77 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.713 2.276 . . . . 1.0 112.411 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.21 129.08 38.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 1.0 109.672 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.55 163.36 34.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 1.0 109.87 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.87 166.89 31.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.79 -1.324 . . . . 1.0 109.79 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 28.4 m -64.16 129.78 41.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 1.0 109.3 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.45 131.64 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 1.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' X' ' 54' ' ' LYS . 20.3 t0 -94.23 126.09 39.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.885 . . . . 1.0 109.697 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -44.83 -16.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -0.986 . . . . 1.0 109.482 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' X' ' 52' ' ' ASP . 98.9 mttt -67.31 -35.77 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.398 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . 0.569 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 2.3 m-85 -84.33 -10.99 57.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 1.0 109.285 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -58.24 -46.0 86.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 1.0 109.646 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 1.0 109.544 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 34.0 mmt180 -63.2 -47.9 80.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 1.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.706 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 77.7 t -65.06 -44.4 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 1.0 109.367 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.38 -48.65 82.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -66.16 -40.4 90.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -1.125 . . . . 1.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 90.0 m -62.6 -49.42 75.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.915 . . . . 1.0 109.461 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.17 -42.0 99.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 1.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -58.68 -36.46 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 1.0 109.536 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' X' ' 69' ' ' THR . 89.2 m-20 -62.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 1.0 109.326 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -67.98 -34.23 76.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.31 -0.869 . . . . 1.0 109.483 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' X' ' 71' ' ' GLY . 10.0 t80 -61.55 -54.81 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.355 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -63.34 -34.11 77.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 1.0 109.342 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.1 m -68.59 -48.26 64.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.0 109.285 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.23 -52.57 2.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 1.0 109.301 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.52 -163.65 25.18 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.5 Cg_exo -66.06 -23.38 53.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.86 2.373 . . . . 1.0 111.967 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.07 -54.76 34.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 1.0 109.24 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -65.45 -36.0 82.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.403 -0.811 . . . . 1.0 109.331 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.447 HG23 ' O ' ' X' ' 75' ' ' VAL . 11.6 m -145.26 81.4 10.42 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.521 ' N ' ' O ' ' X' ' 72' ' ' PRO . 38.2 Cg_exo -60.27 154.36 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.868 2.379 . . . . 1.0 112.228 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.478 ' O ' HG12 ' X' ' 77' ' ' VAL . 52.0 t -49.93 -11.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 1.0 109.446 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.49 ' N ' ' O ' ' X' ' 76' ' ' PRO . 1.3 t -63.94 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 1.0 109.356 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.03 96.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 1.0 109.418 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -64.92 -44.37 89.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 1.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.9 t -59.09 -45.47 90.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 1.0 109.408 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -65.27 -38.07 89.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 1.0 109.535 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.706 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 8.6 t-105 -66.25 -37.9 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 1.0 109.411 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -55.99 -43.97 78.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 1.0 109.212 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.75 -40.39 96.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.535 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.35 -42.85 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 1.0 109.397 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -59.02 -41.32 87.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 1.0 109.492 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.92 -36.92 72.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 1.0 109.338 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.41 -45.15 88.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 1.0 109.33 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.01 -38.27 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.0 109.448 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.58 -45.14 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 1.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.95 -42.72 99.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.549 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -72.4 146.77 46.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.88 . . . . 1.0 109.498 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -101.9 93.62 5.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 1.0 109.535 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 1.0 109.557 179.8 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.1 mt-10 -60.72 136.7 58.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 1.0 109.58 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.47 100.88 13.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 109.477 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.2 p -77.56 169.63 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.0 109.565 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -52.49 -43.78 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.63 -47.89 71.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 1.0 109.527 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 94.5 mt-10 -60.27 -36.68 78.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 1.0 109.461 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -61.1 -42.62 98.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 1.0 109.63 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -59.7 -35.54 74.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 1.0 109.442 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.54 -44.51 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 109.316 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.38 -48.61 78.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.311 -0.868 . . . . 1.0 109.401 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -62.25 -38.3 88.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.23 -0.919 . . . . 1.0 108.92 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' X' ' 15' ' ' LEU . 62.2 tp -61.28 -43.34 99.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 1.0 108.762 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.85 -37.38 81.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.498 -0.751 . . . . 1.0 109.523 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.654 ' O ' HG23 ' X' ' 21' ' ' THR . 86.8 mt-30 -57.87 -48.49 79.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 1.0 109.121 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.41 79.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 1.0 109.412 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.35 -40.28 95.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -0.843 . . . . 1.0 109.299 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.59 -38.16 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 1.0 109.217 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.654 HG23 ' O ' ' X' ' 17' ' ' GLN . 68.4 p -64.13 -13.66 49.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 1.0 109.279 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.12 7.06 42.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 1.0 109.227 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 38.17 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.0 133.19 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.04 96.84 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 1.0 109.166 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.74 161.71 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 1.0 109.41 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.08 144.99 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 1.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.439 ' HE2' HD11 ' X' ' 32' ' ' LEU . 90.0 t80 -61.98 -37.49 85.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 1.0 109.296 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -33.78 64.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.0 109.492 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.07 -38.43 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.427 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.484 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -61.09 -43.89 98.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 1.0 109.456 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.439 HD11 ' HE2' ' X' ' 28' ' ' TYR . 97.1 mt -64.17 -42.11 96.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 1.0 109.39 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 99.2 mttt -62.63 -38.27 89.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 1.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.56 -50.06 75.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0 109.477 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.65 -42.17 99.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 1.0 109.382 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' X' ' 40' ' ' ASP . 66.2 t0 -63.44 -39.61 94.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 1.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.43 -45.31 88.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 1.0 109.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.43 -47.58 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.96 -33.47 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 1.0 109.367 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.7 m-20 -69.78 -19.95 63.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 1.0 109.7 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 7.5 m -54.96 -61.05 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.0 109.481 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.63 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -103.04 -62.86 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.56 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.5 Cg_exo -41.32 -50.09 4.62 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.867 2.378 . . . . 1.0 112.175 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.497 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.6 m-90 -135.06 -147.19 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 1.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.14 -44.52 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 1.0 109.851 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.0 Cg_exo -58.1 -32.7 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.711 2.274 . . . . 1.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.01 124.14 18.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 1.0 109.735 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' X' ' 82' ' ' TYR . 97.0 mt-10 -141.28 161.64 37.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 1.0 109.789 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.04 169.15 41.23 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . 0.475 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 34.7 m -64.17 138.51 58.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.116 -1.226 . . . . 1.0 109.334 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.69 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.22 135.84 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 1.0 109.479 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.69 ' N ' HD13 ' X' ' 51' ' ' ILE . 85.4 m-20 -71.83 136.29 46.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.854 . . . . 1.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -24.41 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 1.0 109.468 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -65.28 -38.96 91.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.0 109.361 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -80.57 -17.79 50.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 1.0 109.25 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.611 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.6 t90 -54.06 -37.42 64.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 1.0 109.665 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -61.53 -39.85 92.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 1.0 109.479 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -66.39 -40.36 89.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 1.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' X' ' 83' ' ' TRP . 71.4 t -61.36 -45.91 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 1.0 109.35 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -44.11 98.46 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -65.75 -40.13 91.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -1.162 . . . . 1.0 109.462 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.26 -53.66 23.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 109.534 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -61.41 -42.61 99.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 1.0 109.485 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -59.46 -36.92 76.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -62.96 -45.2 93.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 1.0 109.28 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -65.48 -38.06 88.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 1.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' X' ' 71' ' ' GLY . 8.9 t80 -60.14 -53.47 57.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 1.0 109.364 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.28 -38.86 92.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 1.0 109.282 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.8 m -64.13 -49.82 70.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.0 109.281 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.64 -52.24 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 1.0 109.329 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.09 -165.13 24.97 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' X' ' 76' ' ' PRO . 12.6 Cg_exo -65.36 -19.89 61.63 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.911 2.408 . . . . 1.0 111.968 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.86 -54.71 41.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.239 -0.913 . . . . 1.0 109.204 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.86 -37.24 85.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.88 80.15 15.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 1.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.1 Cg_exo -58.01 157.68 24.04 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.895 2.397 . . . . 1.0 112.214 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -51.66 -6.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 1.0 109.462 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.549 ' H ' ' C ' ' X' ' 76' ' ' PRO . 77.0 p -61.78 -32.97 73.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 1.0 109.371 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.07 -49.96 73.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 1.0 109.405 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 67.6 m -59.87 -43.77 94.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 1.0 109.442 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' X' ' 48' ' ' GLU . 1.2 t80 -61.43 -43.25 99.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0 109.491 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.611 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.0 t-105 -65.9 -36.0 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 1.0 109.373 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -56.78 -42.59 79.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 1.0 109.272 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.452 ' O ' HD13 ' X' ' 89' ' ' LEU . 93.0 mt -63.92 -42.6 97.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 1.0 109.587 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.12 -41.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 1.0 109.403 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.33 -39.21 72.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -71.08 -37.42 72.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 1.0 109.394 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.452 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.5 mp -64.73 -46.12 83.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.895 . . . . 1.0 109.412 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -74.65 -39.55 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -61.16 -48.99 79.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 1.0 109.512 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.88 -45.0 79.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 1.0 109.596 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.52 127.11 32.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 1.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.42 132.19 51.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 1.0 109.602 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.47 -0.566 . . . . 1.0 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.45 138.83 12.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 1.0 109.44 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.08 102.46 15.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.739 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.9 p -83.98 168.85 15.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 1.0 109.528 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -52.07 -40.94 61.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 1.0 109.325 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.0 -44.94 83.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 1.0 109.396 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.36 -34.26 76.93 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 1.0 109.427 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.078 -1.014 . . . . 1.0 109.49 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -60.87 -50.26 74.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.97 . . . . 1.0 109.779 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' X' ' 35' ' ' PHE . 17.1 m -64.01 -32.81 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 1.0 109.244 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.05 -44.49 87.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 1.0 109.191 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . 0.472 ' NE2' ' OE1' ' X' ' 17' ' ' GLN . 72.6 tp60 -63.25 -37.46 87.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.918 . . . . 1.0 108.807 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.07 -39.46 89.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -0.904 . . . . 1.0 108.751 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.59 -43.12 97.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 1.0 109.095 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.537 ' O ' HG23 ' X' ' 21' ' ' THR . 87.0 mt-30 -54.97 -42.26 72.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 1.0 108.77 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.26 -44.26 92.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 1.0 109.192 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.547 ' CD2' HH21 ' X' ' 22' ' ' ARG . 8.8 mt -63.15 -41.37 99.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.083 -1.01 . . . . 1.0 109.366 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.32 -38.94 91.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.278 -0.889 . . . . 1.0 109.507 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.537 HG23 ' O ' ' X' ' 17' ' ' GLN . 52.4 p -64.46 -29.83 70.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.433 -0.792 . . . . 1.0 109.345 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.547 HH21 ' CD2' ' X' ' 19' ' ' LEU . 77.7 mtm180 -78.48 -13.46 59.82 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 1.0 109.554 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.03 48.21 0.73 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.52 135.58 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.715 -0.874 . . . . 1.0 109.041 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -130.09 97.3 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.406 -0.808 . . . . 1.0 109.252 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.651 HG11 HH11 ' X' ' 58' ' ' ARG . 27.7 m -134.41 160.36 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.596 -0.69 . . . . 1.0 109.559 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.17 152.32 32.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 1.0 109.675 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -63.99 -34.66 78.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 1.0 108.939 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -29.28 70.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 1.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.555 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 41.9 t0 -59.37 -48.48 81.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.0 109.179 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.562 ' CD2' HH22 ' X' ' 58' ' ' ARG . 10.6 mt -62.36 -42.96 99.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.937 . . . . 1.0 108.912 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.76 -42.66 99.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.265 -0.897 . . . . 1.0 108.972 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.719 ' HZ1' ' H ' ' X' ' 50' ' ' THR . 98.0 mttt -67.55 -35.04 78.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 1.0 109.178 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.593 ' O ' HG23 ' X' ' 38' ' ' VAL . 30.1 t80 -59.05 -48.92 79.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 1.0 109.879 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' X' ' 12' ' ' VAL . 46.0 m-85 -63.51 -43.47 97.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 1.0 109.647 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -63.38 -40.79 98.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 1.0 109.274 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.632 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 53.5 t80 -61.6 -46.22 90.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.665 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.593 HG23 ' O ' ' X' ' 34' ' ' PHE . 58.6 t -57.64 -39.36 69.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.048 -1.032 . . . . 1.0 109.039 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.21 -20.01 45.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 1.0 109.543 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' NE2' ' X' ' 47' ' ' GLN . 95.9 m-20 -68.13 -19.95 64.86 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.959 -1.088 . . . . 1.0 109.409 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 18.9 m -55.31 -43.51 74.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 1.0 110.332 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.649 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.7 OUTLIER -126.04 -63.12 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.538 -0.726 . . . . 1.0 109.929 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 50.3 Cg_exo -42.02 -44.07 7.22 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.662 2.242 . . . . 1.0 112.394 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.9 m0 -139.72 -146.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 109.216 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -174.42 -45.24 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 1.0 109.769 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 39.2 Cg_exo -58.66 140.27 94.21 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.612 2.208 . . . . 1.0 112.252 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . 0.459 ' NE2' ' OD2' ' X' ' 40' ' ' ASP . 88.7 mm-40 -105.7 158.0 17.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.592 -0.693 . . . . 1.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.69 146.04 47.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 1.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.55 -155.92 29.9 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.331 -1.507 . . . . 1.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . 0.719 ' H ' ' HZ1' ' X' ' 33' ' ' LYS . 91.4 m -128.42 131.81 48.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.565 -0.962 . . . . 1.0 109.567 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.98 131.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.944 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' X' ' 54' ' ' LYS . 24.7 t0 -93.97 127.36 39.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 1.0 109.141 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -46.87 -16.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 1.0 109.495 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' X' ' 52' ' ' ASP . 65.1 mmtt -66.19 -35.51 80.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 1.0 109.635 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . 0.555 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 1.0 OUTLIER -83.25 -11.6 57.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 1.0 109.636 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.441 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.7 t90 -59.42 -42.94 93.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.88 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -63.85 -40.97 97.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 1.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.651 HH11 HG11 ' X' ' 26' ' ' VAL . 82.3 mtp180 -69.67 -47.19 64.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.0 109.568 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.731 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 85.9 t -64.62 -46.25 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 1.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.03 -45.31 96.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -67.12 -36.66 82.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -1.175 . . . . 1.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 91.7 m -67.37 -47.01 71.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.659 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.632 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.0 m-85 -64.35 -40.07 95.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 1.0 109.535 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -60.23 -37.68 81.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.311 -0.868 . . . . 1.0 109.331 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.09 -48.21 77.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 1.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -62.07 -36.42 81.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.84 . . . . 1.0 109.435 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' X' ' 71' ' ' GLY . 3.0 t80 -61.86 -55.31 31.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.226 -0.921 . . . . 1.0 109.886 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.61 -36.21 83.52 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.973 -1.079 . . . . 1.0 109.711 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -64.44 -45.72 86.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 110.195 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.35 -51.96 2.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.685 -0.635 . . . . 1.0 109.967 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 141.59 -169.7 25.06 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.3 Cg_exo -65.36 -22.31 60.07 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.894 2.396 . . . . 1.0 112.102 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.13 -54.63 42.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 1.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -61.58 -39.21 90.37 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.261 -0.899 . . . . 1.0 109.614 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.29 82.01 8.48 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.449 -0.782 . . . . 1.0 109.346 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.2 Cg_exo -57.55 151.7 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.851 2.367 . . . . 1.0 112.333 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 m -49.53 -11.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.388 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.496 ' N ' ' O ' ' X' ' 76' ' ' PRO . 2.0 t -62.64 -33.12 74.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 1.0 109.371 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.28 -41.84 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.9 . . . . 1.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 1.0 109.404 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -61.43 -44.16 97.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -0.855 . . . . 1.0 109.263 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.95 -42.47 94.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.997 . . . . 1.0 109.681 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.731 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 10.2 t-105 -62.76 -36.19 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 1.0 109.315 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -58.5 -43.25 89.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 1.0 108.861 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.415 ' O ' HD13 ' X' ' 89' ' ' LEU . 89.7 mt -63.54 -40.53 97.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 1.0 109.271 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.0 109.619 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.48 -37.61 70.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.365 -0.835 . . . . 1.0 109.509 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -70.99 -39.79 72.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 1.0 109.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.415 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -63.49 -48.41 77.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 1.0 110.458 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.5 pt -72.43 -42.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.565 -0.709 . . . . 1.0 109.619 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 62.9 t0 -62.56 -37.17 85.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 1.0 109.312 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 1.0 109.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -82.2 135.15 35.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 1.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.99 123.08 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 1.0 109.426 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.705 . . . . 1.0 109.365 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.71 136.33 57.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 1.0 109.578 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.94 99.49 12.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 1.0 109.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.4 p -79.54 167.31 20.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -51.06 -42.34 60.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 1.0 109.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.6 -48.7 71.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 1.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.96 -38.92 87.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 1.0 109.4 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.49 -36.68 84.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.532 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -59.94 -42.04 93.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 1.0 109.417 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.97 -43.33 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.95 . . . . 1.0 109.304 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.36 -43.23 78.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 1.0 109.35 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.31 -35.18 80.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 1.0 108.867 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.82 -42.16 99.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0 108.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.86 -42.43 99.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 1.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.54 ' O ' HG23 ' X' ' 21' ' ' THR . 89.0 mt-30 -56.07 -46.49 78.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 1.0 109.144 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.0 97.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 1.0 109.407 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' X' ' 19' ' ' LEU . 82.5 mt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 1.0 109.319 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.04 -39.36 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 1.0 109.243 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.54 HG23 ' O ' ' X' ' 17' ' ' GLN . 46.8 p -65.65 -29.92 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.0 109.29 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.92 -18.44 59.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 1.0 109.142 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.58 48.52 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.08 135.29 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -1.138 . . . . 1.0 109.397 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.65 101.41 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 1.0 109.125 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 161.5 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.835 . . . . 1.0 109.352 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.89 145.83 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 109.435 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.24 -41.24 99.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 1.0 109.281 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.04 64.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.426 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' CG ' ' X' ' 55' ' ' PHE . 20.6 t70 -59.12 -39.33 81.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.0 109.417 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.52 -43.08 99.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 1.0 109.417 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.29 -41.55 85.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 1.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.5 -38.37 89.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 1.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.02 -48.65 79.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 1.0 109.419 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -61.88 -42.61 99.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 1.0 109.4 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.51 -34.46 77.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.0 109.332 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.55 -46.25 86.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.539 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.91 -50.92 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.589 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' X' ' 43' ' ' PRO . 68.3 mttm -66.35 -29.88 70.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 1.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.0 m-20 -78.25 -18.59 55.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0 109.675 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 3.0 m -53.92 -61.28 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 1.0 109.396 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.624 ' H ' ' CD ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -108.98 -50.91 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 1.0 109.568 -176.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.624 ' CD ' ' H ' ' X' ' 42' ' ' CYS . 52.7 Cg_exo -52.7 -39.34 76.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.885 2.39 . . . . 1.0 112.2 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.485 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -147.49 -150.4 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 1.0 109.544 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' X' ' 41' ' ' THR . 0.2 OUTLIER 172.9 69.31 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.877 . . . . 1.0 109.877 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.72 159.8 38.37 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.693 2.262 . . . . 1.0 112.369 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.25 130.24 45.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 1.0 109.733 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.96 179.8 7.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 1.0 109.763 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.98 -93.43 0.17 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 29.5 m -125.92 144.79 50.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.174 . . . . 1.0 109.35 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.716 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.2 OUTLIER -131.64 132.49 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 1.0 109.544 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.716 ' N ' HD13 ' X' ' 51' ' ' ILE . 65.5 m-20 -66.53 134.04 51.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 109.757 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.31 -29.07 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 1.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -44.61 93.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 1.0 109.44 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . 0.559 ' CG ' ' OD2' ' X' ' 30' ' ' ASP . 4.7 t80 -77.99 -23.22 48.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 1.0 109.285 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.609 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -55.64 -38.08 69.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 1.0 109.639 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.39 -42.1 98.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.933 . . . . 1.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 78.5 mtp85 -67.41 -37.2 82.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 1.0 109.429 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.59 -42.79 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.907 . . . . 1.0 109.356 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.29 91.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -66.82 -37.07 83.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -1.159 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 97.7 m -71.91 -44.62 63.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 1.0 109.553 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.458 ' O ' HG21 ' X' ' 75' ' ' VAL . 3.0 m-85 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 1.0 109.472 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.87 -37.43 79.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 1.0 109.472 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -63.06 -46.25 88.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 1.0 109.32 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -65.77 -31.75 72.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 1.0 109.458 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' X' ' 71' ' ' GLY . 11.2 t80 -59.15 -54.89 41.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 1.0 109.391 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -67.6 -35.65 79.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.853 . . . . 1.0 109.335 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -65.87 -44.02 86.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 1.0 109.345 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.48 -52.55 2.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 1.0 109.275 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -164.47 26.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -73.5 -15.1 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.874 2.383 . . . . 1.0 111.913 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -61.92 -50.22 73.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 1.0 109.198 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -65.62 -43.68 88.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.878 . . . . 1.0 109.396 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.746 HG23 ' O ' ' X' ' 75' ' ' VAL . 32.7 m -150.08 89.03 4.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 1.0 109.406 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.35 -175.03 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.871 2.381 . . . . 1.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.453 ' H ' HG22 ' X' ' 77' ' ' VAL . 5.1 m -62.32 -18.19 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 109.383 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.1 p -62.05 -31.8 72.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 1.0 109.382 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.79 97.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -67.98 -38.64 82.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.431 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -61.29 -51.3 69.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 1.0 109.356 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -60.8 -44.34 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 1.0 109.417 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.609 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.9 t-105 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 109.351 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -56.35 -44.68 80.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 1.0 109.295 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' X' ' 85' ' ' LEU . 89.7 mt -63.27 -40.41 97.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 1.0 109.559 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.25 -42.54 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 1.0 109.327 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.27 -39.94 67.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.495 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.8 -39.09 73.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 1.0 109.413 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.48 -43.96 92.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 1.0 109.356 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' X' ' 93' ' ' LYS . 10.2 pt -76.17 -38.74 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 1.0 109.508 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.2 -45.0 96.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 1.0 109.509 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.88 -41.74 77.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 1.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.3 tttt -85.46 137.82 32.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.0 109.441 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.97 140.86 47.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 1.0 109.531 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 1.0 109.579 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -64.23 133.48 52.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 1.0 109.519 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.73 105.22 16.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 1.0 109.473 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.3 p -87.38 175.13 8.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 1.0 109.58 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.71 -43.63 65.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 1.0 109.435 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . 0.631 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.2 m-70 -67.88 -44.92 75.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 1.0 109.522 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.57 -39.45 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 1.0 109.369 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -62.04 -38.32 88.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.0 109.61 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.1 -41.59 88.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 1.0 109.502 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.65 -44.41 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 1.0 109.33 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -51.02 -46.0 61.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.258 -0.901 . . . . 1.0 109.392 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -66.21 -37.5 85.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 1.0 108.881 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.73 -40.22 96.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.266 -0.896 . . . . 1.0 108.826 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.53 ' HG2' ' HZ2' ' X' ' 20' ' ' LYS . 89.1 tttt -62.83 -42.4 99.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 1.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -53.61 -45.2 69.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.146 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.23 -38.22 88.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 1.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.39 -38.46 89.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.172 -0.955 . . . . 1.0 109.275 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.53 ' HZ2' ' HG2' ' X' ' 16' ' ' LYS . 50.2 mttp -57.31 -43.25 83.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.0 109.301 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.6 p -65.17 -24.44 67.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 1.0 109.284 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -82.15 -6.03 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 1.0 109.197 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.7 47.86 1.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.24 -1.544 . . . . 1.0 109.24 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.674 HG13 ' HE ' ' X' ' 58' ' ' ARG . 54.8 t -122.4 131.82 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -1.101 . . . . 1.0 109.356 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -132.35 88.44 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.98 . . . . 1.0 109.175 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.78 161.99 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 1.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -78.31 148.43 33.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 1.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.451 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 76.5 t80 -61.83 -35.05 77.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 1.0 109.218 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.39 65.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 1.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' X' ' 52' ' ' ASP . 89.2 m-20 -62.24 -39.62 93.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.476 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.01 -44.54 96.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 1.0 109.382 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.93 -41.5 99.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 1.0 109.449 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.27 -31.44 72.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.483 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.45 ' O ' HG23 ' X' ' 38' ' ' VAL . 58.6 t80 -59.28 -46.77 87.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 1.0 109.449 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.15 -44.28 96.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 1.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.77 -47.3 84.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 1.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.45 HG23 ' O ' ' X' ' 34' ' ' PHE . 98.2 t -60.71 -47.04 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 1.0 109.565 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.22 -32.23 73.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 1.0 109.379 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.0 m-20 -67.08 -19.59 65.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 1.0 109.663 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.4 m -54.52 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 1.0 109.371 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.711 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -106.95 -61.06 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 109.467 -177.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.2 Cg_exo -41.25 -45.12 5.63 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.887 2.391 . . . . 1.0 112.218 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.548 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.9 m-90 -135.66 -167.63 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 1.0 109.487 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.808 ' H ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -135.11 -46.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 109.885 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.808 ' CD ' ' H ' ' X' ' 45' ' ' PHE . 28.0 Cg_exo -60.74 142.67 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.73 2.287 . . . . 1.0 112.301 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -117.99 150.67 38.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 1.0 109.643 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -137.77 155.24 49.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.903 . . . . 1.0 109.743 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.55 176.66 47.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 88.3 m -119.39 135.29 54.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 1.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.94 141.15 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 1.0 109.515 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.43 ' OD2' ' OD1' ' X' ' 30' ' ' ASP . 91.4 m-20 -87.44 138.22 31.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 1.0 109.77 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.95 -40.82 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.081 -1.012 . . . . 1.0 109.445 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.99 -39.31 81.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.0 109.388 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -81.75 -18.06 45.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 1.0 109.277 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.632 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 8.1 t90 -63.73 -37.26 86.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.0 109.638 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -56.81 -43.07 80.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 1.0 109.508 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.674 ' HE ' HG13 ' X' ' 24' ' ' VAL . 17.2 mtt85 -67.83 -36.44 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 1.0 109.468 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.497 HG11 ' CH2' ' X' ' 83' ' ' TRP . 39.1 t -65.67 -44.01 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.382 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.47 95.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -67.77 -37.52 82.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 1.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.0 m -64.62 -52.57 56.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 109.448 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.77 -42.51 99.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 1.0 109.479 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.54 -38.95 78.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 1.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.33 -44.46 96.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 1.0 109.311 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -69.29 -32.99 72.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 1.0 109.379 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' X' ' 71' ' ' GLY . 25.6 t80 -64.07 -55.21 23.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 1.0 109.411 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -70.47 -35.92 73.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 1.0 109.323 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -64.58 -47.16 79.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 1.0 109.301 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.48 -52.51 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 1.0 109.195 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -168.57 25.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' X' ' 76' ' ' PRO . 21.3 Cg_endo -70.08 -18.75 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.985 2.456 . . . . 1.0 111.97 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.92 -51.55 69.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 1.0 109.224 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -65.35 -38.94 91.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 1.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.6 82.49 8.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.8 Cg_exo -56.32 161.11 9.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.885 2.39 . . . . 1.0 112.302 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.44 -5.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 1.0 109.455 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.463 ' H ' ' C ' ' X' ' 76' ' ' PRO . 73.0 p -63.9 -33.48 75.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.873 . . . . 1.0 109.396 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 1.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.94 -46.79 80.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 1.0 109.377 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 75.7 m -59.42 -47.96 83.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 1.0 109.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -62.45 -40.23 95.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.0 109.501 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.632 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.6 t-105 -66.53 -36.03 81.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 1.0 109.441 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -56.24 -44.76 79.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 1.0 109.194 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.6 mt -62.94 -39.82 95.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.635 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.0 -43.29 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.344 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.32 -43.3 83.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 1.0 109.438 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -69.45 -35.37 75.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 1.0 109.365 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.42 -47.78 75.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.357 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -74.25 -39.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 1.0 109.402 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -59.37 -46.43 88.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 1.0 109.521 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.91 -41.67 95.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 1.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -69.77 122.6 19.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 1.0 109.483 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.12 102.33 12.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 1.0 109.565 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 96.0 mt-10 -64.39 146.44 54.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 1.0 109.541 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' X' ' 5' ' ' LEU . 76.3 mt -92.58 102.58 15.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 1.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.1 p -84.84 171.58 12.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 1.0 109.579 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -57.13 -41.49 79.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 1.0 109.435 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -66.14 -42.26 89.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 1.0 109.511 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 92.5 mt-10 -66.92 -38.23 85.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 1.0 109.428 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.56 -35.04 75.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 1.0 109.583 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.28 -49.0 78.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 1.0 109.41 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -68.21 -32.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -0.972 . . . . 1.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.46 -45.8 90.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.868 . . . . 1.0 109.334 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -62.43 -37.42 85.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 1.0 108.878 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.67 -42.28 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 1.0 108.738 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.527 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.2 tttt -56.31 -44.18 79.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 1.0 109.523 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -55.13 -42.93 73.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 1.0 109.116 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.582 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -63.57 -37.77 88.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.78 . . . . 1.0 109.392 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' X' ' 19' ' ' LEU . 97.2 mt -63.6 -36.93 85.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.898 . . . . 1.0 109.273 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.33 -40.68 82.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 1.0 109.218 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.0 p -66.42 -31.22 71.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 1.0 109.263 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.582 HH12 ' HB1' ' X' ' 18' ' ' ALA . 84.1 mtt85 -72.89 -18.26 61.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 1.0 109.212 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.78 46.37 0.78 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.309 -1.517 . . . . 1.0 109.309 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.82 132.98 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 1.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.67 95.82 3.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 1.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.02 158.11 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -0.86 . . . . 1.0 109.359 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.15 145.26 46.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.923 . . . . 1.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.527 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 82.3 t80 -57.17 -33.56 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 1.0 109.271 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.5 70.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 1.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.5 m-20 -59.72 -40.75 89.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 1.0 109.409 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.79 -44.53 96.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 1.0 109.345 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 32' ' ' LEU . 90.3 mt -63.97 -42.51 97.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 1.0 109.369 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.94 -37.13 85.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 1.0 109.356 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.04 -50.93 72.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 1.0 109.4 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.43 -42.2 98.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 1.0 109.41 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.62 -38.71 91.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.0 109.277 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -62.51 -46.47 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 1.0 109.52 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.2 -50.11 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 1.0 109.373 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' X' ' 44' ' ' TRP . 21.1 m-20 -69.98 -19.86 63.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 1.0 109.686 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -54.72 -59.34 4.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.967 . . . . 1.0 109.426 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -107.69 -62.02 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 1.0 109.487 -176.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.24 -41.75 4.87 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.919 2.413 . . . . 1.0 112.201 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.2 m-90 -141.83 -159.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 1.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.511 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -173.75 50.18 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 1.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_endo -70.58 166.69 27.79 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.753 2.302 . . . . 1.0 112.327 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.54 138.73 57.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 1.0 109.712 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.62 136.14 37.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 1.0 109.798 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.8 -173.72 37.96 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 141.37 57.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -1.206 . . . . 1.0 109.293 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.691 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.46 134.04 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 1.0 109.567 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.691 ' N ' HD13 ' X' ' 51' ' ' ILE . 98.5 m-20 -64.39 137.28 57.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 1.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.15 -23.02 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 1.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.31 -39.48 92.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 1.0 109.41 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -83.26 -10.13 58.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 1.0 109.247 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.626 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.8 t90 -58.76 -38.16 77.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 1.0 109.651 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -62.15 -40.54 96.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.0 109.466 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 74.8 mtp85 -66.08 -39.13 89.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 1.0 109.396 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.452 HG21 ' CH2' ' X' ' 83' ' ' TRP . 53.7 t -61.95 -43.82 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 1.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.31 -50.7 62.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.74 -41.67 97.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -1.164 . . . . 1.0 109.511 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 81.8 m -65.43 -52.29 54.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 1.0 109.518 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.521 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.8 m-85 -60.98 -41.46 96.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 1.0 109.498 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -63.85 -38.72 92.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 1.0 109.465 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.95 -45.28 89.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.306 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -68.05 -30.56 69.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 1.0 109.461 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' X' ' 71' ' ' GLY . 14.9 t80 -60.44 -55.09 37.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 1.0 109.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -66.95 -36.51 82.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 1.0 109.345 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -63.85 -47.03 82.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 1.0 109.318 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.35 -52.45 2.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 1.0 109.302 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.47 -164.12 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.4 -15.45 31.17 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.928 2.419 . . . . 1.0 112.001 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.11 -54.44 44.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 1.0 109.16 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -63.27 -44.47 95.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 1.0 109.366 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.699 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.2 m -148.81 90.57 4.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 1.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.42 -173.84 1.96 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.85 2.367 . . . . 1.0 112.204 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.94 -16.56 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 1.0 109.431 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.71 -32.52 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 1.0 109.345 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.78 95.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 1.0 109.376 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -65.04 -41.24 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 1.0 109.38 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -59.66 -48.02 83.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -65.51 -43.75 89.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 1.0 109.488 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.626 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.7 t-105 -61.67 -36.46 80.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 1.0 109.389 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -56.77 -43.19 80.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 1.0 109.277 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' X' ' 85' ' ' LEU . 94.6 mt -64.48 -41.14 96.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 1.0 109.642 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.5 -41.29 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.927 . . . . 1.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -56.87 -40.04 75.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 1.0 109.497 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.01 -40.62 78.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 1.0 109.434 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.7 -46.11 86.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 1.0 109.33 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.64 -38.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.399 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.46 -45.07 92.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 1.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.95 -45.55 93.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 1.0 109.586 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.8 127.96 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 1.0 109.495 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -91.73 96.09 10.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 1.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 1.0 109.541 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.359 0.599 . . . . 1.0 109.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.07 138.43 58.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 1.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 5' ' ' LEU . . . . . 0.49 HD22 ' OE1' ' X' ' 13' ' ' GLU . 95.7 mt -77.03 84.63 3.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.576 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.7 p -80.32 172.19 14.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 1.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.6 -43.34 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 1.0 109.447 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . 0.676 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.8 m-70 -68.68 -43.64 75.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 109.484 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.93 -36.59 84.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.0 -38.81 79.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 1.0 109.831 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.27 -49.03 78.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 1.0 109.63 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.22 -35.37 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . 0.49 ' OE1' HD22 ' X' ' 5' ' ' LEU . 79.3 tt0 -62.99 -40.36 97.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.301 -0.874 . . . . 1.0 109.24 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.43 -36.93 85.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.039 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.96 -43.0 99.76 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.25 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.46 -36.94 81.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 1.0 109.417 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.544 ' O ' HG23 ' X' ' 21' ' ' THR . 89.4 mt-30 -58.25 -48.5 80.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.0 109.254 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.3 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.446 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.65 -38.75 92.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 1.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.86 -39.7 95.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.306 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.544 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.2 p -61.77 -29.38 70.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 1.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.15 -17.51 63.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.588 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.13 44.55 0.67 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.738 HG13 ' HE ' ' X' ' 58' ' ' ARG . 30.9 t -122.98 135.64 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.667 -0.902 . . . . 1.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -135.49 99.74 4.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 1.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.54 164.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.485 -0.76 . . . . 1.0 109.625 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.12 146.26 47.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.353 -0.842 . . . . 1.0 109.512 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -62.83 -37.39 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.05 -1.031 . . . . 1.0 109.371 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.49 -34.23 66.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -39.67 90.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 1.0 109.113 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.465 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.23 -43.55 98.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.0 109.526 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' X' ' 32' ' ' LEU . 99.1 mt -63.71 -42.27 97.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 1.0 109.33 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.1 -30.86 71.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 1.0 109.18 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -61.39 -50.21 73.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 1.0 109.607 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -62.28 -46.56 88.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 1.0 109.547 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -65.52 -38.18 88.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.208 -0.932 . . . . 1.0 109.231 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.25 -45.64 93.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 1.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.27 -48.63 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 1.0 109.693 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -67.8 -28.46 67.61 Favored 'General case' 0 C--O 1.192 -1.94 0 O-C-N 121.171 -0.956 . . . . 1.0 108.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.562 ' OD1' ' CZ2' ' X' ' 44' ' ' TRP . 71.0 m-20 -77.93 -20.71 52.3 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 120.032 -1.667 . . . . 1.0 109.796 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 m -54.34 -60.91 2.71 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.99 -1.069 . . . . 1.0 111.275 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 42' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -101.84 -53.95 0.14 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.512 -0.743 . . . . 1.0 110.858 -178.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 43' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' X' ' 42' ' ' CYS . 89.1 Cg_exo -46.02 -43.0 20.68 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.514 2.143 . . . . 1.0 112.601 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 44' ' ' TRP . . . . . 0.562 ' CZ2' ' OD1' ' X' ' 40' ' ' ASP . 0.1 OUTLIER -176.56 131.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 1.0 109.207 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 45' ' ' PHE . . . . . 0.523 ' CE2' ' CD2' ' X' ' 82' ' ' TYR . 0.2 OUTLIER -104.69 105.95 52.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 1.0 109.775 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 46' ' ' PRO . . . . . 0.427 ' CG ' ' HE1' ' X' ' 44' ' ' TRP . 56.4 Cg_endo -83.2 -164.46 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.778 2.318 . . . . 1.0 111.918 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -90.57 122.36 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.363 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.01 154.76 17.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.461 -0.774 . . . . 1.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.19 -93.99 2.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 50' ' ' THR . . . . . 0.489 HG23 HG22 ' X' ' 90' ' ' ILE . 27.3 m -130.92 137.4 49.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -1.007 . . . . 1.0 109.434 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.73 HD13 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -112.67 139.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.543 -0.723 . . . . 1.0 109.381 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.73 ' H ' HD13 ' X' ' 51' ' ' ILE . 85.5 m-20 -68.85 136.61 52.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 1.0 109.76 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.57 -27.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -0.997 . . . . 1.0 109.537 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.68 -41.87 95.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.024 -1.047 . . . . 1.0 109.777 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -75.88 -17.03 59.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 1.0 109.839 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.9 t90 -60.61 -37.74 82.41 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.288 -0.883 . . . . 1.0 109.954 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -59.44 -44.51 92.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 1.0 109.673 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.738 ' HE ' HG13 ' X' ' 24' ' ' VAL . 19.0 mtt85 -64.79 -40.01 94.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.54 -43.67 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.85 -46.92 92.6 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -67.88 -42.1 81.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -1.2 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.98 -51.6 66.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 1.0 109.639 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.98 -44.21 87.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 1.0 109.527 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -56.41 -40.62 74.99 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.272 -0.892 . . . . 1.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.69 -43.29 84.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 1.0 109.324 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -62.86 -35.7 80.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 1.0 109.269 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.515 ' CE2' ' OD1' ' X' ' 68' ' ' ASN . 3.4 t80 -59.26 -55.0 40.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.515 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 84.9 m-20 -65.13 -34.56 78.7 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.041 -1.037 . . . . 1.0 109.771 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -64.16 -48.93 74.08 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.288 -0.883 . . . . 1.0 110.012 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -114.7 -51.93 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.651 -0.655 . . . . 1.0 109.871 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 143.45 -168.87 26.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' X' ' 76' ' ' PRO . 7.4 Cg_exo -67.03 -21.76 48.9 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.998 2.465 . . . . 1.0 111.987 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.91 -51.01 69.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 1.0 109.457 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.53 -45.08 88.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 1.0 109.808 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.759 HG23 ' O ' ' X' ' 75' ' ' VAL . 26.6 m -142.8 82.4 12.34 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.0 109.356 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' X' ' 72' ' ' PRO . 51.5 Cg_endo -79.59 -172.33 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.911 2.407 . . . . 1.0 112.31 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.46 -20.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.922 . . . . 1.0 109.524 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 22.2 p -62.63 -37.85 87.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 1.0 109.563 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.25 79.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 1.0 109.56 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -65.68 -37.06 85.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 1.0 109.416 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -61.6 -45.3 94.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 1.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.523 ' CD2' ' CE2' ' X' ' 45' ' ' PHE . 38.3 m-85 -63.74 -44.24 94.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 1.0 109.732 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.634 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.7 t-105 -64.43 -37.56 87.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.282 -0.886 . . . . 1.0 109.296 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -55.99 -41.73 75.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 1.0 108.829 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.445 ' O ' HD13 ' X' ' 89' ' ' LEU . 95.1 mt -65.57 -40.39 92.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 1.0 109.297 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -64.22 -42.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 1.0 109.485 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -54.81 -39.32 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 1.0 109.264 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -70.39 -39.46 74.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 1.0 109.478 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.445 HD13 ' O ' ' X' ' 85' ' ' LEU . 8.1 mp -62.45 -46.0 90.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 1.0 110.139 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.489 HG22 HG23 ' X' ' 50' ' ' THR . 9.9 pt -74.19 -31.98 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.518 -0.739 . . . . 1.0 109.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.56 -40.55 92.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 1.0 109.374 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.37 -40.19 93.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.0 109.454 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -94.63 115.16 27.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.189 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.97 122.1 28.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 1.0 109.457 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 1.0 109.409 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mtm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.1 9.76 84.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.49 149.96 51.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -1.164 . . . . 1.0 109.499 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.15 139.31 52.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 1.0 109.568 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 5' ' ' LEU . 67.9 mt -90.86 104.08 16.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.855 . . . . 1.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.8 p -82.27 168.63 17.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 1.0 109.565 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -53.84 -41.39 67.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 1.0 109.489 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -66.39 -45.64 79.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 1.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -62.96 -35.99 81.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 1.0 109.428 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.43 -36.97 85.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 1.0 109.578 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -61.63 -41.74 97.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.404 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 t -59.63 -43.32 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.297 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -56.33 -46.92 79.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.228 -0.92 . . . . 1.0 109.347 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.98 -38.0 89.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 1.0 108.884 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.88 -41.51 99.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 1.0 108.772 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.513 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.5 tttt -59.77 -37.73 79.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 1.0 109.474 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -59.15 -44.98 92.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 1.0 109.099 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -63.51 -37.35 86.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 1.0 109.344 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.78 -39.1 93.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 1.0 109.338 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.26 -42.53 86.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 1.0 109.325 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.9 p -63.68 -31.73 72.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 1.0 109.342 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.58 -18.6 61.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 1.0 109.24 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.87 47.85 0.65 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.62 132.92 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 1.0 109.466 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.8 93.96 3.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.144 -0.973 . . . . 1.0 109.226 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.36 160.65 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 1.0 109.363 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . 0.411 ' HZ3' ' HA ' ' X' ' 97' ' ' PRO . 64.0 mttp -72.73 151.45 42.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 1.0 109.453 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.513 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 72.5 t80 -65.67 -40.17 92.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.872 . . . . 1.0 109.257 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.58 57.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.0 109.487 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -61.44 -37.5 83.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 1.0 109.409 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.504 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.23 -45.28 94.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 1.0 109.369 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' X' ' 32' ' ' LEU . 96.7 mt -63.91 -41.41 97.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 1.0 109.405 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 1.0 109.415 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -56.63 -49.14 75.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 1.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -59.95 -42.23 93.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 1.0 109.419 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.22 -44.13 95.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.0 109.292 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -61.2 -45.48 94.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 1.0 109.548 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.93 -44.69 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 1.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 69.9 tttt -64.2 -31.51 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 1.0 109.436 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' X' ' 44' ' ' TRP . 99.0 m-20 -70.7 -19.32 62.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 1.0 109.587 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 30.9 m -53.89 -52.25 61.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 1.0 109.378 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.772 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -116.13 -60.73 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 1.0 109.504 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.772 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 74.0 Cg_exo -41.5 -54.58 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.868 2.379 . . . . 1.0 112.203 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.52 ' O ' ' O ' ' X' ' 40' ' ' ASP . 8.4 m0 -127.65 113.01 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 1.0 109.58 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -61.49 -44.52 92.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 1.0 109.81 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 25.4 Cg_exo -59.6 141.71 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.699 2.266 . . . . 1.0 112.378 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -97.99 159.21 15.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 1.0 109.665 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.43 133.7 12.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.846 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.94 155.23 22.74 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.794 -1.323 . . . . 1.0 109.794 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.476 HG23 HG22 ' X' ' 90' ' ' ILE . 19.6 m -91.91 135.08 34.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 1.0 109.303 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.66 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -102.21 134.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 1.0 109.518 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.66 ' N ' HD13 ' X' ' 51' ' ' ILE . 70.0 m-20 -75.55 137.94 41.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 1.0 109.756 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.95 -34.19 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 1.0 109.392 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.742 ' HZ1' ' H ' ' X' ' 99' ' ' VAL . 98.1 mttt -63.85 -38.05 89.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 1.0 109.452 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.18 -20.36 52.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 1.0 109.245 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.597 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 13.5 t90 -56.18 -33.95 65.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 1.0 109.719 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -59.89 -41.98 92.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 1.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.416 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 72.8 mtp180 -66.38 -39.68 89.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 1.0 109.515 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.572 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 72.8 t -62.76 -43.11 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.33 -46.61 93.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -70.02 -42.2 73.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 1.0 109.494 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.1 m -63.86 -48.41 76.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 1.0 109.544 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.438 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.3 m-85 -61.84 -39.35 91.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 1.0 109.493 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -61.93 -39.67 92.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 1.0 109.456 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -63.07 -44.1 96.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 1.0 109.236 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -65.47 -35.15 80.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 1.0 109.475 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' X' ' 71' ' ' GLY . 5.1 t80 -59.05 -54.39 47.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.87 . . . . 1.0 109.45 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 95.0 m-20 -65.74 -36.57 83.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 1.0 109.311 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -62.93 -47.99 80.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 1.0 109.299 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.76 -52.36 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 1.0 109.209 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.26 -165.93 25.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.459 -1.457 . . . . 1.0 109.459 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -67.19 -16.56 48.99 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.953 2.435 . . . . 1.0 111.952 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.55 -54.6 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 1.0 109.198 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -63.74 -43.6 95.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 1.0 109.404 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.694 HG23 ' O ' ' X' ' 75' ' ' VAL . 27.3 m -148.63 92.42 4.47 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 1.0 109.431 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.55 -166.55 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.873 2.382 . . . . 1.0 112.166 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.66 -12.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 1.0 109.416 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -66.17 -33.2 75.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 1.0 109.421 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.15 -47.18 81.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.446 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -64.92 -45.67 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 1.0 109.4 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -59.77 -47.12 86.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 1.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -63.15 -40.89 98.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 1.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.597 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.5 t-105 -61.69 -37.98 86.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.05 -42.57 76.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.882 . . . . 1.0 109.223 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.31 -41.59 98.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 1.0 109.586 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -63.75 -43.53 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -0.941 . . . . 1.0 109.412 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.54 -37.63 58.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.0 109.501 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.21 -42.3 72.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.0 109.309 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.32 -48.02 83.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 1.0 109.396 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.476 HG22 HG23 ' X' ' 50' ' ' THR . 11.5 pt -72.69 -36.74 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.914 . . . . 1.0 109.434 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -63.11 -39.74 95.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 1.0 109.536 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -63.62 -40.96 98.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 1.0 109.57 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -88.75 117.48 27.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 1.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.75 138.17 56.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 1.0 109.564 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.531 HG22 ' N ' ' X' ' 96' ' ' ASN . 7.8 p -136.86 162.46 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 1.0 109.572 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.531 ' N ' HG22 ' X' ' 95' ' ' VAL . 49.7 t30 -125.29 82.17 62.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 1.0 109.604 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.411 ' HA ' ' HZ3' ' X' ' 27' ' ' LYS . 34.7 Cg_exo -59.28 -147.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.875 2.383 . . . . 1.0 112.301 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -65.89 -49.67 67.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.893 . . . . 1.0 109.411 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.742 ' H ' ' HZ1' ' X' ' 54' ' ' LYS . 59.0 t -123.97 130.31 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 1.0 109.515 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.98 -1.01 . . . . 1.0 109.528 179.762 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.89 79.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -95.41 157.76 15.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.407 -1.055 . . . . 1.0 109.523 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.3 130.81 46.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 1.0 109.423 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 64.4 mt -91.93 104.66 17.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 1.0 109.717 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -82.46 168.37 17.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.434 -0.791 . . . . 1.0 109.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.96 -41.46 67.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 1.0 109.413 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.76 -45.13 79.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 1.0 109.606 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.85 -31.67 73.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.2 -0.938 . . . . 1.0 109.344 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -70.74 -40.65 72.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 1.0 109.925 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -60.66 -49.75 76.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 1.0 109.644 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -65.19 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 1.0 109.361 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.61 -40.96 93.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 1.0 109.019 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.22 -36.41 84.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 1.0 108.875 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.7 -41.42 99.12 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 109.126 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.6 -40.71 88.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 1.0 109.329 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -59.38 -44.57 92.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 1.0 109.046 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.08 -38.61 91.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.301 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.4 HD23 ' HD3' ' X' ' 22' ' ' ARG . 98.6 mt -67.1 -40.98 87.02 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.021 -1.05 . . . . 1.0 109.207 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.41 -30.61 71.34 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.991 -1.068 . . . . 1.0 109.162 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 31.4 p -77.06 -31.46 56.12 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.346 -0.846 . . . . 1.0 109.535 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' CG2' ' X' ' 24' ' ' VAL . 15.9 ptt85 -75.57 -19.3 59.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.112 -0.993 . . . . 1.0 109.29 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.73 48.47 0.3 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.455 ' CG2' ' HE ' ' X' ' 22' ' ' ARG . 69.7 t -123.11 139.47 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 1.0 109.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . 0.508 ' C ' HE22 ' X' ' 98' ' ' GLN . 99.1 mttt -125.39 98.2 5.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.743 . . . . 1.0 109.312 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -132.04 138.63 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 1.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.94 150.15 39.17 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.361 -0.837 . . . . 1.0 109.631 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.15 -35.36 80.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 1.0 109.128 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 1.0 109.305 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -62.88 -37.47 87.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.185 -0.947 . . . . 1.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -63.11 -44.77 94.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 1.0 109.631 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.67 -43.11 94.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 1.0 109.429 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 1.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.86 -48.45 78.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 1.0 109.571 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.82 -41.05 97.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 109.209 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.41 -44.93 95.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 1.0 109.271 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.48 -48.07 79.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.58 -45.03 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.908 . . . . 1.0 109.327 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 51.4 tttm -64.38 -34.22 77.66 Favored 'General case' 0 C--O 1.2 -1.516 0 CA-C-O 122.103 0.954 . . . . 1.0 108.938 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 2.9 m-20 -69.42 -20.73 63.79 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 120.242 -1.536 . . . . 1.0 109.646 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -54.28 -61.04 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.0 110.926 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.54 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -102.68 -59.09 0.09 OUTLIER Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.334 -0.854 . . . . 1.0 110.728 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.8 Cg_exo -41.7 -48.6 5.72 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.599 2.199 . . . . 1.0 112.697 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -125.53 -118.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.0 109.03 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.672 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.9 OUTLIER -177.58 -41.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.0 110.227 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 25.8 Cg_exo -60.84 141.41 94.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.728 2.286 . . . . 1.0 112.231 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.11 164.29 15.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 1.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.0 161.12 30.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 1.0 109.753 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.03 -2.86 58.1 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.086 -1.206 . . . . 1.0 110.086 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -119.63 116.12 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.978 . . . . 1.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.663 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.84 132.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.156 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.663 ' N ' HD13 ' X' ' 51' ' ' ILE . 87.7 m-20 -72.46 131.34 42.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.83 -1.169 . . . . 1.0 109.884 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.26 -42.44 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 1.0 109.581 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -57.37 -42.07 81.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.159 . . . . 1.0 109.43 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . 0.519 ' CE2' ' CG2' ' X' ' 59' ' ' VAL . 86.2 t80 -77.08 -23.76 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 1.0 109.757 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.643 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -59.56 -38.8 82.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.975 . . . . 1.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -57.09 -44.42 83.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.218 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.461 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 77.8 mtp85 -66.69 -39.02 87.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 1.0 109.487 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.519 ' CG2' ' CE2' ' X' ' 55' ' ' PHE . 59.2 t -62.4 -44.1 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 1.0 109.46 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.01 73.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -65.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -1.133 . . . . 1.0 109.498 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 74.0 m -66.33 -55.16 17.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 1.0 109.715 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.52 -37.83 85.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 1.0 109.548 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -38.35 90.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 1.0 109.303 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 1.0 109.438 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -64.8 -35.44 81.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.895 . . . . 1.0 109.579 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' X' ' 71' ' ' GLY . 0.9 OUTLIER -62.15 -54.06 46.54 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.261 -0.9 . . . . 1.0 109.834 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 35.0 t-20 -64.42 -35.52 81.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.909 -1.12 . . . . 1.0 109.674 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -67.24 -46.14 74.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.288 -0.883 . . . . 1.0 109.69 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -115.15 -52.05 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.691 -0.631 . . . . 1.0 109.901 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.76 -169.19 24.23 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' X' ' 76' ' ' PRO . 13.1 Cg_exo -63.33 -22.87 72.04 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.946 2.431 . . . . 1.0 111.99 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.79 -53.06 57.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 1.0 109.346 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -65.37 -43.91 89.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.299 -0.875 . . . . 1.0 109.751 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' X' ' 75' ' ' VAL . 7.3 m -138.79 84.52 17.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.612 -0.68 . . . . 1.0 109.285 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.553 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.5 Cg_exo -60.12 152.8 62.97 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.841 2.36 . . . . 1.0 112.153 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.522 ' O ' HG12 ' X' ' 77' ' ' VAL . 61.0 t -52.03 -4.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.968 . . . . 1.0 109.707 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.553 ' H ' ' C ' ' X' ' 76' ' ' PRO . 51.5 p -65.49 -38.62 90.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.132 -0.98 . . . . 1.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.15 77.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 1.0 109.434 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -62.6 -45.83 91.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 1.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 65.9 m -61.05 -46.76 89.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.72 -37.48 87.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 1.0 109.431 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.643 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.2 t-105 -66.75 -35.17 79.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 1.0 109.214 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -58.07 -45.36 87.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 1.0 108.865 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.72 -42.02 99.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 1.0 109.413 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.6 -45.06 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 1.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -54.19 -44.27 71.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 1.0 109.508 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.98 -35.26 76.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.067 -1.02 . . . . 1.0 109.466 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.22 -49.09 71.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.089 -1.007 . . . . 1.0 110.014 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' X' ' 93' ' ' LYS . 6.0 pt -71.77 -43.07 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 1.0 109.517 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -62.01 -48.34 80.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.68 -44.7 92.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 1.0 109.712 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.5 tttt -81.34 143.25 32.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 1.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.08 138.4 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 1.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.568 HG22 ' N ' ' X' ' 96' ' ' ASN . 9.2 p -136.1 164.42 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.775 . . . . 1.0 109.369 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.568 ' N ' HG22 ' X' ' 95' ' ' VAL . 15.5 t-20 -122.64 82.81 48.22 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.676 -0.64 . . . . 1.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.46 ' HD3' HG13 ' X' ' 95' ' ' VAL . 55.6 Cg_endo -83.97 -166.09 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.022 2.481 . . . . 1.0 112.247 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . 0.508 HE22 ' C ' ' X' ' 25' ' ' LYS . 88.0 mt-30 -64.62 -43.65 93.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 1.0 109.48 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.454 HG12 ' OXT' ' X' ' 100' ' ' MET . 55.9 t -124.18 129.05 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.525 -0.735 . . . . 1.0 109.387 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . 0.454 ' OXT' HG12 ' X' ' 99' ' ' VAL . 97.9 mtp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.972 -1.013 . . . . 1.0 109.389 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 41.4 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.53 21.97 54.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -128.52 158.31 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.658 -0.907 . . . . 1.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' X' ' 4' ' ' GLU . 56.7 mp0 -58.61 144.22 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.231 -0.918 . . . . 1.0 109.436 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 60.4 mt -97.32 101.92 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 82.4 p -80.02 170.97 15.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 1.0 109.497 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.09 -42.02 79.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 1.0 109.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.31 -45.33 80.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 1.0 109.554 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 96.7 mt-10 -62.82 -36.68 83.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 1.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.32 -40.39 97.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 1.0 109.636 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.11 -37.82 81.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 1.0 109.069 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.32 -44.74 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 1.0 109.043 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -56.09 -47.79 77.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0 109.314 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.17 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 1.0 109.002 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.283 -0.885 . . . . 1.0 109.181 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' X' ' 26' ' ' VAL . 86.0 tttt -60.35 -42.01 94.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 1.0 109.063 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -55.05 -44.69 74.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 1.0 109.111 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.08 86.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 1.0 109.168 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' X' ' 16' ' ' LYS . 95.9 mt -62.94 -39.26 94.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 1.0 109.086 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.82 -41.02 90.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.382 -0.824 . . . . 1.0 109.278 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 13.8 m -59.38 -39.06 82.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 1.0 109.225 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.81 -17.81 64.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 1.0 109.26 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.67 46.57 0.96 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.358 -1.497 . . . . 1.0 109.358 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.96 134.73 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.643 -0.916 . . . . 1.0 109.374 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . 0.405 ' O ' ' OE1' ' X' ' 98' ' ' GLN . 70.2 mmtt -124.46 106.75 10.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.637 -0.664 . . . . 1.0 109.231 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.503 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 53.7 t -135.9 159.14 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.657 -0.652 . . . . 1.0 109.531 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . 0.465 ' N ' HG12 ' X' ' 26' ' ' VAL . 99.7 mttt -81.27 143.64 32.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.381 -0.825 . . . . 1.0 109.717 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.5 ' CE2' HD11 ' X' ' 32' ' ' LEU . 88.3 t80 -59.59 -39.2 83.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 1.0 109.354 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.17 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 1.0 109.543 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -64.42 -38.57 91.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 1.0 109.167 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.4 mm? -62.79 -46.06 89.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 1.0 109.676 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' X' ' 28' ' ' TYR . 94.9 mt -63.4 -42.39 98.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 1.0 109.572 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 -36.02 82.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 1.0 109.357 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -60.48 -49.56 77.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 1.0 109.806 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.37 -44.61 90.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 1.0 109.787 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.92 -44.2 96.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 1.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.468 ' O ' ' OG1' ' X' ' 41' ' ' THR . 84.2 t80 -64.11 -45.46 88.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 1.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.36 -43.41 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.275 -0.891 . . . . 1.0 109.95 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.55 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -76.24 -29.19 57.41 Favored 'General case' 0 C--O 1.187 -2.19 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' X' ' 44' ' ' TRP . 79.1 m-20 -78.17 -21.79 49.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.052 0.929 . . . . 1.0 109.83 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 37' ' ' PHE . 11.3 m -62.72 -51.27 67.83 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.363 -1.461 . . . . 1.0 111.669 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -65.11 -64.28 2.79 Favored Pre-proline 0 C--N 1.296 -1.74 0 O-C-N 121.448 -0.782 . . . . 1.0 110.998 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.55 ' CG ' ' O ' ' X' ' 39' ' ' LYS . 27.7 Cg_endo -61.23 -54.19 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.723 2.282 . . . . 1.0 112.792 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.65 ' O ' ' CD2' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -173.67 139.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.092 -1.005 . . . . 1.0 109.287 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.539 ' N ' ' HD3' ' X' ' 46' ' ' PRO . 11.8 p90 -154.42 54.93 1.15 Allowed Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 120.671 -1.268 . . . . 1.0 110.002 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' X' ' 45' ' ' PHE . 38.9 Cg_endo -78.97 -23.0 8.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.673 2.248 . . . . 1.0 112.53 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -75.97 156.16 34.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.905 . . . . 1.0 109.629 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -132.39 151.83 51.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.573 -0.704 . . . . 1.0 109.49 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' X' ' 86' ' ' ILE . . . -150.74 -176.67 23.9 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.2 m -77.37 144.05 38.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -1.18 . . . . 1.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.669 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -135.29 134.45 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.494 -0.753 . . . . 1.0 109.227 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.669 ' N ' HD13 ' X' ' 51' ' ' ILE . 66.2 t0 -65.33 135.62 55.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.932 -1.105 . . . . 1.0 109.801 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 97.2 mt -69.54 -42.29 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.917 -1.115 . . . . 1.0 109.436 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.65 -39.84 77.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 1.0 109.171 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . 0.401 ' CE2' HG23 ' X' ' 59' ' ' VAL . 46.9 t80 -70.5 -36.63 73.91 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.298 -0.876 . . . . 1.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.645 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 17.3 t90 -52.78 -37.79 60.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.163 -0.961 . . . . 1.0 109.458 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -57.32 -44.8 84.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 1.0 109.234 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.446 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 80.1 mtp85 -67.96 -43.15 79.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 1.0 109.514 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.401 HG23 ' CE2' ' X' ' 55' ' ' PHE . 39.7 t -62.5 -43.73 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 1.0 109.467 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.32 -48.81 77.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.49 -38.12 86.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -1.18 . . . . 1.0 109.645 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.4 m -66.73 -48.7 68.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 1.0 109.693 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.437 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.6 m-85 -58.92 -46.19 88.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.333 -0.854 . . . . 1.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -57.13 -40.63 77.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 1.0 109.354 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -63.13 -45.97 89.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.0 109.353 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -64.84 -30.95 71.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 1.0 109.449 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.506 ' O ' ' N ' ' X' ' 71' ' ' GLY . 2.1 t80 -63.26 -54.78 31.92 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.357 -0.839 . . . . 1.0 109.847 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.418 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 76.4 m-20 -65.82 -38.97 90.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.876 -1.14 . . . . 1.0 109.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -62.5 -49.56 74.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.295 -0.878 . . . . 1.0 109.958 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.69 -51.76 2.85 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.996 -0.682 . . . . 1.0 109.97 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.41 -169.46 24.79 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.1 -20.06 50.57 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.985 2.456 . . . . 1.0 112.014 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -57.24 -51.91 67.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.97 . . . . 1.0 109.366 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.94 -46.21 82.52 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 1.0 110.004 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.767 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.8 m -146.01 86.84 6.94 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.537 -0.727 . . . . 1.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.42 -166.51 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.865 2.376 . . . . 1.0 112.41 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.71 -15.97 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.0 109.662 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 36.9 p -61.73 -34.14 75.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 1.0 109.277 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.55 -45.45 75.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.62 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -63.91 -46.15 86.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -61.53 -46.47 89.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 1.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.05 -42.13 98.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 1.0 109.538 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.645 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.8 t-105 -64.53 -36.73 85.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 1.0 109.163 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -55.85 -44.98 78.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 1.0 108.933 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.99 -42.94 99.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0 109.498 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' X' ' 49' ' ' GLY . 1.5 mm -61.46 -41.83 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 1.0 109.49 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.66 -36.87 67.54 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.372 -0.83 . . . . 1.0 109.181 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.86 -41.29 71.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 1.0 109.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.89 -46.98 87.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 1.0 110.403 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 6.4 pt -71.54 -41.91 72.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -0.821 . . . . 1.0 109.704 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.78 -46.71 89.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.888 . . . . 1.0 109.326 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -45.81 90.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 1.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.17 133.0 39.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 1.0 109.453 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.78 126.46 31.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 1.0 109.437 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.639 HG22 ' N ' ' X' ' 96' ' ' ASN . 9.3 p -133.43 168.76 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.521 -0.737 . . . . 1.0 109.329 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.639 ' N ' HG22 ' X' ' 95' ' ' VAL . 17.6 t-20 -125.11 81.61 62.86 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.708 -0.62 . . . . 1.0 109.471 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.537 ' HD3' HG13 ' X' ' 95' ' ' VAL . 58.7 Cg_endo -81.74 -168.67 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.965 2.444 . . . . 1.0 112.265 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . 0.405 ' OE1' ' O ' ' X' ' 25' ' ' LYS . 86.2 mt-30 -66.59 -43.52 84.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 1.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 53.8 t -125.0 133.57 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 1.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.065 -0.969 . . . . 1.0 109.479 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.03 4.63 86.76 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.532 -1.427 . . . . 1.0 109.532 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -129.24 159.87 34.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -1.136 . . . . 1.0 109.451 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.467 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.7 mt-10 -56.46 141.77 41.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 1.0 109.555 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' X' ' 5' ' ' LEU . 86.3 mt -96.89 105.37 17.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 1.0 109.506 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -83.44 172.46 12.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 1.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -56.56 -46.58 80.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 1.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . 0.653 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 3.2 m-70 -66.59 -44.01 83.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 1.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 81.5 mt-10 -60.17 -38.75 84.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 1.0 109.425 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -63.64 -38.48 91.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 1.0 109.555 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.14 -40.22 89.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 1.0 109.468 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.68 -44.37 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 1.0 109.307 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.15 -41.67 75.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 1.0 109.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -66.22 -36.27 82.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 1.0 108.896 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.47 -41.11 98.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.228 -0.92 . . . . 1.0 108.815 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -40.9 98.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.0 109.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.49 -45.27 85.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 1.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.77 85.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 1.0 109.377 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 19' ' ' LEU . 88.6 mt -63.77 -38.66 91.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 1.0 109.364 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.42 -35.54 76.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 1.0 109.316 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -66.16 -39.53 89.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 1.0 109.351 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -68.55 -19.12 64.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.845 . . . . 1.0 109.255 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.22 50.01 0.48 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.97 129.84 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -1.151 . . . . 1.0 109.436 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -126.74 101.73 6.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 1.0 109.145 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.78 162.46 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 1.0 109.36 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.34 145.07 39.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.886 . . . . 1.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -59.94 -39.28 85.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.237 -0.914 . . . . 1.0 109.34 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.55 68.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 1.0 109.414 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.0 -39.62 86.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 1.0 109.392 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.441 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -63.01 -43.76 97.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 1.0 109.393 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.47 -41.52 98.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 1.0 109.435 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.31 -38.53 91.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 1.0 109.42 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.409 ' O ' HG23 ' X' ' 38' ' ' VAL . 61.3 t80 -57.97 -49.06 78.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 1.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -64.01 -45.81 87.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.0 109.365 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -58.52 -43.06 89.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 1.0 109.317 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -66.4 -43.49 85.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 1.0 109.523 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.409 HG23 ' O ' ' X' ' 34' ' ' PHE . 54.7 t -60.42 -45.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 1.0 109.535 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.563 ' NZ ' ' CH2' ' X' ' 44' ' ' TRP . 44.5 tttm -66.62 -32.85 74.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.43 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.9 m-20 -68.85 -19.53 64.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 1.0 109.688 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . 0.407 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 6.4 m -54.01 -61.37 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.0 109.418 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.689 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.71 -60.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 -177.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 71.4 Cg_exo -41.67 -51.81 4.16 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.891 2.394 . . . . 1.0 112.232 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' NZ ' ' X' ' 39' ' ' LYS . 6.5 m0 -132.95 -149.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 1.0 109.551 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.621 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.45 -44.91 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 1.0 109.877 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 36.1 Cg_exo -56.47 -31.74 86.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.725 2.283 . . . . 1.0 112.367 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.09 125.01 24.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 1.0 109.65 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -132.18 159.51 38.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.43 156.42 27.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -64.09 142.8 58.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.178 . . . . 1.0 109.382 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.68 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.73 133.28 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 1.0 109.548 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.68 ' N ' HD13 ' X' ' 51' ' ' ILE . 83.8 m-20 -72.12 135.61 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 1.0 109.756 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 1.0 109.423 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.28 -41.15 97.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 1.0 109.373 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -81.51 -17.48 48.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.0 109.299 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.544 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -58.44 -37.45 75.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.997 . . . . 1.0 109.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.16 -43.47 92.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 1.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -67.09 -37.03 83.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 1.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.65 -43.22 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 1.0 109.33 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.56 -47.46 90.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.504 -1.439 . . . . 1.0 109.504 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.01 -40.34 82.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 1.0 109.44 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.0 m -65.78 -50.28 65.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 1.0 109.439 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.79 -43.2 94.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 1.0 109.519 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -61.99 -33.41 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.0 109.517 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -65.12 -43.01 93.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 1.0 109.335 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.87 -34.96 74.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 1.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' X' ' 71' ' ' GLY . 19.9 t80 -60.26 -54.85 40.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.61 -36.53 82.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.0 109.351 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -64.59 -47.14 79.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 1.0 109.313 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.68 -52.68 2.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 1.0 109.264 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.81 -164.53 26.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -73.45 -14.27 25.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.928 2.418 . . . . 1.0 111.983 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -61.49 -49.76 75.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.0 109.284 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.55 -46.3 73.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 1.0 109.324 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.703 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.5 m -147.24 89.28 5.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 1.0 109.484 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.23 -170.23 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.83 2.353 . . . . 1.0 112.186 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.82 -18.23 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 1.0 109.406 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.6 p -58.55 -30.86 67.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.413 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 1.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.85 -39.66 93.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 1.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 64.7 m -61.79 -46.02 91.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 1.0 109.403 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' CZ ' ' X' ' 45' ' ' PHE . 36.7 m-85 -66.64 -42.38 86.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.877 . . . . 1.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.544 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t-105 -63.86 -34.63 78.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.0 109.289 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.3 -41.05 83.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 1.0 109.202 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.61 -42.44 98.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 1.0 109.577 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.3 -41.38 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 1.0 109.394 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.492 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 47.5 mttt -53.62 -41.36 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 1.0 109.424 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.56 -37.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 1.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.72 -48.69 76.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 1.0 109.378 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -73.31 -41.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 1.0 109.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.09 -42.29 98.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 1.0 109.454 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -64.76 -42.5 95.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 1.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.18 130.28 35.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 1.0 109.459 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.71 114.88 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 1.0 109.524 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p -141.33 151.08 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 1.0 109.62 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.62 HD21 ' H ' ' X' ' 100' ' ' MET . 12.6 t-20 -125.13 83.85 60.09 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 1.0 109.506 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.42 -40.36 85.98 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.878 2.385 . . . . 1.0 112.303 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -151.87 -81.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 1.0 109.439 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.86 101.69 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.548 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . 0.62 ' H ' HD21 ' X' ' 96' ' ' ASN . 94.1 mtp . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.003 -0.998 . . . . 1.0 109.515 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.9 ttp . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.31 8.51 81.18 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -91.15 158.26 16.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 1.0 109.487 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.73 132.34 36.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.97 102.78 15.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.87 . . . . 1.0 109.506 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -82.95 175.66 9.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.0 109.616 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -54.11 -45.55 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 1.0 109.483 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.98 -43.59 87.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.565 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -60.07 -39.46 86.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 1.0 109.387 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.8 -38.18 89.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 1.0 109.606 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -61.79 -35.85 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.911 . . . . 1.0 109.437 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.01 -43.71 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 1.0 109.318 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.55 -44.69 93.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 1.0 109.312 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.6 -37.95 83.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.179 -0.95 . . . . 1.0 108.91 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.74 -40.3 94.6 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.279 -0.888 . . . . 1.0 108.747 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.638 ' HZ2' ' CA ' ' X' ' 28' ' ' TYR . 88.6 tttt -62.58 -41.1 98.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 1.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.62 -44.65 85.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.922 . . . . 1.0 109.139 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.06 98.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.445 -0.785 . . . . 1.0 109.412 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' X' ' 58' ' ' ARG . 95.7 mt -63.81 -38.03 89.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 1.0 109.251 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -58.62 -43.08 89.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.0 109.228 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 67.4 p -63.16 -31.26 72.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 1.0 109.384 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.83 -15.79 61.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 1.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.31 47.16 0.82 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.3 134.28 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -1.123 . . . . 1.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.7 92.98 3.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.937 . . . . 1.0 109.209 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.84 160.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 1.0 109.298 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.0 143.43 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 1.0 109.486 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.638 ' CA ' ' HZ2' ' X' ' 16' ' ' LYS . 89.6 t80 -61.68 -38.48 87.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 1.0 109.296 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.81 65.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 1.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.452 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.0 m-20 -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 1.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.462 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -61.62 -44.58 96.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 1.0 109.391 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.37 -43.74 96.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 1.0 109.329 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.07 -37.45 85.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 1.0 109.378 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.66 -48.13 75.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 1.0 109.376 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -60.95 -41.59 96.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 1.0 109.391 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -65.14 -40.34 94.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 1.0 109.214 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.83 -42.71 99.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 1.0 109.51 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.37 -46.13 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 1.0 109.575 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 1.0 109.404 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' X' ' 44' ' ' TRP . 85.5 m-20 -70.64 -19.3 62.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 1.0 109.694 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 22.2 m -54.9 -52.92 61.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.0 109.445 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.672 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -112.89 -63.65 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 1.0 109.466 -177.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.09 -40.61 4.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.904 2.403 . . . . 1.0 112.15 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.4 m-90 -146.08 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 1.0 109.537 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.608 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 172.29 -45.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 1.0 109.889 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 31.5 Cg_exo -56.1 -35.37 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.693 2.262 . . . . 1.0 112.368 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -64.4 127.98 33.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 1.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -142.15 168.85 18.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 109.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.88 165.63 37.69 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 15.6 m -64.31 141.3 58.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -1.217 . . . . 1.0 109.371 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.652 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -130.0 135.12 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.652 ' N ' HD13 ' X' ' 51' ' ' ILE . 38.8 m-20 -68.85 138.25 54.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 1.0 109.779 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.91 -25.02 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 1.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.97 -40.49 95.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 1.0 109.358 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -76.21 -18.74 58.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 1.0 109.258 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.3 t90 -54.64 -39.09 67.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -62.66 -41.31 99.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.0 109.496 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.454 ' NH2' HD13 ' X' ' 19' ' ' LEU . 79.0 mtp85 -66.61 -38.46 87.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 1.0 109.477 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.525 HG21 ' CH2' ' X' ' 83' ' ' TRP . 51.1 t -63.31 -43.98 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 1.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.7 84.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 1.0 109.511 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -66.18 -37.27 85.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -1.197 . . . . 1.0 109.512 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 82.5 m -69.95 -50.43 42.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 1.0 109.522 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.471 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.5 m-85 -61.11 -43.09 99.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 1.0 109.492 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.6 -40.14 86.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 1.0 109.439 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.68 -45.91 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 1.0 109.373 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -64.53 -35.06 79.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.485 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' X' ' 71' ' ' GLY . 1.9 t80 -59.29 -54.71 43.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 1.0 109.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.442 ' N ' ' CD2' ' X' ' 67' ' ' TYR . 38.7 t30 -64.41 -36.71 85.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 1.0 109.281 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -67.72 -45.19 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 1.0 109.277 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.27 -52.23 2.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 1.0 109.312 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.74 -168.32 24.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.439 -1.464 . . . . 1.0 109.439 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -65.71 -20.07 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.914 2.409 . . . . 1.0 111.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.66 -54.84 39.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 1.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -64.21 -42.98 96.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 1.0 109.352 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.73 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.8 m -150.44 91.38 4.15 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 1.0 109.432 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -82.83 179.97 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.862 2.375 . . . . 1.0 112.213 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.62 -23.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 1.0 109.486 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.464 ' H ' HG23 ' X' ' 78' ' ' THR . 6.5 p -60.85 -34.95 75.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 1.0 109.423 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.38 72.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -69.86 -37.78 76.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 1.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -59.88 -46.98 87.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 1.0 109.403 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -61.9 -40.14 94.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.513 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.668 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.6 t-105 -66.0 -36.18 82.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -58.05 -41.67 83.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 1.0 109.255 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.49 -38.26 90.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.41 -0.806 . . . . 1.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.57 -42.7 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 1.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -57.71 -43.35 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0 109.395 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.25 -36.65 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 1.0 109.383 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.8 -51.95 59.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 1.0 109.352 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 pt -71.41 -41.09 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.0 109.411 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.33 -51.65 67.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.501 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.78 -40.68 92.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 1.0 109.541 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.16 138.77 39.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 1.0 109.533 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.69 93.85 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 1.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 1.078 HG22 ' H ' ' X' ' 96' ' ' ASN . 9.9 p -124.64 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 1.078 ' H ' HG22 ' X' ' 95' ' ' VAL . 20.8 t-20 -124.96 81.77 62.03 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 1.0 109.605 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -83.93 -40.87 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.821 2.347 . . . . 1.0 112.333 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.15 172.87 6.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 1.0 109.437 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 86.4 t -78.41 78.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 1.0 109.539 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.964 -1.017 . . . . 1.0 109.419 179.738 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.17 63.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -129.46 162.07 28.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -1.171 . . . . 1.0 109.543 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.26 131.28 41.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 1.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -96.91 104.54 16.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 1.0 109.486 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -77.64 170.19 17.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.868 . . . . 1.0 109.575 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -50.79 -43.17 58.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 1.0 109.379 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -68.14 -49.0 63.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 1.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.89 -35.87 77.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 1.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -60.86 -41.28 95.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 1.0 109.562 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.7 -36.04 79.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 1.0 109.464 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.41 -45.31 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 1.0 109.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.74 -45.97 81.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 1.0 109.398 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.95 -38.92 90.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 1.0 108.911 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.77 -43.14 99.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 1.0 108.765 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.542 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 88.6 tttt -61.26 -38.6 87.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 1.0 109.486 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.46 -46.95 87.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 1.0 109.145 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.15 93.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.313 -0.867 . . . . 1.0 109.44 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' X' ' 19' ' ' LEU . 97.1 mt -67.08 -40.69 87.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 1.0 109.23 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.19 -42.07 80.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.903 . . . . 1.0 109.242 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 70.3 p -64.96 -33.93 77.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.845 . . . . 1.0 109.299 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.95 -17.64 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 1.0 109.169 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.17 48.24 0.53 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.28 -1.528 . . . . 1.0 109.28 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.92 133.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 1.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -132.0 99.0 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 1.0 109.224 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.23 163.22 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 1.0 109.357 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.92 148.81 32.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 1.0 109.499 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.542 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 59.0 m-85 -63.75 -42.93 97.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.224 -0.923 . . . . 1.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.95 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 1.0 109.455 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.25 -40.34 93.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 1.0 109.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.454 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.1 -45.93 91.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 1.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.13 -41.68 99.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 1.0 109.394 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.509 ' HZ3' ' H ' ' X' ' 50' ' ' THR . 98.4 mttt -67.24 -35.83 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.34 -50.26 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 1.0 109.493 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -61.03 -41.49 96.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.0 109.417 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.56 -39.74 95.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 1.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.37 -45.58 91.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -0.802 . . . . 1.0 109.508 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 76.7 t -58.27 -49.21 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 1.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.5 mttt -64.0 -31.5 72.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.8 m-20 -67.67 -19.14 65.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.85 . . . . 1.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 9.8 m -53.78 -48.43 69.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 1.0 109.403 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.821 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -122.73 -59.6 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.821 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.5 Cg_exo -41.47 -45.69 6.03 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.88 2.386 . . . . 1.0 112.219 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.7 m-90 -139.02 113.67 9.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.152 -0.967 . . . . 1.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -64.91 -43.72 69.4 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 1.0 109.875 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -55.93 130.77 42.13 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.79 2.327 . . . . 1.0 112.373 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -119.05 133.45 55.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 1.0 109.707 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -142.51 127.72 18.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.887 . . . . 1.0 109.789 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.74 147.73 5.38 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.509 ' H ' ' HZ3' ' X' ' 33' ' ' LYS . 31.4 m -88.68 143.26 27.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.099 -1.236 . . . . 1.0 109.414 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.679 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -117.14 130.27 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 1.0 109.538 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.679 ' N ' HD13 ' X' ' 51' ' ' ILE . 45.1 t0 -71.88 136.79 47.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 1.0 109.784 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.74 -25.4 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 1.0 109.464 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.96 -38.66 91.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 1.0 109.396 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -82.74 -18.88 39.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 1.0 109.296 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 11.9 t90 -60.13 -38.38 82.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.0 109.64 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.563 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 31.8 mmt180 -56.88 -43.64 81.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 109.478 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.476 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 81.8 mtp180 -68.75 -39.4 80.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 1.0 109.479 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -61.62 -46.55 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 1.0 109.372 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.49 -48.66 68.92 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.14 -33.99 77.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 1.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.5 m -69.23 -54.04 16.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 1.0 109.454 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -64.14 -43.37 95.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 1.0 109.482 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.4 -32.2 72.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 1.0 109.467 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.43 -45.87 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 1.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -72.67 -28.86 62.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 1.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' X' ' 71' ' ' GLY . 45.1 t80 -60.03 -53.4 58.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 1.0 109.402 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -69.48 -35.67 75.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 1.0 109.336 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.1 m -62.08 -45.86 91.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 1.0 109.258 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.19 -51.25 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 1.0 109.2 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 137.85 -158.5 24.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.8 -13.89 17.59 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.89 2.393 . . . . 1.0 111.953 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.93 -51.6 66.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 1.0 109.213 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -64.36 -40.82 96.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 1.0 109.309 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.78 83.92 9.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 1.0 109.418 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' X' ' 78' ' ' THR . 43.5 Cg_exo -55.46 154.41 24.63 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.827 2.352 . . . . 1.0 112.265 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.493 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.9 p -53.39 -6.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 1.0 109.438 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.518 ' H ' ' C ' ' X' ' 76' ' ' PRO . 63.1 p -61.19 -41.21 96.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.87 . . . . 1.0 109.391 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.62 75.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 1.0 109.385 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -61.13 -42.8 99.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 1.0 109.425 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -63.22 -46.63 86.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -63.19 -41.74 99.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.576 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.599 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 5.6 t-105 -61.42 -37.53 83.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 1.0 109.367 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.95 -44.14 78.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 1.0 109.191 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.578 ' O ' HD13 ' X' ' 89' ' ' LEU . 98.8 mt -65.66 -40.09 92.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 1.0 109.552 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mm -61.6 -41.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.243 -0.91 . . . . 1.0 109.395 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.93 -39.95 79.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 1.0 109.481 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -71.09 -36.73 72.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.389 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.578 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -65.72 -43.27 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 1.0 109.386 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.437 HG22 HG23 ' X' ' 50' ' ' THR . 7.5 pt -78.92 -20.74 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 1.0 109.335 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.34 -50.07 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.485 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.97 -41.23 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 1.0 109.54 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.54 139.54 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 1.0 109.573 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -75.86 92.27 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.0 109.538 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.604 HG22 ' N ' ' X' ' 96' ' ' ASN . 11.2 p -111.14 167.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 1.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.604 ' N ' HG22 ' X' ' 95' ' ' VAL . 0.2 OUTLIER -58.61 108.46 1.33 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 1.0 109.612 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' X' ' 95' ' ' VAL . 29.1 Cg_exo -62.3 -164.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.793 2.328 . . . . 1.0 112.336 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -63.93 -40.82 97.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 1.0 109.481 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.42 132.6 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 109.437 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.992 -1.004 . . . . 1.0 109.4 179.558 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.54 80.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -130.0 157.29 42.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 1.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.46 145.04 47.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 1.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.89 94.79 10.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 1.0 109.511 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -78.41 176.22 9.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.593 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -54.28 -45.84 72.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 1.0 109.436 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.35 -42.49 92.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.46 -39.69 88.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 1.0 109.469 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.61 -42.23 92.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 1.0 109.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -59.33 -35.37 73.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 1.0 109.415 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.4 -44.72 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.0 109.305 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' X' ' 28' ' ' TYR . 46.1 tp10 -55.92 -47.7 77.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 1.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -66.53 -37.13 84.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 1.0 108.868 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.24 -42.65 98.98 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 1.0 108.803 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.553 ' HZ2' ' N ' ' X' ' 28' ' ' TYR . 88.5 tttt -61.85 -42.06 98.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 1.0 109.555 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -52.52 -49.91 63.87 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.177 -0.952 . . . . 1.0 109.158 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.57 80.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.0 109.422 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.434 HD23 HG11 ' X' ' 24' ' ' VAL . 9.8 tp -61.19 -40.38 93.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 1.0 109.251 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.68 -40.71 80.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.303 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -58.61 -33.88 70.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.449 -0.782 . . . . 1.0 109.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.87 -9.97 56.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 1.0 109.19 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.31 44.33 2.2 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.434 HG11 HD23 ' X' ' 19' ' ' LEU . 25.1 t -122.32 135.24 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 1.0 109.387 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -131.36 94.81 3.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.0 109.22 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.471 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 35.3 m -132.8 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 1.0 109.366 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . 0.547 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 68.2 mttm -73.33 147.89 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 109.47 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.562 ' CE2' HD11 ' X' ' 32' ' ' LEU . 51.8 t80 -59.07 -39.28 81.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 1.0 109.203 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.55 59.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 1.0 109.493 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.516 ' CG ' ' CG ' ' X' ' 55' ' ' PHE . 30.2 t0 -61.15 -43.56 98.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 1.0 109.404 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.0 mm? -61.62 -45.35 94.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 1.0 109.409 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' X' ' 28' ' ' TYR . 97.2 mt -63.7 -42.11 98.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 1.0 109.351 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -36.0 82.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 1.0 109.415 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.779 ' O ' HG23 ' X' ' 38' ' ' VAL . 56.2 t80 -57.53 -46.65 83.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 1.0 109.413 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.1 -41.77 90.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 1.0 109.308 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -63.34 -44.07 95.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 109.266 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 38.8 t80 -61.34 -43.59 98.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 1.0 109.54 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.779 HG23 ' O ' ' X' ' 34' ' ' PHE . 50.5 t -59.46 -47.46 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.0 109.535 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.82 -36.76 80.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 1.0 109.425 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' X' ' 44' ' ' TRP . 84.6 m-20 -69.11 -19.65 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 1.0 109.639 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 96.4 m -54.44 -47.78 72.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 1.0 109.41 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.712 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -119.16 -64.34 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 1.0 109.461 -178.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.0 Cg_exo -40.69 -33.82 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.89 2.393 . . . . 1.0 112.174 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 6.2 m-90 -155.94 100.95 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 1.0 109.468 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.684 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -71.22 -39.92 8.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 1.0 109.901 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 26.0 Cg_exo -60.87 -34.32 91.39 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.703 2.269 . . . . 1.0 112.369 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.427 ' OE1' ' OD1' ' X' ' 40' ' ' ASP . 84.4 mt-30 -65.65 124.77 23.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 1.0 109.656 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -144.4 175.16 10.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 1.0 109.847 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.82 165.58 34.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 18.1 m -69.92 137.52 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -1.187 . . . . 1.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.58 139.68 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 1.0 109.504 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -94.26 133.84 37.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 1.0 109.751 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mm -48.71 -23.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 1.0 109.481 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.825 ' HZ1' ' H ' ' X' ' 99' ' ' VAL . 98.7 mttt -65.47 -43.25 90.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 109.353 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' X' ' 55' ' ' PHE . 1.0 OUTLIER -79.79 -16.35 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 1.0 109.296 -178.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 18.1 t90 -59.32 -43.05 92.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 1.0 109.646 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.599 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 32.9 mmt180 -59.72 -42.08 92.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 1.0 109.493 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 63.4 mtp85 -71.55 -46.34 59.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 1.0 109.437 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.586 HG11 ' CH2' ' X' ' 83' ' ' TRP . 81.2 t -64.29 -47.92 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 1.0 109.282 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.15 -47.02 84.1 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -66.15 -37.71 86.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.172 . . . . 1.0 109.462 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 98.7 m -64.11 -56.24 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 1.0 109.48 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.6 m-85 -61.15 -44.77 96.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 1.0 109.459 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.71 -36.94 84.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 1.0 109.49 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.73 -47.15 86.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.0 109.344 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.22 -29.54 68.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.458 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' X' ' 71' ' ' GLY . 39.9 t80 -62.42 -55.05 31.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 1.0 109.429 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -67.52 -34.91 78.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 1.0 109.33 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -66.34 -51.38 57.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 1.0 109.331 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -108.93 -52.44 2.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.85 -162.17 26.29 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' ' N ' ' X' ' 76' ' ' PRO . 18.9 Cg_endo -74.77 -17.88 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.946 2.431 . . . . 1.0 111.956 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.89 -52.12 66.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 1.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -64.78 -39.32 93.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 1.0 109.371 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.91 79.69 13.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 1.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' X' ' 78' ' ' THR . 45.8 Cg_exo -55.33 155.0 21.55 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.772 2.315 . . . . 1.0 112.222 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.79 -5.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.519 ' H ' ' C ' ' X' ' 76' ' ' PRO . 62.2 p -61.11 -33.88 74.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 1.0 109.44 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.3 -36.87 79.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 1.0 109.372 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.89 . . . . 1.0 109.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -61.85 -49.12 77.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 1.0 109.4 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.85 -41.97 95.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 1.0 109.524 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.586 ' CH2' HG11 ' X' ' 59' ' ' VAL . 9.4 t-105 -67.07 -34.66 78.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.89 -43.28 85.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.0 109.243 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' X' ' 85' ' ' LEU . 98.5 mt -67.47 -38.14 83.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.592 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.24 -44.07 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 1.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.41 -43.78 84.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 1.0 109.441 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.89 -36.54 72.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 1.0 109.355 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.56 -50.69 66.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 1.0 109.35 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.42 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.1 pt -70.45 -42.29 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.42 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 86.2 m-20 -61.53 -47.45 85.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.0 109.475 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.03 -38.85 92.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 1.0 109.614 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.93 135.65 49.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.0 109.508 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -88.74 113.21 24.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 1.0 109.638 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.444 HG13 ' HD3' ' X' ' 97' ' ' PRO . 9.8 p -134.76 154.7 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.0 109.626 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -126.28 85.64 59.57 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 109.564 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.444 ' HD3' HG13 ' X' ' 95' ' ' VAL . 28.1 Cg_exo -62.57 -152.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.881 2.387 . . . . 1.0 112.296 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -62.87 -40.12 96.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.0 109.43 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.825 ' H ' ' HZ1' ' X' ' 54' ' ' LYS . 41.6 t -126.31 131.17 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 109.518 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.99 -1.005 . . . . 1.0 109.473 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 16.56 80.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -130.16 161.12 31.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 1.0 109.497 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 80.1 mm-40 -59.87 134.41 57.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 1.0 109.545 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.87 99.76 12.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 1.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -79.61 171.68 14.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 1.0 109.563 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -55.59 -42.96 75.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 1.0 109.436 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -66.36 -44.41 83.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 1.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 90.7 mt-10 -63.3 -33.34 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 1.0 109.427 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -70.52 -39.41 74.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 1.0 109.607 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.95 -49.12 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 1.0 109.364 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' X' ' 35' ' ' PHE . 27.6 m -69.16 -34.18 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 1.0 109.324 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.2 -43.1 92.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.261 -0.9 . . . . 1.0 109.289 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.67 -34.2 77.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 1.0 108.916 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.8 -41.12 99.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.356 -0.84 . . . . 1.0 108.847 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.475 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 87.6 tttt -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.756 . . . . 1.0 109.566 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.44 -45.19 84.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 1.0 109.195 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -65.69 -39.75 91.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 1.0 109.403 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.77 -38.88 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 1.0 109.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 1.0 109.238 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 45.8 p -62.92 -31.37 72.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.09 -17.57 61.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 1.0 109.145 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.29 47.18 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -119.06 130.46 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.429 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.19 98.43 4.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.94 . . . . 1.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.96 160.12 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 109.288 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -74.4 143.99 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 1.0 109.489 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.475 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 63.9 m-85 -61.74 -41.42 97.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.204 -0.935 . . . . 1.0 109.26 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.77 53.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 1.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' CG ' ' X' ' 55' ' ' PHE . 15.4 t70 -63.18 -39.5 94.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 1.0 109.448 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' X' ' 31' ' ' LEU . 4.4 mm? -62.39 -45.56 92.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 1.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.03 -42.95 99.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 1.0 109.364 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' H ' ' X' ' 50' ' ' THR . 98.6 mttt -65.02 -38.86 92.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 1.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -58.31 -49.62 76.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 1.0 109.391 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG11 ' X' ' 12' ' ' VAL . 58.3 m-85 -63.08 -44.14 96.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 1.0 109.404 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.23 -37.54 80.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 1.0 109.265 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.76 -46.78 88.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.918 . . . . 1.0 109.533 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.44 -44.34 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 1.0 109.548 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.29 -25.58 64.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.5 m-20 -73.56 -19.58 60.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.867 . . . . 1.0 109.658 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -54.11 -41.29 68.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 1.0 109.418 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.699 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -128.06 -64.4 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.473 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.699 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 53.9 Cg_exo -40.84 -40.1 3.45 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.879 2.386 . . . . 1.0 112.183 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.517 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -142.66 116.34 9.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 1.0 109.527 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.656 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -66.5 -41.72 42.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 1.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 27.1 Cg_exo -60.82 137.72 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.768 2.312 . . . . 1.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.92 147.74 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 1.0 109.654 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -141.33 157.19 45.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 1.0 109.807 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 164.3 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.626 ' H ' ' NZ ' ' X' ' 33' ' ' LYS . 41.6 m -114.5 129.82 56.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 1.0 109.311 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.0 136.08 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 1.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.67 137.54 36.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 1.0 109.757 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.13 -23.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 1.0 109.437 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -64.68 -39.29 93.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 1.0 109.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . 0.544 ' CG ' ' OD1' ' X' ' 30' ' ' ASP . 3.1 t80 -85.2 -9.98 57.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.955 . . . . 1.0 109.283 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' X' ' 56' ' ' TRP . 11.3 t90 -57.64 -38.24 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 1.0 109.646 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' X' ' 57' ' ' ARG . 14.3 mmm180 -61.41 -38.95 88.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 1.0 109.539 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 76.9 mtp180 -70.19 -36.88 74.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 1.0 109.418 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.535 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 79.4 t -65.32 -42.16 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 1.0 109.315 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.53 -48.77 84.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -66.08 -40.14 90.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -1.141 . . . . 1.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 89.3 m -64.56 -54.28 34.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 1.0 109.509 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.96 -44.46 94.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 1.0 109.446 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -60.1 -37.87 81.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 1.0 109.478 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.38 -41.44 98.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 1.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -66.24 -38.6 88.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.3 -52.45 65.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 1.0 109.402 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.61 -30.14 69.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 1.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.1 m -61.65 -48.14 82.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 1.0 109.257 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 -52.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 1.0 109.269 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.68 29.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' X' ' 76' ' ' PRO . 23.2 Cg_exo -60.17 -23.71 74.64 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.969 2.446 . . . . 1.0 111.899 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -52.44 -51.95 56.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.164 -0.96 . . . . 1.0 109.231 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.0 -42.43 99.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 1.0 109.354 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.4 81.09 14.1 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 1.0 109.485 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.7 Cg_exo -59.62 161.75 17.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.818 2.345 . . . . 1.0 112.277 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.491 ' O ' HG12 ' X' ' 77' ' ' VAL . 76.8 t -50.19 -9.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 1.0 109.444 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.513 ' H ' ' C ' ' X' ' 76' ' ' PRO . 68.1 p -60.21 -35.85 76.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 1.0 109.413 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.94 94.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 1.0 109.414 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.22 -42.8 93.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 1.0 109.411 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -62.77 -45.91 90.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.426 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.513 ' OH ' ' CD2' ' X' ' 45' ' ' PHE . 18.7 m-85 -63.72 -43.25 97.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 1.0 109.475 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.535 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 7.2 t-105 -63.45 -36.87 85.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 1.0 109.389 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.78 -43.54 80.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.4 -0.813 . . . . 1.0 109.223 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.27 -40.59 86.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 1.0 109.613 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -61.5 -42.48 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 1.0 109.241 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -43.2 88.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 1.0 109.508 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 97.0 mt-10 -70.91 -24.61 62.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 1.0 109.347 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.13 -49.3 12.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 6.5 pt -70.47 -42.4 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 1.0 109.426 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 16.6 p-10 -67.69 -9.51 44.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 1.0 109.491 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.428 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 88.5 tttt -62.48 -48.1 81.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 1.0 109.556 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -115.23 125.46 53.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 1.0 109.452 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -71.03 125.69 27.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 1.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.414 HG22 ' N ' ' X' ' 96' ' ' ASN . 7.6 p -137.77 155.29 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 109.566 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.651 ' ND2' ' H ' ' X' ' 100' ' ' MET . 8.2 t-20 -121.69 84.76 43.51 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 1.0 109.55 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.47 -42.2 62.83 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.86 2.373 . . . . 1.0 112.295 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -144.48 -92.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 1.0 109.433 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.86 95.13 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 1.0 109.507 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . 0.651 ' H ' ' ND2' ' X' ' 96' ' ' ASN . 31.0 ttm . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.998 -1.001 . . . . 1.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.9 79.96 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.661 -1.376 . . . . 1.0 109.661 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -130.1 161.97 29.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.97 . . . . 1.0 109.468 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 131.24 49.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 1.0 109.551 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.97 89.61 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 1.0 109.626 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.1 p -82.88 174.99 10.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 1.0 109.554 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -53.14 -41.02 64.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.237 -0.914 . . . . 1.0 109.282 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . 0.547 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 5.1 m-70 -69.25 -43.69 73.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 1.0 109.415 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.96 -39.25 93.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 1.0 109.602 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.93 -36.83 84.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 109.567 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -61.06 -49.73 76.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 1.0 109.925 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.24 -34.25 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 1.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.57 -35.43 80.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.459 -0.776 . . . . 1.0 109.226 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -68.24 -39.16 82.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 1.0 108.959 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -61.43 -41.24 96.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 1.0 108.961 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.28 -40.5 94.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 1.0 109.395 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -56.2 -44.74 79.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 1.0 109.067 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -36.73 82.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 1.0 109.227 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' X' ' 19' ' ' LEU . 93.8 mt -63.27 -38.74 92.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 1.0 109.068 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.53 -41.38 85.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 1.0 109.092 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -60.14 -39.14 85.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 1.0 109.103 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.41 -16.92 63.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 1.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.58 53.15 0.73 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.293 -1.523 . . . . 1.0 109.293 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.549 ' CG2' HH21 ' X' ' 58' ' ' ARG . 38.2 t -122.06 133.4 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.583 -0.951 . . . . 1.0 109.325 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.18 96.52 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' X' ' 54' ' ' LYS . 27.6 m -133.31 163.99 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 1.0 109.503 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.45 147.78 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 1.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.9 -39.95 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 1.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.26 -31.69 63.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.0 109.358 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -59.96 -42.2 93.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 1.0 109.227 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.427 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.3 mm? -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 1.0 109.359 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.26 -41.27 97.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.797 . . . . 1.0 109.28 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.27 -34.74 79.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 1.0 109.394 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.97 -48.86 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 1.0 109.693 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.18 -45.33 93.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.249 -0.907 . . . . 1.0 109.621 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -64.13 -37.85 88.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.0 109.13 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.14 -45.67 92.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 1.0 109.428 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.03 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 1.0 109.595 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.46 -32.69 74.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.011 0.91 . . . . 1.0 109.629 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.4 m-20 -68.26 -20.38 64.79 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.766 -1.209 . . . . 1.0 109.757 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 m -55.15 -57.46 11.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.878 -1.138 . . . . 1.0 110.708 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.636 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.1 OUTLIER -109.85 -59.6 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.042 0 O-C-N 121.514 -0.741 . . . . 1.0 110.634 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.636 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 75.1 Cg_exo -42.2 -42.25 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.494 2.129 . . . . 1.0 112.701 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.8 m-90 -142.62 -158.91 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 1.0 109.361 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.535 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 2.2 t80 -171.84 49.37 0.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 1.0 109.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 29.3 Cg_endo -67.32 -166.42 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.709 2.273 . . . . 1.0 112.132 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.08 140.6 35.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 1.0 109.581 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.4 134.99 42.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 1.0 109.758 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.03 -178.43 43.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.791 -1.324 . . . . 1.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 14.4 m -71.2 141.7 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -1.193 . . . . 1.0 109.275 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.685 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.77 133.58 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.761 0.791 . . . . 1.0 109.212 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.685 ' N ' HD13 ' X' ' 51' ' ' ILE . 56.5 t0 -71.82 136.97 47.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.64 -1.287 . . . . 1.0 110.012 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' X' ' 52' ' ' ASP . 63.7 mt -66.56 -21.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.79 -1.194 . . . . 1.0 109.259 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.572 ' HB2' HG12 ' X' ' 26' ' ' VAL . 65.4 mmtt -64.95 -40.05 94.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 1.0 109.595 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -84.39 -9.64 58.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 1.0 109.616 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.505 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 11.0 t90 -53.67 -39.88 65.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 1.0 109.795 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' X' ' 57' ' ' ARG . 24.5 mmm-85 -62.24 -37.23 84.62 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.172 -0.955 . . . . 1.0 109.486 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.549 HH21 ' CG2' ' X' ' 24' ' ' VAL . 85.6 mmt-85 -68.31 -42.89 78.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.351 -0.843 . . . . 1.0 109.781 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.62 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 93.3 t -61.38 -45.13 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.29 -0.882 . . . . 1.0 109.26 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.55 97.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.68 -42.2 91.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.255 -1.144 . . . . 1.0 109.671 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.92 -50.67 61.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 1.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.48 -44.75 96.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.0 109.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.96 -35.58 75.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.181 -0.949 . . . . 1.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -64.7 -46.16 83.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 1.0 109.412 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 1.0 109.428 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' X' ' 71' ' ' GLY . 9.1 t80 -59.37 -53.29 59.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 1.0 109.716 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.448 ' O ' ' OD1' ' X' ' 68' ' ' ASN . 51.6 t-20 -64.5 -35.92 82.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.856 -1.153 . . . . 1.0 109.473 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -65.02 -45.35 85.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.213 -0.929 . . . . 1.0 109.99 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.34 -51.87 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.141 -0.623 . . . . 1.0 109.893 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 138.74 -164.05 25.78 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 1.0 109.388 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' X' ' 76' ' ' PRO . 8.6 Cg_exo -66.41 -20.65 54.53 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.97 2.446 . . . . 1.0 111.948 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.37 -53.81 52.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 1.0 109.474 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.44 -37.27 86.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.361 -0.837 . . . . 1.0 109.667 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.706 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.5 m -143.59 81.21 12.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.566 -0.709 . . . . 1.0 109.198 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.502 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.0 Cg_exo -59.03 155.11 40.83 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 123.057 2.504 . . . . 1.0 112.287 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.473 ' O ' HG12 ' X' ' 77' ' ' VAL . 72.3 t -51.91 -10.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 1.0 109.303 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.453 ' H ' ' C ' ' X' ' 76' ' ' PRO . 1.4 t -62.28 -33.44 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.94 -45.08 91.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.324 -0.86 . . . . 1.0 109.129 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.33 -43.43 97.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 1.0 109.479 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -61.94 -45.69 92.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 1.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -64.41 -37.22 86.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 1.0 109.433 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.62 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 9.1 t-105 -64.59 -35.54 81.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.87 . . . . 1.0 109.092 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.14 -43.52 95.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 1.0 109.092 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.07 -39.1 93.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.422 -0.799 . . . . 1.0 109.133 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.24 -42.47 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.0 109.552 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.505 ' NZ ' ' CZ2' ' X' ' 56' ' ' TRP . 63.4 mttt -55.96 -43.26 77.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.71 -35.65 79.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.923 -1.11 . . . . 1.0 109.485 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.72 -49.18 71.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.935 . . . . 1.0 109.835 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 9.8 pt -71.96 -40.95 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 1.0 109.308 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.32 -44.61 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.406 -0.809 . . . . 1.0 109.481 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.51 -43.19 94.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 1.0 109.401 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.0 126.17 30.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.139 -0.976 . . . . 1.0 109.498 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.81 127.91 34.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 1.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.631 HG22 ' N ' ' X' ' 96' ' ' ASN . 13.8 p -132.0 170.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 1.0 109.465 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.631 ' N ' HG22 ' X' ' 95' ' ' VAL . 8.3 t-20 -124.01 84.64 54.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.605 -0.684 . . . . 1.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.416 ' HD3' HG13 ' X' ' 95' ' ' VAL . 31.9 Cg_exo -58.43 148.38 80.65 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 123.091 2.528 . . . . 1.0 112.096 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.02 -41.27 62.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -0.929 . . . . 1.0 109.203 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.692 ' O ' HG13 ' X' ' 99' ' ' VAL . 9.1 p -126.47 106.03 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.513 -0.742 . . . . 1.0 109.619 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.986 -1.007 . . . . 1.0 109.572 179.642 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.79 17.38 77.4 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -128.88 160.51 32.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -1.182 . . . . 1.0 109.503 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -58.42 138.3 56.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 1.0 109.584 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' X' ' 5' ' ' LEU . 74.6 mt -98.82 103.57 15.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 1.0 109.495 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.2 p -79.29 171.3 15.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 1.0 109.571 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.5 -40.9 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 1.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.64 -46.2 76.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 1.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -62.51 -38.35 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 1.0 109.405 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -61.49 -40.91 96.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 1.0 109.551 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.95 -36.45 77.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.195 -0.941 . . . . 1.0 109.475 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.03 -44.15 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 1.0 109.34 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.95 -48.06 73.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.286 -0.884 . . . . 1.0 109.317 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -65.62 -36.31 83.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 1.0 108.805 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' X' ' 15' ' ' LEU . 60.3 tp -63.05 -41.76 99.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.291 -0.881 . . . . 1.0 108.834 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 1.0 109.499 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -55.99 -46.88 78.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.19 -0.944 . . . . 1.0 109.122 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.38 -41.01 96.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.378 -0.827 . . . . 1.0 109.343 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' X' ' 19' ' ' LEU . 90.7 mt -64.87 -36.44 84.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 1.0 109.287 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.89 -38.27 87.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 1.0 109.229 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 76.0 p -65.79 -33.47 75.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 1.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -70.78 -19.36 62.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 1.0 109.243 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.29 47.14 0.39 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.325 -1.51 . . . . 1.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -121.55 133.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -1.105 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.99 91.38 2.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.268 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.73 162.15 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 1.0 109.311 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.12 147.05 32.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 1.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -62.68 -34.5 77.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 1.0 109.225 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.35 69.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 1.0 109.403 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 1.0 109.386 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.519 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -60.35 -44.39 95.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 1.0 109.361 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -42.14 99.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.409 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.03 -33.57 76.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.359 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.482 ' O ' HG23 ' X' ' 38' ' ' VAL . 51.2 t80 -59.39 -46.01 89.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 1.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.26 -44.51 96.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 1.0 109.402 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.63 -44.32 94.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 1.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -63.17 -46.19 88.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 1.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.482 HG23 ' O ' ' X' ' 34' ' ' PHE . 69.7 t -60.39 -44.58 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 1.0 109.569 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 1.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 7.1 m-20 -68.32 -19.84 64.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 1.0 109.667 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . 0.409 HG21 ' O ' ' X' ' 74' ' ' LYS . 99.6 m -54.48 -51.48 64.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 1.0 109.393 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.753 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -118.82 -63.16 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 1.0 109.508 -177.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.753 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 54.3 Cg_exo -40.79 -54.22 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.897 2.398 . . . . 1.0 112.168 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -118.36 -128.25 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 1.0 109.503 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.754 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.8 OUTLIER -175.28 -41.62 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 1.0 109.908 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.754 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 34.5 Cg_exo -58.17 132.72 50.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 1.0 112.307 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -119.01 159.27 24.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 109.71 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -74.16 158.59 33.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 1.0 109.758 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.74 -4.18 63.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.855 -1.298 . . . . 1.0 109.855 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -119.7 118.28 30.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 1.0 109.308 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.711 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -136.31 135.1 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 109.497 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.711 ' N ' HD13 ' X' ' 51' ' ' ILE . 67.4 t0 -67.27 130.68 43.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.14 -38.61 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 1.0 109.417 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -61.57 -37.72 84.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 1.0 109.4 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -76.36 -24.21 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 1.0 109.305 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.659 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 10.0 t90 -57.48 -36.46 71.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.612 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.424 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 14.0 mmm180 -60.69 -41.45 95.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 1.0 109.501 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.63 -37.47 79.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 1.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.15 -44.37 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 1.0 109.306 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.35 -48.57 84.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -65.35 -41.12 94.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.163 . . . . 1.0 109.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.24 -42.87 92.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 1.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.44 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.2 m-85 -65.76 -40.02 91.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 1.0 109.483 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.21 -37.95 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 1.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -63.25 -43.93 96.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 1.0 109.307 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.96 -31.73 71.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.477 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' X' ' 71' ' ' GLY . 17.4 t80 -59.65 -55.02 39.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 1.0 109.357 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -68.38 -34.94 76.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 1.0 109.303 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -65.01 -48.03 75.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 1.0 109.283 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -111.75 -52.37 2.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 1.0 109.329 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.97 -165.68 26.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.58 -14.46 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.911 2.407 . . . . 1.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.1 -49.79 74.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.274 -0.891 . . . . 1.0 109.302 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.409 ' O ' HG21 ' X' ' 41' ' ' THR . 59.7 mmtt -66.91 -43.98 81.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 1.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.717 HG23 ' O ' ' X' ' 75' ' ' VAL . 35.3 m -148.46 88.69 5.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 1.0 109.455 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -81.02 -176.0 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.832 2.354 . . . . 1.0 112.267 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -19.67 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 1.0 109.397 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.4 ' H ' HG23 ' X' ' 78' ' ' THR . 19.1 p -59.67 -33.73 71.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 1.0 109.42 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.39 73.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 1.0 109.463 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -61.63 -41.09 96.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 1.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.0 t -59.23 -46.01 89.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 1.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.28 -43.88 93.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.659 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.5 t-105 -64.32 -36.16 83.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -55.38 -43.08 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.0 109.207 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 85' ' ' LEU . 96.5 mt -65.52 -40.83 93.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 1.0 109.565 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.27 -42.28 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 1.0 109.346 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.76 -41.3 70.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 1.0 109.41 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.73 -38.75 73.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.948 . . . . 1.0 109.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.31 -49.59 73.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 1.0 109.372 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.409 HD13 HG21 ' X' ' 90' ' ' ILE . 7.2 pt -70.29 -41.18 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 1.0 109.436 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 69.5 m-20 -59.84 -47.08 87.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.95 . . . . 1.0 109.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.83 -41.82 97.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.61 137.48 38.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.918 . . . . 1.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 1.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.52 HG13 ' HD3' ' X' ' 97' ' ' PRO . 9.8 p -131.55 160.29 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.496 ' N ' HG22 ' X' ' 95' ' ' VAL . 0.7 OUTLIER -119.82 81.66 26.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 1.0 109.597 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' X' ' 99' ' ' VAL . 59.5 Cg_endo -81.97 65.88 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.879 2.386 . . . . 1.0 112.264 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 54.3 -80.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.164 -0.96 . . . . 1.0 109.419 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' X' ' 97' ' ' PRO . 58.0 t -94.18 129.85 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 1.0 109.577 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.052 -0.975 . . . . 1.0 109.493 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.23 3.16 90.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -129.08 160.99 31.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -1.16 . . . . 1.0 109.582 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mt-10 -62.41 146.51 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.517 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.12 101.84 14.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 109.484 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.3 p -83.48 170.28 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 1.0 109.431 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -54.09 -43.19 70.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 1.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -64.65 -43.49 93.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.878 . . . . 1.0 109.543 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 99.2 mt-10 -67.78 -34.91 77.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 1.0 109.371 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.3 -38.28 84.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.882 . . . . 1.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.08 -51.16 69.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.41 -33.29 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 1.0 109.261 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.21 -42.3 85.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.893 . . . . 1.0 109.177 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -63.75 -39.74 95.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.94 . . . . 1.0 108.766 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.45 -40.25 86.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.39 -43.7 98.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 1.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.424 ' O ' HG23 ' X' ' 21' ' ' THR . 99.4 mm-40 -55.91 -44.11 77.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 1.0 109.024 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.8 96.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 1.0 109.276 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' X' ' 19' ' ' LEU . 95.6 mt -65.11 -38.04 89.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -0.899 . . . . 1.0 109.22 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -60.11 -41.39 92.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 1.0 109.297 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.424 HG23 ' O ' ' X' ' 17' ' ' GLN . 69.5 p -63.06 -31.95 73.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.865 . . . . 1.0 109.233 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.29 -17.96 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.0 109.19 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.65 46.61 0.52 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.584 HG22 HH21 ' X' ' 58' ' ' ARG . 55.4 t -121.22 133.33 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.353 -1.086 . . . . 1.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.92 93.57 2.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 1.0 109.215 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.12 161.21 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 1.0 109.342 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -70.36 146.97 50.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.917 . . . . 1.0 109.491 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.67 -35.46 80.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 1.0 109.235 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.9 -34.48 69.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 1.0 109.409 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.16 -44.19 92.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 1.0 109.341 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.496 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.04 -45.96 91.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 1.0 109.436 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.49 -42.65 98.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 1.0 109.395 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.75 -34.36 75.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 1.0 109.384 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.438 ' O ' HG23 ' X' ' 38' ' ' VAL . 41.1 t80 -58.76 -48.46 81.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 1.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -62.03 -43.72 98.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.99 -42.14 99.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 1.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.4 -43.66 96.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' X' ' 34' ' ' PHE . 84.3 t -56.43 -44.5 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -36.34 83.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 1.0 109.351 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.5 m-20 -68.3 -20.56 64.76 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.089 -1.007 . . . . 1.0 109.588 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -54.44 -52.83 60.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.19 -0.944 . . . . 1.0 109.763 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -112.35 -62.76 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.283 -0.886 . . . . 1.0 109.914 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 77.1 Cg_exo -42.33 -39.05 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.57 2.18 . . . . 1.0 112.062 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 -145.61 -146.16 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 1.0 109.435 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.603 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 174.74 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 1.0 109.902 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -54.9 -34.81 87.35 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.793 2.329 . . . . 1.0 112.396 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.89 124.07 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 1.0 109.675 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.66 158.78 43.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 1.0 109.736 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.76 163.59 31.81 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.328 . . . . 1.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 10.6 m -63.3 140.05 58.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.0 109.345 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.706 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -129.98 134.79 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 1.0 109.334 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.706 ' N ' HD13 ' X' ' 51' ' ' ILE . 55.9 t0 -72.79 134.36 44.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 1.0 109.811 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.932 HG22 HH12 ' X' ' 57' ' ' ARG . 80.2 mt -64.13 -28.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 1.0 109.55 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.3 -40.05 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 1.0 109.503 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.18 -22.69 52.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.8 t90 -55.96 -37.61 69.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.142 -0.974 . . . . 1.0 109.728 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.932 HH12 HG22 ' X' ' 53' ' ' ILE . 28.6 mmt-85 -58.05 -38.86 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 1.0 109.46 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.584 HH21 HG22 ' X' ' 24' ' ' VAL . 81.4 mmt-85 -68.79 -39.62 80.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.61 -44.34 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 1.0 109.469 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.92 -48.15 74.82 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.93 -37.07 83.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 1.0 109.434 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.8 m -67.71 -51.16 52.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 1.0 109.675 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.07 -41.19 99.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 1.0 109.421 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.11 -38.72 83.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 1.0 109.445 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.91 -44.44 97.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 1.0 109.36 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -64.74 -37.85 89.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 1.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' X' ' 71' ' ' GLY . 6.5 t80 -60.13 -53.81 53.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 1.0 109.535 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.4 -33.81 76.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 1.0 109.286 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.1 m -68.37 -44.23 75.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 1.0 109.565 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -122.36 -51.76 1.96 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 1.0 109.673 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.74 -164.29 25.2 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.8 Cg_exo -65.35 -21.51 61.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.941 2.428 . . . . 1.0 112.182 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.44 -53.03 61.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.216 -0.928 . . . . 1.0 109.314 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -66.2 -38.52 88.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 1.0 109.401 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.602 HG23 ' O ' ' X' ' 75' ' ' VAL . 30.5 m -143.4 78.63 14.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.0 109.433 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' X' ' 78' ' ' THR . 35.9 Cg_exo -56.41 156.12 22.83 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.855 2.37 . . . . 1.0 112.362 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' X' ' 77' ' ' VAL . 7.8 p -49.03 -11.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 1.0 109.397 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.507 ' N ' ' O ' ' X' ' 76' ' ' PRO . 68.0 p -59.9 -38.1 81.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.0 109.44 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.61 76.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 1.0 109.397 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -63.67 -44.14 94.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 1.0 109.564 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 50.7 m -61.63 -51.68 67.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 1.0 109.553 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -60.56 -41.84 95.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 1.0 109.484 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.676 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 14.2 t-105 -63.13 -40.36 97.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 1.0 109.289 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -56.27 -38.86 71.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 1.0 108.843 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.14 -42.69 99.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.532 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -61.46 -42.33 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 1.0 109.499 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.753 ' HZ2' HG23 ' X' ' 53' ' ' ILE . 60.8 mmtt -55.69 -40.08 71.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 1.0 109.538 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.2 -37.96 84.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.893 . . . . 1.0 109.544 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.89 -41.91 95.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.217 -0.927 . . . . 1.0 109.843 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.89 -43.14 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.0 109.658 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.91 -48.28 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.0 109.537 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.9 -43.96 94.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 1.0 109.646 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.75 130.53 35.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 1.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.97 130.04 40.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.875 . . . . 1.0 109.55 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.495 HG22 ' N ' ' X' ' 96' ' ' ASN . 9.8 p -129.78 160.6 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 1.0 109.604 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.495 ' N ' HG22 ' X' ' 95' ' ' VAL . 0.2 OUTLIER -121.36 83.96 40.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.612 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.412 ' HD3' HG13 ' X' ' 95' ' ' VAL . 50.1 Cg_endo -82.08 -162.39 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.924 2.416 . . . . 1.0 112.293 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -61.02 -43.39 98.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 1.0 109.471 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.33 133.67 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 1.0 109.546 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.944 -1.027 . . . . 1.0 109.415 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mtp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.289 0.566 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.2 89.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -127.64 151.02 49.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -1.18 . . . . 1.0 109.418 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' X' ' 6' ' ' SER . 95.4 mt-10 -53.03 121.69 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 1.0 109.5 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 92.7 mt -55.37 85.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 1.0 109.484 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . 0.531 ' N ' ' O ' ' X' ' 4' ' ' GLU . 10.0 p -81.76 171.68 14.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 1.0 109.599 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . 0.457 ' CG ' HH21 ' X' ' 10' ' ' ARG . 96.4 mt-30 -54.86 -45.86 74.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 1.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -66.55 -41.8 88.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 1.0 109.485 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -37.42 84.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 1.0 109.408 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.457 HH21 ' CG ' ' X' ' 7' ' ' GLN . 86.6 mtm180 -70.54 -38.05 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 1.0 109.62 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.58 -49.72 76.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 1.0 109.441 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.94 -27.63 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.0 109.366 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.1 -40.7 90.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 1.0 109.395 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.41 -39.18 88.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.993 . . . . 1.0 108.92 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.52 -40.56 97.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.275 -0.891 . . . . 1.0 108.855 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.508 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.8 tttt -61.48 -38.66 88.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 1.0 109.498 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -57.87 -46.61 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 1.0 109.144 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.819 . . . . 1.0 109.43 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' X' ' 16' ' ' LYS . 92.1 mt -63.35 -38.99 93.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 1.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.19 -44.7 92.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 1.0 109.246 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -56.27 -39.81 73.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 1.0 109.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -68.77 -17.14 63.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 1.0 109.222 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.06 0.66 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 50.1 t -122.72 136.78 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -1.109 . . . . 1.0 109.381 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.71 88.5 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 1.0 109.205 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.7 165.0 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 1.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -77.01 153.74 34.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 1.0 109.45 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.508 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 99.5 m-85 -61.44 -35.22 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 1.0 109.261 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.812 . . . . 1.0 109.432 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 56.5 t0 -58.52 -45.24 89.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 1.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.505 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.2 mm? -63.11 -45.26 92.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 1.0 109.4 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.39 -43.73 93.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.338 -0.851 . . . . 1.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.3 -33.41 73.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.39 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.501 ' O ' HG23 ' X' ' 38' ' ' VAL . 39.0 t80 -58.89 -48.75 80.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 1.0 109.448 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -64.85 -42.22 95.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.2 -43.2 98.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.283 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.04 -45.11 94.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.366 -0.834 . . . . 1.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 34' ' ' PHE . 96.9 t -59.2 -47.49 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 1.0 109.518 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -66.64 -35.71 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 109.395 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' X' ' 44' ' ' TRP . 91.6 m-20 -65.05 -19.38 65.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 1.0 109.673 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -54.29 -61.68 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.972 . . . . 1.0 109.362 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.681 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -105.77 -60.2 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 1.0 109.509 -178.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.6 Cg_exo -41.36 -44.57 5.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.883 2.389 . . . . 1.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.4 m-90 -143.17 -144.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 1.0 109.504 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.588 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.39 -46.04 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 1.0 109.95 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 31.3 Cg_exo -54.94 -33.77 83.77 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.713 2.276 . . . . 1.0 112.411 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.21 129.08 38.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 1.0 109.672 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.55 163.36 34.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 1.0 109.87 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.87 166.89 31.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.79 -1.324 . . . . 1.0 109.79 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 28.4 m -64.16 129.78 41.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 1.0 109.3 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.45 131.64 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 1.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' X' ' 54' ' ' LYS . 20.3 t0 -94.23 126.09 39.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.885 . . . . 1.0 109.697 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -44.83 -16.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -0.986 . . . . 1.0 109.482 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' X' ' 52' ' ' ASP . 98.9 mttt -67.31 -35.77 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.398 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . 0.569 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 2.3 m-85 -84.33 -10.99 57.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 1.0 109.285 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -58.24 -46.0 86.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 1.0 109.646 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 1.0 109.544 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 34.0 mmt180 -63.2 -47.9 80.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 1.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.706 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 77.7 t -65.06 -44.4 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 1.0 109.367 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.38 -48.65 82.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -66.16 -40.4 90.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -1.125 . . . . 1.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 90.0 m -62.6 -49.42 75.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.915 . . . . 1.0 109.461 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.17 -42.0 99.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 1.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -58.68 -36.46 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 1.0 109.536 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' X' ' 69' ' ' THR . 89.2 m-20 -62.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 1.0 109.326 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -67.98 -34.23 76.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.31 -0.869 . . . . 1.0 109.483 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' X' ' 71' ' ' GLY . 10.0 t80 -61.55 -54.81 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.355 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -63.34 -34.11 77.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 1.0 109.342 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 19.1 m -68.59 -48.26 64.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.0 109.285 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.23 -52.57 2.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 1.0 109.301 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.52 -163.65 25.18 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.5 Cg_exo -66.06 -23.38 53.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.86 2.373 . . . . 1.0 111.967 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.07 -54.76 34.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 1.0 109.24 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -65.45 -36.0 82.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.403 -0.811 . . . . 1.0 109.331 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.447 HG23 ' O ' ' X' ' 75' ' ' VAL . 11.6 m -145.26 81.4 10.42 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.521 ' N ' ' O ' ' X' ' 72' ' ' PRO . 38.2 Cg_exo -60.27 154.36 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.868 2.379 . . . . 1.0 112.228 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.478 ' O ' HG12 ' X' ' 77' ' ' VAL . 52.0 t -49.93 -11.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 1.0 109.446 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.49 ' N ' ' O ' ' X' ' 76' ' ' PRO . 1.3 t -63.94 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 1.0 109.356 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.03 96.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 1.0 109.418 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -64.92 -44.37 89.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 1.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.9 t -59.09 -45.47 90.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 1.0 109.408 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -65.27 -38.07 89.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 1.0 109.535 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.706 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 8.6 t-105 -66.25 -37.9 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 1.0 109.411 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -55.99 -43.97 78.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 1.0 109.212 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.75 -40.39 96.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.535 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.35 -42.85 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 1.0 109.397 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -59.02 -41.32 87.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 1.0 109.492 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.92 -36.92 72.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 1.0 109.338 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.41 -45.15 88.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 1.0 109.33 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.01 -38.27 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.0 109.448 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.58 -45.14 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 1.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.95 -42.72 99.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 1.0 109.549 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -72.4 146.77 46.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.88 . . . . 1.0 109.498 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -101.9 93.62 5.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 1.0 109.535 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.615 HG22 ' N ' ' X' ' 96' ' ' ASN . 7.5 p -95.91 167.53 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 1.0 109.557 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.615 ' N ' HG22 ' X' ' 95' ' ' VAL . 47.9 t30 -126.19 81.1 67.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 1.0 109.603 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.507 ' HD3' HG13 ' X' ' 95' ' ' VAL . 56.0 Cg_endo -82.16 -159.82 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.818 2.345 . . . . 1.0 112.258 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.53 -43.14 94.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 1.0 109.426 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.25 130.95 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 46.9 ttp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.965 -1.017 . . . . 1.0 109.508 179.831 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . 0.454 ' HG2' ' H ' ' X' ' 3' ' ' GLN . 56.9 ttp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.89 82.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' X' ' 1' ' ' MET . 99.2 mm-40 -128.38 155.93 43.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 1.0 109.521 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 97.1 mt-10 -60.72 136.7 58.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 1.0 109.58 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.47 100.88 13.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 109.477 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 15.2 p -77.56 169.63 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.0 109.565 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -52.49 -43.78 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 1.0 109.485 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.63 -47.89 71.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 1.0 109.527 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 94.5 mt-10 -60.27 -36.68 78.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 1.0 109.461 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -61.1 -42.62 98.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 1.0 109.63 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -59.7 -35.54 74.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 1.0 109.442 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.54 -44.51 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 109.316 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.38 -48.61 78.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.311 -0.868 . . . . 1.0 109.401 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -62.25 -38.3 88.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.23 -0.919 . . . . 1.0 108.92 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' X' ' 15' ' ' LEU . 62.2 tp -61.28 -43.34 99.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 1.0 108.762 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.85 -37.38 81.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.498 -0.751 . . . . 1.0 109.523 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.654 ' O ' HG23 ' X' ' 21' ' ' THR . 86.8 mt-30 -57.87 -48.49 79.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 1.0 109.121 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.41 79.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 1.0 109.412 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.35 -40.28 95.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -0.843 . . . . 1.0 109.299 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.59 -38.16 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 1.0 109.217 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.654 HG23 ' O ' ' X' ' 17' ' ' GLN . 68.4 p -64.13 -13.66 49.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 1.0 109.279 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.12 7.06 42.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 1.0 109.227 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 38.17 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.0 133.19 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.04 96.84 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 1.0 109.166 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.74 161.71 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 1.0 109.41 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.08 144.99 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 1.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.439 ' HE2' HD11 ' X' ' 32' ' ' LEU . 90.0 t80 -61.98 -37.49 85.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 1.0 109.296 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -33.78 64.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.0 109.492 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.07 -38.43 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.427 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.484 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -61.09 -43.89 98.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 1.0 109.456 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.439 HD11 ' HE2' ' X' ' 28' ' ' TYR . 97.1 mt -64.17 -42.11 96.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 1.0 109.39 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' X' ' 50' ' ' THR . 99.2 mttt -62.63 -38.27 89.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 1.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.56 -50.06 75.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0 109.477 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.65 -42.17 99.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 1.0 109.382 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' X' ' 40' ' ' ASP . 66.2 t0 -63.44 -39.61 94.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 1.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.43 -45.31 88.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 1.0 109.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.43 -47.58 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.96 -33.47 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 1.0 109.367 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' X' ' 44' ' ' TRP . 89.7 m-20 -69.78 -19.95 63.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 1.0 109.7 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 7.5 m -54.96 -61.05 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.0 109.481 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.63 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.8 OUTLIER -103.04 -62.86 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.56 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.5 Cg_exo -41.32 -50.09 4.62 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.867 2.378 . . . . 1.0 112.175 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.497 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.6 m-90 -135.06 -147.19 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 1.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 175.14 -44.52 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 1.0 109.851 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 39.0 Cg_exo -58.1 -32.7 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.711 2.274 . . . . 1.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.01 124.14 18.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 1.0 109.735 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' X' ' 82' ' ' TYR . 97.0 mt-10 -141.28 161.64 37.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 1.0 109.789 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.04 169.15 41.23 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.475 ' O ' ' NZ ' ' X' ' 33' ' ' LYS . 34.7 m -64.17 138.51 58.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.116 -1.226 . . . . 1.0 109.334 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.69 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -126.22 135.84 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 1.0 109.479 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.69 ' N ' HD13 ' X' ' 51' ' ' ILE . 85.4 m-20 -71.83 136.29 46.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.854 . . . . 1.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -24.41 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 1.0 109.468 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -65.28 -38.96 91.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.0 109.361 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -80.57 -17.79 50.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 1.0 109.25 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.611 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.6 t90 -54.06 -37.42 64.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 1.0 109.665 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -61.53 -39.85 92.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 1.0 109.479 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -66.39 -40.36 89.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 1.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' X' ' 83' ' ' TRP . 71.4 t -61.36 -45.91 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 1.0 109.35 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -44.11 98.46 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -65.75 -40.13 91.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -1.162 . . . . 1.0 109.462 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.26 -53.66 23.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 109.534 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -61.41 -42.61 99.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 1.0 109.485 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -59.46 -36.92 76.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -62.96 -45.2 93.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 1.0 109.28 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -65.48 -38.06 88.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 1.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' X' ' 71' ' ' GLY . 8.9 t80 -60.14 -53.47 57.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 1.0 109.364 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.28 -38.86 92.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 1.0 109.282 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.8 m -64.13 -49.82 70.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.0 109.281 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.64 -52.24 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 1.0 109.329 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 136.09 -165.13 24.97 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' X' ' 76' ' ' PRO . 12.6 Cg_exo -65.36 -19.89 61.63 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.911 2.408 . . . . 1.0 111.968 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.86 -54.71 41.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.239 -0.913 . . . . 1.0 109.204 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.86 -37.24 85.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.88 80.15 15.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 1.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' X' ' 78' ' ' THR . 32.1 Cg_exo -58.01 157.68 24.04 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.895 2.397 . . . . 1.0 112.214 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -51.66 -6.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 1.0 109.462 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.549 ' H ' ' C ' ' X' ' 76' ' ' PRO . 77.0 p -61.78 -32.97 73.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 1.0 109.371 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.07 -49.96 73.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 1.0 109.405 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 67.6 m -59.87 -43.77 94.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 1.0 109.442 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' X' ' 48' ' ' GLU . 1.2 t80 -61.43 -43.25 99.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0 109.491 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.611 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 9.0 t-105 -65.9 -36.0 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 1.0 109.373 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -56.78 -42.59 79.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 1.0 109.272 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.452 ' O ' HD13 ' X' ' 89' ' ' LEU . 93.0 mt -63.92 -42.6 97.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 1.0 109.587 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mm -62.12 -41.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 1.0 109.403 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.33 -39.21 72.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 1.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -71.08 -37.42 72.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 1.0 109.394 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.452 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.5 mp -64.73 -46.12 83.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.895 . . . . 1.0 109.412 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -74.65 -39.55 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -61.16 -48.99 79.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 1.0 109.512 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.88 -45.0 79.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 1.0 109.596 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.52 127.11 32.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 1.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.42 132.19 51.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.589 HG22 ' N ' ' X' ' 96' ' ' ASN . 14.2 p -133.56 167.02 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 1.0 109.602 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.589 ' N ' HG22 ' X' ' 95' ' ' VAL . 20.2 t-20 -126.81 83.38 65.58 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 1.0 109.6 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.466 ' HD3' HG13 ' X' ' 95' ' ' VAL . 31.4 Cg_exo -58.84 -153.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.881 2.387 . . . . 1.0 112.261 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.38 -40.49 93.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 1.0 109.476 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.09 131.62 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 1.0 109.525 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.964 -1.017 . . . . 1.0 109.477 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.35 0.595 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.78 -8.09 80.35 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.691 -1.364 . . . . 1.0 109.691 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -90.37 161.71 15.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -1.105 . . . . 1.0 109.47 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.45 138.83 12.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 1.0 109.44 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.08 102.46 15.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.739 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.9 p -83.98 168.85 15.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 1.0 109.528 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -52.07 -40.94 61.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 1.0 109.325 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.0 -44.94 83.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 1.0 109.396 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.36 -34.26 76.93 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 1.0 109.427 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.078 -1.014 . . . . 1.0 109.49 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -60.87 -50.26 74.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.97 . . . . 1.0 109.779 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' X' ' 35' ' ' PHE . 17.1 m -64.01 -32.81 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 1.0 109.244 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.05 -44.49 87.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 1.0 109.191 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . 0.472 ' NE2' ' OE1' ' X' ' 17' ' ' GLN . 72.6 tp60 -63.25 -37.46 87.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.918 . . . . 1.0 108.807 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.07 -39.46 89.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -0.904 . . . . 1.0 108.751 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.59 -43.12 97.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 1.0 109.095 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.537 ' O ' HG23 ' X' ' 21' ' ' THR . 87.0 mt-30 -54.97 -42.26 72.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 1.0 108.77 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.26 -44.26 92.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 1.0 109.192 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.547 ' CD2' HH21 ' X' ' 22' ' ' ARG . 8.8 mt -63.15 -41.37 99.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.083 -1.01 . . . . 1.0 109.366 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.32 -38.94 91.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.278 -0.889 . . . . 1.0 109.507 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.537 HG23 ' O ' ' X' ' 17' ' ' GLN . 52.4 p -64.46 -29.83 70.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.433 -0.792 . . . . 1.0 109.345 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.547 HH21 ' CD2' ' X' ' 19' ' ' LEU . 77.7 mtm180 -78.48 -13.46 59.82 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 1.0 109.554 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.03 48.21 0.73 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.52 135.58 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.715 -0.874 . . . . 1.0 109.041 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -130.09 97.3 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.406 -0.808 . . . . 1.0 109.252 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.651 HG11 HH11 ' X' ' 58' ' ' ARG . 27.7 m -134.41 160.36 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.596 -0.69 . . . . 1.0 109.559 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.17 152.32 32.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 1.0 109.675 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -63.99 -34.66 78.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 1.0 108.939 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -29.28 70.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 1.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.555 ' OD2' ' CD1' ' X' ' 55' ' ' PHE . 41.9 t0 -59.37 -48.48 81.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.0 109.179 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.562 ' CD2' HH22 ' X' ' 58' ' ' ARG . 10.6 mt -62.36 -42.96 99.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.937 . . . . 1.0 108.912 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.76 -42.66 99.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.265 -0.897 . . . . 1.0 108.972 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.719 ' HZ1' ' H ' ' X' ' 50' ' ' THR . 98.0 mttt -67.55 -35.04 78.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 1.0 109.178 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.593 ' O ' HG23 ' X' ' 38' ' ' VAL . 30.1 t80 -59.05 -48.92 79.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 1.0 109.879 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' X' ' 12' ' ' VAL . 46.0 m-85 -63.51 -43.47 97.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 1.0 109.647 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -63.38 -40.79 98.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 1.0 109.274 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.632 ' CE2' ' CZ ' ' X' ' 63' ' ' PHE . 53.5 t80 -61.6 -46.22 90.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 1.0 109.665 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.593 HG23 ' O ' ' X' ' 34' ' ' PHE . 58.6 t -57.64 -39.36 69.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.048 -1.032 . . . . 1.0 109.039 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.21 -20.01 45.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 1.0 109.543 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' NE2' ' X' ' 47' ' ' GLN . 95.9 m-20 -68.13 -19.95 64.86 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.959 -1.088 . . . . 1.0 109.409 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 18.9 m -55.31 -43.51 74.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 1.0 110.332 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.649 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.7 OUTLIER -126.04 -63.12 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.538 -0.726 . . . . 1.0 109.929 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 50.3 Cg_exo -42.02 -44.07 7.22 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.662 2.242 . . . . 1.0 112.394 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.9 m0 -139.72 -146.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 109.216 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' X' ' 46' ' ' PRO . 0.2 OUTLIER -174.42 -45.24 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 1.0 109.769 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' X' ' 45' ' ' PHE . 39.2 Cg_exo -58.66 140.27 94.21 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.612 2.208 . . . . 1.0 112.252 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.459 ' NE2' ' OD2' ' X' ' 40' ' ' ASP . 88.7 mm-40 -105.7 158.0 17.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.592 -0.693 . . . . 1.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.69 146.04 47.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 1.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.55 -155.92 29.9 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.331 -1.507 . . . . 1.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.719 ' H ' ' HZ1' ' X' ' 33' ' ' LYS . 91.4 m -128.42 131.81 48.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.565 -0.962 . . . . 1.0 109.567 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.98 131.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.944 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' X' ' 54' ' ' LYS . 24.7 t0 -93.97 127.36 39.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 1.0 109.141 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -46.87 -16.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 1.0 109.495 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' X' ' 52' ' ' ASP . 65.1 mmtt -66.19 -35.51 80.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 1.0 109.635 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . 0.555 ' CD1' ' OD2' ' X' ' 30' ' ' ASP . 1.0 OUTLIER -83.25 -11.6 57.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 1.0 109.636 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.441 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.7 t90 -59.42 -42.94 93.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.88 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -63.85 -40.97 97.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 1.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.651 HH11 HG11 ' X' ' 26' ' ' VAL . 82.3 mtp180 -69.67 -47.19 64.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.0 109.568 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.731 HG11 ' CZ3' ' X' ' 83' ' ' TRP . 85.9 t -64.62 -46.25 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 1.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.03 -45.31 96.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -67.12 -36.66 82.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -1.175 . . . . 1.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 91.7 m -67.37 -47.01 71.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 1.0 109.659 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.632 ' CZ ' ' CE2' ' X' ' 37' ' ' PHE . 2.0 m-85 -64.35 -40.07 95.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 1.0 109.535 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -60.23 -37.68 81.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.311 -0.868 . . . . 1.0 109.331 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.09 -48.21 77.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 1.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -62.07 -36.42 81.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.84 . . . . 1.0 109.435 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' X' ' 71' ' ' GLY . 3.0 t80 -61.86 -55.31 31.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.226 -0.921 . . . . 1.0 109.886 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.61 -36.21 83.52 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.973 -1.079 . . . . 1.0 109.711 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -64.44 -45.72 86.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.305 -0.872 . . . . 1.0 110.195 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.35 -51.96 2.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.685 -0.635 . . . . 1.0 109.967 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 141.59 -169.7 25.06 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' X' ' 76' ' ' PRO . 10.3 Cg_exo -65.36 -22.31 60.07 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.894 2.396 . . . . 1.0 112.102 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.13 -54.63 42.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 1.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -61.58 -39.21 90.37 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.261 -0.899 . . . . 1.0 109.614 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.29 82.01 8.48 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.449 -0.782 . . . . 1.0 109.346 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' X' ' 72' ' ' PRO . 32.2 Cg_exo -57.55 151.7 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.851 2.367 . . . . 1.0 112.333 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 m -49.53 -11.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.388 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.496 ' N ' ' O ' ' X' ' 76' ' ' PRO . 2.0 t -62.64 -33.12 74.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 1.0 109.371 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.28 -41.84 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.9 . . . . 1.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 1.0 109.404 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -61.43 -44.16 97.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -0.855 . . . . 1.0 109.263 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.95 -42.47 94.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.997 . . . . 1.0 109.681 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.731 ' CZ3' HG11 ' X' ' 59' ' ' VAL . 10.2 t-105 -62.76 -36.19 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 1.0 109.315 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -58.5 -43.25 89.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 1.0 108.861 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.415 ' O ' HD13 ' X' ' 89' ' ' LEU . 89.7 mt -63.54 -40.53 97.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 1.0 109.271 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.0 109.619 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.48 -37.61 70.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.365 -0.835 . . . . 1.0 109.509 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -70.99 -39.79 72.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 1.0 109.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.415 HD13 ' O ' ' X' ' 85' ' ' LEU . 7.9 mp -63.49 -48.41 77.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 1.0 110.458 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.405 ' CG1' ' N ' ' X' ' 91' ' ' ASP . 7.5 pt -72.43 -42.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.565 -0.709 . . . . 1.0 109.619 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.405 ' N ' ' CG1' ' X' ' 90' ' ' ILE . 62.9 t0 -62.56 -37.17 85.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 1.0 109.312 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 1.0 109.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -82.2 135.15 35.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 1.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.99 123.08 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 1.0 109.426 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.541 HG22 ' N ' ' X' ' 96' ' ' ASN . 14.9 p -133.53 164.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.705 . . . . 1.0 109.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.541 ' N ' HG22 ' X' ' 95' ' ' VAL . 0.2 OUTLIER -128.63 81.56 70.45 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.647 -0.658 . . . . 1.0 109.555 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.484 ' HD3' HG13 ' X' ' 95' ' ' VAL . 30.8 Cg_exo -61.05 -150.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.97 2.447 . . . . 1.0 112.075 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.47 -42.37 87.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 1.0 109.504 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.7 128.47 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.649 -0.657 . . . . 1.0 109.323 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.4 mtm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.062 -0.97 . . . . 1.0 109.31 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.46 -0.02 89.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 1.0 109.598 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -130.12 161.67 30.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 1.0 109.531 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.71 136.33 57.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 1.0 109.578 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.94 99.49 12.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 1.0 109.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.4 p -79.54 167.31 20.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 1.0 109.598 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -51.06 -42.34 60.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 1.0 109.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.6 -48.7 71.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 1.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.96 -38.92 87.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 1.0 109.4 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.49 -36.68 84.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.532 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -59.94 -42.04 93.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 1.0 109.417 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.97 -43.33 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.95 . . . . 1.0 109.304 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.36 -43.23 78.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 1.0 109.35 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.31 -35.18 80.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 1.0 108.867 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.82 -42.16 99.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0 108.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.86 -42.43 99.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 1.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.54 ' O ' HG23 ' X' ' 21' ' ' THR . 89.0 mt-30 -56.07 -46.49 78.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 1.0 109.144 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.0 97.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 1.0 109.407 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' X' ' 19' ' ' LEU . 82.5 mt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 1.0 109.319 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.04 -39.36 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 1.0 109.243 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.54 HG23 ' O ' ' X' ' 17' ' ' GLN . 46.8 p -65.65 -29.92 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.0 109.29 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.92 -18.44 59.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 1.0 109.142 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.58 48.52 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.08 135.29 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -1.138 . . . . 1.0 109.397 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.65 101.41 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 1.0 109.125 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 161.5 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.835 . . . . 1.0 109.352 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.89 145.83 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 109.435 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.24 -41.24 99.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 1.0 109.281 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.04 64.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.426 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' CG ' ' X' ' 55' ' ' PHE . 20.6 t70 -59.12 -39.33 81.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.0 109.417 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' X' ' 31' ' ' LEU . 4.3 mm? -62.52 -43.08 99.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 1.0 109.417 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.29 -41.55 85.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 1.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.5 -38.37 89.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 1.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.02 -48.65 79.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 1.0 109.419 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -61.88 -42.61 99.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 1.0 109.4 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.51 -34.46 77.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.0 109.332 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.55 -46.25 86.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.539 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.91 -50.92 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 1.0 109.589 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' X' ' 43' ' ' PRO . 68.3 mttm -66.35 -29.88 70.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 1.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' X' ' 44' ' ' TRP . 97.0 m-20 -78.25 -18.59 55.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0 109.675 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 3.0 m -53.92 -61.28 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 1.0 109.396 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.624 ' H ' ' CD ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -108.98 -50.91 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 1.0 109.568 -176.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.624 ' CD ' ' H ' ' X' ' 42' ' ' CYS . 52.7 Cg_exo -52.7 -39.34 76.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.885 2.39 . . . . 1.0 112.2 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.485 ' O ' ' O ' ' X' ' 40' ' ' ASP . 5.3 m-90 -147.49 -150.4 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 1.0 109.544 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' X' ' 41' ' ' THR . 0.2 OUTLIER 172.9 69.31 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.877 . . . . 1.0 109.877 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.72 159.8 38.37 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.693 2.262 . . . . 1.0 112.369 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.25 130.24 45.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 1.0 109.733 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.96 179.8 7.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 1.0 109.763 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.98 -93.43 0.17 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 29.5 m -125.92 144.79 50.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.174 . . . . 1.0 109.35 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.716 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.2 OUTLIER -131.64 132.49 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 1.0 109.544 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.716 ' N ' HD13 ' X' ' 51' ' ' ILE . 65.5 m-20 -66.53 134.04 51.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 109.757 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.31 -29.07 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 1.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -44.61 93.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 1.0 109.44 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . 0.559 ' CG ' ' OD2' ' X' ' 30' ' ' ASP . 4.7 t80 -77.99 -23.22 48.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 1.0 109.285 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.609 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 12.6 t90 -55.64 -38.08 69.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 1.0 109.639 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.39 -42.1 98.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.933 . . . . 1.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 78.5 mtp85 -67.41 -37.2 82.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 1.0 109.429 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.59 -42.79 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.907 . . . . 1.0 109.356 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.29 91.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -66.82 -37.07 83.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -1.159 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 97.7 m -71.91 -44.62 63.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 1.0 109.553 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.458 ' O ' HG21 ' X' ' 75' ' ' VAL . 3.0 m-85 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 1.0 109.472 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.87 -37.43 79.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 1.0 109.472 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -63.06 -46.25 88.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 1.0 109.32 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -65.77 -31.75 72.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 1.0 109.458 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' X' ' 71' ' ' GLY . 11.2 t80 -59.15 -54.89 41.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 1.0 109.391 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -67.6 -35.65 79.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.853 . . . . 1.0 109.335 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -65.87 -44.02 86.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 1.0 109.345 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.48 -52.55 2.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 1.0 109.275 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -164.47 26.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.44 -1.464 . . . . 1.0 109.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -73.5 -15.1 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.874 2.383 . . . . 1.0 111.913 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -61.92 -50.22 73.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 1.0 109.198 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -65.62 -43.68 88.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.878 . . . . 1.0 109.396 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.746 HG23 ' O ' ' X' ' 75' ' ' VAL . 32.7 m -150.08 89.03 4.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 1.0 109.406 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.35 -175.03 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.871 2.381 . . . . 1.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.453 ' H ' HG22 ' X' ' 77' ' ' VAL . 5.1 m -62.32 -18.19 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 109.383 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.1 p -62.05 -31.8 72.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 1.0 109.382 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.79 97.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -67.98 -38.64 82.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.431 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -61.29 -51.3 69.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 1.0 109.356 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -60.8 -44.34 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 1.0 109.417 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.609 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.9 t-105 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 109.351 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -56.35 -44.68 80.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 1.0 109.295 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' X' ' 85' ' ' LEU . 89.7 mt -63.27 -40.41 97.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 1.0 109.559 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.25 -42.54 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 1.0 109.327 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.27 -39.94 67.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.495 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.8 -39.09 73.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 1.0 109.413 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.48 -43.96 92.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 1.0 109.356 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' X' ' 93' ' ' LYS . 10.2 pt -76.17 -38.74 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 1.0 109.508 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.2 -45.0 96.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 1.0 109.509 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.88 -41.74 77.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 1.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' X' ' 90' ' ' ILE . 88.3 tttt -85.46 137.82 32.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.0 109.441 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.97 140.86 47.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 1.0 109.531 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 1.06 HG22 ' H ' ' X' ' 96' ' ' ASN . 9.5 p -150.0 -147.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 1.0 109.579 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 1.06 ' H ' HG22 ' X' ' 95' ' ' VAL . 36.0 t-20 -129.99 81.49 68.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 1.0 109.597 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.39 -168.13 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.811 2.34 . . . . 1.0 112.268 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -63.44 -38.59 91.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 1.0 109.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.3 129.64 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 1.0 109.534 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.3 mtp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.022 -0.99 . . . . 1.0 109.457 179.741 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.17 75.11 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -91.08 156.65 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 1.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -64.23 133.48 52.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 1.0 109.519 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.73 105.22 16.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 1.0 109.473 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.3 p -87.38 175.13 8.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 1.0 109.58 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.71 -43.63 65.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 1.0 109.435 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . 0.631 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.2 m-70 -67.88 -44.92 75.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 1.0 109.522 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.57 -39.45 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 1.0 109.369 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -62.04 -38.32 88.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.0 109.61 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.1 -41.59 88.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 1.0 109.502 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.65 -44.41 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 1.0 109.33 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -51.02 -46.0 61.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.258 -0.901 . . . . 1.0 109.392 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -66.21 -37.5 85.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 1.0 108.881 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.73 -40.22 96.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.266 -0.896 . . . . 1.0 108.826 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.53 ' HG2' ' HZ2' ' X' ' 20' ' ' LYS . 89.1 tttt -62.83 -42.4 99.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 1.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -53.61 -45.2 69.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 1.0 109.146 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.23 -38.22 88.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 1.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.39 -38.46 89.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.172 -0.955 . . . . 1.0 109.275 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.53 ' HZ2' ' HG2' ' X' ' 16' ' ' LYS . 50.2 mttp -57.31 -43.25 83.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.0 109.301 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.6 p -65.17 -24.44 67.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 1.0 109.284 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -82.15 -6.03 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 1.0 109.197 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.7 47.86 1.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.24 -1.544 . . . . 1.0 109.24 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.674 HG13 ' HE ' ' X' ' 58' ' ' ARG . 54.8 t -122.4 131.82 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -1.101 . . . . 1.0 109.356 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -132.35 88.44 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.98 . . . . 1.0 109.175 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.78 161.99 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 1.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -78.31 148.43 33.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 1.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.451 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 76.5 t80 -61.83 -35.05 77.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 1.0 109.218 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.39 65.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 1.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' X' ' 52' ' ' ASP . 89.2 m-20 -62.24 -39.62 93.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.476 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.1 mm? -62.01 -44.54 96.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 1.0 109.382 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.93 -41.5 99.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 1.0 109.449 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.27 -31.44 72.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.483 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.45 ' O ' HG23 ' X' ' 38' ' ' VAL . 58.6 t80 -59.28 -46.77 87.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 1.0 109.449 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.15 -44.28 96.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 1.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.77 -47.3 84.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 1.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.45 HG23 ' O ' ' X' ' 34' ' ' PHE . 98.2 t -60.71 -47.04 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 1.0 109.565 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.22 -32.23 73.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 1.0 109.379 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' X' ' 44' ' ' TRP . 98.0 m-20 -67.08 -19.59 65.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 1.0 109.663 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.4 m -54.52 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 1.0 109.371 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.711 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -106.95 -61.06 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 109.467 -177.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 73.2 Cg_exo -41.25 -45.12 5.63 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.887 2.391 . . . . 1.0 112.218 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.548 ' O ' ' O ' ' X' ' 40' ' ' ASP . 4.9 m-90 -135.66 -167.63 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 1.0 109.487 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.808 ' H ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -135.11 -46.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 109.885 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.808 ' CD ' ' H ' ' X' ' 45' ' ' PHE . 28.0 Cg_exo -60.74 142.67 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.73 2.287 . . . . 1.0 112.301 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -117.99 150.67 38.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 1.0 109.643 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -137.77 155.24 49.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.903 . . . . 1.0 109.743 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.55 176.66 47.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 88.3 m -119.39 135.29 54.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 1.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.94 141.15 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 1.0 109.515 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.43 ' OD2' ' OD1' ' X' ' 30' ' ' ASP . 91.4 m-20 -87.44 138.22 31.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 1.0 109.77 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.95 -40.82 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.081 -1.012 . . . . 1.0 109.445 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.99 -39.31 81.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.0 109.388 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -81.75 -18.06 45.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 1.0 109.277 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.632 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 8.1 t90 -63.73 -37.26 86.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.0 109.638 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -56.81 -43.07 80.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 1.0 109.508 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.674 ' HE ' HG13 ' X' ' 24' ' ' VAL . 17.2 mtt85 -67.83 -36.44 80.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 1.0 109.468 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.497 HG11 ' CH2' ' X' ' 83' ' ' TRP . 39.1 t -65.67 -44.01 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 109.382 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.47 95.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -67.77 -37.52 82.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 1.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.0 m -64.62 -52.57 56.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 109.448 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.77 -42.51 99.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 1.0 109.479 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.54 -38.95 78.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 1.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.33 -44.46 96.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 1.0 109.311 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -69.29 -32.99 72.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 1.0 109.379 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' X' ' 71' ' ' GLY . 25.6 t80 -64.07 -55.21 23.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 1.0 109.411 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -70.47 -35.92 73.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 1.0 109.323 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -64.58 -47.16 79.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 1.0 109.301 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.48 -52.51 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 1.0 109.195 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 140.99 -168.57 25.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' X' ' 76' ' ' PRO . 21.3 Cg_endo -70.08 -18.75 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.985 2.456 . . . . 1.0 111.97 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.92 -51.55 69.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 1.0 109.224 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -65.35 -38.94 91.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 1.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.6 82.49 8.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' X' ' 78' ' ' THR . 33.8 Cg_exo -56.32 161.11 9.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.885 2.39 . . . . 1.0 112.302 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.44 -5.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 1.0 109.455 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.463 ' H ' ' C ' ' X' ' 76' ' ' PRO . 73.0 p -63.9 -33.48 75.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.873 . . . . 1.0 109.396 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 1.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.94 -46.79 80.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 1.0 109.377 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 75.7 m -59.42 -47.96 83.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 1.0 109.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -62.45 -40.23 95.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.0 109.501 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.632 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.6 t-105 -66.53 -36.03 81.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 1.0 109.441 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -56.24 -44.76 79.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 1.0 109.194 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.6 mt -62.94 -39.82 95.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.635 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.0 -43.29 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 1.0 109.344 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.32 -43.3 83.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 1.0 109.438 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -69.45 -35.37 75.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 1.0 109.365 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.42 -47.78 75.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 1.0 109.357 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -74.25 -39.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 1.0 109.402 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -59.37 -46.43 88.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 1.0 109.521 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.91 -41.67 95.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 1.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -69.77 122.6 19.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 1.0 109.483 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.12 102.33 12.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 1.0 109.565 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.416 HG22 ' N ' ' X' ' 96' ' ' ASN . 12.5 p -136.45 156.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.59 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.416 ' N ' HG22 ' X' ' 95' ' ' VAL . 43.7 t-20 -128.16 80.31 72.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 1.0 109.57 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.407 ' HD3' HG13 ' X' ' 95' ' ' VAL . 47.8 Cg_exo -54.89 -42.82 65.31 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.899 2.399 . . . . 1.0 112.286 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -144.13 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.413 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.1 104.01 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 1.0 109.455 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.969 -1.015 . . . . 1.0 109.409 179.774 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.07 8.4 83.97 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -128.86 158.86 37.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -1.149 . . . . 1.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 96.0 mt-10 -64.39 146.44 54.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 1.0 109.541 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' X' ' 5' ' ' LEU . 76.3 mt -92.58 102.58 15.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 1.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 14.1 p -84.84 171.58 12.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 1.0 109.579 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -57.13 -41.49 79.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 1.0 109.435 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -66.14 -42.26 89.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 1.0 109.511 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 92.5 mt-10 -66.92 -38.23 85.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 1.0 109.428 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.56 -35.04 75.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 1.0 109.583 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.28 -49.0 78.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 1.0 109.41 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -68.21 -32.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -0.972 . . . . 1.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.46 -45.8 90.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.868 . . . . 1.0 109.334 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -62.43 -37.42 85.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 1.0 108.878 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.67 -42.28 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 1.0 108.738 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.527 ' HZ2' ' HA ' ' X' ' 28' ' ' TYR . 88.2 tttt -56.31 -44.18 79.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 1.0 109.523 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -55.13 -42.93 73.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 1.0 109.116 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.582 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -63.57 -37.77 88.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.78 . . . . 1.0 109.392 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' X' ' 19' ' ' LEU . 97.2 mt -63.6 -36.93 85.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.898 . . . . 1.0 109.273 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.33 -40.68 82.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 1.0 109.218 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.0 p -66.42 -31.22 71.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 1.0 109.263 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.582 HH12 ' HB1' ' X' ' 18' ' ' ALA . 84.1 mtt85 -72.89 -18.26 61.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 1.0 109.212 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.78 46.37 0.78 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.309 -1.517 . . . . 1.0 109.309 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.82 132.98 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 1.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.67 95.82 3.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 1.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.02 158.11 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -0.86 . . . . 1.0 109.359 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.15 145.26 46.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.923 . . . . 1.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.527 ' HA ' ' HZ2' ' X' ' 16' ' ' LYS . 82.3 t80 -57.17 -33.56 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 1.0 109.271 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.5 70.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 1.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . 0.438 ' OD2' ' OD2' ' X' ' 52' ' ' ASP . 95.5 m-20 -59.72 -40.75 89.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 1.0 109.409 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' X' ' 31' ' ' LEU . 4.3 mm? -61.79 -44.53 96.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 1.0 109.345 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' X' ' 32' ' ' LEU . 90.3 mt -63.97 -42.51 97.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 1.0 109.369 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.94 -37.13 85.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 1.0 109.356 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.04 -50.93 72.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 1.0 109.4 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.43 -42.2 98.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 1.0 109.41 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.62 -38.71 91.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.0 109.277 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -62.51 -46.47 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 1.0 109.52 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.2 -50.11 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 1.0 109.61 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 1.0 109.373 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' X' ' 44' ' ' TRP . 21.1 m-20 -69.98 -19.86 63.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 1.0 109.686 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -54.72 -59.34 4.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.967 . . . . 1.0 109.426 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.684 ' H ' ' HD2' ' X' ' 43' ' ' PRO . 0.5 OUTLIER -107.69 -62.02 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 1.0 109.487 -176.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' X' ' 42' ' ' CYS . 78.0 Cg_exo -41.24 -41.75 4.87 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.919 2.413 . . . . 1.0 112.201 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' X' ' 43' ' ' PRO . 3.2 m-90 -141.83 -159.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 1.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.511 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -173.75 50.18 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 1.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_endo -70.58 166.69 27.79 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.753 2.302 . . . . 1.0 112.327 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.54 138.73 57.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 1.0 109.712 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.62 136.14 37.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 1.0 109.798 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.8 -173.72 37.96 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 141.37 57.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -1.206 . . . . 1.0 109.293 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.691 HD13 ' N ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -127.46 134.04 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 1.0 109.567 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.691 ' N ' HD13 ' X' ' 51' ' ' ILE . 98.5 m-20 -64.39 137.28 57.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 1.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.15 -23.02 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 1.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.31 -39.48 92.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 1.0 109.41 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -83.26 -10.13 58.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 1.0 109.247 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.626 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 16.8 t90 -58.76 -38.16 77.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 1.0 109.651 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -62.15 -40.54 96.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.0 109.466 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 74.8 mtp85 -66.08 -39.13 89.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 1.0 109.396 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.452 HG21 ' CH2' ' X' ' 83' ' ' TRP . 53.7 t -61.95 -43.82 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 1.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.31 -50.7 62.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.74 -41.67 97.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -1.164 . . . . 1.0 109.511 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 81.8 m -65.43 -52.29 54.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 1.0 109.518 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.521 ' O ' HG21 ' X' ' 75' ' ' VAL . 2.8 m-85 -60.98 -41.46 96.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 1.0 109.498 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -63.85 -38.72 92.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 1.0 109.465 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.95 -45.28 89.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.306 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -68.05 -30.56 69.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 1.0 109.461 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' X' ' 71' ' ' GLY . 14.9 t80 -60.44 -55.09 37.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 1.0 109.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -66.95 -36.51 82.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 1.0 109.345 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -63.85 -47.03 82.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 1.0 109.318 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.35 -52.45 2.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 1.0 109.302 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 139.47 -164.12 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.4 -15.45 31.17 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.928 2.419 . . . . 1.0 112.001 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.11 -54.44 44.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 1.0 109.16 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -63.27 -44.47 95.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 1.0 109.366 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.699 HG23 ' O ' ' X' ' 75' ' ' VAL . 34.2 m -148.81 90.57 4.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 1.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.42 -173.84 1.96 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.85 2.367 . . . . 1.0 112.204 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.94 -16.56 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 1.0 109.431 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.71 -32.52 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 1.0 109.345 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.78 95.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 1.0 109.376 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -65.04 -41.24 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 1.0 109.38 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -59.66 -48.02 83.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 1.0 109.382 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -65.51 -43.75 89.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 1.0 109.488 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.626 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 6.7 t-105 -61.67 -36.46 80.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 1.0 109.389 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -56.77 -43.19 80.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 1.0 109.277 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' X' ' 85' ' ' LEU . 94.6 mt -64.48 -41.14 96.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 1.0 109.642 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.5 -41.29 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.927 . . . . 1.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -56.87 -40.04 75.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 1.0 109.497 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.01 -40.62 78.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 1.0 109.434 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.7 -46.11 86.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 1.0 109.33 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.64 -38.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 1.0 109.399 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.46 -45.07 92.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 1.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.95 -45.55 93.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 1.0 109.586 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.8 127.96 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 1.0 109.495 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -91.73 96.09 10.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 1.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.621 HG22 ' N ' ' X' ' 96' ' ' ASN . 14.0 p -121.76 170.21 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 1.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.621 ' N ' HG22 ' X' ' 95' ' ' VAL . 36.1 t-20 -129.38 81.88 69.12 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.559 ' HD3' HG13 ' X' ' 95' ' ' VAL . 32.2 Cg_exo -58.59 -151.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.839 2.359 . . . . 1.0 112.321 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -62.54 -69.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 1.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.01 129.09 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 1.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.038 -0.982 . . . . 1.0 109.476 179.909 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.53 83.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -128.95 159.06 37.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.536 -0.979 . . . . 1.0 109.436 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.07 138.43 58.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 1.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.49 HD22 ' OE1' ' X' ' 13' ' ' GLU . 95.7 mt -77.03 84.63 3.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.576 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.7 p -80.32 172.19 14.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 1.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.6 -43.34 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 1.0 109.447 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . 0.676 ' H ' ' CD2' ' X' ' 8' ' ' HIS . 2.8 m-70 -68.68 -43.64 75.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 109.484 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.93 -36.59 84.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.189 -0.944 . . . . 1.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.0 -38.81 79.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 1.0 109.831 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.27 -49.03 78.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 1.0 109.63 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.22 -35.37 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 1.0 109.366 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . 0.49 ' OE1' HD22 ' X' ' 5' ' ' LEU . 79.3 tt0 -62.99 -40.36 97.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.301 -0.874 . . . . 1.0 109.24 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.43 -36.93 85.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 1.0 109.039 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.96 -43.0 99.76 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.25 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.46 -36.94 81.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 1.0 109.417 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.544 ' O ' HG23 ' X' ' 21' ' ' THR . 89.4 mt-30 -58.25 -48.5 80.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.0 109.254 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.3 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.446 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.65 -38.75 92.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 1.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.86 -39.7 95.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.928 . . . . 1.0 109.306 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.544 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.2 p -61.77 -29.38 70.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 1.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.15 -17.51 63.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.588 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.13 44.55 0.67 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.738 HG13 ' HE ' ' X' ' 58' ' ' ARG . 30.9 t -122.98 135.64 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.667 -0.902 . . . . 1.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -135.49 99.74 4.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 1.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.54 164.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.485 -0.76 . . . . 1.0 109.625 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.12 146.26 47.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.353 -0.842 . . . . 1.0 109.512 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -62.83 -37.39 86.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.05 -1.031 . . . . 1.0 109.371 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.49 -34.23 66.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -39.67 90.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 1.0 109.113 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.465 ' N ' HD22 ' X' ' 31' ' ' LEU . 4.4 mm? -62.23 -43.55 98.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.0 109.526 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' X' ' 32' ' ' LEU . 99.1 mt -63.71 -42.27 97.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 1.0 109.33 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.1 -30.86 71.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 1.0 109.18 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -61.39 -50.21 73.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 1.0 109.607 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -62.28 -46.56 88.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 1.0 109.547 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -65.52 -38.18 88.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.208 -0.932 . . . . 1.0 109.231 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.25 -45.64 93.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 1.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.27 -48.63 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 1.0 109.693 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' X' ' 43' ' ' PRO . 98.9 mttt -67.8 -28.46 67.61 Favored 'General case' 0 C--O 1.192 -1.94 0 O-C-N 121.171 -0.956 . . . . 1.0 108.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.562 ' OD1' ' CZ2' ' X' ' 44' ' ' TRP . 71.0 m-20 -77.93 -20.71 52.3 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 120.032 -1.667 . . . . 1.0 109.796 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 m -54.34 -60.91 2.71 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.99 -1.069 . . . . 1.0 111.275 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' X' ' 43' ' ' PRO . 0.0 OUTLIER -101.84 -53.95 0.14 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.512 -0.743 . . . . 1.0 110.858 -178.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' X' ' 42' ' ' CYS . 89.1 Cg_exo -46.02 -43.0 20.68 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.514 2.143 . . . . 1.0 112.601 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.562 ' CZ2' ' OD1' ' X' ' 40' ' ' ASP . 0.1 OUTLIER -176.56 131.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 1.0 109.207 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.523 ' CE2' ' CD2' ' X' ' 82' ' ' TYR . 0.2 OUTLIER -104.69 105.95 52.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 1.0 109.775 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.427 ' CG ' ' HE1' ' X' ' 44' ' ' TRP . 56.4 Cg_endo -83.2 -164.46 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.778 2.318 . . . . 1.0 111.918 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -90.57 122.36 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.363 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.01 154.76 17.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.461 -0.774 . . . . 1.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.19 -93.99 2.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.489 HG23 HG22 ' X' ' 90' ' ' ILE . 27.3 m -130.92 137.4 49.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -1.007 . . . . 1.0 109.434 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.73 HD13 ' H ' ' X' ' 52' ' ' ASP . 0.3 OUTLIER -112.67 139.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.543 -0.723 . . . . 1.0 109.381 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.73 ' H ' HD13 ' X' ' 51' ' ' ILE . 85.5 m-20 -68.85 136.61 52.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 1.0 109.76 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.57 -27.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -0.997 . . . . 1.0 109.537 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.68 -41.87 95.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.024 -1.047 . . . . 1.0 109.777 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -75.88 -17.03 59.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 1.0 109.839 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' NE1' ' X' ' 83' ' ' TRP . 15.9 t90 -60.61 -37.74 82.41 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.288 -0.883 . . . . 1.0 109.954 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -59.44 -44.51 92.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 1.0 109.673 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.738 ' HE ' HG13 ' X' ' 24' ' ' VAL . 19.0 mtt85 -64.79 -40.01 94.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.54 -43.67 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.85 -46.92 92.6 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -67.88 -42.1 81.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -1.2 . . . . 1.0 109.592 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.98 -51.6 66.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 1.0 109.639 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.98 -44.21 87.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 1.0 109.527 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -56.41 -40.62 74.99 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.272 -0.892 . . . . 1.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.69 -43.29 84.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 1.0 109.324 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -62.86 -35.7 80.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 1.0 109.269 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.515 ' CE2' ' OD1' ' X' ' 68' ' ' ASN . 3.4 t80 -59.26 -55.0 40.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.515 ' OD1' ' CE2' ' X' ' 67' ' ' TYR . 84.9 m-20 -65.13 -34.56 78.7 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.041 -1.037 . . . . 1.0 109.771 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -64.16 -48.93 74.08 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.288 -0.883 . . . . 1.0 110.012 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -114.7 -51.93 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.651 -0.655 . . . . 1.0 109.871 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' X' ' 67' ' ' TYR . . . 143.45 -168.87 26.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' X' ' 76' ' ' PRO . 7.4 Cg_exo -67.03 -21.76 48.9 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.998 2.465 . . . . 1.0 111.987 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.91 -51.01 69.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 1.0 109.457 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.53 -45.08 88.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 1.0 109.808 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.759 HG23 ' O ' ' X' ' 75' ' ' VAL . 26.6 m -142.8 82.4 12.34 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.0 109.356 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' X' ' 72' ' ' PRO . 51.5 Cg_endo -79.59 -172.33 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.911 2.407 . . . . 1.0 112.31 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.46 -20.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.922 . . . . 1.0 109.524 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 22.2 p -62.63 -37.85 87.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 1.0 109.563 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.25 79.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 1.0 109.56 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -65.68 -37.06 85.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 1.0 109.416 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -61.6 -45.3 94.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 1.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.523 ' CD2' ' CE2' ' X' ' 45' ' ' PHE . 38.3 m-85 -63.74 -44.24 94.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 1.0 109.732 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.634 ' NE1' ' CD1' ' X' ' 56' ' ' TRP . 7.7 t-105 -64.43 -37.56 87.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.282 -0.886 . . . . 1.0 109.296 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -55.99 -41.73 75.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 1.0 108.829 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.445 ' O ' HD13 ' X' ' 89' ' ' LEU . 95.1 mt -65.57 -40.39 92.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 1.0 109.297 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mm -64.22 -42.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 1.0 109.485 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -54.81 -39.32 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 1.0 109.264 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -70.39 -39.46 74.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 1.0 109.478 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.445 HD13 ' O ' ' X' ' 85' ' ' LEU . 8.1 mp -62.45 -46.0 90.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 1.0 110.139 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.489 HG22 HG23 ' X' ' 50' ' ' THR . 9.9 pt -74.19 -31.98 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.518 -0.739 . . . . 1.0 109.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.56 -40.55 92.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 1.0 109.374 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.37 -40.19 93.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.0 109.454 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -94.63 115.16 27.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 1.0 109.189 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.97 122.1 28.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 1.0 109.457 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.02 150.84 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 1.0 109.409 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -121.48 85.0 42.62 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.7 -45.75 38.78 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.705 2.27 . . . . 1.0 112.468 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -145.31 -78.6 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.541 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.07 100.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.744 -0.598 . . . . 1.0 109.416 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.994 -1.003 . . . . 1.0 109.434 179.824 . . . . . . . . 0 0 . 1 stop_ save_